Jackson Financial (JXN) 10-Q 6 Nov 24 2024 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2024	Nov. 01, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	001-40274
Entity Registrant Name	Jackson Financial Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	98-0486152
Entity Address, Address Line One	1 Corporate Way
Entity Address, City or Town	Lansing
Entity Address, State or Province	MI
Entity Address, Postal Zip Code	48951
City Area Code	517
Local Phone Number	381-5500
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		73,861,777
Amendment Flag	false
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--12-31
Entity Central Index Key	0001822993
Common Stock
Document Information [Line Items]
Title of 12(b) Security	Common Stock, Par Value $0.01 Per Share
Trading Symbol	JXN
Security Exchange Name	NYSE
Depositary Shares
Document Information [Line Items]
Title of 12(b) Security	Depositary Shares, each representing a 1/1,000th interest in a share of Fixed-Rate Reset Noncumulative Perpetual Preferred Stock, Series A
Trading Symbol	JXN PR A
Security Exchange Name	NYSE

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Investments:
Debt Securities, available-for-sale, net of allowance for credit losses of $44 and $21 at September 30, 2024 and December 31, 2023, respectively (amortized cost: 2024 $45,536; 2023 $44,844)	$ 42,289	$ 40,422
Debt Securities, at fair value under fair value option	2,937	2,153
Debt Securities, trading, at fair value	73	68
Equity securities, at fair value	213	394
Mortgage loans, net of allowance for credit losses of $148 and $165 at September 30, 2024 and December 31, 2023, respectively	9,564	10,082
Mortgage loans, at fair value under fair value option	432	481
Policy loans (including $3,535 and $3,457 at fair value under the fair value option at September 30, 2024 and December 31, 2023, respectively)	4,453	4,399
Freestanding derivative instruments	295	390
Other invested assets	2,747	2,466
Total investments	63,003	60,855
Cash and cash equivalents	3,061	2,688
Accrued investment income	528	512
Deferred acquisition costs	11,986	12,302
Reinsurance recoverable, net of allowance for credit losses of $25 and $29 at September 30, 2024 and December 31, 2023, respectively	22,959	25,422
Reinsurance recoverable on market risk benefits, at fair value	149	149
Market risk benefit assets, at fair value	7,615	6,737
Deferred income taxes, net	527	640
Other assets	797	1,294
Separate account assets	235,037	219,656
Total assets	345,662	330,255
Liabilities
Reserves for future policy benefits and claims payable	11,543	11,898
Other contract holder funds	57,334	55,319
Market risk benefit liabilities, at fair value	4,384	4,785
Funds withheld payable under reinsurance treaties (including $3,711 and $3,626 at fair value under the fair value option at September 30, 2024 and December 31, 2023, respectively)	18,103	19,952
Long-term debt	2,033	2,037
Repurchase agreements and securities lending payable	820	19
Collateral payable for derivative instruments	124	780
Freestanding derivative instruments	425	1,210
Separate account liabilities	235,037	219,656
Total liabilities	334,755	319,921
Commitments, Contingencies, and Guarantees (Note 16)
Equity
Series A non-cumulative preferred stock and additional paid in capital, $1.00 par value per share: 24,000 shares authorized; 22,000 shares issued and outstanding at September 30, 2024 and December 31, 2023; liquidation preference $25,000 per share (See Note 19)	533	533
Common stock; 1,000,000,000 shares authorized, $0.01 par value per share and 74,351,061 and 78,660,221 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively (See Note 19)	1	1
Additional paid-in capital	6,025	6,005
Treasury stock, at cost; 20,133,348 and 15,820,785 shares at September 30, 2024 and December 31, 2023, respectively	(909)	(599)
Accumulated other comprehensive income (loss), net of tax expense (benefit) of $(323) and $(178) at September 30, 2024 and December 31, 2023, respectively	(2,383)	(2,808)
Retained earnings	7,431	7,038
Total shareholders' equity	10,698	10,170
Noncontrolling interests	209	164
Total equity	10,907	10,334
Total liabilities and equity	345,662	330,255
Related Party
Liabilities
Other liabilities	2,366	1,988
Nonrelated Party
Liabilities
Other liabilities	$ 2,586	$ 2,277

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Debt securities, available for sale, allowance for credit losses	$ 44	$ 21
Debt securities, available for sale, amortized cost	45,536	44,844
Mortgage loans, allowance for credit loss	148	165
Policy loans, fair value under fair value option	3,535	3,457
Reinsurance recoverable, allowance for credit losses	25	29
Funds withheld payable under reinsurance treaties, fair value under fair value option	$ 3,711	$ 3,626
Preferred stock, par value (in usd per share)	$ 1	$ 1
Preferred stock, shares authorized (in shares)	24,000	24,000
Preferred stock, shares issued (in shares)	22,000	22,000
Preferred stock, shares outstanding (in shares)	22,000	22,000
Preferred stock, liquidation preference (in usd per share)	$ 25,000	$ 25,000
Common stock, authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, par value (in usd per share)	$ 0.01	$ 0.01
Common stock, issued (in shares)	74,351,061	78,660,221
Common stock, outstanding (in shares)	74,351,061	78,660,221
Treasury stock (in shares)	20,133,348	15,820,785
Accumulated other comprehensive income, tax expense (benefit)	$ (323)	$ (178)

Condensed Consolidated Income S

Condensed Consolidated Income Statements - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues
Fee income	$ 2,032	$ 1,950	$ 6,038	$ 5,751
Premiums	31	32	106	109
Net investment income:
Net investment income excluding funds withheld assets	457	458	1,384	1,248
Net investment income on funds withheld assets	269	303	824	862
Total net investment income	726	761	2,208	2,110
Net gains (losses) on derivatives and investments:
Net gains (losses) on derivatives and investments	102	(335)	(4,132)	(5,173)
Net gains (losses) on funds withheld reinsurance treaties	(784)	159	(1,199)	(648)
Total net gains (losses) on derivatives and investments	(682)	(176)	(5,331)	(5,821)
Other income	14	18	25	52
Total revenues	2,121	2,585	3,046	2,201
Benefits and Expenses
Death, other policy benefits and change in policy reserves, net of deferrals	209	232	639	701
(Gain) loss from updating future policy benefits cash flow assumptions, net	0	(1)	(7)	23
Market risk benefits (gains) losses, net	1,172	(2,376)	(2,062)	(5,120)
Interest credited on other contract holder funds, net of deferrals and amortization	275	284	821	864
Interest expense	25	28	76	84
Operating costs and other expenses, net of deferrals	742	626	2,105	1,862
Amortization of deferred acquisition costs	277	290	832	874
Total benefits and expenses	2,700	(917)	2,404	(712)
Pretax income (loss)	(579)	3,502	642	2,913
Income tax expense (benefit)	(113)	712	24	399
Net income (loss)	(466)	2,790	618	2,514
Less: Net income (loss) attributable to noncontrolling interests	3	17	17	21
Net income (loss) attributable to Jackson Financial Inc.	(469)	2,773	601	2,493
Less: Dividends on preferred stock	11	11	33	24
Net income (loss) attributable to Jackson Financial Inc. common shareholders, Basic	(480)	2,762	568	2,469
Net income (loss) attributable to Jackson Financial Inc. common shareholders, Diluted	$ (480)	$ 2,762	$ 568	$ 2,469
Earnings per share
Basic (in usd per share)	$ (6.37)	$ 33.66	$ 7.41	$ 29.95
Diluted (in usd per share)	$ (6.37)	$ 33.35	$ 7.34	$ 29.20

Condensed Consolidated Statemen

Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ (466)	$ 2,790	$ 618	$ 2,514
Other comprehensive income (loss), net of tax:
Change in unrealized gains (losses) on securities with no credit impairment, net of tax expense (benefit) of: $68 and $(62), for the three months ended September 30, 2024 and 2023, respectively, and $54 and $(4), for the nine months ended September 30, 2024 and 2023, respectively.	1,679	(1,223)	1,170	(787)
Change in unrealized gains (losses) on securities with credit impairment, net of tax expense (benefit) of: $(2) and $(4), for the three months ended September 30, 2024 and 2023, respectively, and $(1) and $(7), for the nine months ended September 30, 2024 and 2023, respectively.	(33)	(15)	(28)	(24)
Change in current discount rate related to reserve for future policy benefits, net of tax expense (benefit) of $(61) and $55, for the three months ended September 30, 2024 and 2023, respectively, and $(29) and $44, for the nine months ended September 30, 2024 and 2023, respectively.	(219)	199	(103)	160
Change in non-performance risk on market risk benefits, net of tax expense (benefit) of $(51) and $(216), for the three months ended September 30, 2024 and 2023, respectively, and $(169) and $(321), for the nine months ended September 30, 2024 and 2023, respectively.	(184)	(783)	(614)	(1,158)
Total other comprehensive income (loss)	1,243	(1,822)	425	(1,809)
Comprehensive income (loss)	777	968	1,043	705
Less: Comprehensive income (loss) attributable to noncontrolling interests	3	17	17	21
Comprehensive income (loss) attributable to Jackson Financial Inc.	$ 774	$ 951	$ 1,026	$ 684

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Loss) (Parenthetical) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Change in net unrealized gains (losses) on securities not impaired, tax expense (benefit)	$ 68	$ (62)	$ 54	$ (4)
Change in unrealized gains (losses) on securities for which an allowance for credit losses has been recorded, tax expense (benefit)	(2)	(4)	(1)	(7)
Change in current discount rate related to reserve for future policy benefits, net of tax expense (benefit)	(61)	55	(29)	44
Change in non-performance risk on market risk benefits, net of tax expense (benefit)	$ (51)	$ (216)	$ (169)	$ (321)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Equity - USD ($) $ in Millions	Total	Total Shareholders' Equity	Preferred Stock	Common Stock	Additional Paid-In Capital	Treasury Stock at Cost	Accumulated Other Comprehensive Income	Retained Earnings	Non-Controlling Interests
Balance beginning of period at Dec. 31, 2022	$ 9,378	$ 8,646	$ 0	$ 1	$ 6,063	$ (443)	$ (3,378)	$ 6,403	$ 732
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	2,514	2,493						2,493	21
Other comprehensive income (loss)	(1,809)	(1,809)					(1,809)
Change in equity of noncontrolling interests	22								22
Dividends on preferred stock	(24)	(24)						(24)
Dividends on common stock	(159)	(159)						(159)
Purchase of treasury stock	(236)	(236)				(236)
Issuance of preferred stock	533	533	533
Share based compensation	34	34			(56)	142		(52)
Balance end of period at Sep. 30, 2023	10,253	9,478	533	1	6,007	(537)	(5,187)	8,661	775
Balance beginning of period at Dec. 31, 2022	9,378	8,646	0	1	6,063	(443)	(3,378)	6,403	732
Balance end of period at Dec. 31, 2023	10,334	10,170	533	1	6,005	(599)	(2,808)	7,038	164
Balance beginning of period at Jun. 30, 2023	9,423	8,652	533	1	5,997	(466)	(3,365)	5,952	771
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	2,790	2,773						2,773	17
Other comprehensive income (loss)	(1,822)	(1,822)					(1,822)
Change in equity of noncontrolling interests	(13)								(13)
Dividends on preferred stock	(11)	(11)						(11)
Dividends on common stock	(52)	(52)						(52)
Purchase of treasury stock	(72)	(72)				(72)
Share based compensation	10	10			10	1		(1)
Balance end of period at Sep. 30, 2023	10,253	9,478	533	1	6,007	(537)	(5,187)	8,661	775
Balance end of period at Dec. 31, 2023	10,334	10,170	533	1	6,005	(599)	(2,808)	7,038	164
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	618	601						601	17
Other comprehensive income (loss)	425	425					425
Change in equity of noncontrolling interests	28								28
Dividends on preferred stock	(33)	(33)						(33)
Dividends on common stock	(164)	(164)						(164)
Purchase of treasury stock	(343)	(343)				(343)
Share based compensation	42	42			20	33		(11)
Balance end of period at Sep. 30, 2024	10,907	10,698	533	1	6,025	(909)	(2,383)	7,431	209
Balance beginning of period at Jun. 30, 2024	10,284	10,084	533	1	6,007	(796)	(3,626)	7,965	200
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(466)	(469)						(469)	3
Other comprehensive income (loss)	1,243	1,243					1,243
Change in equity of noncontrolling interests	6								6
Dividends on preferred stock	(11)	(11)						(11)
Dividends on common stock	(54)	(54)						(54)
Purchase of treasury stock	(113)	(113)				(113)
Share based compensation	18	18			18
Balance end of period at Sep. 30, 2024	$ 10,907	$ 10,698	$ 533	$ 1	$ 6,025	$ (909)	$ (2,383)	$ 7,431	$ 209

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net income (loss)	$ 618	$ 2,514
Adjustments to reconcile net income to net cash provided by operating activities:
Net realized losses (gains) on investments	82	235
Net losses (gains) on derivatives	4,050	4,938
Net losses (gains) on funds withheld reinsurance treaties	1,199	648
Net (gain) loss on market risk benefits	(2,062)	(5,120)
(Gain) loss from updating future policy benefits cash flow assumptions, net	(7)	23
Interest credited on other contract holder funds, gross	821	864
Mortality, expense and surrender charges	(410)	(396)
Amortization of discount and premium on investments	(42)	(23)
Deferred income tax expense (benefit)	259	(24)
Share-based compensation	162	74
Change in:
Accrued investment income	(16)	9
Deferred acquisition costs	315	477
Funds withheld, net of reinsurance	58	81
Future policy benefits	(482)	(729)
Other assets and liabilities, net	(277)	105
Net cash provided by (used in) operating activities	4,268	3,676
Sales, maturities and repayments of:
Debt securities	7,970	8,149
Equity securities	201	237
Mortgage loans	1,268	1,871
Purchases of:
Debt securities	(9,250)	(5,930)
Equity securities	(5)	(21)
Mortgage loans	(674)	(1,026)
Settlements related to derivatives and collateral on investments	(3,543)	(4,255)
Other investing activities	(288)	290
Net cash provided by (used in) investing activities	(4,321)	(685)
Policyholders' account balances:
Deposits	14,852	10,850
Withdrawals	(29,185)	(21,397)
Net transfers from (to) separate accounts	14,314	6,785
Proceeds from (payments on) repurchase agreements and securities lending	800	(1,020)
Net proceeds from (payments on) Federal Home Loan Bank notes	(250)	180
Payments on debt	(5)	(46)
Issuance of debt of consolidated investment entities	910	0
Repayments of debt of consolidated investment entities	(506)	0
Contributions from partners of consolidated investments	29	0
Dividends on common stock	(160)	(152)
Dividends on preferred stock	(33)	(24)
Purchase of treasury stock	(343)	(236)
Issuance of preferred stock	0	533
Net cash provided by (used in) financing activities	423	(4,527)
Net increase (decrease) in cash, cash equivalents, and restricted cash	370	(1,536)
Cash, cash equivalents, and restricted cash at beginning of period	2,691	4,301
Total cash, cash equivalents, and restricted cash at end of period	3,061	2,765
Supplemental cash flow information
Income taxes paid (received)	152	(19)
Interest paid	180	126
Non-cash investing activities
Debt securities acquired from exchanges, payments-in-kind, and similar transactions	37	76
Other invested assets acquired from stock splits and stock distributions	0	211
Non-cash financing activities
Non-cash dividend equivalents on stock-based awards	(4)	(7)
Reconciliation to Condensed Consolidated Balance Sheets
Cash and cash equivalents	3,061	2,760
Restricted cash (included in Other assets)	0	5
Total cash, cash equivalents, and restricted cash	$ 3,061	$ 2,765

Business and Basis of Presentat

Business and Basis of Presentation	9 Months Ended
	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business and Basis of Presentation	Business and Basis of Presentation Jackson Financial Inc. ("JFI" or “Jackson Financial”) together with its subsidiaries (the “Company,” which also may be referred to as “we,” “our” or “us”), is a financial services company focused on helping Americans grow and protect their retirement savings and income to enable them to pursue financial freedom for life. Jackson Financial is domiciled in the state of Delaware in the United States (“U.S.”). Prior to September 13, 2021, we were a majority-owned subsidiary of Prudential plc ("Prudential"), London, England and served as Prudential's holding company for its U.S. operations. On September 13, 2021, the Company demerged from Prudential (the "Demerger") and became a stand-alone U.S. public company. Prudential retained an equity interest in the Company after the Demerger, but as of June 30, 2023, sold its entire equity interest in the Company. Jackson Financial’s primary life insurance subsidiary, Jackson National Life Insurance Company and its insurance subsidiaries (collectively, “Jackson”), is licensed to sell group and individual annuity products (including immediate, registered index-linked, deferred fixed, fixed index and variable annuities), and individual life insurance products, including variable universal life, in all 50 states and the District of Columbia. Jackson also participates in the institutional products market through the issuance of guaranteed investment contracts (“GICs”), funding agreements and medium-term note funding agreements. In addition to Jackson, Jackson Financial’s other operating subsidiaries are as follows: • PPM America, Inc. (“PPM”), a registered investment adviser, is the Company’s investment management operation that manages the life insurance companies’ general account investment funds. PPM also provides investment services to other former affiliated and unaffiliated institutional clients. • Brooke Life Insurance Company (“Brooke Life”), the direct parent of Jackson, is a Michigan life insurance company licensed to sell life insurance and annuity products in the state of Michigan. • Brooke Life Reinsurance Company ("Brooke Re"), also a direct subsidiary of Brooke Life, was formed January 1, 2024, as a Michigan captive reinsurance company. Other significant wholly-owned subsidiaries of Jackson are as follows: • Life insurers: Jackson National Life Insurance Company of New York (“Jackson NY” or “JNY”); Squire Reassurance Company II, Inc. (“Squire Re II”); and VFL International Life Company SPC, LTD; • Registered broker-dealer: Jackson National Life Distributors LLC (“JNLD”); and • Registered investment adviser: Jackson National Asset Management LLC (“JNAM”) manages the life insurance companies' separate account funds underlying our variable annuities products, which funds are sub-advised. JNAM manages and oversees those sub-advisers. The Company's Condensed Consolidated Financial Statements also include other insignificant partnerships, limited liability companies (“LLCs”) and other variable interest entities (“VIEs”) in which the Company is deemed the primary beneficiary. Brooke Life Reinsurance Company During the first quarter of 2024, Jackson entered into a reinsurance transaction with Brooke Re and all economics of the transaction were effective as of January 1, 2024. Jackson and Brooke Re are both direct subsidiaries of Brooke Life and the reinsurance transaction eliminates upon consolidation at JFI. The reinsurance transaction primarily provides for the cession from Jackson to Brooke Re of liabilities associated with certain guaranteed benefit riders under our variable annuity contracts and similar products of Jackson (“market risk benefits”), both in-force on the effective date of the reinsurance agreement and written in the future ( i.e. , on a “flow” basis). Brooke Re utilizes a modified U.S. generally accepted accounting principles ("U.S. GAAP") approach primarily related to market risk benefits, to increase alignment between assets and liabilities in response to changes in economic factors. The reinsurance transaction allows us to mitigate the impact of the cash surrender value floor on Jackson’s total adjusted capital, statutory required capital, and risk-based capital ratio, as well as to allow for more efficient economic hedging of the underlying risks of Jackson’s business. Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. GAAP for interim financial information. Accordingly, certain financial information that is normally included in annual financial statements prepared in accordance with U.S. GAAP, but not required for interim reporting purposes, has been condensed or omitted. These Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and the related notes included in our Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the SEC on February 28, 2024, (the "2023 Annual Report"). The condensed consolidated financial information as of December 31, 2023, included herein, has been derived from the audited Consolidated Financial Statements in the 2023 Annual Report. Certain accounting policies, which significantly affect the determination of financial condition, results of operations and cash flows, are summarized in the Notes to Consolidated Financial Statements in the Company’s 2023 Annual Report. In the opinion of management, these Condensed Consolidated Financial Statements include all normal recurring adjustments necessary for a fair presentation of the Company’s results. Operating results for the three and nine months ended September 30, 2024, are not necessarily indicative of the results that may be expected for the full year ending December 31, 2024. All material intercompany accounts and transactions have been eliminated in consolidation. All prior period amounts have been conformed to the current period presentation, unless otherwise indicated below. With the establishment of Brooke Re in the first quarter of 2024, the Company’s hedging program was enhanced to align hedging instruments more closely with market risk benefit reserves, which resulted in higher levels of interest rate hedging consistent with the economics of our business. In connection with this enhanced hedging approach, the Company reviewed its existing interest rate hedging instruments and determined that interest rate swaps that were historically used for duration management purposes should be recharacterized as supporting our hedging of variable annuity market risk benefits. Accordingly, effective January 1, 2024, the periodic settlements and change in settlement accruals on interest rate swaps are now classified as non-operating and excluded from pretax adjusted operating earnings. Prior period amounts have not been adjusted for this prospective recharacterization with respect to interest rate swaps. Additionally, to better represent the underlying performance of our business, we have made certain reclassifications between financial statement line items within the Condensed Consolidated Income Statement and our non-GAAP financial measure of pretax adjusted operating earnings. These reclassifications, described below, had no impact on Net Income or Adjusted Operating Earnings. • Operating derivative income (loss) will no longer be shown as a separate line item within pretax adjusted operating earnings, as these amounts have been reclassified to net investment income. After recharacterizing the interest rate swaps described above, the only item remaining in operating derivatives was periodic settlements and change in settlement accruals on cross-currency swaps that are intended to hedge certain foreign denominated fixed maturity securities. This reclassification only applies to pretax adjusted operating earnings (non-GAAP). • Interest costs related to portfolio leverage transactions (repurchase agreements, Federal Home Loan Bank short-term advances, and cash collateral costs) were reclassified from Interest Expense to Net Investment Income. This reclassification applies to Net Income (GAAP) and pretax adjusted operating earnings (non-GAAP). Use of Estimates The preparation of these Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires the use of estimates and assumptions about future events that affect the amounts reported in the Condensed Consolidated Financial Statements and the accompanying notes. Significant estimates or assumptions, as further discussed in these notes, include: • Valuation of investments and derivative instruments, including fair values of securities deemed to be in an illiquid market and the determination of when an impairment is necessary; • Assumptions used in calculating policy reserves and liabilities, including policyholder behavior, mortality rates, expenses, investment returns and policy crediting rates; • Assumptions as to future earnings levels being sufficient to realize deferred tax benefits; • Estimates related to expectations of credit losses on certain financial assets and off-balance sheet exposures; • Assumptions and estimates associated with the Company’s tax positions, including an estimate of the dividends received deduction, which impact the amount of recognized tax benefits recorded by the Company; • Assumptions used in calculating market risk benefits, including policyholder behavior, mortality rates, and capital market assumptions; and • Assumptions impacting the expected term used in amortizing deferred acquisition costs, including policyholder behavior and mortality rates. These estimates and assumptions are based on management’s best estimates and judgments. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other appropriate factors. As facts and circumstances dictate, these estimates and assumptions may be adjusted. Since future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in estimates, including those resulting from continuing changes in the economic environment, will be reflected in the Consolidated Financial Statements in the periods the estimates are changed.

New Accounting Standards

New Accounting Standards	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
New Accounting Standards	New Accounting Standards Changes in Accounting Principles – Adopted in Current Year In March 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The guidance provides optional expedients for applying U.S. GAAP to contracts and other transactions affected by reference rate reform and was originally effective for contract modifications made between March 12, 2020 and December 31, 2022. In December 2022, the FASB issued ASU 2022-06, “Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848” that defers the sunset date of Topic 848 from December 31, 2022 to December 31, 2024, after which entities will no longer be permitted to apply the relief in Topic 848. If certain criteria are met, an entity will not be required to remeasure or reassess contracts impacted by reference rate reform. The practical expedient allowed by this standard was elected and applied by the Company. The contracts modified met the criteria for the practical expedient and, therefore, the transition did not have a material impact on the Company’s Condensed Consolidated Financial Statements. The Company has completed its transition from the London Interbank Offered Rate ("LIBOR"). Changes in Accounting Principles – Issued but Not Yet Adopted In November 2023, the FASB issued ASU 2023-07, “Improvements to Reportable Segment Disclosures”, which requires a public entity to disclose its significant segment expenses regularly provided to the chief operating decision maker ("CODM") and the amount and composition of other segment items. It also requires a public entity to disclose the title and position of the CODM. The ASU allows a public entity to disclose multiple measurements of segment profit or loss if a CODM uses multiple measures to assess segment’s performance and allocate resources. This ASU also expands the current interim disclosure requirements to require that nearly all of the annual segment disclosures be made on an interim basis. The amendments in this ASU will be effective for the Company for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted, and are to be applied retrospectively. The Company is in the process of evaluating the impact of the new guidance and does not plan to early adopt. In December 2023, the FASB issued ASU 2023-09, “Improvements to Income Tax Disclosures”, which enhances annual income tax disclosures by requiring disclosure of disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. The new requirements in this ASU will be effective for the Company for annual periods beginning after December 15, 2024, with early adoption permitted, and are to be applied on a prospective basis with the option to apply retrospectively. The Company is in the process of evaluating the impact of the new guidance and determining the transition method and the timing of adoption.

Segment Information

Segment Information	9 Months Ended
	Sep. 30, 2024
Segment Reporting [Abstract]
Segment Information	Segment Information The Company has three reportable segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks. The Company reports in Corporate and Other, certain activities and items that are not included in these reportable segments, including the results of PPM Holdings, Inc., the holding company of PPM, which manages the majority of the Company’s general account investment portfolio. The reportable segments reflect how the Company’s chief operating decision maker views and manages the business. The following is a brief description of the Company’s reportable segments, plus its Corporate and Other segment. Retail Annuities The Company’s Retail Annuities segment offers a variety of retirement income and savings products through its diverse suite of products, consisting primarily of variable annuities, registered index-linked annuities ("RILA"), fixed index annuities, fixed annuities, and payout annuities. These products are distributed through various wirehouses, insurance brokers and independent broker-dealers, as well as through banks and financial institutions. The Company’s variable annuities represent an attractive option for retirees and soon-to-be retirees, providing access to equity market appreciation and add-on benefits, including guaranteed lifetime income. A RILA offers customers access to market returns through market index-linked investment options, subject to a cap, and offers a variety of features designed to modify or limit losses. A fixed index annuity is designed for investors who desire principal protection with the opportunity to participate in capped upside investment returns linked to a reference market index. The Company also provides access to guaranteed lifetime income as an add-on benefit. A fixed annuity is a guaranteed product designed to build wealth without market exposure, through a crediting rate that is likely to be superior to interest rates offered by banks or money market funds. The financial results of the variable annuity business within the Company’s Retail Annuities segment are largely dependent on the performance of the contract holder account value, which impacts both the level of fees collected and the benefits paid to the contract holder. The financial results of the Company’s fixed annuities, including the fixed option on variable annuities, RILA and fixed index annuities, are largely dependent on the Company’s ability to earn a spread between earned investment rates on general account assets and the interest credited to contract holders. Institutional Products The Company’s Institutional Products segment consists of traditional Guaranteed Investment Contracts ("GICs"), funding agreements (including agreements issued in conjunction with the Company’s participation in the U.S. Federal Home Loan Bank ("FHLB") program) and medium-term note funding agreements. The Company’s GIC products are marketed to defined contribution pension and profit-sharing retirement plans. Funding agreements are marketed to institutional investors, including corporate cash accounts and securities lending funds, as well as money market funds, and are issued to the FHLB in connection with its program. The financial results of the Company’s institutional products business are primarily dependent on the Company’s ability to earn a spread between earned investment rates on general account assets and the interest credited on GICs and funding agreements. Closed Life and Annuity Blocks The Company's Closed Life and Annuity Blocks segment is primarily composed of blocks of business that have been acquired since 2004. This segment includes various protection products, primarily whole life, universal life, variable universal life, and term life insurance products, as well as fixed, fixed index, and payout annuities. The Closed Life and Annuity Blocks segment also includes a block of group payout annuities that we assumed from John Hancock Life Insurance Company (USA) and John Hancock Life Insurance Company of New York through reinsurance transactions in 2018 and 2019, respectively. The Company historically offered traditional and interest-sensitive life insurance products but discontinued new sales of life insurance products in 2012, as we believe opportunistically acquiring mature blocks of life insurance policies is a more efficient means of diversifying our in-force business than selling new life insurance products. The profitability of the Company’s Closed Life and Annuity Blocks segment is largely driven by its historical ability to appropriately price its products and purchase appropriately priced blocks of business, as realized through underwriting, expense and net gains (losses) on derivatives and investments, and the ability to earn an assumed rate of return on the assets supporting that business. Corporate and Other The Company’s Corporate and Other segment primarily consists of the operations of its investment management subsidiary, PPM, VIEs, and unallocated corporate income and expenses. The Corporate and Other segment also includes certain eliminations and consolidation adjustments. Segment Performance Measurement Segment operating revenues and pretax adjusted operating earnings are non-GAAP financial measures that management believes are critical to the evaluation of the financial performance of the Company’s segments. The Company uses the same accounting policies and procedures to measure segment pretax adjusted operating earnings as used in its reporting of consolidated net income. Its primary measure is pretax adjusted operating earnings, which is defined as net income recorded in accordance with U.S. GAAP, excluding certain items that may be highly variable from period to period due to accounting treatment under U.S. GAAP, or that are non-recurring in nature, as well as certain other revenues and expenses that are not considered to drive underlying performance. Operating revenues and pretax adjusted operating earnings should not be used as a substitute for revenues and net income, respectively, as calculated in accordance with U.S. GAAP. Pretax adjusted operating earnings equals net income adjusted to eliminate the impact of the items described in the following numbered paragraphs. These items are excluded from pretax adjusted operating earnings as they may vary significantly from period to period due to near-term market conditions and, therefore, are not directly comparable or reflective of the underlying performance of our business. We believe these exclusions provide investors a better picture of the drivers of our underlying performance. 1. Net Hedging Results: Comprised of: (i) fees attributed to guaranteed benefits; (ii) net gains (losses) on hedging instruments which includes: (a) changes in the fair value of freestanding derivatives, and related commissions and expenses, used to manage the risk associated with market risk benefits and other guaranteed benefit features, excluding earned income from periodic settlements and changes in settlement accruals on cross-currency swaps; and (b) investment income and change in fair value of certain non-derivative assets used to manage the risk associated with market risk benefits and other guaranteed benefit features; (iii) the movements in reserves, market risk benefits, guaranteed benefit features accounted for as embedded derivative instruments, and related claims and benefit payments; (iv) amortization of the balance of unamortized deferred acquisition costs, at January 1, 2021, the date of transition to current Long Duration Targeted Improvements ("LDTI") accounting guidance, associated with items excluded from pretax adjusted operating earnings prior to transition; and (v) the impact on the valuation of Guaranteed Benefits and Net Hedging Results arising from changes in underlying actuarial assumptions. We believe excluding these items removes the impact to both revenue and related expenses associated with Guaranteed Benefits and Net Hedging Results. 2. Net Realized Investment Gains and Losses: Comprised of: (i) realized investment gains and losses associated with the periodic sales or disposals of securities, excluding those held within our trading portfolio; and (ii) impairments of securities, after adjustment for the non-credit component of the impairment charges. 3. Change in Value of Funds Withheld Embedded Derivative and Net Investment Income on Funds Withheld Assets: Comprised of: (i) the change in fair value of funds withheld embedded derivatives; and (ii) net investment income on funds withheld assets related to funds withheld reinsurance transactions. 4. Other items: Comprised of: (i) the impact of investments that are consolidated in our financial statements due to U.S. GAAP accounting requirements, such as our investments in collateralized loan obligations ("CLOs"), but for which the consolidation effects are not consistent with our economic interest or exposure to those entities, and (ii) one-time or other non-recurring items. 5. Income taxes. Set forth in the tables below is certain information with respect to the Company’s segments (in millions): Three Months Ended September 30, 2024 Retail Annuities Institutional Closed Life Corporate and Total Operating Revenues Fee income $ 1,128 $ — $ 111 $ 12 $ 1,251 Premiums 12 — 22 — 34 Net investment income 196 101 155 — 452 Other income (loss) 8 — 7 (1) 14 Total Operating Revenues 1,344 101 295 11 1,751 Operating Benefits and Expenses Death, other policy benefits and change in policy 26 — 131 — 157 (Gain) loss from updating future policy benefits cash flow assumptions, net (12) — 11 — (1) Interest credited on other contract holder funds, net of deferrals and amortization 88 83 104 — 275 Interest expense 6 — — 19 25 Operating costs and other expenses, net of deferrals 638 1 40 63 742 Amortization of deferred acquisition costs 140 — 2 — 142 Total Operating Benefits and Expenses 886 84 288 82 1,340 Pretax Adjusted Operating Earnings $ 458 $ 17 $ 7 $ (71) $ 411 Three Months Ended September 30, 2023 Retail Annuities Institutional Closed Life Corporate and Total Operating Revenues Fee income $ 1,038 $ — $ 112 $ 11 $ 1,161 Premiums 6 — 30 — 36 Net investment income 110 109 161 14 394 Other income 9 — 8 1 18 Total Operating Revenues 1,163 109 311 26 1,609 Operating Benefits and Expenses Death, other policy benefits and change in policy 24 — 150 — 174 (Gain) loss from updating future policy benefits cash flow assumptions, net (4) — 4 — — Interest credited on other contract holder funds, net 90 87 107 — 284 Interest expense 6 — — 22 28 Operating costs and other expenses, net of deferrals 554 1 41 30 626 Amortization of deferred acquisition costs 139 — 3 — 142 Total Operating Benefits and Expenses 809 88 305 52 1,254 Pretax Adjusted Operating Earnings $ 354 $ 21 $ 6 $ (26) $ 355 Nine Months Ended September 30, 2024 Retail Annuities Institutional Closed Life Corporate and Total Operating Revenues Fee income $ 3,313 $ — $ 335 $ 36 $ 3,684 Premiums 34 — 80 — 114 Net investment income 514 332 486 3 1,335 Other income (loss) 25 — 21 (21) 25 Total Operating Revenues 3,886 332 922 18 5,158 Operating Benefits and Expenses Death, other policy benefits and change in policy 51 — 419 — 470 (Gain) loss from updating future policy benefits cash flow assumptions, net (26) — 17 — (9) Interest credited on other contract holder funds, net of deferrals and amortization 260 252 309 — 821 Interest expense 18 — — 58 76 Operating costs and other expenses, net of deferrals 1,825 3 110 167 2,105 Amortization of deferred acquisition costs 416 — 6 — 422 Total Operating Benefits and Expenses 2,544 255 861 225 3,885 Pretax Adjusted Operating Earnings $ 1,342 $ 77 $ 61 $ (207) $ 1,273 Nine Months Ended September 30, 2023 Retail Annuities Institutional Closed Life Corporate and Total Operating Revenues Fee income $ 3,015 $ — $ 345 $ 37 $ 3,397 Premiums 16 — 102 — 118 Net investment income 317 297 489 39 1,142 Other income 28 — 18 6 52 Total Operating Revenues 3,376 297 954 82 4,709 Operating Benefits and Expenses Death, other policy benefits and change in policy 21 — 467 — 488 (Gain) loss from updating future policy benefits cash flow assumptions, net (6) — 31 — 25 Interest credited on other contract holder funds, net 284 247 333 — 864 Interest expense 18 — — 66 84 Operating costs and other expenses, net of deferrals 1,605 3 122 132 1,862 Amortization of deferred acquisition costs 416 — 8 — 424 Total Operating Benefits and Expenses 2,338 250 961 198 3,747 Pretax Adjusted Operating Earnings $ 1,038 $ 47 $ (7) $ (116) $ 962 Intersegment eliminations in the above tables are included in the Corporate and Other segment. These include the elimination of investment income, between Retail Annuities and the Corporate and Other segments, as well as the elimination from fee income and investment income of investment fees paid by Jackson Financial and its subsidiaries to PPM, which were $21 million and $20 million for the three months ended September 30, 2024 and 2023, respectively, and $60 million and $57 million for the nine months ended September 30, 2024 and 2023, respectively . The following table summarizes the reconciling items from the non-GAAP measure of total operating revenues to the U.S. GAAP measure of total revenues attributable to the Company (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Total operating revenues $ 1,751 $ 1,609 $ 5,158 $ 4,709 Fees attributed to guarantee benefit reserves 779 784 2,347 2,345 Net gains (losses) on hedging instruments and investments (678) (137) (5,313) (5,704) Net investment income (loss) related to noncontrolling interests 3 17 17 21 Consolidated investments (3) 9 13 (32) Net investment income on funds withheld assets 269 303 824 862 Total revenues (1) $ 2,121 $ 2,585 $ 3,046 $ 2,201 (1) Substantially all the Company's revenues originated in the U.S. There were no customers that, individually, generate revenues that exceeded 10% of total revenues. The following table summarizes the reconciling items from the non-GAAP measure of total operating benefits and expenses to the U.S. GAAP measure of total benefits and expenses attributable to the Company (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Total operating benefits and expenses $ 1,340 $ 1,254 $ 3,885 $ 3,747 Net (gain) loss on market risk benefits 1,172 (2,376) (2,062) (5,120) Benefits attributed to guaranteed benefit features 53 57 171 211 Amortization of DAC related to non-operating revenues and expenses 135 148 410 450 Total benefits and expenses $ 2,700 $ (917) $ 2,404 $ (712) The following table summarizes the reconciling items, from the non-GAAP measure of pretax adjusted operating earnings to the U.S. GAAP measure of net income attributable to the Company (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Pretax adjusted operating earnings $ 411 $ 355 $ 1,273 $ 962 Pre-tax reconciling items from adjusted operating income to net income (loss) attributable to Jackson Financial Inc.: Fees attributable to guarantee benefit reserves 779 784 2,347 2,345 Net gains (losses) on hedging instruments 591 (271) (3,068) (4,694) Market risk benefits gains (losses), net (1,172) 2,376 2,062 5,120 Net reserve and embedded derivative movements (493) 45 (1,135) (338) Amortization of DAC associated with non-operating items at date of transition to LDTI (135) (148) (410) (450) Total Guaranteed benefits and net hedging results (430) 2,786 (204) 1,983 Net realized investment gains (losses) (45) (127) (82) (235) Net realized investment gains (losses) on funds withheld assets (784) 159 (1,199) (648) Net investment income on funds withheld assets 269 303 824 862 Other items (3) 9 13 (32) Pretax income (loss) attributable to Jackson Financial Inc. (582) 3,485 625 2,892 Income tax expense (benefit) (113) 712 24 399 Net income (loss) attributable to Jackson Financial Inc. (469) 2,773 601 2,493 Dividends on preferred stock 11 11 33 24 Net income (loss) attributable to Jackson Financial Inc. common shareholders $ (480) $ 2,762 $ 568 $ 2,469

Investments

Investments	9 Months Ended
	Sep. 30, 2024
Investments, Debt and Equity Securities [Abstract]
Investments	Investments Investments consist primarily of fixed-income securities and loans, principally publicly-traded corporate and government bonds, asset-backed securities and mortgage loans. Asset-backed securities include mortgage-backed and other structured securities. The Company generates the majority of its general account deposits from interest-sensitive individual annuity contracts, life insurance products and institutional products on which it has committed to pay a declared rate of interest. The Company's strategy of investing in fixed-income securities and loans seeks the matching of the asset yield with the amounts credited to the interest-sensitive liabilities and to earn a stable return on its investments. Debt Securities The following table sets forth the composition of the fair value of debt securities at September 30, 2024, and December 31, 2023, classified by rating categories as assigned by a nationally recognized statistical rating organization (a “rating agency”), the National Association of Insurance Commissioners (the “NAIC”), or if not rated by such organizations, the Company’s investment advisors. The Company uses the second lowest rating by a rating agency when rating agencies ratings are not equivalent and, for purposes of the table, if not otherwise rated by a rating agency, the NAIC rating of a security is converted to an equivalent rating agency rating. At September 30, 2024 and December 31, 2023, the carrying value of investments rated by the Company’s consolidated investment advisor totaled $233 million and $486 million, respectively. Percent of Total Debt September 30, 2024 December 31, 2023 Investment Rating U.S. government securities 7.6% 10.1% AAA 6.2% 6.5% AA 9.4% 9.0% A 31.8% 31.5% BBB 37.7% 35.9% Investment grade 92.7% 93.0% BB 3.4% 3.5% B and below 3.9% 3.5% Below investment grade 7.3% 7.0% Total debt securities 100.0% 100.0% At September 30, 2024 and December 31, 2023, the total carrying value of debt securities in an unrealized loss position consisted of: September 30, 2024 December 31, 2023 Investment grade securities 77% 77% Below investment grade securities 2% 2% Not rated securities 21% 21% Unrealized losses on debt securities that were below investment grade or not rated were approximately 20% and 21% of the aggregate gross unrealized losses on available-for-sale debt securities at September 30, 2024 and December 31, 2023, respectively. Corporate securities in an unrealized loss position were diversified across industries as follows (in millions, except percentages): September 30, 2024 December 31, 2023 Industries accounting for the largest percentage of corporate gross unrealized losses: Utility 16% 17% Financial Services 13% 14% Largest unrealized loss related to a single corporate obligor $ 54 $ 50 At September 30, 2024 and December 31, 2023, the amortized cost, allowance for credit loss ("ACL"), gross unrealized gains and losses, and fair value of debt securities, including trading securities and securities carried at fair value under the fair value option, were as follows (in millions): Allowance Gross Gross Amortized for Unrealized Unrealized Fair September 30, 2024 Cost (1) Credit Loss Gains Losses Value U.S. government securities $ 4,231 $ — $ 5 $ 787 $ 3,449 Other government securities 1,530 — 2 192 1,340 Public utilities 5,743 16 79 393 5,413 Corporate securities 30,402 9 405 2,038 28,760 Residential mortgage-backed 392 4 13 68 333 Commercial mortgage-backed 1,691 — 4 87 1,608 Other asset-backed securities 4,557 15 25 171 4,396 Total debt securities $ 48,546 $ 44 $ 533 $ 3,736 $ 45,299 Allowance Gross Gross Amortized for Unrealized Unrealized Fair December 31, 2023 Cost (1) Credit Loss Gains Losses Value U.S. government securities $ 5,154 $ — $ 3 $ 845 $ 4,312 Other government securities 1,622 — 1 221 1,402 Public utilities 5,598 — 42 513 5,127 Corporate securities 27,870 15 194 2,572 25,477 Residential mortgage-backed 422 6 12 53 375 Commercial mortgage-backed 1,569 — 1 147 1,423 Other asset-backed securities 4,830 — 6 309 4,527 Total debt securities $ 47,065 $ 21 $ 259 $ 4,660 $ 42,643 (1) Amortized cost, apart from the carrying value for securities carried at fair value under the fair value option and trading securities. The amortized cost, ACL, gross unrealized gains and losses, and fair value of debt securities at September 30, 2024, by contractual maturity, are shown below (in millions). Actual maturities may differ from contractual maturities where securities can be called or prepaid with or without early redemption penalties. Allowance Gross Gross Amortized for Unrealized Unrealized Fair Cost (1) Credit Loss Gains Losses Value Due in 1 year or less $ 1,879 $ — $ 4 $ 8 $ 1,875 Due after 1 year through 5 years 11,043 16 108 149 10,986 Due after 5 years through 10 years 12,859 9 236 662 12,424 Due after 10 years through 20 years 8,896 — 106 1,137 7,865 Due after 20 years 7,229 — 37 1,454 5,812 Residential mortgage-backed 392 4 13 68 333 Commercial mortgage-backed 1,691 — 4 87 1,608 Other asset-backed securities 4,557 15 25 171 4,396 Total $ 48,546 $ 44 $ 533 $ 3,736 $ 45,299 (1) Amortized cost, apart from the carrying value for securities carried at fair value under the fair value option and trading securities. As required by law in various states in which business is conducted, securities with a carrying value of $91 million and $91 million at September 30, 2024 and December 31, 2023, respectively, were on deposit with regulatory authorities. Residential mortgage-backed securities (“RMBS”) include certain RMBS that are collateralized by residential mortgage loans and are neither expressly nor implicitly guaranteed by U.S. government agencies (“non-agency RMBS”). The Company’s non-agency RMBS include investments in securities backed by prime, Alt-A, and subprime loans, as follows (in millions): Allowance Gross Gross Amortized for Unrealized Unrealized Fair September 30, 2024 Cost (1) Credit Loss Gains Losses Value Prime $ 144 $ 2 $ 1 $ 14 $ 129 Alt-A 88 2 6 43 49 Subprime 6 — 4 — 10 Total non-agency RMBS $ 238 $ 4 $ 11 $ 57 $ 188 Allowance Gross Gross Amortized for Unrealized Unrealized Fair December 31, 2023 Cost (1) Credit Loss Gains Losses Value Prime $ 164 $ 2 $ 1 $ 19 $ 144 Alt-A 71 3 5 20 53 Subprime 7 1 4 — 10 Total non-agency RMBS $ 242 $ 6 $ 10 $ 39 $ 207 (1) Amortized cost, apart from carrying value for securities carried at fair value under the fair value option and trading securities. The Company defines its exposure to non-agency RMBS as follows: • Prime loan-backed securities are collateralized by mortgage loans made to the highest rated borrowers. • Alt-A loan-backed securities are collateralized by mortgage loans made to borrowers who lack credit documentation or necessary requirements to obtain prime borrower rates. • Subprime loan-backed securities are collateralized by mortgage loans made to borrowers that have a FICO score of 660 or lower. The following table summarizes the number of securities, fair value and the gross unrealized losses of debt securities, aggregated by investment category and length of time that individual debt securities have been in a continuous loss position (dollars in millions): September 30, 2024 December 31, 2023 Less than 12 months Less than 12 months Gross Fair Gross Fair Unrealized # of Unrealized # of Losses securities Losses securities U.S. government securities $ 41 $ 291 7 $ 52 $ 306 11 Other government securities — — — 1 51 9 Public utilities 5 160 20 11 287 32 Corporate securities 52 1,210 187 50 1,331 227 Residential mortgage-backed 2 36 6 2 48 45 Commercial mortgage-backed 11 183 17 — 46 6 Other asset-backed securities 1 331 38 27 707 55 Total temporarily impaired securities $ 112 $ 2,211 275 $ 143 $ 2,776 385 12 months or longer 12 months or longer Gross Fair Gross Fair Unrealized # of Unrealized # of Losses securities Losses securities U.S. government securities $ 746 $ 2,065 23 $ 793 $ 2,774 23 Other government securities 192 1,277 136 220 1,301 151 Public utilities 388 3,795 459 502 4,105 491 Corporate securities 1,986 14,797 1,890 2,522 17,457 2,207 Residential mortgage-backed 66 203 207 51 251 219 Commercial mortgage-backed 76 1,127 156 147 1,294 177 Other asset-backed securities 170 1,960 235 282 3,141 427 Total temporarily impaired securities $ 3,624 $ 25,224 3,106 $ 4,517 $ 30,323 3,695 Total Total Gross Gross Unrealized Fair # of Unrealized Fair # of Losses Value securities (1) Losses Value securities (1) U.S. government securities $ 787 $ 2,356 28 $ 845 $ 3,080 30 Other government securities 192 1,277 136 221 1,352 157 Public utilities 393 3,955 468 513 4,392 513 Corporate securities 2,038 16,007 2,003 2,572 18,788 2,355 Residential mortgage-backed 68 239 210 53 299 262 Commercial mortgage-backed 87 1,310 171 147 1,340 182 Other asset-backed securities 171 2,291 269 309 3,848 469 Total temporarily impaired securities $ 3,736 $ 27,435 3,285 $ 4,660 $ 33,099 3,968 (1) Certain securities contain multiple lots and fit the criteria of both aging groups. Debt securities in an unrealized loss position as of September 30, 2024 did not require an impairment recognized in earnings as (i) the Company did not intend to sell these debt securities, (ii) it is not more likely than not that the Company will be required to sell these securities before recovery of their amortized cost basis, and (iii) the difference in the fair value compared to the amortized cost was due to factors other than credit loss. Based upon this evaluation, the Company believes it has the ability to generate adequate amounts of cash from normal operations to meet cash requirements with a reasonable margin of safety without requiring the sale of impaired securities. As of September 30, 2024, unrealized losses associated with debt securities are primarily due to widening credit spreads or rising risk-free rates since purchase. As described below, the Company performed analyses of the financial performance of the underlying issues in an unrealized loss position and determined that recovery of the entire amortized cost of each impaired security is expected. Evaluation of Available-for-Sale Debt Securities for Credit Loss For debt securities in an unrealized loss position, management first assesses whether the Company has the intent to sell, or whether it is more likely than not it will be required to sell, the security before the amortized cost basis is fully recovered. If either criterion is met, the amortized cost is written down to fair value through net gains (losses) on derivatives and investments as an impairment. If neither criterion is met, the securities are further evaluated to determine if the cause of the decline in fair value resulted from credit losses or other factors, such as estimates about issuer operations and future earnings potential. The credit loss evaluation for a security may consider the following: the extent to which the fair value is below amortized cost; changes in ratings; whether a significant covenant has been breached; assessments of the issuer’s ability to make scheduled debt payments based upon judgments related to its current and projected financial position, including whether it has filed or indicated a possibility of filing for bankruptcy, has missed or announced it intends to miss a scheduled debt service payment, or has experienced a specific material adverse change that may impair its creditworthiness; the existence of, and realizable value of, any collateral backing the obligations; and the macro-economic and micro-economic outlooks for the issuer and its industry. In addition to the above, the credit loss review of asset-backed securities includes an assessment of future estimated cash flows under expected and stress case scenarios to identify potential shortfalls in contractual payments. These estimated cash flows are developed using available performance indicators from the underlying assets, such as current and projected default or delinquency rates, levels of credit enhancement, current subordination levels, vintage, expected loss severity and other relevant characteristics. For mortgage-backed securities, credit losses are assessed using a cash flow model that estimates the cash flows on the underlying mortgages, using the security-specific collateral characteristics and transaction structure. The model estimates cash flows from the underlying mortgage loans and distributes those cash flows to various tranches of securities based on the transaction structure and any existing subordination and credit enhancements. The cash flow model incorporates actual cash flows on the mortgage-backed securities through the current period and then projects the remaining cash flows using a number of assumptions, including prepayment timing, default rates and loss severity. Specifically, for prime and Alt-A RMBS, the assumed default percentage is dependent on the severity of delinquency status, with foreclosures and real estate owned receiving higher rates, but also includes the currently performing loans. These estimates reflect a combination of data derived by third parties and internally developed assumptions. Where possible, this data is benchmarked against other third-party sources. In addition, these estimates are extrapolated along a default timing curve to estimate the total lifetime pool default rate. When a credit loss is determined to exist and the present value of cash flows expected to be collected is less than the amortized cost of the security, an allowance for credit loss is recorded along with a charge to net gains (losses) on derivatives and investments, limited by the amount that the fair value is less than amortized cost. Any remaining unrealized loss after recording the allowance for credit loss is the non-credit amount and is recorded to other comprehensive income. There are inherent uncertainties in assessing the fair values assigned to the Company’s investments. The Company’s reviews of net present value and fair value involve several criteria including economic conditions, credit loss experience, other issuer-specific developments and estimated future cash flows. These assessments are based on the best available information at the time. Factors such as market liquidity, the widening of bid/ask spreads and a change in the cash flow assumptions can contribute to future price volatility. If actual experience differs negatively from the assumptions and other considerations used in the Condensed Consolidated Financial Statements, unrealized losses currently reported in accumulated other comprehensive income (loss) may be recognized in the Consolidated Income Statements in future periods. The Company currently has no intent to sell securities with unrealized losses considered to be temporary until they mature or recover in value and believes that it has the ability to do so. However, if the specific facts and circumstances surrounding an individual security, or the outlook for its industry sector change, the Company may sell the security prior to its maturity or recovery and realize a loss. The allowance for credit loss for specific debt securities may be increased or reversed in subsequent periods due to changes in the assessment of the present value of cash flows that are expected to be collected. Any changes to the allowance for credit loss are recorded as a provision for (or reversal of) credit loss expense in net gains (losses) on derivatives and investments. When all, or a portion, of a security is deemed uncollectible, the uncollectible portion is written-off with an adjustment to amortized cost and a corresponding reduction to the allowance for credit losses. Accrued interest receivables are presented separate from the amortized cost basis of debt securities. Accrued interest receivables that are determined to be uncollectible are written off with a corresponding reduction to net investment income. Accrued interest of $1 million and $1 million was written off during the three and nine months ended September 30, 2024 and 2023, respectively. The roll-forward of the allowance for credit loss for available-for-sale securities by sector is as follows (in millions): Three Months Ended September 30, 2024 US Other government securities Public Corporate securities Residential mortgage-backed Commercial mortgage-backed Other Total Balance at July 1, 2024 $ — $ — $ — $ 13 $ 6 $ — $ 8 $ 27 Additions for which credit loss was not previously recorded — — 16 — — — — 16 Changes for securities with previously recorded credit loss — — — 2 — — 7 9 Additions for purchases of PCD debt securities (1) — — — — — — — — Reductions from charge-offs — — — (6) — — — (6) Reductions for securities disposed — — — — (2) — — (2) Securities intended/required to be sold before recovery of amortized cost basis — — — — — — — — Balance at September 30, 2024 (2) $ — $ — $ 16 $ 9 $ 4 $ — $ 15 $ 44 Three Months Ended September 30, 2023 US Other government securities Public Corporate securities Residential mortgage-backed Commercial mortgage-backed Other Total Balance at July 1, 2023 $ — $ 3 $ — $ 7 $ 6 $ — $ — $ 16 Additions for which credit loss was not previously recorded — 2 — 15 — 9 — 26 Changes for securities with previously recorded credit loss — — — 2 — — — 2 Additions for purchases of PCD debt securities (1) — — — — — — — — Reductions from charge-offs — — — — — — — — Reductions for securities disposed — — — (1) — — — (1) Securities intended/required to be sold before recovery of amortized cost basis — (2) — (6) — (9) — (17) Balance at September 30, 2023 (2) $ — $ 3 $ — $ 17 $ 6 $ — $ — $ 26 Nine Months Ended September 30, 2024 US Other government securities Public Corporate securities Residential mortgage-backed Commercial mortgage-backed Other Total Balance at January 1, 2024 $ — $ — $ — $ 15 $ 6 $ — $ — $ 21 Additions for which credit loss was not previously recorded — — 16 — — — 1 17 Changes for securities with previously recorded credit loss — — — 2 — — 14 16 Additions for purchases of PCD debt securities (1) — — — — — — — — Reductions from charge-offs — — — (6) — — — (6) Reductions for securities disposed — — — (2) (2) — — (4) Securities intended/required to be sold before recovery of amortized cost basis — — — — — — — — Balance at September 30, 2024 (2) $ — $ — $ 16 $ 9 $ 4 $ — $ 15 $ 44 Nine Months Ended September 30, 2023 US Other government securities Public Corporate securities Residential mortgage-backed Commercial mortgage-backed Other Total Balance at January 1, 2023 $ — $ 2 $ — $ 15 $ 6 $ — $ — $ 23 Additions for which credit loss was not previously recorded — 2 — 48 — 9 — 59 Changes for securities with previously recorded credit loss — 1 — 1 2 — — 4 Additions for purchases of PCD debt securities (1) — — — — — — — — Reductions from charge-offs — — — — — — — — Reductions for securities disposed — — — (24) (2) — — (26) Securities intended/required to be sold before recovery of amortized cost basis — (2) — (23) — (9) — (34) Balance at September 30, 2023 (2) $ — $ 3 $ — $ 17 $ 6 $ — $ — $ 26 (1) Represents purchased credit-deteriorated ("PCD") fixed maturity available-for-sale securities. (2) Accrued interest receivable on debt securities totaled $446 million and $416 million as of September 30, 2024 and 2023, respectively, and was excluded from the determination of credit losses for the three and nine months ended September 30, 2024 and 2023. Net Investment Income The sources of net investment income were as follows (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Debt securities (1) $ 393 $ 432 $ 1,191 $ 1,152 Equity securities 3 (4) 6 (5) Mortgage loans 83 81 248 235 Policy loans 17 17 50 50 Limited partnerships 20 20 106 19 Other investment income 51 24 135 74 Total investment income excluding funds withheld assets 567 570 1,736 1,525 Investment expenses (2)(3) (110) (112) (352) (277) Net investment income excluding funds withheld assets 457 458 1,384 1,248 Net investment income on funds withheld assets (see Note 8) 269 303 824 862 Net investment income $ 726 $ 761 $ 2,208 $ 2,110 (1) Includes changes in fair value gains (losses) on trading securities and includes $(23) million and $(1) million for the three and nine months ended September 30, 2024, respectively, and $51 million and $43 million for the three and nine months ended September 30, 2023, respectively, related to the change in fair value for securities carried under the fair value option. (2) In the first quarter of 2024, interest costs principally associated with repurchase agreements and cash collateral were reclassified from interest expense to net investment income. All prior period amounts have been conformed to current period presentation. (3) Includes expenses from consolidated variable interest entities, which includes changes in fair value of notes issued by those entities, of $(44) million and $(150) million for the three and nine months ended September 30, 2024, respectively, and $(70) million and $(144) million for the three and nine months ended September 30, 2023, respectively. Unrealized gains (losses) included in investment income that were recognized on equity securities held were $10 million and $(16) million for the three months ended September 30, 2024, and 2023, respectively, and $16 million and $(38) million for the nine months ended September 30, 2024 and 2023, respectively. Net Gains (Losses) on Derivatives and Investments The following table summarizes net gains (losses) on derivatives and investments (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Available-for-sale securities Realized gains on sale $ 4 $ 11 $ 21 $ 17 Realized losses on sale (2) (102) (114) (145) Credit loss income (expense) (11) (18) (11) (29) Credit loss income (expense) on mortgage loans 8 (28) 6 (88) Other (1) (44) 10 16 10 Net gains (losses) excluding derivatives and funds withheld assets (45) (127) (82) (235) Net gains (losses) on derivative instruments (see Note 5) 147 (208) (4,050) (4,938) Net gains (losses) on derivatives and investments 102 (335) (4,132) (5,173) Net gains (losses) on funds withheld reinsurance treaties (see Note 8) (784) 159 (1,199) (648) Total net gains (losses) on derivatives and investments $ (682) $ (176) $ (5,331) $ (5,821) (1) Includes the foreign currency gain or loss related to foreign denominated trust instruments supporting funding agreements. Net gains (losses) on funds withheld reinsurance treaties represents income (loss) from the sale of investments held in segregated funds withheld accounts in support of reinsurance agreements for which Jackson retains legal ownership of the underlying investments. These gains (losses) are increased or decreased by changes in the embedded derivative liability related to the Athene Life Re Ltd. ("Athene") funds withheld coinsurance agreement (as described in Item 2, the “Athene Reinsurance Transaction”) and also include (i) changes in the related funds withheld payable, as all economic performance of the investments held in the segregated accounts inure to the benefit of the reinsurers under the respective reinsurance agreements with each reinsurer, and (ii) amortization of the difference between book value and fair value of the investments as of the effective date of the reinsurance agreements with each reinsurer. The aggregate fair value of securities sold at a loss for the three and nine months ended September 30, 2024 was $419 million and $2,314 million, which was approximately 97% and 94% of book value, respectively. The aggregate fair value of securities sold at a loss for the three and nine months ended September 30, 2023 was $756 million and $2,909 million, which was approximately 88% and 94% of book value, respectively. Proceeds from sales of available-for-sale debt securities were $0.6 billion and $3.5 billion during the three and nine months ended September 30, 2024, respectively, and $0.9 billion and $4.2 billion during the three and nine months ended September 30, 2023, respectively. Consolidated Variable Interest Entities ("VIEs") The Company concluded that the following entities are VIEs and that the Company is the primary beneficiary as it has both the power to direct the most significant activities of the VIE and the obligation to absorb losses or the right to receive benefits that could potentially be significant to the VIE. In each case, the Company’s exposure to loss is limited to the capital invested plus, in the cases of the limited liability companies ("LLCs") and the Private Equity Funds, unfunded capital commitments. Creditors of the consolidated VIEs do not have recourse to the general credit of the Company. • The Company funds affiliated LLCs to facilitate the issuance of collateralized loan obligations ("CLOs"). The Company's policy is to record the consolidation of VIEs on a one-month lag due to the timing of when information is available from the VIE. In December 2023, a consolidated CLO expanded its issuance by $97 million, net of the Company’s holding, which was not reflected in the Company's Consolidated Balance Sheet as of December 31, 2023 due to the reporting lag. • Private Equity Funds III – VIII are limited partnership structures that invest the ownership capital in portfolios of various other limited partnership structures. Private Equity Fund IX was created in the third quarter of 2024, but is not expected to be funded by the Company until 2025. The Company sold all of its investment in Private Equity Funds III - VI and the majority of its investment in Private Equity Fund VII during the year ended December 31, 2023. The Company recorded a loss of $97 million on the sale, which it recognized in Net Investment Income for the year ended December 31, 2023. Those entities were deconsolidated as of December 31, 2023. • PPM has created and managed institutional share class mutual funds, where Jackson seeds new funds, or new share classes within a fund, when deemed necessary to develop the requisite track record prior to allowing investment by external parties. Jackson may sell its interest in a fund once opened to investment by external parties. Asset and liability information for the consolidated VIEs included on the Condensed Consolidated Balance Sheets are as follows (in millions): September 30, 2024 December 31, 2023 Assets Debt securities, at fair value under fair value option $ 2,459 $ 2,037 Debt securities, trading 73 68 Equity securities 6 7 Other invested assets 553 396 Cash and cash equivalents 167 93 Other assets 66 49 Total assets $ 3,324 $ 2,650 Liabilities Notes issued by consolidated VIEs, at fair value under fair value option $ 2,366 $ 1,988 Other liabilities 244 98 Total other liabilities 2,610 2,086 Securities lending payable 1 2 Total liabilities $ 2,611 $ 2,088 Equity Noncontrolling interests $ 209 $ 164 Unconsolidated VIEs The Company has concluded the following entities are VIEs but does not consolidate them. Based on analysis of the limited partnerships ("LPs"), LLCs and the mutual funds, the Company is not the primary beneficiary of the VIE because the Company lacks the power to direct the activities of the VIE that most significantly impact the VIE's performance or lacks the obligation to absorb losses or the right to receive benefits that could potentially be significant to the entities, or both. • The Company invests in certain LPs and LLCs. The carrying amounts of the Company’s investments in these LPs and LLCs are recognized in other invested assets on the Condensed Consolidated Balance Sheets. Unfunded capital commitments for these investments are detailed in Note 16 of the Notes to Condensed Consolidated Financial Statements. The Company’s exposure to loss is limited to the capital invested and unfunded capital commitments related to the LPs/LLCs, which was $2,609 million and $2,576 million as of September 30, 2024 and December 31, 2023, respectively. The capital invested in an LP or LLC equals the original capital contributed, increased for additional capital contributed after the initial investment, and reduced for any returns of capital from the LP or LLC. LPs and LLCs are carried at fair value. • The Company invests in certain mutual funds. Mutual funds are recognized in equity securities on the Condensed Consolidated Balance Sheets and were $24 million and $21 million as of September 30, 2024 and December 31, 2023, respectively. The Company’s maximum exposure to loss on these mutual funds is limited to the amortized cost for these investments. The Company makes investments in structured debt securities issued by VIEs for which it is not the manager. These structured debt securities include RMBS, Commercial Mortgage-Backed Securities ("CMBS"), and asset-backed securities ("ABS"). The Company does not consolidate the securitization trusts utilized in these transactions because it does not have the power to direct the activities that most significantly impact the economic performance of these securitization trusts. The Company does not consider its continuing involvement with these VIEs to be significant because it either invests in securities issued by the VIE and was not involved in the design of the VIE or no transfers have occurred between the Company and the VIE. The Company’s maximum exposure to loss on these structured debt securities is limited to the amortized cost of these investments. The Company does not have any further contractual obligations to the VIE. The Company recognizes the variable interest in these VIEs at fair value on the Condensed Consolidated Balance Sheets. Commercial and Residential Mortgage Loans The following table shows commercial mortgage loans, residential mortgage loans, and the respective accrued interest thereon at September 30, 2024 and December 31, 2023 (in millions): September 30, 2024 December 31, 2023 Commercial mortgage loans (1) $ 9,114 $ 9,562 Accrued interest receivable on commercial mortgage loans 36 39 Residential mortgage loans (2) 882 1,001 Accrued interest receivable on residential mortgage loans 6 7 (1) Net of an allowance for credit losses of $143 million and $160 million at each date, respectively. (2) Net of an allowance for credit losses of $5 million and $5 million at each date, respectively. At September 30, 2024, commercial mortgage loans were collateralized by properties located in 36 states, the District of Columbia, and Europe, while residential mortgage loans were collateralized by properties located in 49 states, the District of Columbia, Mexico, and Europe. Evaluation for Credit Losses on Mortgage Loans The Company reviews mortgage loans that are not carried at fair value under the fair value option on a quarterly basis to estimate the ACL with changes in the ACL recorded in net gains (losses) on derivatives and investments. Apart from an ACL recorded on individual mortgage loans where the borrower is experiencing financial difficulties, the Company records an ACL on the pool of mortgage loans based on lifetime expected credit losses. The Company utilizes a third-party forecasting model to estimate lifetime expected credit losses at a loan level for mortgage loans. The model forecasts net operating income and property values for the economic scenario selected. The debt service coverage ratios (“DSCR”) and loan to values (“LTV”) are calculated over the forecastable period by comparing the projected net operating income and property valuations to the loan payment and principal amounts of each loan. The model utilizes historical mortgage loan performance based on DSCRs and LTV to derive probability of default and expected losses based on the economic scenario that is similar to the Company’s expectations of economic factors such as unemployment, gross domestic product growth, and interest rates. The Company determined the forecastable period to be reasonable and supportable for a period of two years beyond the end of the reporting period. Over the following one-year period, the model reverts to the historical performance of the portfolio for the remainder of the contractual term of the loans. In cases where the Company does not have an appropriate length of historical performance, the relevant historical rate from an index or the lifetime expected credit loss calculated from the model may be used. Unfunded commitments are included in the model and an ACL is determined accordingly. Credit loss estimates are pooled by property type and the Company does not include accrued interest in the determination of ACL. For individual loans or for types of loans for which the third-party model is deemed not suitable, the Company utilizes relevant current market data, industry d

Derivative Instruments

Derivative Instruments	9 Months Ended
	Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Derivative Instruments The Company’s business model includes the acceptance, monitoring and mitigation of risk. Specifically, the Company considers, among other factors, exposures to interest rate and equity market movements, foreign exchange rates and other asset or liability prices. The Company uses derivative instruments to mitigate or reduce these risks in accordance with established policies and goals. The Company’s derivative holdings, while effective in managing defined risks, are not structured to meet accounting requirements to be designated as hedging instruments. As a result, freestanding derivatives are carried at fair value with changes recorded in net gains (losses) on derivatives and investments. A summary of the aggregate contractual or notional amounts and fair values of the Company’s freestanding and embedded derivative instruments are as follows (in millions): September 30, 2024 Contractual/ Assets Liabilities Net Notional Fair Fair Fair Value Amount (1) Value Value Asset (Liability) Freestanding derivatives Cross-currency swaps $ 1,714 $ 133 $ 131 $ 2 Equity index call options 1,000 36 — 36 Equity index futures (2) 30,711 — — — Equity index put options 14,000 76 — 76 Interest rate swaps 5,978 4 87 (83) Put-swaptions 3,500 11 141 (130) Interest rate futures (2) 32,767 — — — Total return swaps 1,943 — 36 (36) Total freestanding derivatives 91,613 260 395 (135) Embedded derivatives Fixed index annuity embedded derivatives (3) N/A — 825 (825) Registered index linked annuity embedded derivatives (3) N/A — 2,799 (2,799) Total embedded derivatives N/A — 3,624 (3,624) Derivatives related to funds withheld under reinsurance treaties Cross-currency swaps 158 14 1 13 Cross-currency forwards 1,149 21 29 (8) Funds withheld embedded derivative (4) N/A 1,992 — 1,992 Total derivatives related to funds withheld under reinsurance treaties 1,307 2,027 30 1,997 Total $ 92,920 $ 2,287 $ 4,049 $ (1,762) (1) The notional amount for swaps and swaptions represents the stated principal balance used as a basis for calculating payments. The contractual amount for futures and options represents the market exposure of open positions. (2) Variation margin is considered settlement resulting in the netting of cash received/paid for variation margin against the fair value of the trades. (3) Included within other contract holder funds on the Condensed Consolidated Balance Sheets. The non-performance risk adjustment is included in the balance above. (4) Included within funds withheld payable under reinsurance treaties on the Condensed Consolidated Balance Sheets. December 31, 2023 Contractual/ Assets Liabilities Net Notional Fair Fair Fair Value Amount (1) Value Value Asset (Liability) Freestanding derivatives Cross-currency swaps $ 1,665 $ 123 $ 116 $ 7 Equity index futures (2) 24,739 — — — Equity index put options 26,000 59 — 59 Interest rate swaps 6,228 5 132 (127) Put-swaptions 23,500 153 905 (752) Interest rate futures (2) 33,926 — — — Total return swaps 1,599 1 23 (22) Total freestanding derivatives 117,657 341 1,176 (835) Embedded derivatives Fixed index annuity embedded derivatives (3) N/A — 866 (866) Registered index linked annuity embedded derivatives (3) N/A — 1,224 (1,224) Total embedded derivatives N/A — 2,090 (2,090) Derivatives related to funds withheld under reinsurance treaties Cross-currency swaps 158 14 1 13 Cross-currency forwards 1,410 35 33 2 Funds withheld embedded derivative (4) N/A 2,468 — 2,468 Total derivatives related to funds withheld under reinsurance treaties 1,568 2,517 34 2,483 Total $ 119,225 $ 2,858 $ 3,300 $ (442) (1) The notional amount for swaps and swaptions represents the stated principal balance used as a basis for calculating payments. The contractual amount for futures and options represents the market exposure of open positions. (2) Variation margin is considered settlement resulting in the netting of cash received/paid for variation margin against the fair value of the trades. (3) Included within other contract holder funds on the Condensed Consolidated Balance Sheets. The non-performance risk adjustment is included in the balance above. (4) Included within funds withheld payable under reinsurance treaties on the Condensed Consolidated Balance Sheets. The following table reflects the results of the Company’s derivatives, including gains (losses) and change in fair value of freestanding derivative instruments and embedded derivatives (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Derivatives excluding funds withheld under reinsurance treaties Cross-currency swaps $ 14 $ (16) $ (28) $ (42) Equity index call options 29 (192) 29 (100) Equity index futures (514) (5) (1,677) (2,712) Equity index put options (103) 45 (295) (1,362) Interest rate swaps 76 (137) (25) (189) Interest rate swaps - cleared — — — (10) Put-swaptions 173 (1,013) (460) (840) Interest rate futures 994 938 (351) 537 Total return swaps (82) 70 (280) (93) Fixed index annuity embedded derivatives (4) — (16) (4) Registered index linked annuity embedded derivatives (436) 102 (947) (123) Total net gains (losses) on derivative instruments excluding derivative instruments related to funds withheld under reinsurance treaties 147 (208) (4,050) (4,938) Derivatives related to funds withheld under reinsurance treaties Cross-currency swaps (2) 60 1 58 Cross-currency forwards (28) (36) (12) (57) Funds withheld embedded derivative (530) 451 (476) 194 Total net gains (losses) on derivative instruments related to funds withheld under reinsurance treaties (560) 475 (487) 195 Total net gains (losses) on derivative instruments including derivative instruments related to funds withheld under reinsurance treaties $ (413) $ 267 $ (4,537) $ (4,743) All the Company’s trade agreements for freestanding, over-the-counter derivatives contain credit downgrade provisions that allow a party to assign or terminate derivative transactions if the counterparty’s credit rating declines below an established limit. At September 30, 2024 and December 31, 2023, the fair value of the Company’s net non-cleared, over-the-counter derivative assets by counterparty were $139 million and $117 million, respectively, and held collateral was $139 million and $841 million, respectively, related to these agreements. At September 30, 2024 and December 31, 2023, the fair value of the Company’s net non-cleared, over-the-counter derivative liabilities by counterparty were $269 million and $937 million, respectively, and provided collateral was $297 million and $751 million, respectively, related to these agreements. If all the downgrade provisions had been triggered at September 30, 2024 and December 31, 2023, in aggregate, the Company would have had to disburse nil and $910 million, respectively, and would have been allowed to claim $28 million and nil, respectively. The Company pledged collateral of $1,954 million and $2,616 million as of September 30, 2024 and December 31, 2023, respectively, for initial margin related to uncleared margin for over-the-counter derivatives and exchange-traded futures. Variation margin on exchange traded futures is settled through the netting of cash paid/received for variation margin against the fair value of the trades. Offsetting Assets and Liabilities The Company’s derivative instruments, repurchase agreements and securities lending agreements are subject to master netting arrangements and collateral arrangements. A master netting arrangement with a counterparty creates a right of offset for amounts due to and due from that same counterparty that is enforceable in the event of a default or bankruptcy. The Company recognizes amounts subject to master netting arrangements on a gross basis within the Condensed Consolidated Balance Sheets. The following tables present the gross and net information about the Company’s financial instruments subject to master netting arrangements (in millions): September 30, 2024 Gross Gross Net Amounts Gross Amounts Not Offset Financial Instruments (1) Cash Securities Collateral (2) Net Financial Assets: Freestanding derivative assets $ 295 $ — $ 295 $ 156 $ 130 $ — $ 9 Financial Liabilities: Freestanding derivative liabilities $ 425 $ — $ 425 $ 156 $ 7 $ 254 $ 8 Securities loaned 26 — 26 — 26 — — Repurchase agreements 794 — 794 — — 794 — Repurchase agreements - collateral upgrade 1,551 (1,551) — — — — — Total financial liabilities $ 2,796 $ (1,551) $ 1,245 $ 156 $ 33 $ 1,048 $ 8 (1) Represents the amount that could be offset under master netting or similar arrangements that management elects not to offset on the Condensed Consolidated Balance Sheets. (2) Excludes initial margin amounts for exchange-traded derivatives. December 31, 2023 Gross Gross Net Amounts Gross Amounts Not Offset Financial Instruments (1) Cash Securities Collateral (2) Net Financial Assets: Freestanding derivative assets $ 390 $ — $ 390 $ 273 $ 108 $ — $ 9 Financial Liabilities: Freestanding derivative liabilities $ 1,210 $ — $ 1,210 $ 273 $ 6 $ 744 $ 187 Securities loaned 19 — 19 — 19 — — Repurchase agreements — — — — — — — Total financial liabilities $ 1,229 $ — $ 1,229 $ 273 $ 25 $ 744 $ 187 (1) Represents the amount that could be offset under master netting or similar arrangements that management elects not to offset on the Condensed Consolidated Balance Sheets. (2) Excludes initial margin amounts for exchange-traded derivatives.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The following table summarizes the fair value and carrying value of the Company’s financial instruments (in millions): September 30, 2024 December 31, 2023 Carrying Fair Carrying Fair Assets Debt securities (1) $ 45,299 $ 45,299 $ 42,643 $ 42,643 Equity securities 213 213 394 394 Mortgage loans (1) 9,996 9,609 10,563 9,994 Limited partnerships 2,393 2,393 2,132 2,132 Policy loans (1) 4,453 4,453 4,399 4,399 Freestanding derivative instruments 295 295 390 390 FHLBI capital stock 127 127 108 108 Cash and cash equivalents 3,061 3,061 2,688 2,688 Reinsurance recoverable on market risk benefits 149 149 149 149 Market risk benefit assets 7,615 7,615 6,737 6,737 Separate account assets 235,037 235,037 219,656 219,656 Liabilities Annuity reserves (2) 37,985 39,321 35,251 33,678 Market risk benefit liabilities 4,384 4,384 4,785 4,785 Reserves for guaranteed investment contracts (3) 556 549 700 674 Trust instruments supported by funding agreements (3) 5,461 5,426 5,756 5,601 FHLB funding agreements (3) 1,912 1,859 1,950 1,893 Funds withheld payable under reinsurance treaties (1) 18,103 18,103 19,952 19,952 Long-term debt 2,033 1,888 2,037 1,851 Securities lending payable 26 26 19 19 Freestanding derivative instruments 425 425 1,210 1,210 Notes issued by consolidated VIEs 2,366 2,366 1,988 1,988 Repurchase agreements 794 794 — — FHLB advances — — 250 250 Separate account liabilities 235,037 235,037 219,656 219,656 (1) Includes items carried at fair value under the fair value option and trading securities included as a component of debt securities. (2) Annuity reserves represent only the components of other contract holder funds and reserves for future policy benefits and claims payable that are considered to be financial instruments. (3) Included as a component of other contract holder funds on the Condensed Consolidated Balance Sheets. The following is a discussion of the methodologies used to determine fair values of the financial instruments measured on a recurring basis reported in the following tables. Debt and Equity Securities The fair values for debt and equity securities are determined using information available from independent pricing services, broker-dealer quotes, or internally derived estimates. Priority is given to publicly available prices from independent sources, when available. Securities for which the independent pricing service does not provide a quotation are either submitted to independent broker-dealers for prices or priced internally. Typical inputs used by these three pricing methods include reported trades, benchmark yields, credit spreads, liquidity premiums and/or estimated cash flows based on default and prepayment assumptions. As a result of typical trading volumes and the lack of specific quoted market prices for most debt securities, independent pricing services will normally derive the security prices through recently reported trades for identical or similar securities, making adjustments through the reporting date based upon available market observable information as outlined above. If there are no recently reported trades, the independent pricing services and broker-dealers may use matrix or pricing model processes to develop a security price where future cash flow expectations are developed based upon collateral performance and discounted at relevant market rates. Certain securities are priced using broker-dealer quotes, which may utilize proprietary inputs and models. Additionally, the majority of these quotes are non-binding. These securities are classified as Level 3 in the fair value hierarchy. Included in the pricing of asset-backed securities are estimates of the rate of future prepayments of principal over the remaining life of the securities. Such estimates are derived based on the characteristics of the underlying structure and prepayment assumptions believed to be relevant for the underlying collateral. Actual prepayment experience may vary from these estimates. Internally derived estimates may be used to develop a fair value for securities for which the Company is unable to obtain either a reliable price from an independent pricing service or a suitable broker-dealer quote. These fair value estimates may incorporate Level 2 and Level 3 inputs, as defined below, and are generally derived using expected future cash flows, discounted at market interest rates available from market sources based on the credit quality and duration of the instrument. For securities that may not be reliably priced using these internally developed pricing models, a fair value may be estimated using indicative market prices. These prices are indicative of an exit price, but the assumptions used to establish the fair value may not be observable or corroborated by market observable information and, therefore, represent Level 3 inputs. The Company performs an analysis on the prices and credit spreads received from third parties to ensure that the prices represent a reasonable estimate of the fair value. This process involves quantitative and qualitative analysis and is overseen by investment and accounting professionals. Examples of procedures performed include initial and ongoing review of third-party pricing service methodologies, review of pricing statistics and trends, back testing recent trades and monitoring of trading volumes. In addition, the Company considers whether prices received from independent broker-dealers represent a reasonable estimate of fair value using internal and external cash flow models, which are developed based on spreads and, when available, market indices. As a result of this analysis, if the Company determines there is a more appropriate fair value based upon the available market data, the price received from the third party may be adjusted accordingly. For those securities that were internally valued at September 30, 2024 and December 31, 2023, the pricing model used by the Company utilizes current spread levels of similarly rated securities to determine the market discount rate for the security. Furthermore, appropriate risk premiums for illiquidity and non-performance are incorporated in the discount rate. Cash flows, as estimated by the Company using issuer-specific default statistics and prepayment assumptions, are discounted to determine an estimated fair value. On an ongoing basis, the Company reviews the independent pricing services’ valuation methodologies and related inputs and evaluates the various types of securities in its investment portfolio to determine an appropriate fair value hierarchy distribution based upon trading activity and the observability of inputs. Based on the results of this evaluation, each price is classified into Level 1, 2, or 3. Most prices provided by independent pricing services are classified into Level 2 due to their use of market observable inputs. Limited Partnerships Fair values for limited partnership interests, which are included in other invested assets, are generally determined using the proportion of the Company’s investment in the value of the net assets of each fund (“NAV equivalent”) as a practical expedient for fair value, and generally are recorded on a three-month lag. No adjustments to these amounts were deemed necessary at September 30, 2024 and December 31, 2023. As a result of using the net asset value per share practical expedient, limited partnership interests are not classified in the fair value hierarchy. The Company’s limited partnership interests are not redeemable, and distributions received are generally the result of liquidation of the underlying assets of the partnerships. The Company generally has the ability under the partnership agreements to sell its interest to another limited partner with the prior written consent of the general partner. In cases when the Company expects to sell the limited partnership interest, the estimated sales price is used to determine the fair value rather than the practical expedient. Limited partnership interests expected to be sold are classified as Level 2 in the fair value hierarchy. In cases when a limited partnership’s financial statements are unavailable and a NAV equivalent is not available or practical, the fair value may be based on an internally developed model or provided by the general partner as determined using private transactions, information obtained from the primary co-investor or underlying company, or financial metrics provided by the lead sponsor. These investments are classified as Level 3 in the fair value hierarchy. Policy Loans Policy loans are funds provided to policyholders in return for a claim on the policies values and function like demand deposits, which are redeemable upon repayment, death or surrender, and there is only one market price at which the transaction could be settled – the then current carrying value. The funds provided are limited to the cash surrender value of the underlying policy. The nature of policy loans is to have a negligible default risk as the loans are fully collateralized by the value of the policy. Policy loans do not have a stated maturity and the balances and accrued interest are repaid either by the policyholder or with proceeds from the policy. Due to the collateralized nature of policy loans and unpredictable timing of payments, the Company believes the carrying value of policy loans approximates fair value. The reinsurance related component of policy loans at fair value under the fair value option have been classified as Level 3 within the fair value hierarchy. Freestanding Derivative Instruments Freestanding derivative instruments are reported at fair value, which reflects the estimated amounts, net of payment accruals, that the Company would receive or pay upon sale or termination of the contracts at the reporting date. Changes in fair value are included in net gains (losses) on derivatives and investments. Freestanding derivatives priced using third-party pricing services incorporate inputs that are observable in the market. Inputs used to value derivatives include interest rate swap curves, credit spreads, interest rates, counterparty credit risk, equity volatility and equity index levels. Freestanding derivative instruments classified as: • Level 1 include futures, which are traded on active exchanges. • Level 2 include interest rate swaps, cross currency swaps, cross-currency forwards, credit default swaps, total return swaps, put-swaptions and certain equity index call and put options. These derivative valuations are determined by third-party pricing services using pricing models with inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. • Level 3 include interest rate contingent options that are valued by third-party pricing services utilizing significant unobservable inputs. Cash and Cash Equivalents Cash and cash equivalents primarily include money market instruments and bank deposits. Cash equivalents also include all highly liquid securities and other investments purchased with an original or remaining maturity of three months or less at the date of purchase. Certain money market instruments are valued using unadjusted quoted prices in active markets and are classified as Level 1. Funds Withheld Payable Under Reinsurance Treaties The funds withheld payable under reinsurance treaties includes both the funds withheld payable that are held at fair value under the fair value option and the funds withheld embedded derivative. Both are considered Level 3 in the fair value hierarchy. • The fair value of the funds withheld payable that is held at fair value under the fair value option is equal to the fair value of the assets held as collateral, which primarily consists of policy loans using industry standard valuation techniques. • The funds withheld embedded derivative is determined based upon a total return swap technique referencing the fair value of the investments held under the reinsurance contract and requires certain significant unobservable inputs. Separate Account Assets Separate account assets are comprised of investments in mutual funds that transact regularly, but do not trade in active markets as they are not publicly available and are categorized as Level 2 assets. Market Risk Benefits Variable Annuities Variable annuity contracts issued by the Company may include various guaranteed minimum death, withdrawal, income and accumulation benefits, which are classified as market risk benefits ("MRBs") and measured at fair value. Our MRB assets and MRB liabilities are reported separately on our Condensed Consolidated Balance Sheets. Increases to an asset or decreases to a liability are described as favorable changes to fair value. Changes in fair value are reported in Market risk benefits (gains) losses, net on the Condensed Consolidated Income Statements. However, the change in fair value related to our own non-performance risk is recognized as a component of other comprehensive income ("OCI") and is reported in Change in non-performance on market risk benefits, net of tax expense (benefit) on the Condensed Consolidated Statements of Comprehensive Income (Loss). The fair value of variable annuity guaranteed benefit features classified as MRBs, which have explicit fees, are measured using the attributed fee method as the difference between the present value of projected future liabilities and the present value of projected attributed fees. At the inception of the contract, the Company attributes to the MRB a portion of total fees expected to be assessed against the contract holder's account value to offset the projected claims over the lifetime of the contract. The attributed fee is expressed as a percentage of total projected future fees at inception of the contract. This percentage of total projected fees is considered a fixed term of the MRB feature and is held static over the life of the contract. As the Company may issue contracts that have projected future liabilities greater than the projected future guaranteed benefit fees at issue, the Company may also attribute mortality and expense charges when performing this calculation. The percentage of guaranteed benefit fees and the percentage of mortality and expense charges may not exceed 100% of the total projected fees as of contract inception. In subsequent valuations, both the present value of future projected liabilities and the present value of projected attributed fees are remeasured based on current market conditions and policyholder behavior assumptions. The Company has ceded the guaranteed minimum income benefit (“GMIB”) features elected on certain annuity contracts to an unrelated party. The GMIBs ceded under this reinsurance treaty are classified as a MRB in their entirety. The reinsurance contract is measured at fair value and reported in Reinsurance recoverable on market risk benefits. Changes in fair value are recorded in Market risk benefits (gains) losses, net. Due to the inability to economically reinsure or hedge new issues of the GMIB, the Company discontinued offering the benefit in 2009. Fair values for MRBs related to variable annuities, including the contract reinsuring GMIB features, are calculated using internally developed models because active, observable markets do not exist for those guaranteed benefits. The fair value calculation is based on the present value of future cash flows comprised of future expected benefit payments, less future attributed rider fees, over the lives of the contracts. Estimating these cash flows requires numerous estimates and subjective judgments related to capital market inputs, as well as actuarially determined assumptions related to expectations concerning policyholder behavior. Capital market inputs include expected market rates of return, market volatility, correlations of market index returns to fund returns, and discount rates, which includes an adjustment for non-performance risk. The more significant actuarial assumptions include benefit utilization by policyholders, lapse, mortality, and withdrawal rates. Best estimate assumptions plus risk margins are used as applicable. At each valuation date, the fair value calculation reflects expected returns based on treasury rates as of that date to determine the value of expected future cash flows produced in a stochastic process. Volatility assumptions are based on a weighting of available market data for implied market volatility for durations up to 10 years, grading to a historical volatility level by year 15, where such long-term historical volatility levels contain an explicit risk margin. Non-performance risk is incorporated into the calculation through the adjustment of the risk-free rate curve based on credit spreads for debt and debt-like instruments issued by the Company or its insurance operating subsidiaries, adjusted, as necessary, to reflect the financial strength ratings of the issuing insurance subsidiaries. Risk margins are also incorporated into the model assumptions, particularly for policyholder behavior. Estimates of future policyholder behavior are subjective and are based primarily on the Company’s experience. As markets change, mature and evolve and actual policyholder behavior emerges, management continually evaluates the appropriateness of its assumptions for the fair value model. The use of the models and assumptions described above requires a significant amount of judgment. Management believes this results in an amount that the Company would be required to transfer for a liability, or receive for an asset, to or from a willing buyer or seller, if one existed, for those market participants to assume the risks associated with the guaranteed benefits and the related reinsurance. However, the ultimate settlement amount of the asset or liability, which is currently unknown, could likely be significantly different than this fair value. Fixed Index Annuities The longevity riders issued on fixed index annuities are classified as MRBs and measured at fair value. Similar to the variable annuity guaranteed benefit features, these contracts have explicit fees and are measured using the attributed fee method. The Company attributes a percentage of total projected future fees expected to be assessed against the policyholder to offset the projected future claims over the lifetime of the contract. If the fees attributed are insufficient to offset the claims at issue, the shortfall is borrowed from the host contract rather than recognizing a loss at inception. RILA RILA guaranteed benefit features are classified as MRBs and measured at fair value. The fair value measurement represents the present value of future claims payable by the MRB feature. At inception, the value of the MRB is deducted from the value of the contract resulting in no gain or loss. See Note 12 - Market Risk Benefits of the Notes to Condensed Consolidated Financial Statements for more information regarding MRBs. Fixed Index Annuities The fair value of the index-linked crediting derivative feature embedded in fixed index annuities, included in Annuity Reserves in the above tables, is calculated using the closed form Black-Scholes Option Pricing model or Monte Carlo simulations, as appropriate for the type of option, incorporating such factors as the volatility of returns, the level of interest rates and the time remaining until the option expires. Additionally, although not a significant input, assumed withdrawal rates are used to estimate the expected volume of embedded options that will be realized by policyholders. RILA The fair value of the index-linked crediting derivative feature embedded in RILAs, included in Annuity Reserves in the above table, is calculated using the closed form Black-Scholes Option Pricing model, incorporating such factors as the volatility of returns, the level of interest rates and the time remaining until the option expires. Additionally, although not a significant input, assumed withdrawal rates are used to estimate the expected volume of embedded options that will be realized by policyholders. Notes Issued by Consolidated VIEs These notes are issued by CLOs and are carried at fair value under the fair value option based on the fair values of corresponding fixed maturity collateral. The CLO liabilities are also reduced by the fair value of the beneficial interest the Company retains in the CLO and the carrying value of any beneficial interests that represent compensation for services. As the notes are valued based on the reference collateral, they are classified as Level 2. Fair Value Option The Company elected the fair value option for debt securities related to certain consolidated investments totaling $2,459 million and $2,037 million at September 30, 2024 and December 31, 2023, respectively. These debt securities are reflected on the Company’s Condensed Consolidated Balance Sheets as debt securities, at fair value under the fair value option. During the third quarter of 2024, the Company began purchasing certain debt securities for purposes of mitigating components of the Company’s exposure to changes in the value of certain market risk benefits. The Company elected the fair value option on these debt securities, with changes in fair value reflected in net income, to align with the corresponding changes in the value of the market risk benefits recognized through net income. These debt securities totaling $323 million and nil at September 30, 2024 and December 31, 2023, respectively, are presented as debt securities, at fair value under the fair value option in the Condensed Consolidated Balance Sheets. The Company has elected the fair value option for certain funds withheld assets, which are held as collateral for reinsurance, totaling $4,121 million and $4,054 million at September 30, 2024 and December 31, 2023, respectively, as discussed above, and includes mortgage loans as discussed below. The Company elected the fair value option for certain mortgage loans held under the funds withheld reinsurance agreement with Athene. The fair value option was elected for these mortgage loans, purchased or funded after December 31, 2021, to mitigate inconsistency in earnings that would otherwise result between these mortgage loan assets and the funds withheld liability, including the associated embedded derivative, and are valued using third-party pricing services. Changes in fair value are reflected in net investment income on the Condensed Consolidated Income Statements. The fair value and aggregate contractual principal for mortgage loans where the fair value option was elected after December 31, 2021, were as follows (in millions): September 30, December 31, 2024 2023 Fair value $ 432 $ 481 Aggregate contractual principal 441 491 As of September 30, 2024, no loans in good standing for which the fair value option was elected were in non-accrual status, and no loans were more than 90 days past due and still accruing interest. The Company elected the fair value option for notes issued by consolidated VIEs totaling $2,366 million and $1,988 million at September 30, 2024 and December 31, 2023, respectively. Income and changes in unrealized gains and losses on other assets for which the Company has elected the fair value option are immaterial to the Company’s Condensed Consolidated Financial Statements. Assets and Liabilities Measured at Fair Value on a Recurring Basis The following tables summarize the Company’s assets and liabilities that are carried at fair value by hierarchy levels (in millions): September 30, 2024 Total Level 1 Level 2 Level 3 Assets Debt securities U.S. government securities $ 3,449 $ 3,449 $ — $ — Other government securities 1,340 — 1,184 156 Public utilities 5,413 — 5,326 87 Corporate securities 28,760 — 28,650 110 Residential mortgage-backed 333 — 333 — Commercial mortgage-backed 1,608 — 1,608 — Other asset-backed securities 4,396 — 3,495 901 Equity securities 213 — 206 7 Mortgage loans 432 — — 432 Limited partnerships (1) 172 — — 172 Policy loans 3,535 — — 3,535 Freestanding derivative instruments 295 — 295 — Cash and cash equivalents 3,061 3,061 — — Reinsurance recoverable on market risk benefits 149 — — 149 Market risk benefit assets 7,615 — — 7,615 Separate account assets 235,037 — 235,037 — Total $ 295,808 $ 6,510 $ 276,134 $ 13,164 Liabilities Embedded derivative liabilities (2) $ 3,624 $ — $ 3,624 $ — Funds withheld payable under reinsurance treaties (3) 1,719 — — 1,719 Freestanding derivative instruments 425 — 425 — Notes issued by consolidated VIEs 2,366 — 2,366 — Market risk benefit liabilities 4,384 — — 4,384 Total $ 12,518 $ — $ 6,415 $ 6,103 (1) Excludes $2,221 million of limited partnership investments measured at NAV. (2) Includes the embedded derivative liabilities of $2,799 million related to RILA and $825 million liability of fixed index annuities, both included in other contract holder funds on the Condensed Consolidated Balance Sheets. (3) Includes the Athene embedded derivative asset of $1,992 million and funds withheld payable under reinsurance treaties at fair value under the fair value option. December 31, 2023 Total Level 1 Level 2 Level 3 Assets Debt securities U.S. government securities $ 4,312 $ 4,312 $ — $ — Other government securities 1,402 — 1,252 150 Public utilities 5,127 — 5,086 41 Corporate securities 25,477 — 25,394 83 Residential mortgage-backed 375 — 375 — Commercial mortgage-backed 1,423 — 1,423 — Other asset-backed securities 4,527 — 3,552 975 Equity securities 394 182 204 8 Mortgage loans 481 — — 481 Limited partnerships (1) 135 — — 135 Policy loans 3,457 — — 3,457 Freestanding derivative instruments 390 — 390 — Cash and cash equivalents 2,688 2,688 — — Reinsurance recoverable on market risk benefits 149 — — 149 Market risk benefit assets 6,737 — — 6,737 Separate account assets 219,656 — 219,656 — Total $ 276,730 $ 7,182 $ 257,332 $ 12,216 Liabilities Embedded derivative liabilities (2) $ 2,090 $ — $ 2,090 $ — Funds withheld payable under reinsurance treaties (3) 1,158 — — 1,158 Freestanding derivative instruments 1,210 — 1,210 — Notes issued by consolidated VIEs 1,988 — 1,988 — Market risk benefit liabilities 4,785 — — 4,785 Total $ 11,231 $ — $ 5,288 $ 5,943 (1) Excludes $1,997 million of limited partnership investments measured at NAV. (2) Includes the embedded derivative liabilities of $1,224 million related to RILA and $866 million of fixed index annuities, both included in other contract holder funds on the Condensed Consolidated Balance Sheets. (3) Includes the Athene embedded derivative asset of $2,468 million and funds withheld payable under reinsurance treaties at fair value under the fair value option. Assets and Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3) Level 3 Assets and Liabilities by Price Source The table below presents the balances of Level 3 assets and liabilities measured at fair value with their corresponding pricing sources (in millions): September 30, 2024 Assets Total Internal External Debt securities: Other government securities $ 156 $ — $ 156 Public utilities 87 44 43 Corporate 110 — 110 Other asset-backed securities 901 — 901 Equity securities 7 1 6 Mortgage loans 432 — 432 Limited partnerships 172 1 171 Policy loans 3,535 3,535 — Reinsurance recoverable on market risk benefits 149 149 — Market risk benefit assets 7,615 7,615 — Total $ 13,164 $ 11,345 $ 1,819 Liabilities Funds withheld payable under reinsurance treaties (1) 1,719 1,719 — Market risk benefit liabilities 4,384 4,384 — Total $ 6,103 $ 6,103 $ — (1) Includes the Athene Embedded Derivative asset of $1,992 million and funds withheld payable under reinsurance treaties at fair value under the fair value option. December 31, 2023 Assets Total Internal External Debt securities: Other government securities $ 150 $ — $ 150 Public utilities 41 41 — Corporate 83 — 83 Other asset-backed securities 975 50 925 Equity securities 8 1 7 Mortgage loans 481 — 481 Limited partnerships 135 1 134 Policy loans 3,457 3,457 — Reinsurance recoverable on market risk benefits 149 149 — Market risk benefit assets 6,737 6,737 — Total $ 12,216 $ 10,436 $ 1,780 Liabilities Funds withheld payable under reinsurance treaties (1) 1,158 1,158 — Market risk benefit liabilities 4,785 4,785 — Total $ 5,943 $ 5,943 $ — (1) Includes the Athene Embedded Derivative asset of $2,468 million and funds withheld payable under reinsurance treaties at fair value under the fair value option. External pricing sources for securities represent unadjusted prices from independent pricing services and independent indicative broker quotes where pricing inputs are not readily available. Quantitative Information Regarding Internally-Priced Level 3 Assets and Liabilities The table below presents quantitative information on internally-priced Level 3 assets and liabilities that use significant unobservable inputs (in millions): As of September 30, 2024 Fair Valuation Technique(s) Significant Unobservable Input(s) Assumption or Input Range Impact of Increase in Input on Fair Value Assets Reinsurance recoverable on market risk benefits $ 149 Discounted cash Mortality (1) 0.01% - 20.71% Increase Lapse (2) 1.47% - 8.55% Increase Utilization (3) 0.00% - 50.00% Decrease Withdrawal (4) 47.50% - 50.00% Decrease Non-performance risk adjustment (5) 0.10% - 1.29% Increase Long-term Equity Volatility (6) 18.50% Decrease Market risk benefit assets $ 7,615 Discounted cash flow Mortality (1) 0.01% - 23.46% Increase Lapse (2) 0.05% - 37.06% Increase Utilization (3) 0.00% - 100.00% Decrease Withdrawal (4) 11.25% - 100.00% Decrease Non-performance risk adjustment (5) 0.83% - 1.85% Increase Long-term Equity Volatility (6) 18.50% Decrease Liabilities Market risk benefit liabilities $ 4,384 Discounted cash flow Mortality (1) 0.01% - 23.46% Decrease Lapse (2) 0.05% - 37.06% Decrease Utilization (3) 0.00% - 100.00% Increase Withdrawal (4) 11.25% - 100.00% Increase Non-performance risk adjustment (5) 0.83% - 1.85% Decrease Long-term Equity Volatility (6) 18.50% Increase (1) Mortality rates vary by attained age, tax qualification status, guaranteed benefit election, and duration. The range displayed reflects ages from the minimum issue age for the benefit through age 95, which corresponds to the typical maturity age. A mortality improvement assumption is also applied. (2) Base lapse rates vary by contract-level factors, such as product type, surrender charge schedule and optional benefits election. Lapse rates are further adjusted based on the degree to which a guaranteed benefit is in-the-money, with lower lapse applying when benefits are more in-the-money. Lapse rates are also adjusted to reflect lower lapse expectations when guaranteed benefits are utilized. (3) The utilization rate represents the expected percentage of contracts that will utilize the benefit through annuitization (GMIB) or commencement of withdrawals (GMWB). Utilization may vary by benefit type, attained age, duration, tax qualification status, benefit provision, and degree to which the guaranteed benefit is in-the-money. (4) The withdrawal rate represents the percentage of annual withdrawal assumed relative to the maximum allowable withdrawal amount under the free partial withdrawal provision or the GMWB, as applicable. Free partial withdrawal rates vary based on the product type and duration. Withdrawal rates on contracts with a GMWB vary based on attained age, tax qualification status, GMWB type and GMWB benefit provisions. (5) Non-performance risk adjustment is applied as a spread over the risk-free rate to determine the rate used to discount the related cash flows and varies by projection year. (6) Long-term equity volatility represents the equity volatility beyond the period for which observable equity volatilities are available. As of December 31, 2023 Fair Valuation Technique(s) Significant Unobservable Input(s) Assumption or Input Range Impact of Increase in Input on Fair Value Assets Reinsurance recoverable on market risk benefits $ 149 Discounted cash flow Mortality (1) 0.01% - 20.71% Increase Lapse (2) 1.47% - 8.55% Increase Utilization (3) 0.00% - 50.00% Decrease Withdrawal (4) 47.50% - 50.00% Decrease Non-performance risk adjustment (5) 0.10% - 1.50% Increase Long-term Equity Volatility (6) 18.50% Decrease Market risk benefit assets $ 6,737 Discounted cash flow Mortality (1) 0.01% - 23.46% Increase Lapse (2) 0.05% - 37.06% Increase Utilization (3) 0.00% - 100.00% Decrease Withdrawal (4) 11.25% - 100.00% Decrease Non-performance risk adjustment (5) 0.70% - 2.11% Increase Long-term Equity Volatility (6) 18.50% Decrease Liabilities Market risk benefit liabilities $ 4,785 Discoun

Deferred Acquisition Costs

Deferred Acquisition Costs	9 Months Ended
	Sep. 30, 2024
Insurance [Abstract]
Deferred Acquisition Costs	Deferred Acquisition Costs Certain costs that are directly related to the successful acquisition of new or renewal insurance business are capitalized as deferred acquisition costs ("DAC") in the period in which they are incurred. These costs primarily pertain to commissions and certain costs associated with policy issuance and underwriting. All other acquisition costs are expensed as incurred. Contracts are grouped into cohorts by contract type and issue year. For traditional and limited-payment insurance contracts, contracts are grouped consistent with the groupings used in estimating the associated liability. DAC are amortized into expense on a constant level basis over the expected term of the grouped contracts. For traditional and limited-payment insurance contracts, amortization is determined based on projected in force amounts. For non-traditional contracts, amortization is determined based on projected policy counts . The expected term used to amortize DAC is determined using best estimate assumptions, including mortality and persistency, consistent with the best estimate assumptions used to determine the reserve for future policy benefits, MRBs, and additional liabilities for applicable contracts. For amortization of DAC related to contracts without these balances, assumptions used to determine expected term are developed in a similar manner. The amortization rate is determined using all information available as of the end of the reporting period, including actual experience and any assumption updates. Annually, or as circumstances warrant, a comprehensive review of assumptions is conducted, and assumptions are revised as appropriate. If assumptions are revised, the amortization rate is calculated using revised assumptions such that the effect of revised assumptions is recognized prospectively as of the beginning of that reporting period. Unamortized DAC are written off when a contract is internally replaced and substantially changed. Substantially unchanged contracts are treated as a continuation of the replaced contract, with no change to the unamortized DAC at the time of the replacement. The following table presents the roll-forward of the DAC (in millions). The current period amortization is based on the end of the period estimates of mortality and persistency. The amortization pattern is revised on a prospective basis at the beginning of the period based on the period’s actual experience. Nine Months Ended September 30, Year Ended December 31, 2024 2023 Variable Annuities Balance, beginning of period $ 11,967 $ 12,699 Deferrals of acquisition costs 308 394 Amortization (802) (1,126) Variable Annuities balance, end of period $ 11,473 $ 11,967 Reconciliation of total DAC Variable Annuities balance, end of period $ 11,473 $ 11,967 Other product lines, end of period 513 335 Total balance, end of period $ 11,986 $ 12,302

Reinsurance

Reinsurance	9 Months Ended
	Sep. 30, 2024
Insurance [Abstract]
Reinsurance	Reinsurance The Company, through its subsidiary insurance companies, assumes and cedes reinsurance from and to other insurance companies to limit losses from large exposures. However, if the reinsurer is unable to meet its obligations, the originating issuer of the coverage retains the liability. The Company reinsures certain of its risks to other reinsurers on a coinsurance, coinsurance with funds withheld, modified coinsurance, or yearly renewable term basis. The Company regularly monitors the financial strength ratings of its reinsurers. Athene Reinsurance The Company entered into a funds withheld coinsurance agreement with Athene effective June 1, 2020, to reinsure on a 100% quota share basis, a block of Jackson’s in-force fixed and fixed-index annuity product liabilities in exchange for a $1.2 billion ceding commission. The coinsurance with funds withheld agreement ("the coinsurance agreement") required Jackson to establish a segregated account in which the investments supporting the ceded obligations are maintained. While the economic benefits of the investments flow to Athene, Jackson retains physical possession and legal ownership of the investments supporting the reserve. Further, the investments in the segregated account are not available to settle any policyholder obligations other than those specifically covered by the coinsurance agreement and are not available to settle obligations to general creditors of Jackson. The profit and loss with respect to obligations ceded to Athene are included in periodic net settlements pursuant to the coinsurance agreement. To further support its obligations under the coinsurance agreement, Athene procured $1.2 billion in letters of credit for Jackson’s benefit and established a trust account for Jackson’s benefit, which had a book value of approximately $80 million at September 30, 2024. Swiss Re Reinsurance Jackson has three retrocession reinsurance agreements (“retro treaties”) with Swiss Reinsurance Company Ltd. (“SRZ”). Pursuant to these retro treaties, Jackson ceded certain blocks of business to SRZ on a 100% coinsurance with funds withheld basis, subject to pre-existing reinsurance with other parties. As a result of the reinsurance agreements with SRZ, Jackson withholds certain assets, primarily in the form of policy loans and debt securities, as collateral for the reinsurance recoverable. The Company has also acquired certain blocks of business that are closed to new business and wholly ceded to non-affiliates. These include both direct and assumed accident and health businesses, direct and assumed life insurance business, and certain institutional annuities. GMIB Reinsurance The Company’s guaranteed minimum income benefits (“GMIBs”) are reinsured with an unrelated party. GMIB reinsured benefits are subject to aggregate annual claim limits. Deductibles also apply on reinsurance of GMIB business issued since March 1, 2005. The Company discontinued offering the GMIB in 2009. Reinsurance Recoverables and Reinsured Market Risk Benefits Ceded reinsurance agreements are reported on a gross basis on the Company’s Condensed Consolidated Balance Sheets as an asset for amounts recoverable from reinsurers or as a component of other assets or liabilities for amounts, such as premiums, owed to or due from reinsurers. Reinsurance recoverables relating to reinsurance of traditional and limited-payment contracts are required to be recognized and measured in a manner consistent with liabilities relating to the underlying reinsured contracts, including using consistent assumptions. Reinsurance contracts may be executed subsequent to the direct contract issue dates, and market interest rates may have changed between the date that the underlying insurance contracts were issued and the date the reinsurance contract is recognized in the financial statements, resulting in the underlying discount rate differing between the direct and reinsured business. The Company regularly monitors the financial strength ratings of its reinsurers. At September 30, 2024 and December 31, 2023, the Company had an allowance for credit losses (“ACL”) of $25 million and $29 million, respectively, on its reinsurance recoverables, which are reported net of ACL on the Condensed Consolidated Balance Sheets. The ACL considers the credit quality of the reinsurer and is generally determined based on probability of default and loss given default assumptions, after considering any applicable collateral arrangements. For reinsurance recoverables that are collateralized, the amount of collateral is expected to be adjusted as necessary as a result of fair value changes in that collateral. If the fair value of the collateral at the reporting date is less than the carrying value of the reinsurance recoverable, the Company recognizes an ACL on the difference between the fair value of the collateral at the reporting date and the carrying value of the reinsurance recoverable. Additions to or releases of the ACL are reported in Death, other policyholder benefits, and changes in reserves, net of deferrals in the Condensed Consolidated Income Statements. Reinsurance recoverable on market risk benefits is recognized at fair value with changes being recognized in current period earnings within market risk benefit (gains) losses, net. Non-performance risk of the reinsurer is incorporated into the calculation through the adjustment of the risk-free rate curve based on credit spreads observed on instruments issued by similarly-rated life insurance companies. The Company’s reinsurance contract that cedes only the GMIB elected on certain variable annuity products is classified as a reinsurance recoverable on market risk benefits. These reinsured MRBs may have direct MRB balances recorded as either assets or liabilities; however, because the unit of account for the reinsured MRB is the reinsurance contract, the ceded MRB is presented in total within reinsurance recoverable on market risk benefits. The fees used to determine the fair value of the reinsurance recoverable on market risk benefits are those defined in the reinsurance contract. Guaranteed benefits related to the optional lifetime income rider offered on certain fixed index annuities are MRBs that are reinsured with Athene. The reinsured MRBs are measured using a non-option valuation approach that uses cash flow assumptions and an attributed fee ratio consistent with those used to measure the MRBs on the direct contract and a discount rate that considers the reinsurer’s credit risk. The attributed fee is locked-in at inception of the contract. Components of the Company’s reinsurance recoverable excluding MRBs were as follows (in millions): September 30, December 31, 2024 2023 Reserves: Life $ 5,380 $ 5,370 Accident and health 508 510 Annuity benefits (1) 16,411 18,873 Claims liability and other 660 669 Total $ 22,959 $ 25,422 (1) Other annuity benefits primarily attributable to fixed and fixed index annuities reinsured with Athene. Components of the Company’s reinsurance recoverable on market risk benefits were as follows (in millions): September 30, December 31, 2024 2023 Variable annuity $ 78 $ 90 Other product lines 71 59 Total $ 149 $ 149 Reinsurance and Funds Withheld Payable Under Reinsurance Treaties Under the reinsurance agreement with Athene and the retro treaties with SRZ, the Company maintains ownership of the underlying investments instead of transferring them to the reinsurer and, as a result, records a funds withheld liability payable to the reinsurer. Investment returns earned on withheld assets are paid by the Company to the reinsurer, pursuant to the terms of the agreements. Investment income and net gains (losses) on derivatives and investments are reported net of gains or losses on the funds withheld payable under reinsurance treaties. The amounts credited to reinsurers on the funds withheld payable is based on the return earned on those assets. The return earned on the assets is subject to the credit risk of the original issuer of the instrument rather than Jackson’s own creditworthiness, which results in an embedded derivative (total return swap). Funds withheld under reinsurance agreement with Athene The Company recognizes a liability for the embedded derivative related to the funds withheld under the reinsurance agreement with Athene within funds withheld payable under reinsurance treaties in the Condensed Consolidated Balance Sheets. The embedded derivative is measured at fair value with changes in fair value reported in net gains (losses) on derivatives and investments in the Condensed Consolidated Income Statements. At inception of the reinsurance agreement with Athene, the fair value of the withheld investments differed from their book value and, accordingly, while the investments are held, the amortization of this difference is reported in net gains (losses) on derivatives and investments in the Condensed Consolidated Income Statements. See Note 5 - Derivative Instruments of the Notes to Condensed Consolidated Financial Statements for more information on the embedded derivative. Funds withheld under reinsurance agreements with SRZ At execution of the retro treaties with SRZ, the Company elected the fair value option for the withheld assets, as well as the related funds withheld payable. Accordingly, the embedded derivative is not bifurcated or separately measured. The funds withheld payable is measured at fair value with changes in fair value reported in net gains (losses) on derivatives and investments. The fair value of the funds withheld payable is equal to the fair value of the assets held as collateral. The following assets and liabilities were held in support of reserves associated with the Company’s funds withheld reinsurance agreements and were reported in the respective financial statement line items in the Condensed Consolidated Balance Sheets (in millions): September 30, December 31, 2024 2023 Assets Debt securities, available-for-sale $ 10,344 $ 11,526 Debt securities, at fair value under the fair value option 155 116 Equity securities 148 151 Mortgage loans 2,658 3,067 Mortgage loans, at fair value under the fair value option 432 481 Policy loans 3,548 3,471 Freestanding derivative instruments, net 5 15 Other invested assets 752 709 Cash and cash equivalents 224 543 Accrued investment income 118 146 Other assets and liabilities, net (29) 1 Total assets (1) $ 18,355 $ 20,226 Liabilities Funds held under reinsurance treaties (2) $ 18,103 $ 19,952 Total liabilities $ 18,103 $ 19,952 (1) Certain assets are reported at amortized cost while the fair value of those assets is reported in the embedded derivative in the funds withheld liability. (2) Includes funds withheld embedded derivative asset (liability) of $1,992 million and $2,468 million at September 30, 2024 and December 31, 2023, respectively. The sources of income related to funds withheld under reinsurance treaties reported in net investment income in the Condensed Consolidated Income Statements were as follows (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Debt securities (1) $ 133 $ 162 $ 415 $ 494 Equity securities 8 2 17 (36) Mortgage loans (2) 47 48 141 174 Policy loans 82 80 246 238 Limited partnerships 11 17 39 32 Other investment income 3 13 13 16 Total investment income on funds withheld assets 284 322 871 918 Other investment expenses on funds withheld assets (3) (15) (19) (47) (56) Total net investment income on funds withheld reinsurance treaties $ 269 $ 303 $ 824 $ 862 (1) Includes $1 million and $2 million for the three and nine months ended September 30, 2024, respectively, and $1 million and $3 million for the three and nine months ended September 30, 2023, respectively, related to the change in fair value for securities carried under the fair value option. (2) Includes $4 million and $1 million for the three and nine months ended September 30, 2024, respectively, and $(5) million and $(7) million for the three and nine months ended September 30, 2023, respectively, related to the change in fair value for mortgage loans carried under the fair value option. (3) Includes management fees. The gains and losses on funds withheld reinsurance treaties as a component of net gains (losses) on derivatives and investments in the Condensed Consolidated Income Statements were as follows (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Available-for-sale securities Realized gains on sale $ 2 $ 8 $ 5 $ 24 Realized losses on sale (13) (13) (43) (61) Credit loss expense (12) (10) (18) (8) Credit loss expense on mortgage loans 1 (10) 8 (17) Other 16 (16) 6 (4) Net gains (losses) on non-derivative investments (6) (41) (42) (66) Net gains (losses) on derivative instruments (30) 24 (11) 1 Net gains (losses) on funds withheld payable under reinsurance treaties (1) (748) 176 (1,146) (583) Total net gains (losses) on derivatives and investments $ (784) $ 159 $ (1,199) $ (648) (1) Includes the Athene embedded derivative gain (loss) of $(530) million and $(476) million for the three and nine months ended September 30, 2024, respectively, and $451 million and $194 million for the three and nine months ended September 30, 2023, respectively.

Reserves for Future Policy Bene

Reserves for Future Policy Benefits and Claims Payable	9 Months Ended
	Sep. 30, 2024
Insurance [Abstract]
Reserves for Future Policy Benefits and Claims Payable	Reserves for Future Policy Benefits and Claims Payable Reserves for Future Policy Benefits For non-participating traditional and limited-payment insurance contracts, the reserve for future policy benefits represents the present value of estimated future policy benefits to be paid to or on behalf of policyholders in future periods and certain related expenses less the present value of estimated future net premiums. Reserves for future policy benefits for non-participating traditional and limited-payment insurance contracts are measured using the net premium ratio ("NPR") measurement model. The NPR measurement model accrues for future policy benefits in proportion to the premium revenue recognized. The reserve for future policy benefits is derived from the Company's best estimate of future net premium and future benefits and expenses, which is based on best estimate assumptions including mortality, persistency, claims expense, and discount rate. On an annual basis, or as circumstances warrant, we conduct a comprehensive review of our current best estimate assumptions based on our experience, industry benchmarking, and other factors, as applicable. Expense assumptions are updated based on estimates of expected non-level costs, such as termination or settlement costs, and costs after the premium-paying period and exclude acquisition costs or any costs that are required to be charged to expenses as incurred. Updates to assumptions are applied on a retrospective basis, and the change in the reserve for future policy benefits resulting from updates to assumptions is reported separately on the Condensed Consolidated Income Statements within the (Gain) loss from updating future policy benefits cash flow assumptions, net. Each reporting period the reserve for future policy benefits is updated to reflect actual experience to date. The Company establishes cohorts, which are groupings used to measure reserves for future policy benefits. In determining cohorts, the Company considered both qualitative and quantitative factors, including the issue year, type of product, product features, and legal entity. The discount rate used to estimate reserves for future policy benefits is consistent with an upper-medium grade (low-credit risk) fixed-income corporate instrument yield, which has been interpreted to represent a single-A corporate instrument yield. This discount rate curve is determined by fitting a parametric function to yields to maturity and related times to maturity of market observable single-A rated corporate instruments. The discount rate used to recognize interest accretion on the reserves for future policy benefits is locked at the initial measurement of the cohort. Each reporting period, the reserve for future policy benefits is remeasured using the current discount rate. The difference between the reserve calculated using the current discount rate and the reserve calculated using the locked-in discount rate is recorded in OCI. For limited-payment insurance contracts, premiums are paid over a period shorter than the period over which benefits are provided. Gross premiums received in excess of the net premium are deferred and recognized as a deferred profit liability ("DPL"). The DPL is included within the reserve for future policy benefits and profits are recognized in income as a component of benefit expenses on a constant relationship with the amount of expected future benefit payments. Interest is accreted on the balance of the DPL using the discount rate locked in at the initial measurement of the cohort. Measurement of the DPL uses best estimate assumptions for mortality. These assumptions are similarly subject to the annual review process discussed above. Additional Liabilities – Universal Life-type For universal life-type insurance contracts, a liability is recognized for the policyholder’s account value as discussed further in Note 10 of the Notes to Condensed Consolidated Financial Statements. Where these contracts provide additional benefits beyond the account balance or base insurance coverage that are not market risk benefits or embedded derivatives, liabilities in addition to the policyholder’s account value are recognized. These additional liabilities for annuitization, death and other insurance benefits are reported within reserves for future policy benefits and claims payable. The methodology uses a benefit ratio defined as a constant percentage of the assessment base. This ratio is multiplied by current period assessments to determine the reserve accrual for the period. The assumptions used in the measurement of the additional liabilities for annuitization, death and other insurance benefits are based on best estimate assumptions including mortality, persistency, investment returns, and discount rates. These assumptions are similarly subject to the annual review process discussed above. As available-for-sale debt securities are carried at fair value, an adjustment is made to these additional liabilities equal to the change in liability that would have occurred if such securities had been sold at their stated fair value and the proceeds reinvested at current yields. This adjustment, along with the change in net unrealized gains (losses) on available-for-sale debt securities, net of applicable tax, is credited or charged directly to equity as a component of OCI. See Note 10 - Other Contract Holder Funds of the Notes to Condensed Consolidated Financial Statements for more information regarding other contract holder funds. Other Future Policy Benefits and Claims Payable In conjunction with a prior acquisition, the Company recorded a fair value adjustment at acquisition related to certain annuity and interest-sensitive liability blocks of business to reflect the cost of the interest guarantees within the in-force liabilities, based on the difference between the guaranteed interest rate and an assumed new money guaranteed interest rate at acquisition. This adjustment is included in other future policy benefits and claims payable as disclosed in the table below. This liability is remeasured at the end of each period, taking into account changes in the in-force block. Any resulting change in the liability is recorded as a Gain (loss) from updating future policy benefits cash flow assumptions, net through the Condensed Consolidated Income Statements. In addition, annuity and life claims liabilities in course of settlement are included in other future policy benefits and claims payable as disclosed in the table below. The following table summarizes the Company’s reserves for future policy benefits and claims payable balances (in millions): September 30, December 31, 2024 2023 Reserves for future policy benefits Payout Annuities $ 1,143 $ 1,090 Closed Block Life 3,847 3,994 Closed Block Annuity 4,056 4,215 Reserves for future policy benefits 9,046 9,299 Additional liabilities Closed Block Life 1,104 1,153 Other future policy benefits and claims payable 1,393 1,446 Reserves for future policy benefits and claims payable $ 11,543 $ 11,898 The following tables present the roll-forward of components of reserves for future policy benefits (in millions): Present Value of Expected Net Premiums Nine Months Ended September 30, Year Ended December 31, 2024 2023 Payout Closed Block Closed Block Payout Closed Block Closed Block Annuities Life Annuity Annuities Life Annuity Balance, beginning of period $ — $ 1,140 $ — $ — $ 1,287 $ — Beginning of period cumulative effect of changes in discount rate assumptions — 113 — — 161 — Beginning balance at original discount rate — 1,253 — — 1,448 — Effect of changes in cash flow assumptions — — — — 22 — Effect of actual variances from expected experience — (20) — — (95) — Balance adjusted for variances from expectation — 1,233 — — 1,375 — Issuances — 3 — — 6 — Interest accrual — 33 — — 38 — Net premiums collected — (99) — — (166) — Ending balance at original discount rate — 1,170 — — 1,253 — End of period cumulative effect of changes in discount rate assumptions — (88) — — (113) — Balance, end of period $ — $ 1,082 $ — $ — $ 1,140 $ — Present Value of Expected Future Policy Benefits Nine Months Ended September 30, Year Ended December 31, 2024 2023 Payout Closed Block Closed Block Payout Closed Block Closed Block Annuities Life Annuity Annuities Life Annuity Balance, beginning of period $ 1,090 $ 5,134 $ 4,215 $ 1,042 $ 5,448 $ 4,434 Beginning of period cumulative effect of changes in discount rate assumptions 99 767 185 132 958 275 Beginning balance at original discount rate (including DPL of $42, $0 and $626 in September 30, 2024, and $40, $0 and $671 in December 31, 2023 for payout annuities, closed block life and closed block annuity, respectively) 1,189 5,901 4,400 1,174 6,406 4,709 Effect of changes in cash flow assumptions — — — — 65 (3) Effect of actual variances from expected experience (32) (4) — (16) (95) (8) Balance adjusted for variances from expectation 1,157 5,897 4,400 1,158 6,376 4,698 Issuances 126 8 — 117 15 1 Interest accrual 34 127 138 43 195 194 Benefits payments (102) (460) (359) (129) (685) (493) Ending balance of original discount rate (including DPL of $46, $0 and $590 in September 30, 2024, and $42, $0 and $626 in December 31, 2023 for payout annuities, closed block life and closed block annuity, respectively) 1,215 5,572 4,179 1,189 5,901 4,400 End of period cumulative effect of changes in discount rate assumptions (72) (643) (123) (99) (767) (185) Balance, end of period $ 1,143 $ 4,929 $ 4,056 $ 1,090 $ 5,134 $ 4,215 Reserves for future policy benefits 1,143 3,847 4,056 1,090 3,994 4,215 Less: Reinsurance recoverable 113 2,135 4 94 2,200 4 Reserves for future policy benefits, after reinsurance recoverable $ 1,030 $ 1,712 $ 4,052 $ 996 $ 1,794 $ 4,211 The following table presents the weighted average duration of the reserves for future policy benefits. The weighted average duration represents average cohort-level duration weighted by the benefit reserves amount: Payout Closed Block Closed Block Annuities Life Annuity September 30, 2024 Weighted average duration (years) 7.1 7.1 6.9 December 31, 2023 Weighted average duration (years) 7.0 7.2 7.0 The discount rate assumption was updated based on current market data. Discount rates were lower in the third quarter of 2024 compared to the fourth quarter of 2023. Discount rates decreased primarily due to decreases in risk-free rates. The following table presents the amount of undiscounted and discounted expected future gross premiums and expected future benefit payments for future policy benefits for non-participating traditional and limited-payment insurance contracts (in millions). The discounted premiums are calculated using the current discount rate, while the undiscounted cash flows represent the gross cash flows before any discounting is applied: September 30, 2024 December 31, 2023 Undiscounted Discounted Undiscounted Discounted Payout Annuities Expected future benefit payments $ 1,649 $ 1,097 $ 1,579 $ 1,043 Expected future gross premiums — — — — Closed Block Life Expected future benefit payments 7,257 5,043 7,729 5,251 Expected future gross premiums 4,675 2,931 5,056 3,119 Closed Block Annuity Expected future benefit payments 5,131 3,443 5,421 3,565 Expected future gross premiums $ — $ — $ — $ — The following table presents the amount of revenue and interest related to non-participating traditional and limited-pay insurance contracts recognized in the Condensed Consolidated Income Statements (in millions): Gross Premiums Interest Expense Nine Months Ended September 30, 2024 Year Ended December 31, 2023 Nine Months Ended September 30, 2024 Year Ended December 31, 2023 Payout Annuities $ 34 $ 22 $ 34 $ 43 Closed Block Life 232 340 94 157 Closed Block Annuity — 1 138 194 Total $ 266 $ 363 $ 266 $ 394 The following table presents the weighted average interest rate for the reserves for future policy benefits at the cohort's level for the locked-in discount rate (interest accretion rate), and current discount rate, weighted by the cohort's benefit reserve amount: September 30, 2024 December 31, 2023 Payout Annuities Interest accretion rate 4.00 % 3.86 % Current discount rate 4.89 % 5.12 % Closed Block Life Interest accretion rate 3.07 % 3.07 % Current discount rate 4.96 % 5.06 % Closed Block Annuity Interest accretion rate 4.40 % 4.40 % Current discount rate 4.90 % 5.12 % The following table presents a roll-forward of Closed Block Life additional liabilities for annuitization, death and other insurance benefits (in millions): Nine Months Ended September 30, 2024 Year Ended December 31, 2023 Balance, beginning of period $ 1,153 $ 1,131 Beginning of period cumulative effect of changes in shadow adjustments 17 41 Beginning balance excluding shadow 1,170 1,172 Effect of changes in cash flow assumptions — 44 Effect of actual variances from expected experience 10 46 Interest accrual 42 56 Net assessments collected (101) (148) Ending balance excluding shadow 1,121 1,170 End of period cumulative effect of changes in shadow adjustments (17) (17) Balance, end of period $ 1,104 $ 1,153 The following table presents the weighted average duration of Closed Block Life additional liabilities for annuitization, death and other insurance benefits. The weighted average duration represents average cohort-level duration weighted by the benefit reserves amount: September 30, 2024 December 31, 2023 Weighted average duration (years) 9.5 9.7 The following table presents assessments and interest expense of Closed Block Life additional liabilities for annuitization, death and other insurance benefits recognized in the Condensed Consolidated Income Statements (in millions): Assessments Interest Expense Nine Months Ended September 30, 2024 Year Ended December 31, 2023 Nine Months Ended September 30, 2024 Year Ended December 31, 2023 Additional liability for annuitization, death and other insurance benefits $ (101) $ (148) $ 42 $ 56 The following table presents the weighted average current discount rate of Closed Block Life additional liabilities for annuitization, death and other insurance benefits, applied at the cohort level weighted by reserve benefit amount: September 30, 2024 December 31, 2023 Weighted average current discount rate 4.98 % 4.97 %

Other Contract Holder Funds

Other Contract Holder Funds	9 Months Ended
	Sep. 30, 2024
Participating Insurance [Abstract]
Other Contract Holder Funds	Other Contract Holder Funds Other contract holder funds represent the policyholder account balance on our universal life-type products, investment contracts, and the fair value of the embedded derivatives associated with the indexed crediting features on our fixed index annuities and registered index-linked annuities. Universal life type contracts have, as a principal component, an account balance in which interest is credited to policyholders and assessments are deducted for mortality risk and contract administration. The account balance is recognized as a liability within other contract holder funds, and the liability is updated each period for fee and assessment deductions and increased for interest or returns credited to the account balance. Certain of our universal life type contracts contain features that are not classified as market risk benefits or embedded derivatives but provide additional benefits beyond the account balance or base insurance coverage for which a liability in addition to the account balance is necessary. These additional liabilities for death or other insurance benefits are reported as a component of reserves for future policy benefits and claims payable in the Condensed Consolidated Balance Sheets. See Note 9 - Reserves for Future Policy Benefits and Claims Payable of the Notes to the Condensed Consolidated Financial Statements for more information regarding these additional liabilities. Certain contracts without significant mortality or morbidity risk and certain annuities that lack insurance risk are treated as investment contracts. For investment contracts, payments received are reported as liabilities and accounted for in a manner consistent with the accounting for interest-bearing or other financial instruments, within other contract holder funds. The Company issues a variety of annuity products including fixed annuities, fixed index annuities, registered index linked annuities, variable annuities and payout annuities. For annuity contracts that are classified as investment contracts, the liability is the account balance as of the reporting date, reported within the other contract holder funds. For the variable annuity products, only the allocations to fixed fund options are reported in other contract holder funds. For our fixed index annuities and registered index linked annuities, the equity-linked option issued by the Company is accounted for as an embedded derivative measured at fair value and reported as a component of other contract holder funds on the Condensed Consolidated Balance Sheets with changes in fair value recorded in net income within net gains (losses) on derivatives and investments. The fair value is determined using an option-budget method with capital market inputs of market index returns and discount rates as well as actuarial assumptions including lapse, mortality and withdrawal rates. Favorable equity market movements cause increases in future contract holder benefits, resulting in an increase in the fair value of the embedded derivative liability (and vice versa). The Company also establishes a host contract reserve to support the underlying guaranteed account value growth. This host contract liability is included as a component of other contract holder funds on the Condensed Consolidated Balance Sheets. Interest is accreted to the host contract liability using an effective yield method. Our annuity products may contain certain features or guarantees that are classified as MRBs. These market risk benefits are a component of the market risk benefits line items in the Condensed Consolidated Balance Sheet. See Note 12 - Market Risk Benefits of the Notes to Condensed Consolidated Financial Statements for more information regarding market risk benefits. The Company’s institutional products business is comprised of the guaranteed investment contracts, medium-term funding agreement-backed notes and funding agreements (including agreements issued in conjunction with the Company’s participation in the U.S. Federal Home Loan Bank ("FHLB") program) described below. The Company has established a $27 billion aggregate Global Medium-Term Note ("MTN") program. Jackson National Life Global Funding was formed as a statutory business trust, solely for the purpose of issuing Medium-Term Note instruments to institutional investors, the proceeds of which are deposited with the Company and secured by the issuance of funding agreements. The carrying values at September 30, 2024 and December 31, 2023 totaled $5.5 billion and $5.8 billion, respectively. Those Medium-Term Note instruments issued in a foreign currency have been hedged for changes in exchange rates using cross-currency swaps. The unrealized foreign currency gains and losses on those Medium-Term Note instruments are included in the carrying value of the trust instruments supported by funding agreements. Trust instrument liabilities are adjusted to reflect the effects of foreign currency translation gains and losses using exchange rates as of the reporting date. Foreign currency translation gains and losses are included in net gains (losses) on derivatives and investments. Jackson is a member of the FHLBI primarily for the purpose of participating in the bank’s mortgage-collateralized loan advance program with long-term funding facilities. Advances are in the form of funding agreements, short-term and long-term borrowings issued to FHLBI. At September 30, 2024 and December 31, 2023, the Company held $127 million and $108 million of FHLBI capital stock, respectively, supporting $2.0 billion and $2.3 billion in funding agreements and short-term and long-term borrowings at September 30, 2024 and December 31, 2023, respectively. At September 30, 2024 and December 31, 2023, the funding agreements and short-term and long-term borrowings were collateralized by mortgage-related securities and commercial mortgage loans with a carrying value of $3.0 billion and $3.5 billion, respectively. The following table presents the liabilities for other contract holder funds (in millions): September 30, 2024 December 31, 2023 Payout Annuity $ 852 $ 860 Variable Annuity 7,509 8,396 Fixed Annuity 9,593 9,736 Fixed Indexed Annuities 8,990 10,243 RILA 10,250 5,219 Closed Block Life 10,884 11,039 Closed Block Annuity 1,163 1,252 Institutional Products 7,929 8,406 Other Product Lines 164 168 Total other contract holder funds $ 57,334 $ 55,319 The following table presents a roll-forward of other contract holder funds, gross of reinsurance (in millions): Fixed Closed Closed Payout Variable Fixed Indexed Block Block Annuity Annuity Annuity Annuities RILA Life Annuity Total Balance as of January 1, 2024 $ 860 $ 8,396 $ 9,736 $ 10,243 $ 5,219 $ 11,039 $ 1,252 $ 46,745 Deposits 165 544 1,080 127 4,187 218 3 6,324 Surrenders, withdrawals and benefits (194) (1,596) (1,339) (1,610) (130) (462) (125) (5,456) Net transfers from (to) separate accounts — 51 — — — — — 51 Investment performance / change in value of equity option — — — 108 950 — — 1,058 Interest credited 21 171 233 135 24 455 33 1,072 Policy charges and other — (57) (117) (13) — (366) — (553) Balance as of September 30, 2024 $ 852 $ 7,509 $ 9,593 $ 8,990 $ 10,250 $ 10,884 $ 1,163 $ 49,241 Fixed Closed Closed Payout Variable Fixed Indexed Block Block Annuity Annuity Annuity Annuities RILA Life Annuity Total Balance as of January 1, 2023 $ 837 $ 10,259 $ 11,696 $ 11,787 $ 1,875 $ 11,215 $ 1,319 $ 48,988 Deposits 202 995 234 211 2,890 307 4 4,843 Surrenders, withdrawals and benefits (231) (1,788) (2,406) (1,954) (70) (738) (115) (7,302) Net transfers from (to) separate accounts — (1,256) — — — — — (1,256) Investment performance / change in value of equity option — — — 51 509 — — 560 Interest credited 25 273 342 210 14 730 44 1,638 Policy charges and other 27 (87) (130) (62) 1 (475) — (726) Balance as of December 31, 2023 $ 860 $ 8,396 $ 9,736 $ 10,243 $ 5,219 $ 11,039 $ 1,252 $ 46,745 The following table presents weighted average crediting rate, net amount at risk, and cash surrender value of contract holder account balances (dollars in millions): Fixed Closed Closed Payout Variable Fixed Indexed Block Block Annuity Annuity Annuity Annuities RILA Life Annuity September 30, 2024 Weighted-average crediting rate (1) 3.29 % 3.04 % 3.24 % 2.00 % 0.31 % 5.57 % 3.78 % Net amount at risk (2) $ — $ — $ — $ — $ — $ 15,937 $ — Cash surrender value (3) $ — $ 7,449 $ 9,447 $ 8,778 $ 9,837 $ 10,817 $ 1,162 December 31, 2023 Weighted-average crediting rate (1) 2.91 % 3.25 % 3.51 % 2.05 % 0.27 % 6.61 % 3.51 % Net amount at risk (2) $ — $ — $ — $ — $ — $ 16,619 $ — Cash surrender value (3) $ — $ 8,306 $ 9,639 $ 9,999 $ 4,896 $ 10,970 $ 1,252 (1) Weighted average crediting rate is the average crediting rate weighted by contract holder account balances invested in fixed account funds. (2) Net amount at risk represents the standard excess benefit base for guaranteed death benefits on universal life type products. The net amount at risk associated with market risk benefits are presented within Note 12 of the Notes to Condensed Consolidated Financial Statements. (3) Cash surrender value represents the amount of the contract holder’s account balance distributable at the balance sheet date less the applicable surrender charges. At September 30, 2024 and December 31, 2023, excluding reinsurance business, approximately 94% and 92% of the Company’s annuity account values correspond to crediting rates that are at the minimum guaranteed interest rates, respectively. At September 30, 2024 and December 31, 2023, excluding reinsurance business, approximately 82% and 64% of the Company’s closed block life account values correspond to crediting rates that are at the minimum guaranteed interest rates, respectively. The following table presents contract holder account balances invested in fixed account funds by range of guaranteed minimum crediting rates and the related range of the difference between rates being credited to other contract holder funds and the respective guaranteed minimums (in millions): September 30, 2024 At Guaranteed 1 Basis Point-50 51 Basis Points-150 Greater Than 150 Range of Guaranteed Minimum Crediting Rate Minimum Basis Points Above Basis Points Above Basis Points Above Total Variable Annuities 0.00%-1.50% $ — $ 11 $ — $ — $ 11 1.51%-2.50% 159 — — — 159 Greater than 2.50% 7,339 — — — 7,339 Total $ 7,498 $ 11 $ — $ — $ 7,509 Fixed Annuities 0.00%-1.50% $ 28 $ 46 $ 39 $ 1 $ 114 1.51%-2.50% 25 1 1 — 27 Greater than 2.50% 1,741 43 1 251 2,036 Total $ 1,794 $ 90 $ 41 $ 252 $ 2,177 Fixed Indexed Annuities 0.00%-1.50% $ 3 $ 9 $ 2 $ 38 $ 52 1.51%-2.50% — — — — — Greater than 2.50% 18 — 86 23 127 Total $ 21 $ 9 $ 88 $ 61 $ 179 RILA 0.00%-1.50% $ 6 $ — $ 4 $ 3 $ 13 1.51%-2.50% — — — — — Greater than 2.50% 79 9 — — 88 Total $ 85 $ 9 $ 4 $ 3 $ 101 Closed Block Life 0.00%-1.50% $ — $ — $ — $ — $ — 1.51%-2.50% 1 11 — — 12 Greater than 2.50% 5,506 409 746 5 6,666 Total $ 5,507 $ 420 $ 746 $ 5 $ 6,678 Closed Block Annuity 0.00%-1.50% $ — $ — $ — $ — $ — 1.51%-2.50% — — 1 12 13 Greater than 2.50% 963 20 25 — 1,008 Total $ 963 $ 20 $ 26 $ 12 $ 1,021 December 31, 2023 At Guaranteed 1 Basis Point-50 51 Basis Points-150 Greater Than 150 Range of Guaranteed Minimum Crediting Rate Minimum Basis Points Above Basis Points Above Basis Points Above Total Variable Annuities 0.00%-1.50% $ — $ 12 $ 1 $ — $ 13 1.51%-2.50% 173 — — — 173 Greater than 2.50% 8,186 — — 24 8,210 Total $ 8,359 $ 12 $ 1 $ 24 $ 8,396 Fixed Annuities 0.00%-1.50% $ 17 $ 55 $ 70 $ 1 $ 143 1.51%-2.50% 29 1 1 — 31 Greater than 2.50% 721 51 1 271 1,044 Total $ 767 $ 107 $ 72 $ 272 $ 1,218 Fixed Indexed Annuities 0.00%-1.50% $ 4 $ 9 $ 3 $ 43 $ 59 1.51%-2.50% — — — — — Greater than 2.50% 21 — 62 10 93 Total $ 25 $ 9 $ 65 $ 53 $ 152 RILA 0.00%-1.50% $ 7 $ — $ 4 $ 1 $ 12 1.51%-2.50% — — — — — Greater than 2.50% 39 12 — — 51 Total $ 46 $ 12 $ 4 $ 1 $ 63 Closed Block Life 0.00%-1.50% $ — $ — $ — $ — $ — 1.51%-2.50% — — — — — Greater than 2.50% 4,425 1,830 603 16 6,874 Total $ 4,425 $ 1,830 $ 603 $ 16 $ 6,874 Closed Block Annuity 0.00%-1.50% $ — $ — $ — $ — $ — 1.51%-2.50% — — 1 12 13 Greater than 2.50% 896 169 23 — 1,088 Total $ 896 $ 169 $ 24 $ 12 $ 1,101 Contracts or contract features that provide protection to the contract holder from capital market risk and expose the Company to other-than-nominal capital market risk are classified as MRBs. All long-duration insurance contracts and certain investment contracts are subject to MRB evaluation. MRBs are measured at fair value at the contract level and can be in either an asset or liability position. For contracts that contain multiple MRB features, the MRBs are valued together as a single compound MRB. Market risk benefit assets and Market risk benefit liabilities are reported separately on the Condensed Consolidated Balance Sheets. Changes in fair value are reported in Net (gains) losses on market risk benefits on the Condensed Consolidated Income Statements. However, the change in fair value related to our own non-performance risk is reported as a component of other comprehensive income in Change in non-performance risk on market risk benefits on the Condensed Consolidated Statements of Comprehensive Income (Loss). A description of the items effecting the change in fair value by category is as follows: • Changes in interest rates — movement in risk free rates (impacts both assumed future separate account returns and discounting of cash flows) • Fund performance — separate account returns gross of fees • Change in equity index volatility — movement in implied volatility • Expected policyholder behavior — policyholder behavior as assumed in reserving • Actual policyholder behavior different than expected — difference between actual behavior during the period versus assumed behavior • Time — effect of passage of time including reduction to separate account balances from fees, the change in proximity of future cash flows, and impacts to policy features such as bonus credits • Change in assumptions — changes in assumptions resulting from our periodic review • Change in non-performance risk — changes in Jackson’s non-performance risk See Note 6 - Fair Value Measurements of the Notes to Condensed Consolidated Financial Statements for more information regarding fair value measurements. Additionally, when an annuitization occurs (for annuitization benefits) or upon extinguishment of the account balance (for withdrawal benefits), the balance related to the MRB is derecognized and the amount deducted (after derecognition of any related amount included in accumulated other comprehensive income) is used in the calculation of the liability for future policy benefits for the resulting payout annuity. Variable Annuities Variable annuity contracts issued by the Company offer various guaranteed minimum death, withdrawal, income and accumulation benefits. These guaranteed benefit features, as well as the reinsurance recoverable on the Company’s GMIB, are classified as MRBs and measured at fair value. The Company discontinued offering the GMIB in 2009 and the GMAB in 2011. Variable annuity guaranteed benefit features classified as MRBs, which have explicit fees, are measured using the attributed fee method. Under the attributed fee method, fair value is measured as the difference between the present value of projected future liabilities and the present value of projected attributed fees. At the inception of the contract, the Company attributes to the MRB a portion of total fees expected to be assessed against the contract holder to offset the projected claims over the lifetime of the contract. The attributed fee is expressed as a percentage of total projected future fees at inception of the contract. This percentage of total projected fees is considered a fixed term of the MRB feature and is held static over the life of the contract. This percentage may not exceed 100% of the total projected contract fees as of contract inception. As the Company may issue contracts that have projected future liabilities greater than the projected future guaranteed benefit fees at issue, the Company may also attribute mortality and expense charges when performing this calculation. In subsequent valuations, both the present value of future projected liabilities and the present value of projected attributed fees are remeasured based on current market conditions and policyholder behavior assumptions. Fixed Index Annuities The longevity riders issued on fixed index annuities are classified as MRBs and measured at fair value. Similar to the variable annuity guaranteed benefits features, these contracts have explicit fees and are measured using the attributed fee method. The Company attributes a percentage of total projected future fees expected to be assessed against the policyholder to offset the projected future claims over the lifetime of the contract. If the fees attributed are insufficient to offset the claims at issue, the shortfall is borrowed from the host contract rather than recognizing a loss at inception. RILA RILA guaranteed benefit features are classified as MRBs and measured at fair value. The fair value measurement represents the present value of future claims payable by the MRB feature. At inception, the value of the MRB is deducted from the value of the contract resulting in no gain or loss. The following table presents the reconciliation of the market risk benefits balance in the Condensed Consolidated Balance Sheets (in millions): September 30, 2024 December 31, 2023 Variable Other Variable Other Annuities Product Lines Total Annuities Product Lines Total Market risk benefit - (assets) $ (7,611) $ (4) $ (7,615) $ (6,732) $ (5) $ (6,737) Market risk benefit - liabilities 4,311 73 4,384 4,732 53 4,785 Market risk benefit - net (asset) liability $ (3,300) $ 69 $ (3,231) $ (2,000) $ 48 $ (1,952) The following table presents the roll-forward of the net MRB (assets) liabilities for variable annuities (dollars in millions): Nine Months Ended September 30, 2024 Year Ended December 31, 2023 Net MRB balance, beginning of period $ (2,000) $ 767 Beginning of period cumulative effect of changes in non-performance risk 972 2,185 Net MRB balance, beginning of period, before effect of changes in non-performance risk (1,028) 2,952 Effect of changes in interest rates (601) (733) Effect of fund performance (3,567) (5,401) Effect of changes in equity index volatility (143) (1,107) Effect of expected policyholder behavior 610 612 Effect of actual policyholder behavior different from expected 514 483 Effect of time 1,100 1,829 Effect of changes in assumptions 7 337 Net MRB balance, end of period, before effect of changes in non-performance risk (3,108) (1,028) End of period cumulative effect of changes in non-performance risk (192) (972) Net MRB balance, end of period, gross (3,300) (2,000) Reinsurance recoverable on market risk benefits at fair value, end of period (78) (90) Net MRB balance, end of period, net of reinsurance (3,378) (2,090) Weighted average attained age (years) (1) 70 69 Net amount at risk (2) $ 5,527 $ 8,225 (1) Weighted-average attained age is defined as the average age of policyholders weighted by account value. (2) Net amount at risk (NAR) is defined as of the valuation date for each contract as the greater of Death Benefit NAR (DBNAR) and Living Benefit NAR (LBNAR), as applicable, where DBNAR is the GMDB benefit base in excess of the account value, and LBNAR is the actuarial present value of guaranteed living benefits in excess of the account value. At each reporting date, the Company regularly evaluates the inputs and assumptions to be used to measure the fair value of the MRB assets and MRB liabilities. In prior periods, the non-performance risk adjustment was determined based on credit spreads indicated by a blend of yields on similarly rated peer debt and yields on Company debt. Starting June 30, 2023, non-performance risk is incorporated into the calculation through the adjustment of the risk-free rate curve based only on credit spreads for debt and debt-like instruments issued by the Company or its insurance operating subsidiaries, adjusted, as necessary, to reflect the financial strength ratings of the issuing insurance subsidiaries. The change was made as a result of management’s determination that the reliability of credit spreads on debt and debt-like instruments issued by the Company as a measure of company-specific credit risk has increased due to sustained levels of market trading volume of these instruments.

Separate Account Assets and Lia

Separate Account Assets and Liabilities	9 Months Ended
	Sep. 30, 2024
Separate Accounts Disclosure [Abstract]
Separate Account Assets and Liabilities	Separate Account Assets and Liabilities The Company issues variable contracts through its separate accounts for which investment income and investment gains and losses accrue directly to, and investment risk is borne by, the contract holder (traditional variable annuities). The Company also issues variable annuity and life contracts through separate accounts where the Company contractually guarantees to the contract holder (variable contracts with guarantees) either a) return of no less than total deposits made to the account adjusted for any partial withdrawals, b) total deposits made to the account adjusted for any partial withdrawals plus a minimum return, or c) the highest account value on a specified anniversary date adjusted for any withdrawals following the contract anniversary. These guarantees include benefits that are payable in the event of death (guaranteed minimum death benefits, or "GMDB"), at annuitization (guaranteed minimum income benefits, or "GMIB"), upon the depletion of funds (guaranteed minimum withdrawal benefits, or "GMWB") or at the end of a specified period (guaranteed minimum accumulation benefits, or "GMAB"). These guarantees are classified as market risk benefits. See Note 12 - Market Risk Benefits of the Notes to Condensed Consolidated Financial Statements for more information regarding market risk benefits. The separate account assets supporting the variable portion of both traditional variable annuities and variable contracts with guarantees are carried at fair value and reported as summary total separate account assets with an equivalent summary total reported for separate account liabilities. At September 30, 2024 and December 31, 2023, the assets and liabilities associated with variable life and annuity contracts were $235 billion and $220 billion, respectively. Investment risks associated with market value changes are borne by the contract holders, except to the extent of minimum guarantees made by the Company. Separate account net investment income, net investment realized and unrealized gains and losses, and the related liability changes are offset within the same line item in the Condensed Consolidated Income Statements. Amounts assessed against the contract holders for mortality, variable annuity benefit guarantees, administrative, and other services are reported in revenue as fee income. Included in the separate account assets and liabilities described above is a Jackson issued group variable annuity contract designed for use in connection with and issued to the Company’s Defined Contribution Retirement Plan. These deposits are allocated to the Jackson National Separate Account - II, which had balances of $216 million and $198 million at September 30, 2024 and December 31, 2023, respectively. The Company receives administrative fees for managing the funds. These fees are recorded as earned and included in fee income in the Condensed Consolidated Income Statements. The following table presents the roll-forward of the separate account balance for variable annuities (in millions): Nine Months Ended September 30, 2024 Year Ended December 31, 2023 Balance as of beginning of period $ 219,381 $ 195,550 Deposits 7,244 8,545 Surrenders, withdrawals and benefits (19,519) (17,029) Net transfer from (to) general account (51) 1,256 Investment performance 29,794 33,807 Policy charges and other (2,113) (2,748) Balance as of end of period, gross $ 234,736 $ 219,381 Cash surrender value (1) $ 229,939 $ 214,395 (1) Cash surrender value represents the amount of the contract holder’s account balances distributable at the balance sheet date less applicable surrender charges. The following table presents the reconciliation of the separate account balance in the Condensed Consolidated Balance Sheets (in millions): September 30, 2024 December 31, 2023 Variable Annuities $ 234,736 $ 219,381 Other Product Lines 301 275 Total $ 235,037 $ 219,656 The following table presents aggregate fair value of assets, by major investment asset category, supporting separate accounts (in millions): September 30, 2024 December 31, 2023 Variable Annuities By Fund Type Equity $ 167,216 $ 154,020 Bond 20,242 19,801 Balanced 44,531 42,831 Money Market 2,747 2,729 Total Variable Annuities 234,736 219,381 Other Product Lines 301 275 Total Separate Accounts $ 235,037 $ 219,656

Market Risk Benefits

Market Risk Benefits	9 Months Ended
	Sep. 30, 2024
Participating Insurance [Abstract]
Market Risk Benefits	Other Contract Holder Funds Other contract holder funds represent the policyholder account balance on our universal life-type products, investment contracts, and the fair value of the embedded derivatives associated with the indexed crediting features on our fixed index annuities and registered index-linked annuities. Universal life type contracts have, as a principal component, an account balance in which interest is credited to policyholders and assessments are deducted for mortality risk and contract administration. The account balance is recognized as a liability within other contract holder funds, and the liability is updated each period for fee and assessment deductions and increased for interest or returns credited to the account balance. Certain of our universal life type contracts contain features that are not classified as market risk benefits or embedded derivatives but provide additional benefits beyond the account balance or base insurance coverage for which a liability in addition to the account balance is necessary. These additional liabilities for death or other insurance benefits are reported as a component of reserves for future policy benefits and claims payable in the Condensed Consolidated Balance Sheets. See Note 9 - Reserves for Future Policy Benefits and Claims Payable of the Notes to the Condensed Consolidated Financial Statements for more information regarding these additional liabilities. Certain contracts without significant mortality or morbidity risk and certain annuities that lack insurance risk are treated as investment contracts. For investment contracts, payments received are reported as liabilities and accounted for in a manner consistent with the accounting for interest-bearing or other financial instruments, within other contract holder funds. The Company issues a variety of annuity products including fixed annuities, fixed index annuities, registered index linked annuities, variable annuities and payout annuities. For annuity contracts that are classified as investment contracts, the liability is the account balance as of the reporting date, reported within the other contract holder funds. For the variable annuity products, only the allocations to fixed fund options are reported in other contract holder funds. For our fixed index annuities and registered index linked annuities, the equity-linked option issued by the Company is accounted for as an embedded derivative measured at fair value and reported as a component of other contract holder funds on the Condensed Consolidated Balance Sheets with changes in fair value recorded in net income within net gains (losses) on derivatives and investments. The fair value is determined using an option-budget method with capital market inputs of market index returns and discount rates as well as actuarial assumptions including lapse, mortality and withdrawal rates. Favorable equity market movements cause increases in future contract holder benefits, resulting in an increase in the fair value of the embedded derivative liability (and vice versa). The Company also establishes a host contract reserve to support the underlying guaranteed account value growth. This host contract liability is included as a component of other contract holder funds on the Condensed Consolidated Balance Sheets. Interest is accreted to the host contract liability using an effective yield method. Our annuity products may contain certain features or guarantees that are classified as MRBs. These market risk benefits are a component of the market risk benefits line items in the Condensed Consolidated Balance Sheet. See Note 12 - Market Risk Benefits of the Notes to Condensed Consolidated Financial Statements for more information regarding market risk benefits. The Company’s institutional products business is comprised of the guaranteed investment contracts, medium-term funding agreement-backed notes and funding agreements (including agreements issued in conjunction with the Company’s participation in the U.S. Federal Home Loan Bank ("FHLB") program) described below. The Company has established a $27 billion aggregate Global Medium-Term Note ("MTN") program. Jackson National Life Global Funding was formed as a statutory business trust, solely for the purpose of issuing Medium-Term Note instruments to institutional investors, the proceeds of which are deposited with the Company and secured by the issuance of funding agreements. The carrying values at September 30, 2024 and December 31, 2023 totaled $5.5 billion and $5.8 billion, respectively. Those Medium-Term Note instruments issued in a foreign currency have been hedged for changes in exchange rates using cross-currency swaps. The unrealized foreign currency gains and losses on those Medium-Term Note instruments are included in the carrying value of the trust instruments supported by funding agreements. Trust instrument liabilities are adjusted to reflect the effects of foreign currency translation gains and losses using exchange rates as of the reporting date. Foreign currency translation gains and losses are included in net gains (losses) on derivatives and investments. Jackson is a member of the FHLBI primarily for the purpose of participating in the bank’s mortgage-collateralized loan advance program with long-term funding facilities. Advances are in the form of funding agreements, short-term and long-term borrowings issued to FHLBI. At September 30, 2024 and December 31, 2023, the Company held $127 million and $108 million of FHLBI capital stock, respectively, supporting $2.0 billion and $2.3 billion in funding agreements and short-term and long-term borrowings at September 30, 2024 and December 31, 2023, respectively. At September 30, 2024 and December 31, 2023, the funding agreements and short-term and long-term borrowings were collateralized by mortgage-related securities and commercial mortgage loans with a carrying value of $3.0 billion and $3.5 billion, respectively. The following table presents the liabilities for other contract holder funds (in millions): September 30, 2024 December 31, 2023 Payout Annuity $ 852 $ 860 Variable Annuity 7,509 8,396 Fixed Annuity 9,593 9,736 Fixed Indexed Annuities 8,990 10,243 RILA 10,250 5,219 Closed Block Life 10,884 11,039 Closed Block Annuity 1,163 1,252 Institutional Products 7,929 8,406 Other Product Lines 164 168 Total other contract holder funds $ 57,334 $ 55,319 The following table presents a roll-forward of other contract holder funds, gross of reinsurance (in millions): Fixed Closed Closed Payout Variable Fixed Indexed Block Block Annuity Annuity Annuity Annuities RILA Life Annuity Total Balance as of January 1, 2024 $ 860 $ 8,396 $ 9,736 $ 10,243 $ 5,219 $ 11,039 $ 1,252 $ 46,745 Deposits 165 544 1,080 127 4,187 218 3 6,324 Surrenders, withdrawals and benefits (194) (1,596) (1,339) (1,610) (130) (462) (125) (5,456) Net transfers from (to) separate accounts — 51 — — — — — 51 Investment performance / change in value of equity option — — — 108 950 — — 1,058 Interest credited 21 171 233 135 24 455 33 1,072 Policy charges and other — (57) (117) (13) — (366) — (553) Balance as of September 30, 2024 $ 852 $ 7,509 $ 9,593 $ 8,990 $ 10,250 $ 10,884 $ 1,163 $ 49,241 Fixed Closed Closed Payout Variable Fixed Indexed Block Block Annuity Annuity Annuity Annuities RILA Life Annuity Total Balance as of January 1, 2023 $ 837 $ 10,259 $ 11,696 $ 11,787 $ 1,875 $ 11,215 $ 1,319 $ 48,988 Deposits 202 995 234 211 2,890 307 4 4,843 Surrenders, withdrawals and benefits (231) (1,788) (2,406) (1,954) (70) (738) (115) (7,302) Net transfers from (to) separate accounts — (1,256) — — — — — (1,256) Investment performance / change in value of equity option — — — 51 509 — — 560 Interest credited 25 273 342 210 14 730 44 1,638 Policy charges and other 27 (87) (130) (62) 1 (475) — (726) Balance as of December 31, 2023 $ 860 $ 8,396 $ 9,736 $ 10,243 $ 5,219 $ 11,039 $ 1,252 $ 46,745 The following table presents weighted average crediting rate, net amount at risk, and cash surrender value of contract holder account balances (dollars in millions): Fixed Closed Closed Payout Variable Fixed Indexed Block Block Annuity Annuity Annuity Annuities RILA Life Annuity September 30, 2024 Weighted-average crediting rate (1) 3.29 % 3.04 % 3.24 % 2.00 % 0.31 % 5.57 % 3.78 % Net amount at risk (2) $ — $ — $ — $ — $ — $ 15,937 $ — Cash surrender value (3) $ — $ 7,449 $ 9,447 $ 8,778 $ 9,837 $ 10,817 $ 1,162 December 31, 2023 Weighted-average crediting rate (1) 2.91 % 3.25 % 3.51 % 2.05 % 0.27 % 6.61 % 3.51 % Net amount at risk (2) $ — $ — $ — $ — $ — $ 16,619 $ — Cash surrender value (3) $ — $ 8,306 $ 9,639 $ 9,999 $ 4,896 $ 10,970 $ 1,252 (1) Weighted average crediting rate is the average crediting rate weighted by contract holder account balances invested in fixed account funds. (2) Net amount at risk represents the standard excess benefit base for guaranteed death benefits on universal life type products. The net amount at risk associated with market risk benefits are presented within Note 12 of the Notes to Condensed Consolidated Financial Statements. (3) Cash surrender value represents the amount of the contract holder’s account balance distributable at the balance sheet date less the applicable surrender charges. At September 30, 2024 and December 31, 2023, excluding reinsurance business, approximately 94% and 92% of the Company’s annuity account values correspond to crediting rates that are at the minimum guaranteed interest rates, respectively. At September 30, 2024 and December 31, 2023, excluding reinsurance business, approximately 82% and 64% of the Company’s closed block life account values correspond to crediting rates that are at the minimum guaranteed interest rates, respectively. The following table presents contract holder account balances invested in fixed account funds by range of guaranteed minimum crediting rates and the related range of the difference between rates being credited to other contract holder funds and the respective guaranteed minimums (in millions): September 30, 2024 At Guaranteed 1 Basis Point-50 51 Basis Points-150 Greater Than 150 Range of Guaranteed Minimum Crediting Rate Minimum Basis Points Above Basis Points Above Basis Points Above Total Variable Annuities 0.00%-1.50% $ — $ 11 $ — $ — $ 11 1.51%-2.50% 159 — — — 159 Greater than 2.50% 7,339 — — — 7,339 Total $ 7,498 $ 11 $ — $ — $ 7,509 Fixed Annuities 0.00%-1.50% $ 28 $ 46 $ 39 $ 1 $ 114 1.51%-2.50% 25 1 1 — 27 Greater than 2.50% 1,741 43 1 251 2,036 Total $ 1,794 $ 90 $ 41 $ 252 $ 2,177 Fixed Indexed Annuities 0.00%-1.50% $ 3 $ 9 $ 2 $ 38 $ 52 1.51%-2.50% — — — — — Greater than 2.50% 18 — 86 23 127 Total $ 21 $ 9 $ 88 $ 61 $ 179 RILA 0.00%-1.50% $ 6 $ — $ 4 $ 3 $ 13 1.51%-2.50% — — — — — Greater than 2.50% 79 9 — — 88 Total $ 85 $ 9 $ 4 $ 3 $ 101 Closed Block Life 0.00%-1.50% $ — $ — $ — $ — $ — 1.51%-2.50% 1 11 — — 12 Greater than 2.50% 5,506 409 746 5 6,666 Total $ 5,507 $ 420 $ 746 $ 5 $ 6,678 Closed Block Annuity 0.00%-1.50% $ — $ — $ — $ — $ — 1.51%-2.50% — — 1 12 13 Greater than 2.50% 963 20 25 — 1,008 Total $ 963 $ 20 $ 26 $ 12 $ 1,021 December 31, 2023 At Guaranteed 1 Basis Point-50 51 Basis Points-150 Greater Than 150 Range of Guaranteed Minimum Crediting Rate Minimum Basis Points Above Basis Points Above Basis Points Above Total Variable Annuities 0.00%-1.50% $ — $ 12 $ 1 $ — $ 13 1.51%-2.50% 173 — — — 173 Greater than 2.50% 8,186 — — 24 8,210 Total $ 8,359 $ 12 $ 1 $ 24 $ 8,396 Fixed Annuities 0.00%-1.50% $ 17 $ 55 $ 70 $ 1 $ 143 1.51%-2.50% 29 1 1 — 31 Greater than 2.50% 721 51 1 271 1,044 Total $ 767 $ 107 $ 72 $ 272 $ 1,218 Fixed Indexed Annuities 0.00%-1.50% $ 4 $ 9 $ 3 $ 43 $ 59 1.51%-2.50% — — — — — Greater than 2.50% 21 — 62 10 93 Total $ 25 $ 9 $ 65 $ 53 $ 152 RILA 0.00%-1.50% $ 7 $ — $ 4 $ 1 $ 12 1.51%-2.50% — — — — — Greater than 2.50% 39 12 — — 51 Total $ 46 $ 12 $ 4 $ 1 $ 63 Closed Block Life 0.00%-1.50% $ — $ — $ — $ — $ — 1.51%-2.50% — — — — — Greater than 2.50% 4,425 1,830 603 16 6,874 Total $ 4,425 $ 1,830 $ 603 $ 16 $ 6,874 Closed Block Annuity 0.00%-1.50% $ — $ — $ — $ — $ — 1.51%-2.50% — — 1 12 13 Greater than 2.50% 896 169 23 — 1,088 Total $ 896 $ 169 $ 24 $ 12 $ 1,101 Contracts or contract features that provide protection to the contract holder from capital market risk and expose the Company to other-than-nominal capital market risk are classified as MRBs. All long-duration insurance contracts and certain investment contracts are subject to MRB evaluation. MRBs are measured at fair value at the contract level and can be in either an asset or liability position. For contracts that contain multiple MRB features, the MRBs are valued together as a single compound MRB. Market risk benefit assets and Market risk benefit liabilities are reported separately on the Condensed Consolidated Balance Sheets. Changes in fair value are reported in Net (gains) losses on market risk benefits on the Condensed Consolidated Income Statements. However, the change in fair value related to our own non-performance risk is reported as a component of other comprehensive income in Change in non-performance risk on market risk benefits on the Condensed Consolidated Statements of Comprehensive Income (Loss). A description of the items effecting the change in fair value by category is as follows: • Changes in interest rates — movement in risk free rates (impacts both assumed future separate account returns and discounting of cash flows) • Fund performance — separate account returns gross of fees • Change in equity index volatility — movement in implied volatility • Expected policyholder behavior — policyholder behavior as assumed in reserving • Actual policyholder behavior different than expected — difference between actual behavior during the period versus assumed behavior • Time — effect of passage of time including reduction to separate account balances from fees, the change in proximity of future cash flows, and impacts to policy features such as bonus credits • Change in assumptions — changes in assumptions resulting from our periodic review • Change in non-performance risk — changes in Jackson’s non-performance risk See Note 6 - Fair Value Measurements of the Notes to Condensed Consolidated Financial Statements for more information regarding fair value measurements. Additionally, when an annuitization occurs (for annuitization benefits) or upon extinguishment of the account balance (for withdrawal benefits), the balance related to the MRB is derecognized and the amount deducted (after derecognition of any related amount included in accumulated other comprehensive income) is used in the calculation of the liability for future policy benefits for the resulting payout annuity. Variable Annuities Variable annuity contracts issued by the Company offer various guaranteed minimum death, withdrawal, income and accumulation benefits. These guaranteed benefit features, as well as the reinsurance recoverable on the Company’s GMIB, are classified as MRBs and measured at fair value. The Company discontinued offering the GMIB in 2009 and the GMAB in 2011. Variable annuity guaranteed benefit features classified as MRBs, which have explicit fees, are measured using the attributed fee method. Under the attributed fee method, fair value is measured as the difference between the present value of projected future liabilities and the present value of projected attributed fees. At the inception of the contract, the Company attributes to the MRB a portion of total fees expected to be assessed against the contract holder to offset the projected claims over the lifetime of the contract. The attributed fee is expressed as a percentage of total projected future fees at inception of the contract. This percentage of total projected fees is considered a fixed term of the MRB feature and is held static over the life of the contract. This percentage may not exceed 100% of the total projected contract fees as of contract inception. As the Company may issue contracts that have projected future liabilities greater than the projected future guaranteed benefit fees at issue, the Company may also attribute mortality and expense charges when performing this calculation. In subsequent valuations, both the present value of future projected liabilities and the present value of projected attributed fees are remeasured based on current market conditions and policyholder behavior assumptions. Fixed Index Annuities The longevity riders issued on fixed index annuities are classified as MRBs and measured at fair value. Similar to the variable annuity guaranteed benefits features, these contracts have explicit fees and are measured using the attributed fee method. The Company attributes a percentage of total projected future fees expected to be assessed against the policyholder to offset the projected future claims over the lifetime of the contract. If the fees attributed are insufficient to offset the claims at issue, the shortfall is borrowed from the host contract rather than recognizing a loss at inception. RILA RILA guaranteed benefit features are classified as MRBs and measured at fair value. The fair value measurement represents the present value of future claims payable by the MRB feature. At inception, the value of the MRB is deducted from the value of the contract resulting in no gain or loss. The following table presents the reconciliation of the market risk benefits balance in the Condensed Consolidated Balance Sheets (in millions): September 30, 2024 December 31, 2023 Variable Other Variable Other Annuities Product Lines Total Annuities Product Lines Total Market risk benefit - (assets) $ (7,611) $ (4) $ (7,615) $ (6,732) $ (5) $ (6,737) Market risk benefit - liabilities 4,311 73 4,384 4,732 53 4,785 Market risk benefit - net (asset) liability $ (3,300) $ 69 $ (3,231) $ (2,000) $ 48 $ (1,952) The following table presents the roll-forward of the net MRB (assets) liabilities for variable annuities (dollars in millions): Nine Months Ended September 30, 2024 Year Ended December 31, 2023 Net MRB balance, beginning of period $ (2,000) $ 767 Beginning of period cumulative effect of changes in non-performance risk 972 2,185 Net MRB balance, beginning of period, before effect of changes in non-performance risk (1,028) 2,952 Effect of changes in interest rates (601) (733) Effect of fund performance (3,567) (5,401) Effect of changes in equity index volatility (143) (1,107) Effect of expected policyholder behavior 610 612 Effect of actual policyholder behavior different from expected 514 483 Effect of time 1,100 1,829 Effect of changes in assumptions 7 337 Net MRB balance, end of period, before effect of changes in non-performance risk (3,108) (1,028) End of period cumulative effect of changes in non-performance risk (192) (972) Net MRB balance, end of period, gross (3,300) (2,000) Reinsurance recoverable on market risk benefits at fair value, end of period (78) (90) Net MRB balance, end of period, net of reinsurance (3,378) (2,090) Weighted average attained age (years) (1) 70 69 Net amount at risk (2) $ 5,527 $ 8,225 (1) Weighted-average attained age is defined as the average age of policyholders weighted by account value. (2) Net amount at risk (NAR) is defined as of the valuation date for each contract as the greater of Death Benefit NAR (DBNAR) and Living Benefit NAR (LBNAR), as applicable, where DBNAR is the GMDB benefit base in excess of the account value, and LBNAR is the actuarial present value of guaranteed living benefits in excess of the account value. At each reporting date, the Company regularly evaluates the inputs and assumptions to be used to measure the fair value of the MRB assets and MRB liabilities. In prior periods, the non-performance risk adjustment was determined based on credit spreads indicated by a blend of yields on similarly rated peer debt and yields on Company debt. Starting June 30, 2023, non-performance risk is incorporated into the calculation through the adjustment of the risk-free rate curve based only on credit spreads for debt and debt-like instruments issued by the Company or its insurance operating subsidiaries, adjusted, as necessary, to reflect the financial strength ratings of the issuing insurance subsidiaries. The change was made as a result of management’s determination that the reliability of credit spreads on debt and debt-like instruments issued by the Company as a measure of company-specific credit risk has increased due to sustained levels of market trading volume of these instruments.

Long-Term Debt

Long-Term Debt	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Long-Term Debt	Long-Term Debt Liabilities for the Company’s debt are primarily carried at an amount equal to the principal balance net of any unamortized original issuance discount or premium. Original issuance discount or premium and any debt issue costs, if applicable, are recognized as a component of interest expense over the period the debt is expected to be outstanding. The aggregate carrying value of long-term debt was as follows (in millions): September 30, December 31, 2024 2023 Long-Term Debt Senior Notes due 2027 $ 398 $ 398 Senior Notes due 2031 496 495 Senior Notes due 2032 347 347 Senior Notes due 2051 490 490 Surplus notes due 2027 250 250 FHLBI bank loans due 2034 & 2035 52 57 Total long-term debt $ 2,033 $ 2,037 The following table presents the contractual maturities of the Company's long-term debt as of September 30, 2024 (in millions): Calendar Year 2025 2026 2027 2028 2029 and thereafter Total Long-term debt $ — $ — $ 648 $ — $ 1,385 $ 2,033 Revolving Credit Facility On February 24, 2023, the Company replaced the 2021 Revolving Credit Facility that was due to expire in February 2024, and entered into a revolving credit facility (the "2023 Revolving Credit Facility") with a syndicate of banks and Bank of America, N.A., as Administrative Agent. The 2023 Revolving Credit Facility provides for borrowings for working capital and other general corporate purposes under aggregate commitments of $1.0 billion, with a sub-limit of $500 million available for letters of credit. The 2023 Revolving Credit Facility further provides for the ability to request, subject to customary terms and conditions, an increase in commitments thereunder by up to an additional $500 million. The credit agreement for the 2023 Revolving Credit Facility contains financial maintenance covenants, including a minimum adjusted consolidated net worth test of no less than 70% of our adjusted consolidated net worth as of September 30, 2022 (plus (to the extent positive) or minus (to the extent negative) 70% of the impact on such adjusted consolidated net worth resulting from the application of a one-time transition adjustment for the LDTI accounting change for insurance contracts, and plus 50% of the aggregate amount of any increase in adjusted consolidated net worth resulting from equity issuances by the Company and its consolidated subsidiaries after September 30, 2022), and a maximum consolidated indebtedness to total capitalization ratio test not to exceed 35%. Commitments under the 2023 Revolving Credit Facility terminate on February 24, 2028. Line of Credit Agreement Jackson is a party to an Uncommitted Money Market Line Credit Agreement dated April 6, 2023, among Jackson, Jackson Financial, and Société Générale. This agreement is an uncommitted short-term cash advance facility that provides an additional form of liquidity to Jackson and to Jackson Financial. The aggregate borrowing capacity under the agreement is $500 million and each cash advance request must be at least $100 thousand. The interest rate is set by the lender at the time of the borrowing and is fixed for the duration of the advance. Jackson and Jackson Financial are jointly and severally liable to repay any advance under the agreement, which must be repaid prior to the last day of the quarter in which the advance was drawn.

Federal Home Loan Bank Advances

Federal Home Loan Bank Advances	9 Months Ended
	Sep. 30, 2024
Other Liabilities Disclosure [Abstract]
Federal Home Loan Bank Advances	Federal Home Loan Bank Advances The Company, through its subsidiary, Jackson, entered into an advance program with the FHLBI in which interest rates were either fixed or variable based on the FHLBI cost of funds or market rates. Advances of nil and $250 million were outstanding at September 30, 2024 and December 31, 2023, respectively, and were recorded in other liabilities. Interest expense on such advances was $1 million and nil for the three months ended September 30, 2024 and 2023, respectively, and $4 million and $6 million for the nine months ended September 30, 2024 and 2023, respectively. See Note 10 - Other Contract Holder Funds of the Notes Condensed Consolidated Financial Statements for the carrying value of total collateralization of our FHLB obligations

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company uses the estimated annual effective tax rate ("ETR") method in computing the interim tax provision. Certain items, including those deemed unusual, infrequent, or that cannot be reliably estimated, are treated as discrete items and excluded from the estimated annual ETR. In these cases, the actual tax expense or benefit is reported in the same period as the related item. Certain tax effects are also not reflected in the estimated annual ETR, primarily certain changes in the realizability of deferred tax assets and uncertain tax positions and are recorded in the period in which the change occurs. The estimated annual ETR is revised, as necessary, at the end of successive interim reporting periods. The Company’s effective income tax rate was 19.3% and 3.9% for the three and nine months ended September 30, 2024, respectively, compared with 20.5% and 13.8% for the same periods in 2023, respectively. The ETR differs from the statutory rate of 21% primarily due to the dividends received deduction, utilization of foreign tax credits, and valuation allowance. The change in the ETR for the three and nine months ended September 30, 2024 compared to the three and nine months ended September 30, 2023 was due to the relationship of taxable income to consolidated pre-tax income (loss). The ETR differs for the nine months ended September 30, 2024 from the full year-ended December 31, 2023 ETR of 0.5% due to the relationship of taxable income to consolidated pre-tax income. On September 12, 2024, the U.S. Treasury Department and the Internal Revenue Service released proposed regulations addressing the application of the corporate alternative minimum tax (“CAMT”) that was enacted as part of the Inflation Reduction Act of 2022 (“IRA”). The proposed regulations are generally applicable to tax years ending after September 12, 2024 and consistent with many of the provisions provided in prior CAMT guidance. The Company did not elect to early adopt the proposed regulations for the 2023 tax returns and relied on reasonable interpretations of previously published guidance resulting in a reduction of $263 million to the CAMT liability and related CAMT deferred tax asset as of September 30, 2024. In addition, the determination of the estimated 2024 CAMT liability considered carryover impacts from the 2023 tax return and consideration of the applicability of the proposed regulations resulting in a reduction of $158 million to the CAMT liability and related CAMT deferred tax asset as of September 30, 2024. For the nine months ended September 30, 2024 and 2023, the Company recorded an estimate of $7 million and $450 million, respectively, for the provision of the CAMT with an offsetting increase to the deferred tax asset for the credit carryover resulting in no impact to total tax expense. The U.S. Treasury Department is expected to issue Final Regulations after the year ended December 31, 2024, which may materially change the estimated provision of the CAMT. The Company is required to evaluate the recoverability of its deferred tax assets and establish a valuation allowance, if necessary, to reduce its deferred tax asset to an amount that is more likely than not to be realizable. Considerable judgment and the use of estimates are required when determining whether a valuation allowance is necessary and, if so, the amount of such valuation allowance. When evaluating the need for a valuation allowance, the Company considers many factors, including: the nature and character of the deferred tax assets and liabilities; taxable income in prior carryback years; future reversals of temporary differences; the length of time carryovers can be utilized; and any tax planning strategies the Company would employ to avoid a tax benefit from expiring unused. The Company has adopted an accounting policy to analyze the ability to recover the CAMT credit carryover deferred tax asset separately from the deferred tax assets generated under the regular tax system. For the nine months ended September 30, 2024, changes in market conditions and interest rates impacted the unrealized tax gains and losses in the available for sale securities portfolio resulting in deferred tax assets related to net unrealized tax capital losses. The deferred tax asset relates to the unrealized losses for which the carryforward period has not yet begun, and as such, when assessing its recoverability, we consider our ability and intent to hold the underlying securities to recovery. As of September 30, 2024, based on all available evidence, we concluded that a valuation allowance should be established on a portion of the deferred tax asset related to unrealized losses that are not more likely than not to be realized. For the three and nine months ended September 30, 2024, the Company recorded a decrease of $295 million and a decrease of $218 million, respectively, to the valuation allowance associated with the unrealized tax losses in the Company's available for sale securities portfolio and a change of nil related to both realized and unrealized losses on capital assets of the Non-life Companies. The $295 million decrease for the three months ended September 30, 2024, to the valuation allowance consists of $306 million tax benefit recorded to other comprehensive income and $11 million tax expense recorded in the income tax expense. The $218 million decrease for the nine months ended September 30, 2024 to the valuation allowance consists of $206 million tax benefit recorded to other comprehensive income and $12 million tax benefit recorded in the income tax expense. At September 30, 2024 and December 31, 2023, the Company has recorded a total valuation allowance for $471 million and $689 million, respectively, associated with the unrealized tax losses in the Life Companies' available for sale securities portfolio where it is not more likely than not that the full tax benefit of the losses will be realized.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies The Company and its subsidiaries are involved in litigation arising in the ordinary course of business. It is the opinion of management that the ultimate disposition of such litigation will not have a material adverse effect on the Company's financial condition. Jackson has been named in civil litigation proceedings, which appear to be substantially similar to other class action litigation brought against many life insurers including allegations of misconduct in the sale and service of insurance products. The Company accrues for legal contingencies once the contingency is deemed to be probable and reasonably estimable.

Operating Costs and Other Expen

Operating Costs and Other Expenses	9 Months Ended
	Sep. 30, 2024
Operating Costs And Other Expenses [Abstract]
Operating Costs and Other Expenses	Operating Costs and Other Expenses The following table is a summary of the Company’s operating costs and other expenses (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Asset-based commission expenses $ 285 $ 259 $ 843 $ 764 Other commission expenses 261 190 691 541 Sub-advisor expenses 82 80 244 234 General and administrative expenses 310 232 839 706 Deferral of acquisition costs (196) (135) (512) (383) Total operating costs and other expenses $ 742 $ 626 $ 2,105 $ 1,862

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) The following table represents changes in the balance of accumulated other comprehensive income ("AOCI"), net of income tax, related to unrealized investment gains (losses) (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Balance, beginning of period (1) $ (3,626) $ (3,365) $ (2,808) $ (3,378) Change in unrealized gains (losses) of investments 1,735 (1,405) 1,134 (958) Change in current discount rate - reserve for future policy benefits (2) (280) 254 (132) 204 Change in non-performance risk on market risk benefits (235) (999) (783) (1,479) Change in unrealized gains (losses) - other (5) 3 (2) (8) Change in deferred tax asset 33 247 148 318 Other comprehensive income (loss) before reclassifications 1,248 (1,900) 365 (1,923) Reclassifications from AOCI, net of tax (5) 78 60 114 Other comprehensive income (loss) 1,243 (1,822) 425 (1,809) Balance, end of period (1) $ (2,383) $ (5,187) $ (2,383) $ (5,187) (1) Includes $(1,336) million and $(1,612) million related to the investments held within the funds withheld account related to the Athene Reinsurance Transaction as of September 30, 2024 and December 31, 2023, respectively. (2) Represents the impact of changes in the discount rate used in the remeasurement of our direct reserves for future policy benefits and claims payable, net of the remeasurement of ceded reserves for future policy benefits and claims payable. The following table represents amounts reclassified out of AOCI (in millions): AOCI Components Amounts Affected Line Item in the Condensed Three Months Ended September 30, 2024 2023 Net unrealized investment gain (loss): Net realized gain (loss) on investments $ 20 $ 112 Net gains (losses) on derivatives and investments Other impaired securities (38) (14) Net gains (losses) on derivatives and investments Net unrealized gain (loss) (18) 98 Income tax expense (benefit) (13) 20 Reclassifications, net of income taxes $ (5) $ 78 AOCI Components Amounts Affected Line Item in the Condensed Nine Months Ended September 30, 2024 2023 Net unrealized investment gain (loss): Net realized gain (loss) on investments $ 96 $ 188 Net gains (losses) on derivatives and investments Other impaired securities (33) (44) Net gains (losses) on derivatives and investments Net unrealized gain (loss), before income taxes 63 144 Income tax expense (benefit) 3 30 Reclassifications, net of income taxes $ 60 $ 114

Equity

Equity	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Equity	Equity Preferred Stock On March 13, 2023, the Company issued and sold 22,000,000 depositary shares (the “Depositary Shares”), each representing a 1/1,000th fractional interest in a share of the Company’s Fixed-Rate Reset Noncumulative Perpetual Preferred Stock, Series A, $25,000 liquidation preference per share (equivalent to $25 per Depositary Share), with a 5-year dividend rate reset period and noncumulative dividends (the “Series A Preferred Stock”). After underwriting discounts and expenses, we received net proceeds of approximately $533 million. The Series A Preferred Stock carries i) an initial dividend rate of 8.000% per annum to but excluding, March 30, 2028; and ii) from, and including, March 30, 2028, during each reset period, at a rate per annum equal to the Five-year U.S. Treasury Rate We may, at our option, redeem the shares of Series A Preferred Stock (a) in whole but not in part at any time prior to March 30, 2028, (i) within 90 days after the occurrence of a “rating agency event” at a redemption price equal to $25,500 per share (equivalent to $25.50 per Depositary Share), plus an amount equal to any accrued but unpaid dividends to, but excluding, the redemption date, or (ii) within 90 days after the occurrence of a “regulatory capital event,” at a redemption price equal to $25,000 per share (equivalent to $25 per Depositary Share), plus an amount equal to any accrued but unpaid dividends to, but excluding, the redemption date, or (b) in whole or in part, from time to time, on or after March 30, 2028, at a redemption price equal to $25,000 per share (equivalent to $25 per Depositary Share), plus an amount equal to any accrued but unpaid dividends to, but excluding, the redemption date. If we redeem any shares of Series A Preferred Stock, a proportionate number of Depositary Shares will be redeemed. Holders of Depositary Shares have no right to require the redemption or repurchase of the Series A Preferred Stock or the Depositary Shares. The net proceeds from the sale were used for general corporate purposes, including the repayment of senior notes that matured in November 2023. The following table presents the declaration date, record date, payment date and dividends paid per preferred share of, and per depositary share representing the Series A Preferred Stock: Dividends Paid Declaration Date Record Date Payment Date Per Preferred Share Per Depositary Share Quarter Ended 03/31/2024 February 20, 2024 March 12, 2024 April 1, 2024 $500 $0.50 06/30/2024 May 2, 2024 June 6, 2024 July 1, 2024 $500 $0.50 09/30/2024 August 1, 2024 September 5, 2024 September 30, 2024 $500 $0.50 Quarter Ended 03/31/2023 None 06/30/2023 May 8, 2023 June 1, 2023 June 30, 2023 $594.44 $0.59444 09/30/2023 August 7, 2023 August 31, 2023 October 2, 2023 $500.00 $0.50000 Common Stock At September 30, 2024 and December 31, 2023, the Company was authorized to issue up to 1 billion shares of common stock with a par value of $0.01 per share. Share Repurchase Program On February 27, 2023 and August 1, 2024, our Board of Directors authorized increases of $450 million and $750 million, respectively, in our existing authorization to repurchase shares of our outstanding common stock as part of the Company's share repurchase program. The Company expects to repurchase common shares from time to time in the open market or in privately negotiated transactions. The timing, form and amount of the share repurchases under the program are at the discretion of management and will depend on a variety of factors, including funds available at the Company, other potential uses for such funds, market conditions, the Company's capital position, legal requirements and other factors. The repurchase program may be modified, extended or terminated by the Board at any time. It does not have an expiration date. There can be no assurance that we will continue share repurchases or approve any further increase to our current, or approve any new, stock repurchase program, or no assurance to the amount of any repurchases that may be made pursuant to such programs. Through September 30, 2024, we have incurred $3 million of excise tax in connection with share repurchases that exceeded stock issuances. The excise tax incurred was recognized as part of the cost basis of the treasury stock acquired and not reported as income tax expense. The following table represents share repurchase activities as part of our share repurchase program: Period Number of Shares Repurchased Total Payments Average Price Paid Per Share 2023 (January 1- March 31) 1,721,737 $ 70 $ 40.42 2023 (April 1- June 30) 1,394,797 47 33.87 2023 (July 1- September 30) 1,873,727 71 38.13 2023 (October 1- December 31) 1,512,263 67 44.37 Total 2023 6,502,524 $ 255 $ 39.27 2024 (January 1- March 31) 2,157,372 116 53.76 2024 (April 1- June 30) 1,294,473 90 69.16 2024 (July 1- September 30) 1,352,821 113 83.39 2024 (October 1- November 1) 489,284 48 98.12 Total 2024 5,293,950 $ 367 $ 69.19 The following table presents changes in the number of shares of common stock outstanding: Common Stock Issued Treasury Stock Total Common Stock Outstanding Shares at December 31, 2023 94,481,006 (15,820,785) 78,660,221 Share-based compensation programs 3,403 492,103 (1) 495,506 Shares repurchased under repurchase program — (4,804,666) (4,804,666) Shares at September 30, 2024 94,484,409 (20,133,348) 74,351,061 (1) Represents net shares issued from treasury stock pursuant to the Company’s share-based compensation programs. Dividends to Shareholders Any declaration of cash dividends on common stock will be at the discretion of JFI’s Board of Directors and will depend on our financial condition, earnings, liquidity and capital requirements, regulatory constraints, level of indebtedness, preferred stock, contractual restrictions with respect to paying cash dividends, restrictions imposed by Delaware law, general business conditions and any other factors that JFI’s Board of Directors deems relevant in making any such determination. Therefore, there can be no assurance that we will pay any cash dividends to holders of our stock or as to the amount of any such cash dividend. The following table presents declaration date, record date, payment date and dividends paid per share of JFI’s common stock: Declaration Date Record Date Payment Date Dividends Paid Per Share Quarter Ended 03/31/2024 February 20, 2024 March 12, 2024 March 21, 2024 $0.70 06/30/2024 May 2, 2024 June 6, 2024 June 20, 2024 $0.70 09/30/2024 August 1, 2024 September 5, 2024 September 19, 2024 $0.70 Quarter Ended 03/31/2023 February 27, 2023 March 14, 2023 March 23, 2023 $0.62 06/30/2023 May 8, 2023 June 1, 2023 June 15, 2023 $0.62 09/30/2023 August 7, 2023 August 31, 2023 September 14, 2023 $0.62

Earnings Per Share

Earnings Per Share	9 Months Ended
	Sep. 30, 2024
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share Basic earnings per share is calculated by dividing net income (loss) attributable to Jackson Financial common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is calculated by dividing the net income (loss) attributable to Jackson Financial common shareholders, by the weighted-average number of shares of common stock outstanding for the period, plus shares representing the dilutive effect of share-based awards. Beginning in 2021, the Company granted its first share-based awards subject to vesting provisions of the 2021 Omnibus Incentive Plan, which have a dilutive effect. See Note 18 - Share-Based Compensation of the Notes to Consolidated Financial Statements in the Company’s 2023 Annual Report for further description of share-based awards. The following table sets forth the calculation of earnings per common share: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 (in millions, except share and per share data) Net income (loss) attributable to Jackson Financial Inc. $ (469) $ 2,773 $ 601 $ 2,493 Less: Preferred stock dividends 11 11 33 24 Net income (loss) attributable to Jackson Financial Inc. common shareholders $ (480) $ 2,762 $ 568 $ 2,469 Weighted average shares of common stock outstanding - basic 75,374,073 82,061,813 76,673,053 82,432,264 Dilutive common shares — 760,005 701,495 2,108,923 Weighted average shares of common stock outstanding - diluted (1) 75,374,073 82,821,818 77,374,548 84,541,187 Earnings per share—common stock Basic $ (6.37) $ 33.66 $ 7.41 $ 29.95 Diluted $ (6.37) $ 33.35 $ 7.34 $ 29.20 (1) If we reported a net loss attributable to Jackson Financial Inc., all common stock equivalents are anti-dilutive and are therefore excluded from the calculation of diluted shares and diluted per share amounts. The shares excluded from the diluted EPS calculation were 751,646 shares for the three months ended September 30, 2024.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2024
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events The Company has evaluated subsequent events through the date these Condensed Consolidated Financial Statements were issued. Dividends Declared to Shareholders On November 1, 2024, our Board of Directors approved a cash dividend on JFI's common stock of $0.70 per share for the fourth quarter 2024, payable on December 19, 2024, to common shareholders of record on December 5, 2024. The Company also announced the declaration of a cash dividend of $0.50 per depositary share, each representing a 1/1,000th interest in a share of Fixed-Rate Reset Noncumulative Perpetual Preferred Stock, Series A. The dividend will be payable on December 30, 2024, to preferred shareholders of record at the close of business on December 5, 2024.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net income (loss) attributable to Jackson Financial Inc.	$ (469)	$ 2,773	$ 601	$ 2,493

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	9 Months Ended
	Sep. 30, 2024 shares	Sep. 30, 2024 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		During the three months ended September 30, 2024, the following trading arrangements were adopted or terminated by directors and officers of Jackson Financial. Any such contract, instruction or written plan for the purchase or sale of Jackson Financial’s securities was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) as defined under the securities laws. NAME AND TITLE OF DIRECTOR OR OFFICER DATE OF TERMINATION OF TRADING ARRANGEMENT (1) DURATION OF TRADING ARRANGEMENT (1) # OF AGGREGATE SHARES TO BE SOLD PURSUANT TO THE TRADING ARRANGEMENT Scott Romine, President and CEO of Jackson National Life Distributors LLC, and Executive Vice President of Jackson August 13, 2024 June 18, 2024 - September 30, 2024 22,000 shares of common stock (1) Mr. Romine’s Rule 10b5-1 trading plan (the “Plan”) was scheduled to expire upon the earlier of September 30, 2024, or the sale of all shares subject
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Terminated	false
Scott Romine [Member]
Trading Arrangements, by Individual
Name	Scott Romine
Title	President and CEO of Jackson National Life Distributors LLC, and Executive Vice President of Jackson
Rule 10b5-1 Arrangement Terminated	true
Termination Date	August 13, 2024
Arrangement Duration	104 days
Aggregate Available	22,000	22,000

New Accounting Standards (Polic

New Accounting Standards (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. GAAP for interim financial information. Accordingly, certain financial information that is normally included in annual financial statements prepared in accordance with U.S. GAAP, but not required for interim reporting purposes, has been condensed or omitted. These Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and the related notes included in our Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the SEC on February 28, 2024, (the "2023 Annual Report"). The condensed consolidated financial information as of December 31, 2023, included herein, has been derived from the audited Consolidated Financial Statements in the 2023 Annual Report. Certain accounting policies, which significantly affect the determination of financial condition, results of operations and cash flows, are summarized in the Notes to Consolidated Financial Statements in the Company’s 2023 Annual Report.
Consolidation	All material intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of these Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires the use of estimates and assumptions about future events that affect the amounts reported in the Condensed Consolidated Financial Statements and the accompanying notes. Significant estimates or assumptions, as further discussed in these notes, include: • Valuation of investments and derivative instruments, including fair values of securities deemed to be in an illiquid market and the determination of when an impairment is necessary; • Assumptions used in calculating policy reserves and liabilities, including policyholder behavior, mortality rates, expenses, investment returns and policy crediting rates; • Assumptions as to future earnings levels being sufficient to realize deferred tax benefits; • Estimates related to expectations of credit losses on certain financial assets and off-balance sheet exposures; • Assumptions and estimates associated with the Company’s tax positions, including an estimate of the dividends received deduction, which impact the amount of recognized tax benefits recorded by the Company; • Assumptions used in calculating market risk benefits, including policyholder behavior, mortality rates, and capital market assumptions; and • Assumptions impacting the expected term used in amortizing deferred acquisition costs, including policyholder behavior and mortality rates. These estimates and assumptions are based on management’s best estimates and judgments. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other appropriate factors. As facts and circumstances dictate, these estimates and assumptions may be adjusted. Since future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in estimates, including those resulting from continuing changes in the economic environment, will be reflected in the Consolidated Financial Statements in the periods the estimates are changed.
Changes in Accounting Principles – Adopted in Current Year and Issued but Not Yet Adopted	Changes in Accounting Principles – Adopted in Current Year In March 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The guidance provides optional expedients for applying U.S. GAAP to contracts and other transactions affected by reference rate reform and was originally effective for contract modifications made between March 12, 2020 and December 31, 2022. In December 2022, the FASB issued ASU 2022-06, “Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848” that defers the sunset date of Topic 848 from December 31, 2022 to December 31, 2024, after which entities will no longer be permitted to apply the relief in Topic 848. If certain criteria are met, an entity will not be required to remeasure or reassess contracts impacted by reference rate reform. The practical expedient allowed by this standard was elected and applied by the Company. The contracts modified met the criteria for the practical expedient and, therefore, the transition did not have a material impact on the Company’s Condensed Consolidated Financial Statements. The Company has completed its transition from the London Interbank Offered Rate ("LIBOR"). Changes in Accounting Principles – Issued but Not Yet Adopted In November 2023, the FASB issued ASU 2023-07, “Improvements to Reportable Segment Disclosures”, which requires a public entity to disclose its significant segment expenses regularly provided to the chief operating decision maker ("CODM") and the amount and composition of other segment items. It also requires a public entity to disclose the title and position of the CODM. The ASU allows a public entity to disclose multiple measurements of segment profit or loss if a CODM uses multiple measures to assess segment’s performance and allocate resources. This ASU also expands the current interim disclosure requirements to require that nearly all of the annual segment disclosures be made on an interim basis. The amendments in this ASU will be effective for the Company for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted, and are to be applied retrospectively. The Company is in the process of evaluating the impact of the new guidance and does not plan to early adopt. In December 2023, the FASB issued ASU 2023-09, “Improvements to Income Tax Disclosures”, which enhances annual income tax disclosures by requiring disclosure of disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. The new requirements in this ASU will be effective for the Company for annual periods beginning after December 15, 2024, with early adoption permitted, and are to be applied on a prospective basis with the option to apply retrospectively. The Company is in the process of evaluating the impact of the new guidance and determining the transition method and the timing of adoption.

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Sep. 30, 2024
Segment Reporting [Abstract]
Certain Information with Respect to Segments	Set forth in the tables below is certain information with respect to the Company’s segments (in millions): Three Months Ended September 30, 2024 Retail Annuities Institutional Closed Life Corporate and Total Operating Revenues Fee income $ 1,128 $ — $ 111 $ 12 $ 1,251 Premiums 12 — 22 — 34 Net investment income 196 101 155 — 452 Other income (loss) 8 — 7 (1) 14 Total Operating Revenues 1,344 101 295 11 1,751 Operating Benefits and Expenses Death, other policy benefits and change in policy 26 — 131 — 157 (Gain) loss from updating future policy benefits cash flow assumptions, net (12) — 11 — (1) Interest credited on other contract holder funds, net of deferrals and amortization 88 83 104 — 275 Interest expense 6 — — 19 25 Operating costs and other expenses, net of deferrals 638 1 40 63 742 Amortization of deferred acquisition costs 140 — 2 — 142 Total Operating Benefits and Expenses 886 84 288 82 1,340 Pretax Adjusted Operating Earnings $ 458 $ 17 $ 7 $ (71) $ 411 Three Months Ended September 30, 2023 Retail Annuities Institutional Closed Life Corporate and Total Operating Revenues Fee income $ 1,038 $ — $ 112 $ 11 $ 1,161 Premiums 6 — 30 — 36 Net investment income 110 109 161 14 394 Other income 9 — 8 1 18 Total Operating Revenues 1,163 109 311 26 1,609 Operating Benefits and Expenses Death, other policy benefits and change in policy 24 — 150 — 174 (Gain) loss from updating future policy benefits cash flow assumptions, net (4) — 4 — — Interest credited on other contract holder funds, net 90 87 107 — 284 Interest expense 6 — — 22 28 Operating costs and other expenses, net of deferrals 554 1 41 30 626 Amortization of deferred acquisition costs 139 — 3 — 142 Total Operating Benefits and Expenses 809 88 305 52 1,254 Pretax Adjusted Operating Earnings $ 354 $ 21 $ 6 $ (26) $ 355 Nine Months Ended September 30, 2024 Retail Annuities Institutional Closed Life Corporate and Total Operating Revenues Fee income $ 3,313 $ — $ 335 $ 36 $ 3,684 Premiums 34 — 80 — 114 Net investment income 514 332 486 3 1,335 Other income (loss) 25 — 21 (21) 25 Total Operating Revenues 3,886 332 922 18 5,158 Operating Benefits and Expenses Death, other policy benefits and change in policy 51 — 419 — 470 (Gain) loss from updating future policy benefits cash flow assumptions, net (26) — 17 — (9) Interest credited on other contract holder funds, net of deferrals and amortization 260 252 309 — 821 Interest expense 18 — — 58 76 Operating costs and other expenses, net of deferrals 1,825 3 110 167 2,105 Amortization of deferred acquisition costs 416 — 6 — 422 Total Operating Benefits and Expenses 2,544 255 861 225 3,885 Pretax Adjusted Operating Earnings $ 1,342 $ 77 $ 61 $ (207) $ 1,273 Nine Months Ended September 30, 2023 Retail Annuities Institutional Closed Life Corporate and Total Operating Revenues Fee income $ 3,015 $ — $ 345 $ 37 $ 3,397 Premiums 16 — 102 — 118 Net investment income 317 297 489 39 1,142 Other income 28 — 18 6 52 Total Operating Revenues 3,376 297 954 82 4,709 Operating Benefits and Expenses Death, other policy benefits and change in policy 21 — 467 — 488 (Gain) loss from updating future policy benefits cash flow assumptions, net (6) — 31 — 25 Interest credited on other contract holder funds, net 284 247 333 — 864 Interest expense 18 — — 66 84 Operating costs and other expenses, net of deferrals 1,605 3 122 132 1,862 Amortization of deferred acquisition costs 416 — 8 — 424 Total Operating Benefits and Expenses 2,338 250 961 198 3,747 Pretax Adjusted Operating Earnings $ 1,038 $ 47 $ (7) $ (116) $ 962
Reconciliation of Segment Operating Revenues to Total Revenues	The following table summarizes the reconciling items from the non-GAAP measure of total operating revenues to the U.S. GAAP measure of total revenues attributable to the Company (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Total operating revenues $ 1,751 $ 1,609 $ 5,158 $ 4,709 Fees attributed to guarantee benefit reserves 779 784 2,347 2,345 Net gains (losses) on hedging instruments and investments (678) (137) (5,313) (5,704) Net investment income (loss) related to noncontrolling interests 3 17 17 21 Consolidated investments (3) 9 13 (32) Net investment income on funds withheld assets 269 303 824 862 Total revenues (1) $ 2,121 $ 2,585 $ 3,046 $ 2,201 (1) Substantially all the Company's revenues originated in the U.S. There were no customers that, individually, generate revenues that exceeded 10% of total revenues.
Reconciliation of Segment Operating Benefits and Expenses to Total Benefits and Expenses	The following table summarizes the reconciling items from the non-GAAP measure of total operating benefits and expenses to the U.S. GAAP measure of total benefits and expenses attributable to the Company (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Total operating benefits and expenses $ 1,340 $ 1,254 $ 3,885 $ 3,747 Net (gain) loss on market risk benefits 1,172 (2,376) (2,062) (5,120) Benefits attributed to guaranteed benefit features 53 57 171 211 Amortization of DAC related to non-operating revenues and expenses 135 148 410 450 Total benefits and expenses $ 2,700 $ (917) $ 2,404 $ (712)
Reconciliation of Segment Pretax Adjusted Operating Earnings to Net Income	The following table summarizes the reconciling items, from the non-GAAP measure of pretax adjusted operating earnings to the U.S. GAAP measure of net income attributable to the Company (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Pretax adjusted operating earnings $ 411 $ 355 $ 1,273 $ 962 Pre-tax reconciling items from adjusted operating income to net income (loss) attributable to Jackson Financial Inc.: Fees attributable to guarantee benefit reserves 779 784 2,347 2,345 Net gains (losses) on hedging instruments 591 (271) (3,068) (4,694) Market risk benefits gains (losses), net (1,172) 2,376 2,062 5,120 Net reserve and embedded derivative movements (493) 45 (1,135) (338) Amortization of DAC associated with non-operating items at date of transition to LDTI (135) (148) (410) (450) Total Guaranteed benefits and net hedging results (430) 2,786 (204) 1,983 Net realized investment gains (losses) (45) (127) (82) (235) Net realized investment gains (losses) on funds withheld assets (784) 159 (1,199) (648) Net investment income on funds withheld assets 269 303 824 862 Other items (3) 9 13 (32) Pretax income (loss) attributable to Jackson Financial Inc. (582) 3,485 625 2,892 Income tax expense (benefit) (113) 712 24 399 Net income (loss) attributable to Jackson Financial Inc. (469) 2,773 601 2,493 Dividends on preferred stock 11 11 33 24 Net income (loss) attributable to Jackson Financial Inc. common shareholders $ (480) $ 2,762 $ 568 $ 2,469

Investments (Tables)

Investments (Tables)	9 Months Ended
	Sep. 30, 2024
Investments, Debt and Equity Securities [Abstract]
Schedule of Composition of Fair Value of Debt Securities Classified by Rating	At September 30, 2024 and December 31, 2023, the carrying value of investments rated by the Company’s consolidated investment advisor totaled $233 million and $486 million, respectively. Percent of Total Debt September 30, 2024 December 31, 2023 Investment Rating U.S. government securities 7.6% 10.1% AAA 6.2% 6.5% AA 9.4% 9.0% A 31.8% 31.5% BBB 37.7% 35.9% Investment grade 92.7% 93.0% BB 3.4% 3.5% B and below 3.9% 3.5% Below investment grade 7.3% 7.0% Total debt securities 100.0% 100.0%
Schedule of Total Carrying Value Debt Securities in Unrealized Loss Position	At September 30, 2024 and December 31, 2023, the total carrying value of debt securities in an unrealized loss position consisted of: September 30, 2024 December 31, 2023 Investment grade securities 77% 77% Below investment grade securities 2% 2% Not rated securities 21% 21% Corporate securities in an unrealized loss position were diversified across industries as follows (in millions, except percentages): September 30, 2024 December 31, 2023 Industries accounting for the largest percentage of corporate gross unrealized losses: Utility 16% 17% Financial Services 13% 14% Largest unrealized loss related to a single corporate obligor $ 54 $ 50
Schedule of Debt Securities - Amortized Cost, Gross Unrealized Gains and Losses, Fair Value and Allowance for Credit Loss and Maturities	At September 30, 2024 and December 31, 2023, the amortized cost, allowance for credit loss ("ACL"), gross unrealized gains and losses, and fair value of debt securities, including trading securities and securities carried at fair value under the fair value option, were as follows (in millions): Allowance Gross Gross Amortized for Unrealized Unrealized Fair September 30, 2024 Cost (1) Credit Loss Gains Losses Value U.S. government securities $ 4,231 $ — $ 5 $ 787 $ 3,449 Other government securities 1,530 — 2 192 1,340 Public utilities 5,743 16 79 393 5,413 Corporate securities 30,402 9 405 2,038 28,760 Residential mortgage-backed 392 4 13 68 333 Commercial mortgage-backed 1,691 — 4 87 1,608 Other asset-backed securities 4,557 15 25 171 4,396 Total debt securities $ 48,546 $ 44 $ 533 $ 3,736 $ 45,299 Allowance Gross Gross Amortized for Unrealized Unrealized Fair December 31, 2023 Cost (1) Credit Loss Gains Losses Value U.S. government securities $ 5,154 $ — $ 3 $ 845 $ 4,312 Other government securities 1,622 — 1 221 1,402 Public utilities 5,598 — 42 513 5,127 Corporate securities 27,870 15 194 2,572 25,477 Residential mortgage-backed 422 6 12 53 375 Commercial mortgage-backed 1,569 — 1 147 1,423 Other asset-backed securities 4,830 — 6 309 4,527 Total debt securities $ 47,065 $ 21 $ 259 $ 4,660 $ 42,643 (1) Amortized cost, apart from the carrying value for securities carried at fair value under the fair value option and trading securities. The amortized cost, ACL, gross unrealized gains and losses, and fair value of debt securities at September 30, 2024, by contractual maturity, are shown below (in millions). Actual maturities may differ from contractual maturities where securities can be called or prepaid with or without early redemption penalties. Allowance Gross Gross Amortized for Unrealized Unrealized Fair Cost (1) Credit Loss Gains Losses Value Due in 1 year or less $ 1,879 $ — $ 4 $ 8 $ 1,875 Due after 1 year through 5 years 11,043 16 108 149 10,986 Due after 5 years through 10 years 12,859 9 236 662 12,424 Due after 10 years through 20 years 8,896 — 106 1,137 7,865 Due after 20 years 7,229 — 37 1,454 5,812 Residential mortgage-backed 392 4 13 68 333 Commercial mortgage-backed 1,691 — 4 87 1,608 Other asset-backed securities 4,557 15 25 171 4,396 Total $ 48,546 $ 44 $ 533 $ 3,736 $ 45,299 (1) Amortized cost, apart from the carrying value for securities carried at fair value under the fair value option and trading securities.
Schedule of Residential Mortgage-Backed Securities	The Company’s non-agency RMBS include investments in securities backed by prime, Alt-A, and subprime loans, as follows (in millions): Allowance Gross Gross Amortized for Unrealized Unrealized Fair September 30, 2024 Cost (1) Credit Loss Gains Losses Value Prime $ 144 $ 2 $ 1 $ 14 $ 129 Alt-A 88 2 6 43 49 Subprime 6 — 4 — 10 Total non-agency RMBS $ 238 $ 4 $ 11 $ 57 $ 188 Allowance Gross Gross Amortized for Unrealized Unrealized Fair December 31, 2023 Cost (1) Credit Loss Gains Losses Value Prime $ 164 $ 2 $ 1 $ 19 $ 144 Alt-A 71 3 5 20 53 Subprime 7 1 4 — 10 Total non-agency RMBS $ 242 $ 6 $ 10 $ 39 $ 207 (1) Amortized cost, apart from carrying value for securities carried at fair value under the fair value option and trading securities.
Schedule of Debt Securities in Continuous Unrealized Loss Position	The following table summarizes the number of securities, fair value and the gross unrealized losses of debt securities, aggregated by investment category and length of time that individual debt securities have been in a continuous loss position (dollars in millions): September 30, 2024 December 31, 2023 Less than 12 months Less than 12 months Gross Fair Gross Fair Unrealized # of Unrealized # of Losses securities Losses securities U.S. government securities $ 41 $ 291 7 $ 52 $ 306 11 Other government securities — — — 1 51 9 Public utilities 5 160 20 11 287 32 Corporate securities 52 1,210 187 50 1,331 227 Residential mortgage-backed 2 36 6 2 48 45 Commercial mortgage-backed 11 183 17 — 46 6 Other asset-backed securities 1 331 38 27 707 55 Total temporarily impaired securities $ 112 $ 2,211 275 $ 143 $ 2,776 385 12 months or longer 12 months or longer Gross Fair Gross Fair Unrealized # of Unrealized # of Losses securities Losses securities U.S. government securities $ 746 $ 2,065 23 $ 793 $ 2,774 23 Other government securities 192 1,277 136 220 1,301 151 Public utilities 388 3,795 459 502 4,105 491 Corporate securities 1,986 14,797 1,890 2,522 17,457 2,207 Residential mortgage-backed 66 203 207 51 251 219 Commercial mortgage-backed 76 1,127 156 147 1,294 177 Other asset-backed securities 170 1,960 235 282 3,141 427 Total temporarily impaired securities $ 3,624 $ 25,224 3,106 $ 4,517 $ 30,323 3,695 Total Total Gross Gross Unrealized Fair # of Unrealized Fair # of Losses Value securities (1) Losses Value securities (1) U.S. government securities $ 787 $ 2,356 28 $ 845 $ 3,080 30 Other government securities 192 1,277 136 221 1,352 157 Public utilities 393 3,955 468 513 4,392 513 Corporate securities 2,038 16,007 2,003 2,572 18,788 2,355 Residential mortgage-backed 68 239 210 53 299 262 Commercial mortgage-backed 87 1,310 171 147 1,340 182 Other asset-backed securities 171 2,291 269 309 3,848 469 Total temporarily impaired securities $ 3,736 $ 27,435 3,285 $ 4,660 $ 33,099 3,968 (1) Certain securities contain multiple lots and fit the criteria of both aging groups.
Schedule of Rollforward of Debt Securities Allowance for Credit Loss	The roll-forward of the allowance for credit loss for available-for-sale securities by sector is as follows (in millions): Three Months Ended September 30, 2024 US Other government securities Public Corporate securities Residential mortgage-backed Commercial mortgage-backed Other Total Balance at July 1, 2024 $ — $ — $ — $ 13 $ 6 $ — $ 8 $ 27 Additions for which credit loss was not previously recorded — — 16 — — — — 16 Changes for securities with previously recorded credit loss — — — 2 — — 7 9 Additions for purchases of PCD debt securities (1) — — — — — — — — Reductions from charge-offs — — — (6) — — — (6) Reductions for securities disposed — — — — (2) — — (2) Securities intended/required to be sold before recovery of amortized cost basis — — — — — — — — Balance at September 30, 2024 (2) $ — $ — $ 16 $ 9 $ 4 $ — $ 15 $ 44 Three Months Ended September 30, 2023 US Other government securities Public Corporate securities Residential mortgage-backed Commercial mortgage-backed Other Total Balance at July 1, 2023 $ — $ 3 $ — $ 7 $ 6 $ — $ — $ 16 Additions for which credit loss was not previously recorded — 2 — 15 — 9 — 26 Changes for securities with previously recorded credit loss — — — 2 — — — 2 Additions for purchases of PCD debt securities (1) — — — — — — — — Reductions from charge-offs — — — — — — — — Reductions for securities disposed — — — (1) — — — (1) Securities intended/required to be sold before recovery of amortized cost basis — (2) — (6) — (9) — (17) Balance at September 30, 2023 (2) $ — $ 3 $ — $ 17 $ 6 $ — $ — $ 26 Nine Months Ended September 30, 2024 US Other government securities Public Corporate securities Residential mortgage-backed Commercial mortgage-backed Other Total Balance at January 1, 2024 $ — $ — $ — $ 15 $ 6 $ — $ — $ 21 Additions for which credit loss was not previously recorded — — 16 — — — 1 17 Changes for securities with previously recorded credit loss — — — 2 — — 14 16 Additions for purchases of PCD debt securities (1) — — — — — — — — Reductions from charge-offs — — — (6) — — — (6) Reductions for securities disposed — — — (2) (2) — — (4) Securities intended/required to be sold before recovery of amortized cost basis — — — — — — — — Balance at September 30, 2024 (2) $ — $ — $ 16 $ 9 $ 4 $ — $ 15 $ 44 Nine Months Ended September 30, 2023 US Other government securities Public Corporate securities Residential mortgage-backed Commercial mortgage-backed Other Total Balance at January 1, 2023 $ — $ 2 $ — $ 15 $ 6 $ — $ — $ 23 Additions for which credit loss was not previously recorded — 2 — 48 — 9 — 59 Changes for securities with previously recorded credit loss — 1 — 1 2 — — 4 Additions for purchases of PCD debt securities (1) — — — — — — — — Reductions from charge-offs — — — — — — — — Reductions for securities disposed — — — (24) (2) — — (26) Securities intended/required to be sold before recovery of amortized cost basis — (2) — (23) — (9) — (34) Balance at September 30, 2023 (2) $ — $ 3 $ — $ 17 $ 6 $ — $ — $ 26 (1) Represents purchased credit-deteriorated ("PCD") fixed maturity available-for-sale securities. (2) Accrued interest receivable on debt securities totaled $446 million and $416 million as of September 30, 2024 and 2023, respectively, and was excluded from the determination of credit losses for the three and nine months ended September 30, 2024 and 2023.
Schedule of Sources of Net Investment Income	The sources of net investment income were as follows (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Debt securities (1) $ 393 $ 432 $ 1,191 $ 1,152 Equity securities 3 (4) 6 (5) Mortgage loans 83 81 248 235 Policy loans 17 17 50 50 Limited partnerships 20 20 106 19 Other investment income 51 24 135 74 Total investment income excluding funds withheld assets 567 570 1,736 1,525 Investment expenses (2)(3) (110) (112) (352) (277) Net investment income excluding funds withheld assets 457 458 1,384 1,248 Net investment income on funds withheld assets (see Note 8) 269 303 824 862 Net investment income $ 726 $ 761 $ 2,208 $ 2,110 (1) Includes changes in fair value gains (losses) on trading securities and includes $(23) million and $(1) million for the three and nine months ended September 30, 2024, respectively, and $51 million and $43 million for the three and nine months ended September 30, 2023, respectively, related to the change in fair value for securities carried under the fair value option. (2) In the first quarter of 2024, interest costs principally associated with repurchase agreements and cash collateral were reclassified from interest expense to net investment income. All prior period amounts have been conformed to current period presentation. (3) Includes expenses from consolidated variable interest entities, which includes changes in fair value of notes issued by those entities, of $(44) million and $(150) million for the three and nine months ended September 30, 2024, respectively, and $(70) million and $(144) million for the three and nine months ended September 30, 2023, respectively. The sources of income related to funds withheld under reinsurance treaties reported in net investment income in the Condensed Consolidated Income Statements were as follows (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Debt securities (1) $ 133 $ 162 $ 415 $ 494 Equity securities 8 2 17 (36) Mortgage loans (2) 47 48 141 174 Policy loans 82 80 246 238 Limited partnerships 11 17 39 32 Other investment income 3 13 13 16 Total investment income on funds withheld assets 284 322 871 918 Other investment expenses on funds withheld assets (3) (15) (19) (47) (56) Total net investment income on funds withheld reinsurance treaties $ 269 $ 303 $ 824 $ 862 (1) Includes $1 million and $2 million for the three and nine months ended September 30, 2024, respectively, and $1 million and $3 million for the three and nine months ended September 30, 2023, respectively, related to the change in fair value for securities carried under the fair value option. (2) Includes $4 million and $1 million for the three and nine months ended September 30, 2024, respectively, and $(5) million and $(7) million for the three and nine months ended September 30, 2023, respectively, related to the change in fair value for mortgage loans carried under the fair value option. (3) Includes management fees.
Schedule of Net Gains (Losses) on Derivatives and Investments	The following table summarizes net gains (losses) on derivatives and investments (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Available-for-sale securities Realized gains on sale $ 4 $ 11 $ 21 $ 17 Realized losses on sale (2) (102) (114) (145) Credit loss income (expense) (11) (18) (11) (29) Credit loss income (expense) on mortgage loans 8 (28) 6 (88) Other (1) (44) 10 16 10 Net gains (losses) excluding derivatives and funds withheld assets (45) (127) (82) (235) Net gains (losses) on derivative instruments (see Note 5) 147 (208) (4,050) (4,938) Net gains (losses) on derivatives and investments 102 (335) (4,132) (5,173) Net gains (losses) on funds withheld reinsurance treaties (see Note 8) (784) 159 (1,199) (648) Total net gains (losses) on derivatives and investments $ (682) $ (176) $ (5,331) $ (5,821) (1) Includes the foreign currency gain or loss related to foreign denominated trust instruments supporting funding agreements.
Schedule of Asset and Liability Information for Consolidated VIEs	Asset and liability information for the consolidated VIEs included on the Condensed Consolidated Balance Sheets are as follows (in millions): September 30, 2024 December 31, 2023 Assets Debt securities, at fair value under fair value option $ 2,459 $ 2,037 Debt securities, trading 73 68 Equity securities 6 7 Other invested assets 553 396 Cash and cash equivalents 167 93 Other assets 66 49 Total assets $ 3,324 $ 2,650 Liabilities Notes issued by consolidated VIEs, at fair value under fair value option $ 2,366 $ 1,988 Other liabilities 244 98 Total other liabilities 2,610 2,086 Securities lending payable 1 2 Total liabilities $ 2,611 $ 2,088 Equity Noncontrolling interests $ 209 $ 164
Schedule of Commercial Mortgage Loans and Residential Mortgage Loans	The following table shows commercial mortgage loans, residential mortgage loans, and the respective accrued interest thereon at September 30, 2024 and December 31, 2023 (in millions): September 30, 2024 December 31, 2023 Commercial mortgage loans (1) $ 9,114 $ 9,562 Accrued interest receivable on commercial mortgage loans 36 39 Residential mortgage loans (2) 882 1,001 Accrued interest receivable on residential mortgage loans 6 7 (1) Net of an allowance for credit losses of $143 million and $160 million at each date, respectively. (2)
Schedule of Rollforward of Mortgagees Allowance for Credit Loss	The following table provides the change in the allowance for credit losses in the Company’s mortgage loan portfolios (in millions): Three Months Ended September 30, 2024 Apartment Hotel Office Retail Warehouse Other Residential Mortgage Total Balance at July 1, 2024 $ 27 $ 5 $ 70 $ 27 $ 19 $ 7 $ 5 $ 160 Charge offs, net of recoveries (3) — — — — — — (3) Additions from purchase of PCD mortgage loans — — — — — — — — Provision (release) (4) — (4) 5 (1) (5) — (9) Balance at September 30, 2024 (1) (2) $ 20 $ 5 $ 66 $ 32 $ 18 $ 2 $ 5 $ 148 Three Months Ended September 30, 2023 Apartment Hotel Office Retail Warehouse Other Residential Mortgage Total Balance at July 1, 2023 $ 16 $ 7 $ 91 $ 25 $ 12 $ 3 $ 8 $ 162 Charge offs, net of recoveries — — — — — — — — Additions from purchase of PCD mortgage loans — — — — — — — — Provision (release) 8 (1) 30 — 4 — (3) 38 Balance at September 30, 2023 (1) (2) $ 24 $ 6 $ 121 $ 25 $ 16 $ 3 $ 5 $ 200 Nine Months Ended September 30, 2024 Apartment Hotel Office Retail Warehouse Other Residential Mortgage Total Balance at January 1, 2024 $ 28 $ 4 $ 78 $ 27 $ 17 $ 6 $ 5 $ 165 Charge offs, net of recoveries (3) — — — — — — (3) Additions from purchase of PCD mortgage loans — — — — — — — — Provision (release) (5) 1 (12) 5 1 (4) — (14) Balance at September 30, 2024 (1) (2) $ 20 $ 5 $ 66 $ 32 $ 18 $ 2 $ 5 $ 148 Nine Months Ended September 30, 2023 Apartment Hotel Office Retail Warehouse Other Residential Mortgage Total Balance at January 1, 2023 $ 16 $ 20 $ 15 $ 21 $ 16 $ 3 $ 4 $ 95 Charge offs, net of recoveries — — — — — — — — Additions from purchase of PCD mortgage loans — — — — — — — — Provision (release) 8 (14) 106 4 — — 1 105 Balance at September 30, 2023 (1) (2) $ 24 $ 6 $ 121 $ 25 $ 16 $ 3 $ 5 $ 200 (1) Accrued interest receivable totaled $42 million and $45 million as of September 30, 2024 and 2023, respectively, and was excluded from the determination of credit losses. (2) Accrued interest amounting to $1 million and $2 million was written off as of September 30, 2024 and 2023, respectively, relating to loans that were greater than 90 days delinquent or in the process of foreclosure.
Schedule of Impaired Financing Receivables	The following table provides information about our impaired residential mortgage loans (in millions): September 30, 2024 December 31, 2023 Recorded investment $ 32 $ 24 Unpaid principal balance 36 27 Related loan allowance 2 1 Average recorded investment 29 19 Investment income recognized — 1
Schedule of Information About Credit Quality and Vintage Year of Commercial Mortgage Loans	The following tables provide information about the credit quality with vintage year and category of mortgage loans (dollars in millions): September 30, 2024 2024 2023 2022 2021 2020 Prior Revolving Total % of Commercial mortgage loans Loan to value ratios: Less than 70% $ 432 $ 639 $ 579 $ 636 $ 518 $ 4,799 $ 4 $ 7,607 83 % 70% - 80% 17 49 204 352 170 262 — 1,054 12 % 80% - 100% — — 167 23 — 172 — 362 4 % Greater than 100% — — — — 28 63 — 91 1 % Total commercial mortgage loans 449 688 950 1,011 716 5,296 4 9,114 100 % Debt service coverage ratios: Greater than 1.20x 433 577 677 680 678 4,990 4 8,039 88 % 1.00x - 1.20x 16 103 196 331 38 207 — 891 10 % Less than 1.00x — 8 77 — — 99 — 184 2 % Total commercial mortgage loans 449 688 950 1,011 716 5,296 4 9,114 100 % Residential mortgage loans Performing 93 139 44 115 31 355 — 777 88 % Nonperforming — 16 51 7 6 25 — 105 12 % Total residential mortgage loans 93 155 95 122 37 380 — 882 100 % Total mortgage loans $ 542 $ 843 $ 1,045 $ 1,133 $ 753 $ 5,676 $ 4 $ 9,996 100 % December 31, 2023 2023 2022 2021 2020 2019 Prior Revolving Total % of Commercial mortgage loans Loan to value ratios: Less than 70% $ 659 $ 800 $ 937 $ 653 $ 1,251 $ 4,300 $ 4 $ 8,604 90 % 70% - 80% 24 138 325 122 61 41 — 711 7 % 80% - 100% — 25 — 37 41 93 — 196 2 % Greater than 100% — — 26 — 22 3 — 51 1 % Total commercial mortgage loans 683 963 1,288 812 1,375 4,437 4 9,562 100 % Debt service coverage ratios: Greater than 1.20x 546 611 932 667 1,302 4,189 4 8,251 86 % 1.00x - 1.20x 129 277 356 145 30 191 — 1,128 12 % Less than 1.00x 8 75 — — 43 57 — 183 2 % Total commercial mortgage loans 683 963 1,288 812 1,375 4,437 4 9,562 100 % Residential mortgage loans Performing 193 136 155 36 30 361 — 911 91 % Nonperforming 3 41 10 7 3 26 — 90 9 % Total residential mortgage loans 196 177 165 43 33 387 — 1,001 100 % Total mortgage loans $ 879 $ 1,140 $ 1,453 $ 855 $ 1,408 $ 4,824 $ 4 $ 10,563 100 % September 30, 2024 In Good Standing (1) Restructured Greater than 90 Days Delinquent In the Process of Foreclosure Total Carrying Value Apartment $ 2,515 $ — $ — $ — $ 2,515 Hotel 821 — — — 821 Office 1,260 40 2 — 1,302 Retail 1,830 — — — 1,830 Warehouse 2,053 — — — 2,053 Other 593 — — — 593 Total commercial 9,072 40 2 — 9,114 Residential (2) 777 — 73 32 882 Total $ 9,849 $ 40 $ 75 $ 32 $ 9,996 December 31, 2023 In Good Standing (1) Restructured Greater than 90 Days Delinquent In the Process of Foreclosure Total Carrying Value Apartment $ 2,841 $ — $ — $ — $ 2,841 Hotel 767 — — — 767 Office 1,379 — — — 1,379 Retail 1,864 — — — 1,864 Warehouse 2,016 — — — 2,016 Other 695 — — — 695 Total commercial 9,562 — — — 9,562 Residential (2) 911 — 66 24 1,001 Total $ 10,473 $ — $ 66 $ 24 $ 10,563 (1) At September 30, 2024 and December 31, 2023, includes mezzanine and bridge loans in good standing of $350 million and $368 million in the Apartment category, $27 million and $21 million in the Hotel category, $138 million and $171 million in the Office category, $32 million and $32 million in the Retail category, $268 million and $287 million in the Warehouse category, and $23 million and $48 million in the Other category, respectively. At September 30, 2024 and December 31, 2023, includes restructured mezzanine and bridge loans of $24 million and nil in the Office category. (2) At September 30, 2024 and December 31, 2023, includes $18 million and $22 million of loans purchased when the loans were greater than 90 days delinquent and $3 million and $5 million of loans in process of foreclosure, all of which are loans supported with insurance or other guarantees provided by various governmental programs, respectively.
Schedule of Mortgage Loans Identified to Borrowers Experiencing Financial Difficulty	The following table provides information about the mortgage loans modified during the periods indicated to borrowers experiencing financial difficulty (dollars in millions): Term Extension Amortized Percent of Three Months Ended September 30, 2024 Commercial mortgage loans $ — — % Three Months Ended September 30, 2023 Commercial mortgage loans $ — — % Term Extension Amortized Percent of Nine Months Ended September 30, 2024 Commercial mortgage loans $ 24 0.26 % Nine Months Ended September 30, 2023 Commercial mortgage loans $ 17 0.18 % The following table describes the financial effect of the modifications made to the loans noted above: Term Extension Financial Effect Nine Months Ended September 30, 2024 Commercial mortgage loans Granted extension of term for three Nine Months Ended September 30, 2023 Commercial mortgage loans Granted extension of term for three Payment Status (Amortized Cost Basis) Current 30-89 Days Past Due 90+ Days Past Due September 30, 2024 Commercial mortgage loans $ 40 $ — $ — September 30, 2023 Commercial mortgage loans $ 17 $ — $ —

Derivative Instruments (Tables)

Derivative Instruments (Tables)	9 Months Ended
	Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Aggregate Contractual Notional Amounts and Fair Values of Derivatives	A summary of the aggregate contractual or notional amounts and fair values of the Company’s freestanding and embedded derivative instruments are as follows (in millions): September 30, 2024 Contractual/ Assets Liabilities Net Notional Fair Fair Fair Value Amount (1) Value Value Asset (Liability) Freestanding derivatives Cross-currency swaps $ 1,714 $ 133 $ 131 $ 2 Equity index call options 1,000 36 — 36 Equity index futures (2) 30,711 — — — Equity index put options 14,000 76 — 76 Interest rate swaps 5,978 4 87 (83) Put-swaptions 3,500 11 141 (130) Interest rate futures (2) 32,767 — — — Total return swaps 1,943 — 36 (36) Total freestanding derivatives 91,613 260 395 (135) Embedded derivatives Fixed index annuity embedded derivatives (3) N/A — 825 (825) Registered index linked annuity embedded derivatives (3) N/A — 2,799 (2,799) Total embedded derivatives N/A — 3,624 (3,624) Derivatives related to funds withheld under reinsurance treaties Cross-currency swaps 158 14 1 13 Cross-currency forwards 1,149 21 29 (8) Funds withheld embedded derivative (4) N/A 1,992 — 1,992 Total derivatives related to funds withheld under reinsurance treaties 1,307 2,027 30 1,997 Total $ 92,920 $ 2,287 $ 4,049 $ (1,762) (1) The notional amount for swaps and swaptions represents the stated principal balance used as a basis for calculating payments. The contractual amount for futures and options represents the market exposure of open positions. (2) Variation margin is considered settlement resulting in the netting of cash received/paid for variation margin against the fair value of the trades. (3) Included within other contract holder funds on the Condensed Consolidated Balance Sheets. The non-performance risk adjustment is included in the balance above. (4) Included within funds withheld payable under reinsurance treaties on the Condensed Consolidated Balance Sheets. December 31, 2023 Contractual/ Assets Liabilities Net Notional Fair Fair Fair Value Amount (1) Value Value Asset (Liability) Freestanding derivatives Cross-currency swaps $ 1,665 $ 123 $ 116 $ 7 Equity index futures (2) 24,739 — — — Equity index put options 26,000 59 — 59 Interest rate swaps 6,228 5 132 (127) Put-swaptions 23,500 153 905 (752) Interest rate futures (2) 33,926 — — — Total return swaps 1,599 1 23 (22) Total freestanding derivatives 117,657 341 1,176 (835) Embedded derivatives Fixed index annuity embedded derivatives (3) N/A — 866 (866) Registered index linked annuity embedded derivatives (3) N/A — 1,224 (1,224) Total embedded derivatives N/A — 2,090 (2,090) Derivatives related to funds withheld under reinsurance treaties Cross-currency swaps 158 14 1 13 Cross-currency forwards 1,410 35 33 2 Funds withheld embedded derivative (4) N/A 2,468 — 2,468 Total derivatives related to funds withheld under reinsurance treaties 1,568 2,517 34 2,483 Total $ 119,225 $ 2,858 $ 3,300 $ (442) (1) The notional amount for swaps and swaptions represents the stated principal balance used as a basis for calculating payments. The contractual amount for futures and options represents the market exposure of open positions. (2) Variation margin is considered settlement resulting in the netting of cash received/paid for variation margin against the fair value of the trades. (3) Included within other contract holder funds on the Condensed Consolidated Balance Sheets. The non-performance risk adjustment is included in the balance above. (4) Included within funds withheld payable under reinsurance treaties on the Condensed Consolidated Balance Sheets.
Gains and Losses, and Change in Fair Value of Derivatives	The following table reflects the results of the Company’s derivatives, including gains (losses) and change in fair value of freestanding derivative instruments and embedded derivatives (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Derivatives excluding funds withheld under reinsurance treaties Cross-currency swaps $ 14 $ (16) $ (28) $ (42) Equity index call options 29 (192) 29 (100) Equity index futures (514) (5) (1,677) (2,712) Equity index put options (103) 45 (295) (1,362) Interest rate swaps 76 (137) (25) (189) Interest rate swaps - cleared — — — (10) Put-swaptions 173 (1,013) (460) (840) Interest rate futures 994 938 (351) 537 Total return swaps (82) 70 (280) (93) Fixed index annuity embedded derivatives (4) — (16) (4) Registered index linked annuity embedded derivatives (436) 102 (947) (123) Total net gains (losses) on derivative instruments excluding derivative instruments related to funds withheld under reinsurance treaties 147 (208) (4,050) (4,938) Derivatives related to funds withheld under reinsurance treaties Cross-currency swaps (2) 60 1 58 Cross-currency forwards (28) (36) (12) (57) Funds withheld embedded derivative (530) 451 (476) 194 Total net gains (losses) on derivative instruments related to funds withheld under reinsurance treaties (560) 475 (487) 195 Total net gains (losses) on derivative instruments including derivative instruments related to funds withheld under reinsurance treaties $ (413) $ 267 $ (4,537) $ (4,743)
Gross and Net Information About Financial Instruments Subject to Master Netting Arrangements - Assets	The following tables present the gross and net information about the Company’s financial instruments subject to master netting arrangements (in millions): September 30, 2024 Gross Gross Net Amounts Gross Amounts Not Offset Financial Instruments (1) Cash Securities Collateral (2) Net Financial Assets: Freestanding derivative assets $ 295 $ — $ 295 $ 156 $ 130 $ — $ 9 Financial Liabilities: Freestanding derivative liabilities $ 425 $ — $ 425 $ 156 $ 7 $ 254 $ 8 Securities loaned 26 — 26 — 26 — — Repurchase agreements 794 — 794 — — 794 — Repurchase agreements - collateral upgrade 1,551 (1,551) — — — — — Total financial liabilities $ 2,796 $ (1,551) $ 1,245 $ 156 $ 33 $ 1,048 $ 8 (1) Represents the amount that could be offset under master netting or similar arrangements that management elects not to offset on the Condensed Consolidated Balance Sheets. (2) Excludes initial margin amounts for exchange-traded derivatives. December 31, 2023 Gross Gross Net Amounts Gross Amounts Not Offset Financial Instruments (1) Cash Securities Collateral (2) Net Financial Assets: Freestanding derivative assets $ 390 $ — $ 390 $ 273 $ 108 $ — $ 9 Financial Liabilities: Freestanding derivative liabilities $ 1,210 $ — $ 1,210 $ 273 $ 6 $ 744 $ 187 Securities loaned 19 — 19 — 19 — — Repurchase agreements — — — — — — — Total financial liabilities $ 1,229 $ — $ 1,229 $ 273 $ 25 $ 744 $ 187 (1) Represents the amount that could be offset under master netting or similar arrangements that management elects not to offset on the Condensed Consolidated Balance Sheets. (2) Excludes initial margin amounts for exchange-traded derivatives.
Gross and Net Information About Financial Instruments Subject to Master Netting Arrangements - Liabilities	The following tables present the gross and net information about the Company’s financial instruments subject to master netting arrangements (in millions): September 30, 2024 Gross Gross Net Amounts Gross Amounts Not Offset Financial Instruments (1) Cash Securities Collateral (2) Net Financial Assets: Freestanding derivative assets $ 295 $ — $ 295 $ 156 $ 130 $ — $ 9 Financial Liabilities: Freestanding derivative liabilities $ 425 $ — $ 425 $ 156 $ 7 $ 254 $ 8 Securities loaned 26 — 26 — 26 — — Repurchase agreements 794 — 794 — — 794 — Repurchase agreements - collateral upgrade 1,551 (1,551) — — — — — Total financial liabilities $ 2,796 $ (1,551) $ 1,245 $ 156 $ 33 $ 1,048 $ 8 (1) Represents the amount that could be offset under master netting or similar arrangements that management elects not to offset on the Condensed Consolidated Balance Sheets. (2) Excludes initial margin amounts for exchange-traded derivatives. December 31, 2023 Gross Gross Net Amounts Gross Amounts Not Offset Financial Instruments (1) Cash Securities Collateral (2) Net Financial Assets: Freestanding derivative assets $ 390 $ — $ 390 $ 273 $ 108 $ — $ 9 Financial Liabilities: Freestanding derivative liabilities $ 1,210 $ — $ 1,210 $ 273 $ 6 $ 744 $ 187 Securities loaned 19 — 19 — 19 — — Repurchase agreements — — — — — — — Total financial liabilities $ 1,229 $ — $ 1,229 $ 273 $ 25 $ 744 $ 187 (1) Represents the amount that could be offset under master netting or similar arrangements that management elects not to offset on the Condensed Consolidated Balance Sheets. (2) Excludes initial margin amounts for exchange-traded derivatives.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value and Carrying Value of Financial Instruments	The following table summarizes the fair value and carrying value of the Company’s financial instruments (in millions): September 30, 2024 December 31, 2023 Carrying Fair Carrying Fair Assets Debt securities (1) $ 45,299 $ 45,299 $ 42,643 $ 42,643 Equity securities 213 213 394 394 Mortgage loans (1) 9,996 9,609 10,563 9,994 Limited partnerships 2,393 2,393 2,132 2,132 Policy loans (1) 4,453 4,453 4,399 4,399 Freestanding derivative instruments 295 295 390 390 FHLBI capital stock 127 127 108 108 Cash and cash equivalents 3,061 3,061 2,688 2,688 Reinsurance recoverable on market risk benefits 149 149 149 149 Market risk benefit assets 7,615 7,615 6,737 6,737 Separate account assets 235,037 235,037 219,656 219,656 Liabilities Annuity reserves (2) 37,985 39,321 35,251 33,678 Market risk benefit liabilities 4,384 4,384 4,785 4,785 Reserves for guaranteed investment contracts (3) 556 549 700 674 Trust instruments supported by funding agreements (3) 5,461 5,426 5,756 5,601 FHLB funding agreements (3) 1,912 1,859 1,950 1,893 Funds withheld payable under reinsurance treaties (1) 18,103 18,103 19,952 19,952 Long-term debt 2,033 1,888 2,037 1,851 Securities lending payable 26 26 19 19 Freestanding derivative instruments 425 425 1,210 1,210 Notes issued by consolidated VIEs 2,366 2,366 1,988 1,988 Repurchase agreements 794 794 — — FHLB advances — — 250 250 Separate account liabilities 235,037 235,037 219,656 219,656 (1) Includes items carried at fair value under the fair value option and trading securities included as a component of debt securities. (2) Annuity reserves represent only the components of other contract holder funds and reserves for future policy benefits and claims payable that are considered to be financial instruments. (3) Included as a component of other contract holder funds on the Condensed Consolidated Balance Sheets.
Fair Value Option	The fair value and aggregate contractual principal for mortgage loans where the fair value option was elected after December 31, 2021, were as follows (in millions): September 30, December 31, 2024 2023 Fair value $ 432 $ 481 Aggregate contractual principal 441 491
Assets and Liabilities Carried at Fair Value by Hierarchy Levels	The following tables summarize the Company’s assets and liabilities that are carried at fair value by hierarchy levels (in millions): September 30, 2024 Total Level 1 Level 2 Level 3 Assets Debt securities U.S. government securities $ 3,449 $ 3,449 $ — $ — Other government securities 1,340 — 1,184 156 Public utilities 5,413 — 5,326 87 Corporate securities 28,760 — 28,650 110 Residential mortgage-backed 333 — 333 — Commercial mortgage-backed 1,608 — 1,608 — Other asset-backed securities 4,396 — 3,495 901 Equity securities 213 — 206 7 Mortgage loans 432 — — 432 Limited partnerships (1) 172 — — 172 Policy loans 3,535 — — 3,535 Freestanding derivative instruments 295 — 295 — Cash and cash equivalents 3,061 3,061 — — Reinsurance recoverable on market risk benefits 149 — — 149 Market risk benefit assets 7,615 — — 7,615 Separate account assets 235,037 — 235,037 — Total $ 295,808 $ 6,510 $ 276,134 $ 13,164 Liabilities Embedded derivative liabilities (2) $ 3,624 $ — $ 3,624 $ — Funds withheld payable under reinsurance treaties (3) 1,719 — — 1,719 Freestanding derivative instruments 425 — 425 — Notes issued by consolidated VIEs 2,366 — 2,366 — Market risk benefit liabilities 4,384 — — 4,384 Total $ 12,518 $ — $ 6,415 $ 6,103 (1) Excludes $2,221 million of limited partnership investments measured at NAV. (2) Includes the embedded derivative liabilities of $2,799 million related to RILA and $825 million liability of fixed index annuities, both included in other contract holder funds on the Condensed Consolidated Balance Sheets. (3) Includes the Athene embedded derivative asset of $1,992 million and funds withheld payable under reinsurance treaties at fair value under the fair value option. December 31, 2023 Total Level 1 Level 2 Level 3 Assets Debt securities U.S. government securities $ 4,312 $ 4,312 $ — $ — Other government securities 1,402 — 1,252 150 Public utilities 5,127 — 5,086 41 Corporate securities 25,477 — 25,394 83 Residential mortgage-backed 375 — 375 — Commercial mortgage-backed 1,423 — 1,423 — Other asset-backed securities 4,527 — 3,552 975 Equity securities 394 182 204 8 Mortgage loans 481 — — 481 Limited partnerships (1) 135 — — 135 Policy loans 3,457 — — 3,457 Freestanding derivative instruments 390 — 390 — Cash and cash equivalents 2,688 2,688 — — Reinsurance recoverable on market risk benefits 149 — — 149 Market risk benefit assets 6,737 — — 6,737 Separate account assets 219,656 — 219,656 — Total $ 276,730 $ 7,182 $ 257,332 $ 12,216 Liabilities Embedded derivative liabilities (2) $ 2,090 $ — $ 2,090 $ — Funds withheld payable under reinsurance treaties (3) 1,158 — — 1,158 Freestanding derivative instruments 1,210 — 1,210 — Notes issued by consolidated VIEs 1,988 — 1,988 — Market risk benefit liabilities 4,785 — — 4,785 Total $ 11,231 $ — $ 5,288 $ 5,943 (1) Excludes $1,997 million of limited partnership investments measured at NAV. (2) Includes the embedded derivative liabilities of $1,224 million related to RILA and $866 million of fixed index annuities, both included in other contract holder funds on the Condensed Consolidated Balance Sheets. (3) Includes the Athene embedded derivative asset of $2,468 million and funds withheld payable under reinsurance treaties at fair value under the fair value option.
Balances of Level 3 Assets and Liabilities Measured at Fair Value with Corresponding Pricing Sources	The table below presents the balances of Level 3 assets and liabilities measured at fair value with their corresponding pricing sources (in millions): September 30, 2024 Assets Total Internal External Debt securities: Other government securities $ 156 $ — $ 156 Public utilities 87 44 43 Corporate 110 — 110 Other asset-backed securities 901 — 901 Equity securities 7 1 6 Mortgage loans 432 — 432 Limited partnerships 172 1 171 Policy loans 3,535 3,535 — Reinsurance recoverable on market risk benefits 149 149 — Market risk benefit assets 7,615 7,615 — Total $ 13,164 $ 11,345 $ 1,819 Liabilities Funds withheld payable under reinsurance treaties (1) 1,719 1,719 — Market risk benefit liabilities 4,384 4,384 — Total $ 6,103 $ 6,103 $ — (1) Includes the Athene Embedded Derivative asset of $1,992 million and funds withheld payable under reinsurance treaties at fair value under the fair value option. December 31, 2023 Assets Total Internal External Debt securities: Other government securities $ 150 $ — $ 150 Public utilities 41 41 — Corporate 83 — 83 Other asset-backed securities 975 50 925 Equity securities 8 1 7 Mortgage loans 481 — 481 Limited partnerships 135 1 134 Policy loans 3,457 3,457 — Reinsurance recoverable on market risk benefits 149 149 — Market risk benefit assets 6,737 6,737 — Total $ 12,216 $ 10,436 $ 1,780 Liabilities Funds withheld payable under reinsurance treaties (1) 1,158 1,158 — Market risk benefit liabilities 4,785 4,785 — Total $ 5,943 $ 5,943 $ — (1) Includes the Athene Embedded Derivative asset of $2,468 million and funds withheld payable under reinsurance treaties at fair value under the fair value option.
Quantitative Information on Significant Internally-Priced Level 3 Assets and Liabilities	The table below presents quantitative information on internally-priced Level 3 assets and liabilities that use significant unobservable inputs (in millions): As of September 30, 2024 Fair Valuation Technique(s) Significant Unobservable Input(s) Assumption or Input Range Impact of Increase in Input on Fair Value Assets Reinsurance recoverable on market risk benefits $ 149 Discounted cash Mortality (1) 0.01% - 20.71% Increase Lapse (2) 1.47% - 8.55% Increase Utilization (3) 0.00% - 50.00% Decrease Withdrawal (4) 47.50% - 50.00% Decrease Non-performance risk adjustment (5) 0.10% - 1.29% Increase Long-term Equity Volatility (6) 18.50% Decrease Market risk benefit assets $ 7,615 Discounted cash flow Mortality (1) 0.01% - 23.46% Increase Lapse (2) 0.05% - 37.06% Increase Utilization (3) 0.00% - 100.00% Decrease Withdrawal (4) 11.25% - 100.00% Decrease Non-performance risk adjustment (5) 0.83% - 1.85% Increase Long-term Equity Volatility (6) 18.50% Decrease Liabilities Market risk benefit liabilities $ 4,384 Discounted cash flow Mortality (1) 0.01% - 23.46% Decrease Lapse (2) 0.05% - 37.06% Decrease Utilization (3) 0.00% - 100.00% Increase Withdrawal (4) 11.25% - 100.00% Increase Non-performance risk adjustment (5) 0.83% - 1.85% Decrease Long-term Equity Volatility (6) 18.50% Increase (1) Mortality rates vary by attained age, tax qualification status, guaranteed benefit election, and duration. The range displayed reflects ages from the minimum issue age for the benefit through age 95, which corresponds to the typical maturity age. A mortality improvement assumption is also applied. (2) Base lapse rates vary by contract-level factors, such as product type, surrender charge schedule and optional benefits election. Lapse rates are further adjusted based on the degree to which a guaranteed benefit is in-the-money, with lower lapse applying when benefits are more in-the-money. Lapse rates are also adjusted to reflect lower lapse expectations when guaranteed benefits are utilized. (3) The utilization rate represents the expected percentage of contracts that will utilize the benefit through annuitization (GMIB) or commencement of withdrawals (GMWB). Utilization may vary by benefit type, attained age, duration, tax qualification status, benefit provision, and degree to which the guaranteed benefit is in-the-money. (4) The withdrawal rate represents the percentage of annual withdrawal assumed relative to the maximum allowable withdrawal amount under the free partial withdrawal provision or the GMWB, as applicable. Free partial withdrawal rates vary based on the product type and duration. Withdrawal rates on contracts with a GMWB vary based on attained age, tax qualification status, GMWB type and GMWB benefit provisions. (5) Non-performance risk adjustment is applied as a spread over the risk-free rate to determine the rate used to discount the related cash flows and varies by projection year. (6) Long-term equity volatility represents the equity volatility beyond the period for which observable equity volatilities are available. As of December 31, 2023 Fair Valuation Technique(s) Significant Unobservable Input(s) Assumption or Input Range Impact of Increase in Input on Fair Value Assets Reinsurance recoverable on market risk benefits $ 149 Discounted cash flow Mortality (1) 0.01% - 20.71% Increase Lapse (2) 1.47% - 8.55% Increase Utilization (3) 0.00% - 50.00% Decrease Withdrawal (4) 47.50% - 50.00% Decrease Non-performance risk adjustment (5) 0.10% - 1.50% Increase Long-term Equity Volatility (6) 18.50% Decrease Market risk benefit assets $ 6,737 Discounted cash flow Mortality (1) 0.01% - 23.46% Increase Lapse (2) 0.05% - 37.06% Increase Utilization (3) 0.00% - 100.00% Decrease Withdrawal (4) 11.25% - 100.00% Decrease Non-performance risk adjustment (5) 0.70% - 2.11% Increase Long-term Equity Volatility (6) 18.50% Decrease Liabilities Market risk benefit liabilities $ 4,785 Discounted cash flow Mortality (1) 0.01% - 23.46% Decrease Lapse (2) 0.05% - 37.06% Decrease Utilization (3) 0.00% - 100.00% Increase Withdrawal (4) 11.25% - 100.00% Increase Non-performance risk adjustment (5) 0.70% - 2.11% Decrease Long-term Equity Volatility (6) 18.50% Increase (1) Mortality rates vary by attained age, tax qualification status, guaranteed benefit election, and duration. The range displayed reflects ages from the minimum issue age for the benefit through age 95, which corresponds to the typical maturity age. A mortality improvement assumption is also applied. (2) Base lapse rates vary by contract-level factors, such as product type, surrender charge schedule and optional benefits election. Lapse rates are further adjusted based on the degree to which a guaranteed benefit is in-the-money, with lower lapse applying when benefits are more in-the-money. Lapse rates are also adjusted to reflect lower lapse expectations when guaranteed benefits are utilized. (3) The utilization rate represents the expected percentage of contracts that will utilize the benefit through annuitization (GMIB) or commencement of withdrawals (GMWB). Utilization may vary by benefit type, attained age, duration, tax qualification status, benefit provision, and degree to which the guaranteed benefit is in-the-money. (4) The withdrawal rate represents the percentage of annual withdrawal assumed relative to the maximum allowable withdrawal amount under the free partial withdrawal provision or the GMWB, as applicable. Free partial withdrawal rates vary based on the product type and duration. Withdrawal rates on contracts with a GMWB vary based on attained age, tax qualification status, GMWB type and GMWB benefit provisions. (5) Non-performance risk adjustment is applied as a spread over the risk-free rate to determine the rate used to discount the related cash flows and varies by projection year. (6)
Rollforwards of Financial Instruments for Which Significant Unobservable Inputs (Level 3) are Used - Assets	The tables below provide roll-forwards for the three and nine months ended September 30, 2024 and 2023 of the financial instruments for which significant unobservable inputs (Level 3) are used in the fair value measurement. Gains and losses in the tables below include changes in fair value due partly to observable and unobservable factors. The Company utilizes derivative instruments to manage the risk associated with certain assets and liabilities. However, the derivative instruments hedging the related risks may not be classified within the same fair value hierarchy level as the associated assets and liabilities. Therefore, the impact of the derivative instruments reported in Level 3 may vary significantly from the total income effect of the hedged instruments. Total Realized/Unrealized Gains (Losses) Included in Purchases, Fair Value Sales, Transfers Fair Value as of Net Other Issuances in and/or as of July 1, Income Comprehensive and (out of) September 30, Three Months Ended September 30, 2024 2024 (Loss) Income (Loss) Settlements Level 3 2024 Assets Debt securities Other government securities $ 151 $ — $ 5 $ — $ — $ 156 Public utilities 44 — (12) — 55 87 Corporate securities 73 3 2 21 11 110 Other asset-backed securities 919 (1) 15 (11) (21) 901 Equity securities 7 — — — — 7 Mortgage loans 430 4 — (2) — 432 Limited partnerships 152 12 — 8 — 172 Policy loans 3,511 68 — (44) — 3,535 Reinsurance recoverable on market risk benefits 121 28 — — — 149 Market risk benefit assets 8,556 (941) — — — 7,615 Liabilities Funds withheld payable under reinsurance treaties (1,161) (601) — 43 — (1,719) Market risk benefit liabilities (3,890) (260) (234) — — (4,384) Total Realized/Unrealized Gains (Losses) Included in Purchases, Fair Value Sales, Transfers Fair Value as of Net Other Issuances in and/or as of July 1, Income Comprehensive and (out of) September 30, Three Months Ended September 30, 2023 2023 (Loss) Income (Loss) Settlements Level 3 2023 Assets Debt securities Corporate securities $ 21 $ (2) $ — $ 22 $ 3 $ 44 Equity securities 86 (2) — — — 84 Mortgage loans 509 (5) — (28) — 476 Limited partnerships 422 (17) — (10) 29 424 Policy loans 3,438 (32) — 26 — 3,432 Reinsurance recoverable on market risk benefits 194 (27) — — — 167 Market risk benefit assets 5,957 858 — — — 6,815 Liabilities Funds withheld payable under reinsurance treaties (701) 481 — (27) — (247) Market risk benefit liabilities (4,463) 1,545 (999) — — (3,917) Total Realized/Unrealized Gains (Losses) Included in Purchases, Fair Value Sales, Transfers Fair Value as of Net Other Issuances in and/or as of January 1, Income Comprehensive and (out of) September 30, Nine Months Ended September 30, 2024 2024 (Loss) Income (Loss) Settlements Level 3 2024 Assets Debt securities Other government securities $ 150 $ — $ 6 $ — $ — $ 156 Public utilities 41 (1) (11) 3 55 87 Corporate securities 83 8 1 19 (1) 110 Other asset-backed securities 975 (1) 15 (67) (21) 901 Equity securities 8 (1) — — — 7 Mortgage loans 481 1 — (50) — 432 Limited partnerships 135 19 — 18 — 172 Policy loans 3,457 179 — (101) — 3,535 Reinsurance recoverable on market risk benefits 149 — — — — 149 Market risk benefit assets 6,737 878 — — — 7,615 Liabilities Funds withheld payable under reinsurance treaties (1,158) (657) — 96 — (1,719) Market risk benefit liabilities (4,785) 1,184 (783) — — (4,384) Total Realized/Unrealized Gains (Losses) Included in Purchases, Fair Value Sales, Transfers Fair Value as of Net Other Issuances in and/or as of January 1, Income Comprehensive and (out of) September 30, Nine Months Ended September 30, 2023 2023 (Loss) Income (Loss) Settlements Level 3 2023 Assets Debt securities Corporate securities $ 56 $ (11) $ — $ 18 $ (19) $ 44 Equity securities 122 (37) — — (1) 84 Mortgage loans 582 (7) — (99) — 476 Limited partnerships 440 (39) — 1 22 424 Policy loans 3,419 75 — (62) — 3,432 Reinsurance recoverable on market risk benefits 221 (54) — — — 167 Market risk benefit assets 4,865 1,950 — — — 6,815 Liabilities Funds withheld payable under reinsurance treaties (424) 119 — 58 — (247) Market risk benefit liabilities (5,662) 3,224 (1,479) — — (3,917)
Rollforwards of Financial Instruments for Which Significant Unobservable Inputs (Level 3) are Used - Liabilities	The tables below provide roll-forwards for the three and nine months ended September 30, 2024 and 2023 of the financial instruments for which significant unobservable inputs (Level 3) are used in the fair value measurement. Gains and losses in the tables below include changes in fair value due partly to observable and unobservable factors. The Company utilizes derivative instruments to manage the risk associated with certain assets and liabilities. However, the derivative instruments hedging the related risks may not be classified within the same fair value hierarchy level as the associated assets and liabilities. Therefore, the impact of the derivative instruments reported in Level 3 may vary significantly from the total income effect of the hedged instruments. Total Realized/Unrealized Gains (Losses) Included in Purchases, Fair Value Sales, Transfers Fair Value as of Net Other Issuances in and/or as of July 1, Income Comprehensive and (out of) September 30, Three Months Ended September 30, 2024 2024 (Loss) Income (Loss) Settlements Level 3 2024 Assets Debt securities Other government securities $ 151 $ — $ 5 $ — $ — $ 156 Public utilities 44 — (12) — 55 87 Corporate securities 73 3 2 21 11 110 Other asset-backed securities 919 (1) 15 (11) (21) 901 Equity securities 7 — — — — 7 Mortgage loans 430 4 — (2) — 432 Limited partnerships 152 12 — 8 — 172 Policy loans 3,511 68 — (44) — 3,535 Reinsurance recoverable on market risk benefits 121 28 — — — 149 Market risk benefit assets 8,556 (941) — — — 7,615 Liabilities Funds withheld payable under reinsurance treaties (1,161) (601) — 43 — (1,719) Market risk benefit liabilities (3,890) (260) (234) — — (4,384) Total Realized/Unrealized Gains (Losses) Included in Purchases, Fair Value Sales, Transfers Fair Value as of Net Other Issuances in and/or as of July 1, Income Comprehensive and (out of) September 30, Three Months Ended September 30, 2023 2023 (Loss) Income (Loss) Settlements Level 3 2023 Assets Debt securities Corporate securities $ 21 $ (2) $ — $ 22 $ 3 $ 44 Equity securities 86 (2) — — — 84 Mortgage loans 509 (5) — (28) — 476 Limited partnerships 422 (17) — (10) 29 424 Policy loans 3,438 (32) — 26 — 3,432 Reinsurance recoverable on market risk benefits 194 (27) — — — 167 Market risk benefit assets 5,957 858 — — — 6,815 Liabilities Funds withheld payable under reinsurance treaties (701) 481 — (27) — (247) Market risk benefit liabilities (4,463) 1,545 (999) — — (3,917) Total Realized/Unrealized Gains (Losses) Included in Purchases, Fair Value Sales, Transfers Fair Value as of Net Other Issuances in and/or as of January 1, Income Comprehensive and (out of) September 30, Nine Months Ended September 30, 2024 2024 (Loss) Income (Loss) Settlements Level 3 2024 Assets Debt securities Other government securities $ 150 $ — $ 6 $ — $ — $ 156 Public utilities 41 (1) (11) 3 55 87 Corporate securities 83 8 1 19 (1) 110 Other asset-backed securities 975 (1) 15 (67) (21) 901 Equity securities 8 (1) — — — 7 Mortgage loans 481 1 — (50) — 432 Limited partnerships 135 19 — 18 — 172 Policy loans 3,457 179 — (101) — 3,535 Reinsurance recoverable on market risk benefits 149 — — — — 149 Market risk benefit assets 6,737 878 — — — 7,615 Liabilities Funds withheld payable under reinsurance treaties (1,158) (657) — 96 — (1,719) Market risk benefit liabilities (4,785) 1,184 (783) — — (4,384) Total Realized/Unrealized Gains (Losses) Included in Purchases, Fair Value Sales, Transfers Fair Value as of Net Other Issuances in and/or as of January 1, Income Comprehensive and (out of) September 30, Nine Months Ended September 30, 2023 2023 (Loss) Income (Loss) Settlements Level 3 2023 Assets Debt securities Corporate securities $ 56 $ (11) $ — $ 18 $ (19) $ 44 Equity securities 122 (37) — — (1) 84 Mortgage loans 582 (7) — (99) — 476 Limited partnerships 440 (39) — 1 22 424 Policy loans 3,419 75 — (62) — 3,432 Reinsurance recoverable on market risk benefits 221 (54) — — — 167 Market risk benefit assets 4,865 1,950 — — — 6,815 Liabilities Funds withheld payable under reinsurance treaties (424) 119 — 58 — (247) Market risk benefit liabilities (5,662) 3,224 (1,479) — — (3,917)
Components of Amounts Included in Purchases, Sales, Issuances and Settlements	The components of the amounts included in purchases, sales, issuances and settlements for the three and nine months ended September 30, 2024 and 2023 shown above are as follows (in millions): Three Months Ended September 30, 2024 Purchases Sales Issuances Settlements Total Assets Debt securities Public utilities $ — $ — $ — $ — $ — Corporate securities $ 30 $ (9) $ — $ — $ 21 Other asset-backed securities 93 (104) — — (11) Mortgage loans 65 (67) — — (2) Limited partnerships 8 — — — 8 Policy loans — — 8 (52) (44) Total $ 196 $ (180) $ 8 $ (52) $ (28) Liabilities Funds withheld payable under reinsurance treaties $ — $ — $ (13) $ 56 $ 43 Three Months Ended September 30, 2023 Purchases Sales Issuances Settlements Total Assets Debt securities Corporate securities $ 27 $ (5) $ — $ — $ 22 Mortgage loans 45 (73) — — (28) Limited partnerships 1 (11) — — (10) Policy loans — — 76 (50) 26 Total $ 73 $ (89) $ 76 $ (50) $ 10 Liabilities Funds withheld payable under reinsurance treaties $ — $ — $ (96) $ 69 $ (27) Nine Months Ended September 30, 2024 Purchases Sales Issuances Settlements Total Assets Debt securities Public utilities $ 3 $ — $ — $ — $ 3 Corporate securities 43 (24) — — 19 Other asset-backed securities 200 (267) — — (67) Mortgage loans 156 (206) — — (50) Limited partnerships 18 — — — 18 Policy loans — — 71 (172) (101) Total $ 420 $ (497) $ 71 $ (172) $ (178) Liabilities Funds withheld payable under reinsurance treaties $ — $ — $ (357) $ 453 $ 96 Nine Months Ended September 30, 2023 Purchases Sales Issuances Settlements Total Assets Debt securities Corporate securities $ 27 $ (9) $ — $ — $ 18 Mortgage loans 180 (279) — — (99) Limited partnerships 19 (18) — — 1 Policy loans — — 111 (173) (62) Total $ 226 $ (306) $ 111 $ (173) $ (142) Liabilities Funds withheld payable under reinsurance treaties $ — $ — $ (132) $ 190 $ 58
Portion of Gains (Losses) Included in Net Income or Other Comprehensive Income	The portion of gains (losses) included in net income (loss) or OCI attributable to the change in unrealized gains and losses on Level 3 financial instruments still held was as follows (in millions): Three Months Ended September 30, 2024 2023 Included in Included in OCI Included in Included in OCI Assets Debt securities Other government securities $ — $ 5 $ — $ — Public utilities — (12) — — Corporate securities 1 2 2 — Other asset-backed securities 1 9 — — Equity securities — — (2) — Mortgage loans 4 — (5) — Limited partnerships 18 — (17) — Policy loans 68 — (32) — Reinsurance recoverable on market risk benefits 28 — (27) — Market risk benefit assets (941) — 858 — Liabilities Funds withheld payable under reinsurance treaties (601) — 481 — Market risk benefit liabilities (260) (234) 1,545 (999) Nine Months Ended September 30, 2024 2023 Included in Included in OCI Included in Included in OCI Assets Debt securities Other government securities $ — $ 6 $ — $ — Public utilities (1) (11) — — Corporate securities 2 1 (7) — Other asset-backed securities — 9 — — Equity securities — — (37) — Mortgage loans 1 — (7) — Limited partnerships 19 — (39) — Policy loans 179 — 75 — Reinsurance recoverable on market risk benefits — — (54) — Market risk benefit assets 878 — 1,950 — Liabilities Funds withheld payable under reinsurance treaties (657) — 119 — Market risk benefit liabilities 1,184 (783) 3,224 (1,479)
Carrying Amount and Fair Value by Hierarchy of Certain Financial Instruments Not Reported at Fair Value	The table below presents the carrying amount and fair value by fair value hierarchy level of certain financial instruments that are not reported at fair value (in millions): September 30, 2024 Fair Value Carrying Total Level 1 Level 2 Level 3 Assets Mortgage loans $ 9,564 $ 9,177 $ — $ — $ 9,177 Policy loans 918 918 — — 918 FHLBI capital stock 127 127 127 — — Liabilities Annuity reserves (1) $ 34,361 $ 35,697 $ — $ — $ 35,697 Reserves for guaranteed investment contracts (2) 556 549 — — 549 Trust instruments supported by funding agreements (2) 5,461 5,426 — — 5,426 FHLB funding agreements (2) 1,912 1,859 — — 1,859 Funds withheld payable under reinsurance treaties 16,384 16,384 — — 16,384 Long-term debt 2,033 1,888 — 1,888 — Securities lending payable (3) 26 26 — 26 — Repurchase agreements (3) 794 794 — 794 — Separate account liabilities (5) 235,037 235,037 — 235,037 — December 31, 2023 Fair Value Carrying Total Level 1 Level 2 Level 3 Assets Mortgage loans $ 10,082 $ 9,513 $ — $ — $ 9,513 Policy loans 942 942 — — 942 FHLBI capital stock 108 108 108 — — Liabilities Annuity reserves (1) $ 33,161 $ 31,588 $ — $ — $ 31,588 Reserves for guaranteed investment contracts (2) 700 674 — — 674 Trust instruments supported by funding agreements (2) 5,756 5,601 — — 5,601 FHLB funding agreements (2) 1,950 1,893 — — 1,893 Funds withheld payable under reinsurance treaties 18,794 18,794 — — 18,794 Long-term debt 2,037 1,851 — 1,851 — Securities lending payable (3) 19 19 — 19 — FHLB advances (4) 250 250 — 250 — Separate account liabilities (5) 219,656 219,656 — 219,656 — (1) Annuity reserves represent only the components of other contract holder funds that are considered to be financial instruments. (2) Included as a component of other contract holder funds on the Condensed Consolidated Balance Sheets. (3) Included as a component of repurchase agreements and securities lending payable on the Condensed Consolidated Balance Sheets. (4) Included as a component of other liabilities on the Condensed Consolidated Balance Sheets. (5) The values of separate account liabilities are set equal to the values of separate account assets.

Deferred Acquisition Costs (Tab

Deferred Acquisition Costs (Tables)	9 Months Ended
	Sep. 30, 2024
Insurance [Abstract]
Deferred Acquisition Costs	The following table presents the roll-forward of the DAC (in millions). The current period amortization is based on the end of the period estimates of mortality and persistency. The amortization pattern is revised on a prospective basis at the beginning of the period based on the period’s actual experience. Nine Months Ended September 30, Year Ended December 31, 2024 2023 Variable Annuities Balance, beginning of period $ 11,967 $ 12,699 Deferrals of acquisition costs 308 394 Amortization (802) (1,126) Variable Annuities balance, end of period $ 11,473 $ 11,967 Reconciliation of total DAC Variable Annuities balance, end of period $ 11,473 $ 11,967 Other product lines, end of period 513 335 Total balance, end of period $ 11,986 $ 12,302

Reinsurance (Tables)

Reinsurance (Tables)	9 Months Ended
	Sep. 30, 2024
Insurance [Abstract]
Components of Reinsurance Recoverable, and Premiums and Benefits	Components of the Company’s reinsurance recoverable excluding MRBs were as follows (in millions): September 30, December 31, 2024 2023 Reserves: Life $ 5,380 $ 5,370 Accident and health 508 510 Annuity benefits (1) 16,411 18,873 Claims liability and other 660 669 Total $ 22,959 $ 25,422 (1)
Schedule of Market Risk Benefit, Activity	Components of the Company’s reinsurance recoverable on market risk benefits were as follows (in millions): September 30, December 31, 2024 2023 Variable annuity $ 78 $ 90 Other product lines 71 59 Total $ 149 $ 149 The following table presents a roll-forward of Closed Block Life additional liabilities for annuitization, death and other insurance benefits (in millions): Nine Months Ended September 30, 2024 Year Ended December 31, 2023 Balance, beginning of period $ 1,153 $ 1,131 Beginning of period cumulative effect of changes in shadow adjustments 17 41 Beginning balance excluding shadow 1,170 1,172 Effect of changes in cash flow assumptions — 44 Effect of actual variances from expected experience 10 46 Interest accrual 42 56 Net assessments collected (101) (148) Ending balance excluding shadow 1,121 1,170 End of period cumulative effect of changes in shadow adjustments (17) (17) Balance, end of period $ 1,104 $ 1,153 The following table presents the weighted average duration of Closed Block Life additional liabilities for annuitization, death and other insurance benefits. The weighted average duration represents average cohort-level duration weighted by the benefit reserves amount: September 30, 2024 December 31, 2023 Weighted average duration (years) 9.5 9.7 The following table presents assessments and interest expense of Closed Block Life additional liabilities for annuitization, death and other insurance benefits recognized in the Condensed Consolidated Income Statements (in millions): Assessments Interest Expense Nine Months Ended September 30, 2024 Year Ended December 31, 2023 Nine Months Ended September 30, 2024 Year Ended December 31, 2023 Additional liability for annuitization, death and other insurance benefits $ (101) $ (148) $ 42 $ 56 The following table presents the weighted average current discount rate of Closed Block Life additional liabilities for annuitization, death and other insurance benefits, applied at the cohort level weighted by reserve benefit amount: September 30, 2024 December 31, 2023 Weighted average current discount rate 4.98 % 4.97 % The following table presents the reconciliation of the market risk benefits balance in the Condensed Consolidated Balance Sheets (in millions): September 30, 2024 December 31, 2023 Variable Other Variable Other Annuities Product Lines Total Annuities Product Lines Total Market risk benefit - (assets) $ (7,611) $ (4) $ (7,615) $ (6,732) $ (5) $ (6,737) Market risk benefit - liabilities 4,311 73 4,384 4,732 53 4,785 Market risk benefit - net (asset) liability $ (3,300) $ 69 $ (3,231) $ (2,000) $ 48 $ (1,952)
Assets and Liabilities Held in Support of Reserves Associated with Funds Withheld Reinsurance Agreements	The following assets and liabilities were held in support of reserves associated with the Company’s funds withheld reinsurance agreements and were reported in the respective financial statement line items in the Condensed Consolidated Balance Sheets (in millions): September 30, December 31, 2024 2023 Assets Debt securities, available-for-sale $ 10,344 $ 11,526 Debt securities, at fair value under the fair value option 155 116 Equity securities 148 151 Mortgage loans 2,658 3,067 Mortgage loans, at fair value under the fair value option 432 481 Policy loans 3,548 3,471 Freestanding derivative instruments, net 5 15 Other invested assets 752 709 Cash and cash equivalents 224 543 Accrued investment income 118 146 Other assets and liabilities, net (29) 1 Total assets (1) $ 18,355 $ 20,226 Liabilities Funds held under reinsurance treaties (2) $ 18,103 $ 19,952 Total liabilities $ 18,103 $ 19,952 (1) Certain assets are reported at amortized cost while the fair value of those assets is reported in the embedded derivative in the funds withheld liability. (2) Includes funds withheld embedded derivative asset (liability) of $1,992 million and $2,468 million at September 30, 2024 and December 31, 2023, respectively.
Schedule of Sources of Income Related to Funds Withheld Under Reinsurance Treaties	The sources of net investment income were as follows (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Debt securities (1) $ 393 $ 432 $ 1,191 $ 1,152 Equity securities 3 (4) 6 (5) Mortgage loans 83 81 248 235 Policy loans 17 17 50 50 Limited partnerships 20 20 106 19 Other investment income 51 24 135 74 Total investment income excluding funds withheld assets 567 570 1,736 1,525 Investment expenses (2)(3) (110) (112) (352) (277) Net investment income excluding funds withheld assets 457 458 1,384 1,248 Net investment income on funds withheld assets (see Note 8) 269 303 824 862 Net investment income $ 726 $ 761 $ 2,208 $ 2,110 (1) Includes changes in fair value gains (losses) on trading securities and includes $(23) million and $(1) million for the three and nine months ended September 30, 2024, respectively, and $51 million and $43 million for the three and nine months ended September 30, 2023, respectively, related to the change in fair value for securities carried under the fair value option. (2) In the first quarter of 2024, interest costs principally associated with repurchase agreements and cash collateral were reclassified from interest expense to net investment income. All prior period amounts have been conformed to current period presentation. (3) Includes expenses from consolidated variable interest entities, which includes changes in fair value of notes issued by those entities, of $(44) million and $(150) million for the three and nine months ended September 30, 2024, respectively, and $(70) million and $(144) million for the three and nine months ended September 30, 2023, respectively. The sources of income related to funds withheld under reinsurance treaties reported in net investment income in the Condensed Consolidated Income Statements were as follows (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Debt securities (1) $ 133 $ 162 $ 415 $ 494 Equity securities 8 2 17 (36) Mortgage loans (2) 47 48 141 174 Policy loans 82 80 246 238 Limited partnerships 11 17 39 32 Other investment income 3 13 13 16 Total investment income on funds withheld assets 284 322 871 918 Other investment expenses on funds withheld assets (3) (15) (19) (47) (56) Total net investment income on funds withheld reinsurance treaties $ 269 $ 303 $ 824 $ 862 (1) Includes $1 million and $2 million for the three and nine months ended September 30, 2024, respectively, and $1 million and $3 million for the three and nine months ended September 30, 2023, respectively, related to the change in fair value for securities carried under the fair value option. (2) Includes $4 million and $1 million for the three and nine months ended September 30, 2024, respectively, and $(5) million and $(7) million for the three and nine months ended September 30, 2023, respectively, related to the change in fair value for mortgage loans carried under the fair value option. (3) Includes management fees.
Gains And Losses On Funds Withheld Reinsurance Treaties	The gains and losses on funds withheld reinsurance treaties as a component of net gains (losses) on derivatives and investments in the Condensed Consolidated Income Statements were as follows (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Available-for-sale securities Realized gains on sale $ 2 $ 8 $ 5 $ 24 Realized losses on sale (13) (13) (43) (61) Credit loss expense (12) (10) (18) (8) Credit loss expense on mortgage loans 1 (10) 8 (17) Other 16 (16) 6 (4) Net gains (losses) on non-derivative investments (6) (41) (42) (66) Net gains (losses) on derivative instruments (30) 24 (11) 1 Net gains (losses) on funds withheld payable under reinsurance treaties (1) (748) 176 (1,146) (583) Total net gains (losses) on derivatives and investments $ (784) $ 159 $ (1,199) $ (648) (1) Includes the Athene embedded derivative gain (loss) of $(530) million and $(476) million for the three and nine months ended September 30, 2024, respectively, and $451 million and $194 million for the three and nine months ended September 30, 2023, respectively.

Reserves for Future Policy Be_2

Reserves for Future Policy Benefits and Claims Payable (Tables)	9 Months Ended
	Sep. 30, 2024
Insurance [Abstract]
Schedule of Reserves for Future Policy Benefits and Claims Payable Balances	The following table summarizes the Company’s reserves for future policy benefits and claims payable balances (in millions): September 30, December 31, 2024 2023 Reserves for future policy benefits Payout Annuities $ 1,143 $ 1,090 Closed Block Life 3,847 3,994 Closed Block Annuity 4,056 4,215 Reserves for future policy benefits 9,046 9,299 Additional liabilities Closed Block Life 1,104 1,153 Other future policy benefits and claims payable 1,393 1,446 Reserves for future policy benefits and claims payable $ 11,543 $ 11,898
Balances of and changes in liability for future policy benefits, and Revenue and interest recognized	The following tables present the roll-forward of components of reserves for future policy benefits (in millions): Present Value of Expected Net Premiums Nine Months Ended September 30, Year Ended December 31, 2024 2023 Payout Closed Block Closed Block Payout Closed Block Closed Block Annuities Life Annuity Annuities Life Annuity Balance, beginning of period $ — $ 1,140 $ — $ — $ 1,287 $ — Beginning of period cumulative effect of changes in discount rate assumptions — 113 — — 161 — Beginning balance at original discount rate — 1,253 — — 1,448 — Effect of changes in cash flow assumptions — — — — 22 — Effect of actual variances from expected experience — (20) — — (95) — Balance adjusted for variances from expectation — 1,233 — — 1,375 — Issuances — 3 — — 6 — Interest accrual — 33 — — 38 — Net premiums collected — (99) — — (166) — Ending balance at original discount rate — 1,170 — — 1,253 — End of period cumulative effect of changes in discount rate assumptions — (88) — — (113) — Balance, end of period $ — $ 1,082 $ — $ — $ 1,140 $ — Present Value of Expected Future Policy Benefits Nine Months Ended September 30, Year Ended December 31, 2024 2023 Payout Closed Block Closed Block Payout Closed Block Closed Block Annuities Life Annuity Annuities Life Annuity Balance, beginning of period $ 1,090 $ 5,134 $ 4,215 $ 1,042 $ 5,448 $ 4,434 Beginning of period cumulative effect of changes in discount rate assumptions 99 767 185 132 958 275 Beginning balance at original discount rate (including DPL of $42, $0 and $626 in September 30, 2024, and $40, $0 and $671 in December 31, 2023 for payout annuities, closed block life and closed block annuity, respectively) 1,189 5,901 4,400 1,174 6,406 4,709 Effect of changes in cash flow assumptions — — — — 65 (3) Effect of actual variances from expected experience (32) (4) — (16) (95) (8) Balance adjusted for variances from expectation 1,157 5,897 4,400 1,158 6,376 4,698 Issuances 126 8 — 117 15 1 Interest accrual 34 127 138 43 195 194 Benefits payments (102) (460) (359) (129) (685) (493) Ending balance of original discount rate (including DPL of $46, $0 and $590 in September 30, 2024, and $42, $0 and $626 in December 31, 2023 for payout annuities, closed block life and closed block annuity, respectively) 1,215 5,572 4,179 1,189 5,901 4,400 End of period cumulative effect of changes in discount rate assumptions (72) (643) (123) (99) (767) (185) Balance, end of period $ 1,143 $ 4,929 $ 4,056 $ 1,090 $ 5,134 $ 4,215 Reserves for future policy benefits 1,143 3,847 4,056 1,090 3,994 4,215 Less: Reinsurance recoverable 113 2,135 4 94 2,200 4 Reserves for future policy benefits, after reinsurance recoverable $ 1,030 $ 1,712 $ 4,052 $ 996 $ 1,794 $ 4,211 The following table presents the weighted average duration of the reserves for future policy benefits. The weighted average duration represents average cohort-level duration weighted by the benefit reserves amount: Payout Closed Block Closed Block Annuities Life Annuity September 30, 2024 Weighted average duration (years) 7.1 7.1 6.9 December 31, 2023 Weighted average duration (years) 7.0 7.2 7.0 The following table presents the amount of undiscounted and discounted expected future gross premiums and expected future benefit payments for future policy benefits for non-participating traditional and limited-payment insurance contracts (in millions). The discounted premiums are calculated using the current discount rate, while the undiscounted cash flows represent the gross cash flows before any discounting is applied: September 30, 2024 December 31, 2023 Undiscounted Discounted Undiscounted Discounted Payout Annuities Expected future benefit payments $ 1,649 $ 1,097 $ 1,579 $ 1,043 Expected future gross premiums — — — — Closed Block Life Expected future benefit payments 7,257 5,043 7,729 5,251 Expected future gross premiums 4,675 2,931 5,056 3,119 Closed Block Annuity Expected future benefit payments 5,131 3,443 5,421 3,565 Expected future gross premiums $ — $ — $ — $ — The following table presents the amount of revenue and interest related to non-participating traditional and limited-pay insurance contracts recognized in the Condensed Consolidated Income Statements (in millions): Gross Premiums Interest Expense Nine Months Ended September 30, 2024 Year Ended December 31, 2023 Nine Months Ended September 30, 2024 Year Ended December 31, 2023 Payout Annuities $ 34 $ 22 $ 34 $ 43 Closed Block Life 232 340 94 157 Closed Block Annuity — 1 138 194 Total $ 266 $ 363 $ 266 $ 394 The following table presents the weighted average interest rate for the reserves for future policy benefits at the cohort's level for the locked-in discount rate (interest accretion rate), and current discount rate, weighted by the cohort's benefit reserve amount: September 30, 2024 December 31, 2023 Payout Annuities Interest accretion rate 4.00 % 3.86 % Current discount rate 4.89 % 5.12 % Closed Block Life Interest accretion rate 3.07 % 3.07 % Current discount rate 4.96 % 5.06 % Closed Block Annuity Interest accretion rate 4.40 % 4.40 % Current discount rate 4.90 % 5.12 %
Schedule of Market Risk Benefit, Activity	Components of the Company’s reinsurance recoverable on market risk benefits were as follows (in millions): September 30, December 31, 2024 2023 Variable annuity $ 78 $ 90 Other product lines 71 59 Total $ 149 $ 149 The following table presents a roll-forward of Closed Block Life additional liabilities for annuitization, death and other insurance benefits (in millions): Nine Months Ended September 30, 2024 Year Ended December 31, 2023 Balance, beginning of period $ 1,153 $ 1,131 Beginning of period cumulative effect of changes in shadow adjustments 17 41 Beginning balance excluding shadow 1,170 1,172 Effect of changes in cash flow assumptions — 44 Effect of actual variances from expected experience 10 46 Interest accrual 42 56 Net assessments collected (101) (148) Ending balance excluding shadow 1,121 1,170 End of period cumulative effect of changes in shadow adjustments (17) (17) Balance, end of period $ 1,104 $ 1,153 The following table presents the weighted average duration of Closed Block Life additional liabilities for annuitization, death and other insurance benefits. The weighted average duration represents average cohort-level duration weighted by the benefit reserves amount: September 30, 2024 December 31, 2023 Weighted average duration (years) 9.5 9.7 The following table presents assessments and interest expense of Closed Block Life additional liabilities for annuitization, death and other insurance benefits recognized in the Condensed Consolidated Income Statements (in millions): Assessments Interest Expense Nine Months Ended September 30, 2024 Year Ended December 31, 2023 Nine Months Ended September 30, 2024 Year Ended December 31, 2023 Additional liability for annuitization, death and other insurance benefits $ (101) $ (148) $ 42 $ 56 The following table presents the weighted average current discount rate of Closed Block Life additional liabilities for annuitization, death and other insurance benefits, applied at the cohort level weighted by reserve benefit amount: September 30, 2024 December 31, 2023 Weighted average current discount rate 4.98 % 4.97 % The following table presents the reconciliation of the market risk benefits balance in the Condensed Consolidated Balance Sheets (in millions): September 30, 2024 December 31, 2023 Variable Other Variable Other Annuities Product Lines Total Annuities Product Lines Total Market risk benefit - (assets) $ (7,611) $ (4) $ (7,615) $ (6,732) $ (5) $ (6,737) Market risk benefit - liabilities 4,311 73 4,384 4,732 53 4,785 Market risk benefit - net (asset) liability $ (3,300) $ 69 $ (3,231) $ (2,000) $ 48 $ (1,952)

Other Contract Holder Funds (Ta

Other Contract Holder Funds (Tables)	9 Months Ended
	Sep. 30, 2024
Participating Insurance [Abstract]
Policyholder Account Balance And Liability For Unpaid Claims And Claims Adjustment Expense	The following table presents the liabilities for other contract holder funds (in millions): September 30, 2024 December 31, 2023 Payout Annuity $ 852 $ 860 Variable Annuity 7,509 8,396 Fixed Annuity 9,593 9,736 Fixed Indexed Annuities 8,990 10,243 RILA 10,250 5,219 Closed Block Life 10,884 11,039 Closed Block Annuity 1,163 1,252 Institutional Products 7,929 8,406 Other Product Lines 164 168 Total other contract holder funds $ 57,334 $ 55,319
Policyholder Account Balance	The following table presents a roll-forward of other contract holder funds, gross of reinsurance (in millions): Fixed Closed Closed Payout Variable Fixed Indexed Block Block Annuity Annuity Annuity Annuities RILA Life Annuity Total Balance as of January 1, 2024 $ 860 $ 8,396 $ 9,736 $ 10,243 $ 5,219 $ 11,039 $ 1,252 $ 46,745 Deposits 165 544 1,080 127 4,187 218 3 6,324 Surrenders, withdrawals and benefits (194) (1,596) (1,339) (1,610) (130) (462) (125) (5,456) Net transfers from (to) separate accounts — 51 — — — — — 51 Investment performance / change in value of equity option — — — 108 950 — — 1,058 Interest credited 21 171 233 135 24 455 33 1,072 Policy charges and other — (57) (117) (13) — (366) — (553) Balance as of September 30, 2024 $ 852 $ 7,509 $ 9,593 $ 8,990 $ 10,250 $ 10,884 $ 1,163 $ 49,241 Fixed Closed Closed Payout Variable Fixed Indexed Block Block Annuity Annuity Annuity Annuities RILA Life Annuity Total Balance as of January 1, 2023 $ 837 $ 10,259 $ 11,696 $ 11,787 $ 1,875 $ 11,215 $ 1,319 $ 48,988 Deposits 202 995 234 211 2,890 307 4 4,843 Surrenders, withdrawals and benefits (231) (1,788) (2,406) (1,954) (70) (738) (115) (7,302) Net transfers from (to) separate accounts — (1,256) — — — — — (1,256) Investment performance / change in value of equity option — — — 51 509 — — 560 Interest credited 25 273 342 210 14 730 44 1,638 Policy charges and other 27 (87) (130) (62) 1 (475) — (726) Balance as of December 31, 2023 $ 860 $ 8,396 $ 9,736 $ 10,243 $ 5,219 $ 11,039 $ 1,252 $ 46,745 The following table presents weighted average crediting rate, net amount at risk, and cash surrender value of contract holder account balances (dollars in millions): Fixed Closed Closed Payout Variable Fixed Indexed Block Block Annuity Annuity Annuity Annuities RILA Life Annuity September 30, 2024 Weighted-average crediting rate (1) 3.29 % 3.04 % 3.24 % 2.00 % 0.31 % 5.57 % 3.78 % Net amount at risk (2) $ — $ — $ — $ — $ — $ 15,937 $ — Cash surrender value (3) $ — $ 7,449 $ 9,447 $ 8,778 $ 9,837 $ 10,817 $ 1,162 December 31, 2023 Weighted-average crediting rate (1) 2.91 % 3.25 % 3.51 % 2.05 % 0.27 % 6.61 % 3.51 % Net amount at risk (2) $ — $ — $ — $ — $ — $ 16,619 $ — Cash surrender value (3) $ — $ 8,306 $ 9,639 $ 9,999 $ 4,896 $ 10,970 $ 1,252 (1) Weighted average crediting rate is the average crediting rate weighted by contract holder account balances invested in fixed account funds. (2) Net amount at risk represents the standard excess benefit base for guaranteed death benefits on universal life type products. The net amount at risk associated with market risk benefits are presented within Note 12 of the Notes to Condensed Consolidated Financial Statements. (3)
Policyholder Account Balance, Guaranteed Minimum Crediting Rate	The following table presents contract holder account balances invested in fixed account funds by range of guaranteed minimum crediting rates and the related range of the difference between rates being credited to other contract holder funds and the respective guaranteed minimums (in millions): September 30, 2024 At Guaranteed 1 Basis Point-50 51 Basis Points-150 Greater Than 150 Range of Guaranteed Minimum Crediting Rate Minimum Basis Points Above Basis Points Above Basis Points Above Total Variable Annuities 0.00%-1.50% $ — $ 11 $ — $ — $ 11 1.51%-2.50% 159 — — — 159 Greater than 2.50% 7,339 — — — 7,339 Total $ 7,498 $ 11 $ — $ — $ 7,509 Fixed Annuities 0.00%-1.50% $ 28 $ 46 $ 39 $ 1 $ 114 1.51%-2.50% 25 1 1 — 27 Greater than 2.50% 1,741 43 1 251 2,036 Total $ 1,794 $ 90 $ 41 $ 252 $ 2,177 Fixed Indexed Annuities 0.00%-1.50% $ 3 $ 9 $ 2 $ 38 $ 52 1.51%-2.50% — — — — — Greater than 2.50% 18 — 86 23 127 Total $ 21 $ 9 $ 88 $ 61 $ 179 RILA 0.00%-1.50% $ 6 $ — $ 4 $ 3 $ 13 1.51%-2.50% — — — — — Greater than 2.50% 79 9 — — 88 Total $ 85 $ 9 $ 4 $ 3 $ 101 Closed Block Life 0.00%-1.50% $ — $ — $ — $ — $ — 1.51%-2.50% 1 11 — — 12 Greater than 2.50% 5,506 409 746 5 6,666 Total $ 5,507 $ 420 $ 746 $ 5 $ 6,678 Closed Block Annuity 0.00%-1.50% $ — $ — $ — $ — $ — 1.51%-2.50% — — 1 12 13 Greater than 2.50% 963 20 25 — 1,008 Total $ 963 $ 20 $ 26 $ 12 $ 1,021 December 31, 2023 At Guaranteed 1 Basis Point-50 51 Basis Points-150 Greater Than 150 Range of Guaranteed Minimum Crediting Rate Minimum Basis Points Above Basis Points Above Basis Points Above Total Variable Annuities 0.00%-1.50% $ — $ 12 $ 1 $ — $ 13 1.51%-2.50% 173 — — — 173 Greater than 2.50% 8,186 — — 24 8,210 Total $ 8,359 $ 12 $ 1 $ 24 $ 8,396 Fixed Annuities 0.00%-1.50% $ 17 $ 55 $ 70 $ 1 $ 143 1.51%-2.50% 29 1 1 — 31 Greater than 2.50% 721 51 1 271 1,044 Total $ 767 $ 107 $ 72 $ 272 $ 1,218 Fixed Indexed Annuities 0.00%-1.50% $ 4 $ 9 $ 3 $ 43 $ 59 1.51%-2.50% — — — — — Greater than 2.50% 21 — 62 10 93 Total $ 25 $ 9 $ 65 $ 53 $ 152 RILA 0.00%-1.50% $ 7 $ — $ 4 $ 1 $ 12 1.51%-2.50% — — — — — Greater than 2.50% 39 12 — — 51 Total $ 46 $ 12 $ 4 $ 1 $ 63 Closed Block Life 0.00%-1.50% $ — $ — $ — $ — $ — 1.51%-2.50% — — — — — Greater than 2.50% 4,425 1,830 603 16 6,874 Total $ 4,425 $ 1,830 $ 603 $ 16 $ 6,874 Closed Block Annuity 0.00%-1.50% $ — $ — $ — $ — $ — 1.51%-2.50% — — 1 12 13 Greater than 2.50% 896 169 23 — 1,088 Total $ 896 $ 169 $ 24 $ 12 $ 1,101

Separate Account Assets and L_2

Separate Account Assets and Liabilities (Tables)	9 Months Ended
	Sep. 30, 2024
Separate Accounts Disclosure [Abstract]
Roll forward of the Separate Account Balance	The following table presents the roll-forward of the separate account balance for variable annuities (in millions): Nine Months Ended September 30, 2024 Year Ended December 31, 2023 Balance as of beginning of period $ 219,381 $ 195,550 Deposits 7,244 8,545 Surrenders, withdrawals and benefits (19,519) (17,029) Net transfer from (to) general account (51) 1,256 Investment performance 29,794 33,807 Policy charges and other (2,113) (2,748) Balance as of end of period, gross $ 234,736 $ 219,381 Cash surrender value (1) $ 229,939 $ 214,395 (1) Cash surrender value represents the amount of the contract holder’s account balances distributable at the balance sheet date less applicable surrender charges. The following table presents the roll-forward of the net MRB (assets) liabilities for variable annuities (dollars in millions): Nine Months Ended September 30, 2024 Year Ended December 31, 2023 Net MRB balance, beginning of period $ (2,000) $ 767 Beginning of period cumulative effect of changes in non-performance risk 972 2,185 Net MRB balance, beginning of period, before effect of changes in non-performance risk (1,028) 2,952 Effect of changes in interest rates (601) (733) Effect of fund performance (3,567) (5,401) Effect of changes in equity index volatility (143) (1,107) Effect of expected policyholder behavior 610 612 Effect of actual policyholder behavior different from expected 514 483 Effect of time 1,100 1,829 Effect of changes in assumptions 7 337 Net MRB balance, end of period, before effect of changes in non-performance risk (3,108) (1,028) End of period cumulative effect of changes in non-performance risk (192) (972) Net MRB balance, end of period, gross (3,300) (2,000) Reinsurance recoverable on market risk benefits at fair value, end of period (78) (90) Net MRB balance, end of period, net of reinsurance (3,378) (2,090) Weighted average attained age (years) (1) 70 69 Net amount at risk (2) $ 5,527 $ 8,225 (1) Weighted-average attained age is defined as the average age of policyholders weighted by account value. (2) Net amount at risk (NAR) is defined as of the valuation date for each contract as the greater of Death Benefit NAR (DBNAR) and Living Benefit NAR (LBNAR), as applicable, where DBNAR is the GMDB benefit base in excess of the account value, and LBNAR is the actuarial present value of guaranteed living benefits in excess of the account value.
Roll forward of the Separate Account Balance in the Consolidated Balance Sheet	The following table presents the reconciliation of the separate account balance in the Condensed Consolidated Balance Sheets (in millions): September 30, 2024 December 31, 2023 Variable Annuities $ 234,736 $ 219,381 Other Product Lines 301 275 Total $ 235,037 $ 219,656
Schedule of Separate Account Balances	The following table presents aggregate fair value of assets, by major investment asset category, supporting separate accounts (in millions): September 30, 2024 December 31, 2023 Variable Annuities By Fund Type Equity $ 167,216 $ 154,020 Bond 20,242 19,801 Balanced 44,531 42,831 Money Market 2,747 2,729 Total Variable Annuities 234,736 219,381 Other Product Lines 301 275 Total Separate Accounts $ 235,037 $ 219,656

Market Risk Benefits (Tables)

Market Risk Benefits (Tables)	9 Months Ended
	Sep. 30, 2024
Participating Insurance [Abstract]
Schedule of Market Risk Benefit, Activity	Components of the Company’s reinsurance recoverable on market risk benefits were as follows (in millions): September 30, December 31, 2024 2023 Variable annuity $ 78 $ 90 Other product lines 71 59 Total $ 149 $ 149 The following table presents a roll-forward of Closed Block Life additional liabilities for annuitization, death and other insurance benefits (in millions): Nine Months Ended September 30, 2024 Year Ended December 31, 2023 Balance, beginning of period $ 1,153 $ 1,131 Beginning of period cumulative effect of changes in shadow adjustments 17 41 Beginning balance excluding shadow 1,170 1,172 Effect of changes in cash flow assumptions — 44 Effect of actual variances from expected experience 10 46 Interest accrual 42 56 Net assessments collected (101) (148) Ending balance excluding shadow 1,121 1,170 End of period cumulative effect of changes in shadow adjustments (17) (17) Balance, end of period $ 1,104 $ 1,153 The following table presents the weighted average duration of Closed Block Life additional liabilities for annuitization, death and other insurance benefits. The weighted average duration represents average cohort-level duration weighted by the benefit reserves amount: September 30, 2024 December 31, 2023 Weighted average duration (years) 9.5 9.7 The following table presents assessments and interest expense of Closed Block Life additional liabilities for annuitization, death and other insurance benefits recognized in the Condensed Consolidated Income Statements (in millions): Assessments Interest Expense Nine Months Ended September 30, 2024 Year Ended December 31, 2023 Nine Months Ended September 30, 2024 Year Ended December 31, 2023 Additional liability for annuitization, death and other insurance benefits $ (101) $ (148) $ 42 $ 56 The following table presents the weighted average current discount rate of Closed Block Life additional liabilities for annuitization, death and other insurance benefits, applied at the cohort level weighted by reserve benefit amount: September 30, 2024 December 31, 2023 Weighted average current discount rate 4.98 % 4.97 % The following table presents the reconciliation of the market risk benefits balance in the Condensed Consolidated Balance Sheets (in millions): September 30, 2024 December 31, 2023 Variable Other Variable Other Annuities Product Lines Total Annuities Product Lines Total Market risk benefit - (assets) $ (7,611) $ (4) $ (7,615) $ (6,732) $ (5) $ (6,737) Market risk benefit - liabilities 4,311 73 4,384 4,732 53 4,785 Market risk benefit - net (asset) liability $ (3,300) $ 69 $ (3,231) $ (2,000) $ 48 $ (1,952)
Roll forward of the Separate Account Balance	The following table presents the roll-forward of the separate account balance for variable annuities (in millions): Nine Months Ended September 30, 2024 Year Ended December 31, 2023 Balance as of beginning of period $ 219,381 $ 195,550 Deposits 7,244 8,545 Surrenders, withdrawals and benefits (19,519) (17,029) Net transfer from (to) general account (51) 1,256 Investment performance 29,794 33,807 Policy charges and other (2,113) (2,748) Balance as of end of period, gross $ 234,736 $ 219,381 Cash surrender value (1) $ 229,939 $ 214,395 (1) Cash surrender value represents the amount of the contract holder’s account balances distributable at the balance sheet date less applicable surrender charges. The following table presents the roll-forward of the net MRB (assets) liabilities for variable annuities (dollars in millions): Nine Months Ended September 30, 2024 Year Ended December 31, 2023 Net MRB balance, beginning of period $ (2,000) $ 767 Beginning of period cumulative effect of changes in non-performance risk 972 2,185 Net MRB balance, beginning of period, before effect of changes in non-performance risk (1,028) 2,952 Effect of changes in interest rates (601) (733) Effect of fund performance (3,567) (5,401) Effect of changes in equity index volatility (143) (1,107) Effect of expected policyholder behavior 610 612 Effect of actual policyholder behavior different from expected 514 483 Effect of time 1,100 1,829 Effect of changes in assumptions 7 337 Net MRB balance, end of period, before effect of changes in non-performance risk (3,108) (1,028) End of period cumulative effect of changes in non-performance risk (192) (972) Net MRB balance, end of period, gross (3,300) (2,000) Reinsurance recoverable on market risk benefits at fair value, end of period (78) (90) Net MRB balance, end of period, net of reinsurance (3,378) (2,090) Weighted average attained age (years) (1) 70 69 Net amount at risk (2) $ 5,527 $ 8,225 (1) Weighted-average attained age is defined as the average age of policyholders weighted by account value. (2) Net amount at risk (NAR) is defined as of the valuation date for each contract as the greater of Death Benefit NAR (DBNAR) and Living Benefit NAR (LBNAR), as applicable, where DBNAR is the GMDB benefit base in excess of the account value, and LBNAR is the actuarial present value of guaranteed living benefits in excess of the account value.

Long-Term Debt (Tables)

Long-Term Debt (Tables)	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Aggregate Carrying Value of Long-Term Debt	The aggregate carrying value of long-term debt was as follows (in millions): September 30, December 31, 2024 2023 Long-Term Debt Senior Notes due 2027 $ 398 $ 398 Senior Notes due 2031 496 495 Senior Notes due 2032 347 347 Senior Notes due 2051 490 490 Surplus notes due 2027 250 250 FHLBI bank loans due 2034 & 2035 52 57 Total long-term debt $ 2,033 $ 2,037
Contractual Maturities of Long-term Debt	The following table presents the contractual maturities of the Company's long-term debt as of September 30, 2024 (in millions): Calendar Year 2025 2026 2027 2028 2029 and thereafter Total Long-term debt $ — $ — $ 648 $ — $ 1,385 $ 2,033

Operating Costs and Other Exp_2

Operating Costs and Other Expenses (Tables)	9 Months Ended
	Sep. 30, 2024
Operating Costs And Other Expenses [Abstract]
Schedule of Operating Costs and Other Expenses	The following table is a summary of the Company’s operating costs and other expenses (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Asset-based commission expenses $ 285 $ 259 $ 843 $ 764 Other commission expenses 261 190 691 541 Sub-advisor expenses 82 80 244 234 General and administrative expenses 310 232 839 706 Deferral of acquisition costs (196) (135) (512) (383) Total operating costs and other expenses $ 742 $ 626 $ 2,105 $ 1,862

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Schedule of Changes in Accumulated Other Comprehensive Income	The following table represents changes in the balance of accumulated other comprehensive income ("AOCI"), net of income tax, related to unrealized investment gains (losses) (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Balance, beginning of period (1) $ (3,626) $ (3,365) $ (2,808) $ (3,378) Change in unrealized gains (losses) of investments 1,735 (1,405) 1,134 (958) Change in current discount rate - reserve for future policy benefits (2) (280) 254 (132) 204 Change in non-performance risk on market risk benefits (235) (999) (783) (1,479) Change in unrealized gains (losses) - other (5) 3 (2) (8) Change in deferred tax asset 33 247 148 318 Other comprehensive income (loss) before reclassifications 1,248 (1,900) 365 (1,923) Reclassifications from AOCI, net of tax (5) 78 60 114 Other comprehensive income (loss) 1,243 (1,822) 425 (1,809) Balance, end of period (1) $ (2,383) $ (5,187) $ (2,383) $ (5,187) (1) Includes $(1,336) million and $(1,612) million related to the investments held within the funds withheld account related to the Athene Reinsurance Transaction as of September 30, 2024 and December 31, 2023, respectively. (2) Represents the impact of changes in the discount rate used in the remeasurement of our direct reserves for future policy benefits and claims payable, net of the remeasurement of ceded reserves for future policy benefits and claims payable.
Schedule of Amounts Reclassified Out of AOCI	The following table represents amounts reclassified out of AOCI (in millions): AOCI Components Amounts Affected Line Item in the Condensed Three Months Ended September 30, 2024 2023 Net unrealized investment gain (loss): Net realized gain (loss) on investments $ 20 $ 112 Net gains (losses) on derivatives and investments Other impaired securities (38) (14) Net gains (losses) on derivatives and investments Net unrealized gain (loss) (18) 98 Income tax expense (benefit) (13) 20 Reclassifications, net of income taxes $ (5) $ 78 AOCI Components Amounts Affected Line Item in the Condensed Nine Months Ended September 30, 2024 2023 Net unrealized investment gain (loss): Net realized gain (loss) on investments $ 96 $ 188 Net gains (losses) on derivatives and investments Other impaired securities (33) (44) Net gains (losses) on derivatives and investments Net unrealized gain (loss), before income taxes 63 144 Income tax expense (benefit) 3 30 Reclassifications, net of income taxes $ 60 $ 114

Equity (Tables)

Equity (Tables)	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Schedule of Dividends Paid	The following table presents the declaration date, record date, payment date and dividends paid per preferred share of, and per depositary share representing the Series A Preferred Stock: Dividends Paid Declaration Date Record Date Payment Date Per Preferred Share Per Depositary Share Quarter Ended 03/31/2024 February 20, 2024 March 12, 2024 April 1, 2024 $500 $0.50 06/30/2024 May 2, 2024 June 6, 2024 July 1, 2024 $500 $0.50 09/30/2024 August 1, 2024 September 5, 2024 September 30, 2024 $500 $0.50 Quarter Ended 03/31/2023 None 06/30/2023 May 8, 2023 June 1, 2023 June 30, 2023 $594.44 $0.59444 09/30/2023 August 7, 2023 August 31, 2023 October 2, 2023 $500.00 $0.50000 The following table presents declaration date, record date, payment date and dividends paid per share of JFI’s common stock: Declaration Date Record Date Payment Date Dividends Paid Per Share Quarter Ended 03/31/2024 February 20, 2024 March 12, 2024 March 21, 2024 $0.70 06/30/2024 May 2, 2024 June 6, 2024 June 20, 2024 $0.70 09/30/2024 August 1, 2024 September 5, 2024 September 19, 2024 $0.70 Quarter Ended 03/31/2023 February 27, 2023 March 14, 2023 March 23, 2023 $0.62 06/30/2023 May 8, 2023 June 1, 2023 June 15, 2023 $0.62 09/30/2023 August 7, 2023 August 31, 2023 September 14, 2023 $0.62
Schedule of Share Repurchase Activities	The following table represents share repurchase activities as part of our share repurchase program: Period Number of Shares Repurchased Total Payments Average Price Paid Per Share 2023 (January 1- March 31) 1,721,737 $ 70 $ 40.42 2023 (April 1- June 30) 1,394,797 47 33.87 2023 (July 1- September 30) 1,873,727 71 38.13 2023 (October 1- December 31) 1,512,263 67 44.37 Total 2023 6,502,524 $ 255 $ 39.27 2024 (January 1- March 31) 2,157,372 116 53.76 2024 (April 1- June 30) 1,294,473 90 69.16 2024 (July 1- September 30) 1,352,821 113 83.39 2024 (October 1- November 1) 489,284 48 98.12 Total 2024 5,293,950 $ 367 $ 69.19
Schedule of Changes in Number of Shares of Common Stock Outstanding	The following table presents changes in the number of shares of common stock outstanding: Common Stock Issued Treasury Stock Total Common Stock Outstanding Shares at December 31, 2023 94,481,006 (15,820,785) 78,660,221 Share-based compensation programs 3,403 492,103 (1) 495,506 Shares repurchased under repurchase program — (4,804,666) (4,804,666) Shares at September 30, 2024 94,484,409 (20,133,348) 74,351,061 (1) Represents net shares issued from treasury stock pursuant to the Company’s share-based compensation programs.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2024
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth the calculation of earnings per common share: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 (in millions, except share and per share data) Net income (loss) attributable to Jackson Financial Inc. $ (469) $ 2,773 $ 601 $ 2,493 Less: Preferred stock dividends 11 11 33 24 Net income (loss) attributable to Jackson Financial Inc. common shareholders $ (480) $ 2,762 $ 568 $ 2,469 Weighted average shares of common stock outstanding - basic 75,374,073 82,061,813 76,673,053 82,432,264 Dilutive common shares — 760,005 701,495 2,108,923 Weighted average shares of common stock outstanding - diluted (1) 75,374,073 82,821,818 77,374,548 84,541,187 Earnings per share—common stock Basic $ (6.37) $ 33.66 $ 7.41 $ 29.95 Diluted $ (6.37) $ 33.35 $ 7.34 $ 29.20 (1) If we reported a net loss attributable to Jackson Financial Inc., all common stock equivalents are anti-dilutive and are therefore excluded from the calculation of diluted shares and diluted per share amounts. The shares excluded from the diluted EPS calculation were 751,646 shares for the three months ended September 30, 2024.

Segment Information - Segment R

Segment Information - Segment Results (Details) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) segment	Sep. 30, 2023 USD ($)
Segment Reporting [Abstract]
Number of reportable segments | segment			3
Segment Reporting Information [Line Items]
Fee income	$ 2,032	$ 1,950	$ 6,038	$ 5,751
Premiums	31	32	106	109
Net investment income	726	761	2,208	2,110
Other income (loss)	14	18	25	52
Total revenues	2,121	2,585	3,046	2,201
Death, other policy benefits and change in policy reserves, net of deferrals	209	232	639	701
(Gain) loss from updating future policy benefits cash flow assumptions, net	0	(1)	(7)	23
Interest credited on other contract holder funds, net of deferrals and amortization	275	284	821	864
Interest expense	25	28	76	84
Operating costs and other expenses, net of deferrals	742	626	2,105	1,862
Amortization of deferred acquisition costs	277	290	832	874
Pretax income (loss)	(579)	3,502	642	2,913
Corporate And Reconciling Items
Segment Reporting Information [Line Items]
Fee income	1,251	1,161	3,684	3,397
Premiums	34	36	114	118
Net investment income	452	394	1,335	1,142
Other income (loss)	14	18	25	52
Total revenues	1,751	1,609	5,158	4,709
Death, other policy benefits and change in policy reserves, net of deferrals	157	174	470	488
(Gain) loss from updating future policy benefits cash flow assumptions, net	(1)	0	(9)	25
Interest credited on other contract holder funds, net of deferrals and amortization	275	284	821	864
Interest expense	25	28	76	84
Operating costs and other expenses, net of deferrals	742	626	2,105	1,862
Amortization of deferred acquisition costs	142	142	422	424
Total Operating Benefits and Expenses	1,340	1,254	3,885	3,747
Pretax income (loss)	411	355	1,273	962
Operating Segments
Segment Reporting Information [Line Items]
Total Operating Benefits and Expenses	1,340	1,254	3,885	3,747
Operating Segments | Retail Annuities
Segment Reporting Information [Line Items]
Fee income	1,128	1,038	3,313	3,015
Premiums	12	6	34	16
Net investment income	196	110	514	317
Other income (loss)	8	9	25	28
Total revenues	1,344	1,163	3,886	3,376
Death, other policy benefits and change in policy reserves, net of deferrals	26	24	51	21
(Gain) loss from updating future policy benefits cash flow assumptions, net	(12)	(4)	(26)	(6)
Interest credited on other contract holder funds, net of deferrals and amortization	88	90	260	284
Interest expense	6	6	18	18
Operating costs and other expenses, net of deferrals	638	554	1,825	1,605
Amortization of deferred acquisition costs	140	139	416	416
Total Operating Benefits and Expenses	886	809	2,544	2,338
Pretax income (loss)	458	354	1,342	1,038
Operating Segments | Institutional Products
Segment Reporting Information [Line Items]
Fee income	0	0	0	0
Premiums	0	0	0	0
Net investment income	101	109	332	297
Other income (loss)	0	0	0	0
Total revenues	101	109	332	297
Death, other policy benefits and change in policy reserves, net of deferrals	0	0	0	0
(Gain) loss from updating future policy benefits cash flow assumptions, net	0	0	0	0
Interest credited on other contract holder funds, net of deferrals and amortization	83	87	252	247
Interest expense	0	0	0	0
Operating costs and other expenses, net of deferrals	1	1	3	3
Amortization of deferred acquisition costs	0	0	0	0
Total Operating Benefits and Expenses	84	88	255	250
Pretax income (loss)	17	21	77	47
Operating Segments | Closed Life and Annuity Blocks
Segment Reporting Information [Line Items]
Fee income	111	112	335	345
Premiums	22	30	80	102
Net investment income	155	161	486	489
Other income (loss)	7	8	21	18
Total revenues	295	311	922	954
Death, other policy benefits and change in policy reserves, net of deferrals	131	150	419	467
(Gain) loss from updating future policy benefits cash flow assumptions, net	11	4	17	31
Interest credited on other contract holder funds, net of deferrals and amortization	104	107	309	333
Interest expense	0	0	0	0
Operating costs and other expenses, net of deferrals	40	41	110	122
Amortization of deferred acquisition costs	2	3	6	8
Total Operating Benefits and Expenses	288	305	861	961
Pretax income (loss)	7	6	61	(7)
Corporate and Other
Segment Reporting Information [Line Items]
Fee income	12	11	36	37
Premiums	0	0	0	0
Net investment income	0	14	3	39
Other income (loss)	(1)	1	(21)	6
Total revenues	11	26	18	82
Death, other policy benefits and change in policy reserves, net of deferrals	0	0	0	0
(Gain) loss from updating future policy benefits cash flow assumptions, net	0	0	0	0
Interest credited on other contract holder funds, net of deferrals and amortization	0	0	0	0
Interest expense	19	22	58	66
Operating costs and other expenses, net of deferrals	63	30	167	132
Amortization of deferred acquisition costs	0	0	0	0
Total Operating Benefits and Expenses	82	52	225	198
Pretax income (loss)	(71)	(26)	(207)	(116)
Intersegment eliminations
Segment Reporting Information [Line Items]
Total revenues	$ 21	$ 20	$ 60	$ 57

Segment Information - Reconcili

Segment Information - Reconciliation of Revenues (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Segment Reporting Information [Line Items]
Total revenues	$ 2,121	$ 2,585	$ 3,046	$ 2,201
Net gains (losses) on hedging instruments and investments	102	(335)	(4,132)	(5,173)
Net investment income on funds withheld assets	269	303	824	862
Corporate And Reconciling Items
Segment Reporting Information [Line Items]
Total revenues	1,751	1,609	5,158	4,709
Segment Reconciling Items
Segment Reporting Information [Line Items]
Fees attributed to guarantee benefit reserves	779	784	2,347	2,345
Net gains (losses) on hedging instruments and investments	(678)	(137)	(5,313)	(5,704)
Net investment income (loss) related to noncontrolling interests	3	17	17	21
Consolidated investments	(3)	9	13	(32)
Net investment income on funds withheld assets	$ 269	$ 303	$ 824	$ 862

Segment Information - Reconci_2

Segment Information - Reconciliation of Benefits and Expenses (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Segment Reporting Information [Line Items]
Total benefits and expenses	$ 2,700	$ (917)	$ 2,404	$ (712)
Operating Segments
Segment Reporting Information [Line Items]
Total operating benefits and expenses	1,340	1,254	3,885	3,747
Segment Reconciling Items
Segment Reporting Information [Line Items]
Net (gain) loss on market risk benefits	1,172	(2,376)	(2,062)	(5,120)
Benefits attributed to guaranteed benefit features	53	57	171	211
Amortization of DAC related to non-operating revenues and expenses	$ 135	$ 148	$ 410	$ 450

Segment Information - Reconci_3

Segment Information - Reconciliation of Net Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Segment Reporting Information [Line Items]
Pretax adjusted operating earnings	$ (579)	$ 3,502	$ 642	$ 2,913
Guaranteed Benefits And Hedging Results [Abstract]
Net gains (losses) on hedging instruments			(4,050)	(4,938)
Market risk benefits gains (losses), net	(1,172)	2,376	2,062	5,120
Net realized investment gains (losses)			(82)	(235)
Net investment income on funds withheld assets	269	303	824	862
Pretax income (loss) attributable to Jackson Financial Inc.	(582)	3,485	625	2,892
Income tax expense (benefit)	(113)	712	24	399
Net income (loss) attributable to Jackson Financial Inc.	(469)	2,773	601	2,493
Dividends on preferred stock	11	11	33	24
Net income (loss) attributable to Jackson Financial Inc. common shareholders, Basic	(480)	2,762	568	2,469
Corporate And Reconciling Items
Segment Reporting Information [Line Items]
Pretax adjusted operating earnings	411	355	1,273	962
Segment Reconciling Items
Guaranteed Benefits And Hedging Results [Abstract]
Fees attributed to guarantee benefit reserves	779	784	2,347	2,345
Net gains (losses) on hedging instruments	591	(271)	(3,068)	(4,694)
Market risk benefits gains (losses), net	(1,172)	2,376	2,062	5,120
Net reserve and embedded derivative movements	(493)	45	(1,135)	(338)
Amortization of DAC associated with non-operating items at date of transition to LDTI	(135)	(148)	(410)	(450)
Total Guaranteed benefits and net hedging results	(430)	2,786	(204)	1,983
Net realized investment gains (losses)	(45)	(127)	(82)	(235)
Net realized investment gains (losses) on funds withheld assets	(784)	159	(1,199)	(648)
Net investment income on funds withheld assets	269	303	824	862
Other items	$ (3)	$ 9	$ 13	$ (32)

Investments - Composition of Fa

Investments - Composition of Fair Value of Debt Securities Classified by Rating (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Summary of Investment Holdings [Line Items]
Debt securities, rated by investment advisor	$ 233	$ 486
Percent of Total Debt Securities Carrying Value	100%	100%
Investment grade
Summary of Investment Holdings [Line Items]
Percent of Total Debt Securities Carrying Value	92.70%	93%
Investment grade | U.S. government securities
Summary of Investment Holdings [Line Items]
Percent of Total Debt Securities Carrying Value	7.60%	10.10%
Investment grade | AAA
Summary of Investment Holdings [Line Items]
Percent of Total Debt Securities Carrying Value	6.20%	6.50%
Investment grade | AA
Summary of Investment Holdings [Line Items]
Percent of Total Debt Securities Carrying Value	9.40%	9%
Investment grade | A
Summary of Investment Holdings [Line Items]
Percent of Total Debt Securities Carrying Value	31.80%	31.50%
Investment grade | BBB
Summary of Investment Holdings [Line Items]
Percent of Total Debt Securities Carrying Value	37.70%	35.90%
Below investment grade
Summary of Investment Holdings [Line Items]
Percent of Total Debt Securities Carrying Value	7.30%	7%
Below investment grade | BB
Summary of Investment Holdings [Line Items]
Percent of Total Debt Securities Carrying Value	3.40%	3.50%
Below investment grade | B and below
Summary of Investment Holdings [Line Items]
Percent of Total Debt Securities Carrying Value	3.90%	3.50%

Investments - Total Carrying Va

Investments - Total Carrying Value Debt Securities in Unrealized Loss Position (Details)	Sep. 30, 2024	Dec. 31, 2023
Investment grade securities
Percent of total debt securities carrying value
Debt securities in an unrealized loss position, percentage	77%	77%
Below investment grade securities
Percent of total debt securities carrying value
Debt securities in an unrealized loss position, percentage	2%	2%
Not rated securities
Percent of total debt securities carrying value
Debt securities in an unrealized loss position, percentage	21%	21%

Investments - Narrative (Detail

Investments - Narrative (Details)	3 Months Ended			9 Months Ended		12 Months Ended
	Sep. 30, 2024 USD ($) state	Mar. 31, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) state	Sep. 30, 2023 USD ($)	Dec. 31, 2023 USD ($)
Percent of total debt securities carrying value
Securities on deposit with regulatory authorities	$ 91,000,000			$ 91,000,000		$ 91,000,000
Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List Not Disclosed Flag				Accrued interest receivables	Accrued interest receivables
Accrued interest written off	1,000,000		$ 1,000,000	$ 1,000,000	$ 1,000,000
Aggregate fair value of securities sold at a loss	$ 419,000,000		$ 756,000,000	$ 2,314,000,000	$ 2,909,000,000
Aggregate fair value of securities sold at a loss, percentage of book value	97%		88%	94%	94%
Proceeds from sales of available-for-sale debt securities	$ 600,000,000		$ 900,000,000	$ 3,500,000,000	$ 4,200,000,000
Collateralized loan obligation						97,000,000
Estimated loss from divestiture						97,000,000
Unconsolidated VIEs, exposure to loss	2,609,000,000			2,609,000,000		2,576,000,000
Equity securities	213,000,000			213,000,000		394,000,000
Stressed loans	29,000,000		16,000,000	29,000,000	16,000,000
Policy loans, fair value under fair value option	3,535,000,000			3,535,000,000		3,457,000,000
Policy loans not held as collateral for reinsurance	900,000,000			900,000,000		900,000,000
Other invested assets	2,747,000,000			2,747,000,000		2,466,000,000
Securities loaned	$ 25,000,000			$ 25,000,000		19,000,000
Securities loaned, minimum percent of fair value required as collateral	102%			102%
Securities loaned, cash collateral	$ 26,000,000			$ 26,000,000		19,000,000
Outstanding repurchase agreement balance	794,000,000			794,000,000		0
Corporate securities				803,000,000		0
Interest expense	25,000,000		28,000,000	76,000,000	84,000,000
Collateral upgrade transactions	$ 1,551,000,000			$ 1,551,000,000		0
Commercial mortgage loans
Percent of total debt securities carrying value
Financing receivables, collateralized by properties, number of states | state	36			36
Residential mortgage loans
Percent of total debt securities carrying value
Financing receivables, collateralized by properties, number of states | state	49			49
Unconsolidated VIEs
Percent of total debt securities carrying value
Equity securities	$ 24,000,000			$ 24,000,000		21,000,000
Equity securities
Percent of total debt securities carrying value
Unrealized gains (losses)	10,000,000		(16,000,000)	16,000,000	(38,000,000)
Federal Home Loan Bank capital stock
Percent of total debt securities carrying value
Other invested assets	127,000,000			127,000,000		108,000,000
Real estate
Percent of total debt securities carrying value
Other invested assets	227,000,000			227,000,000		226,000,000
Real estate, foreclosed properties
Percent of total debt securities carrying value
Other invested assets	8,000,000			8,000,000		6,000,000
Limited partnerships
Percent of total debt securities carrying value
Other invested assets	2,400,000,000			2,400,000,000		2,100,000,000
Repurchase agreements
Percent of total debt securities carrying value
Interest expense	13,000,000		16,000,000	54,000,000	41,000,000
Collateral upgrade transactions
Percent of total debt securities carrying value
Corporate securities	32,000,000		0	53,000,000	0
Interest expense	$ 36,000,000		$ 0	59,000,000	$ 0
Collateral upgrade transactions		$ 1,500,000,000
Period of notice prior to termination		150 days
Corporate securities, collateral upgrade				$ 1,600,000,000		$ 0
Below investment grade or not rated
Percent of total debt securities carrying value
Debt securities, unrealized losses, percentage	20%			20%		21%

Investments - Schedule of Unrea

Investments - Schedule of Unrealized Loss Position were Diversified Across Industries (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Utility
Percent of total debt securities carrying value
Debt securities, unrealized losses, percentage	16%	17%
Financial Services
Percent of total debt securities carrying value
Debt securities, unrealized losses, percentage	13%	14%
Corporate securities | Single corporate obligor
Percent of total debt securities carrying value
Debt securities, unrealized loss	$ 54	$ 50

Investments - Debt Securities -

Investments - Debt Securities - Amortized Cost, Gross Unrealized Gains and Losses, Fair Value and Allowance For Credit Loss (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Summary of Investment Holdings [Line Items]
Amortized Cost	$ 48,546	$ 47,065
Allowance for Credit Loss	44	21
Gross Unrealized Gains	533	259
Gross Unrealized Losses	3,736	4,660
Fair Value	45,299	42,643
U.S. government securities
Summary of Investment Holdings [Line Items]
Amortized Cost	4,231	5,154
Allowance for Credit Loss	0	0
Gross Unrealized Gains	5	3
Gross Unrealized Losses	787	845
Fair Value	3,449	4,312
Other government securities
Summary of Investment Holdings [Line Items]
Amortized Cost	1,530	1,622
Allowance for Credit Loss	0	0
Gross Unrealized Gains	2	1
Gross Unrealized Losses	192	221
Fair Value	1,340	1,402
Public utilities
Summary of Investment Holdings [Line Items]
Amortized Cost	5,743	5,598
Allowance for Credit Loss	16	0
Gross Unrealized Gains	79	42
Gross Unrealized Losses	393	513
Fair Value	5,413	5,127
Corporate securities
Summary of Investment Holdings [Line Items]
Amortized Cost	30,402	27,870
Allowance for Credit Loss	9	15
Gross Unrealized Gains	405	194
Gross Unrealized Losses	2,038	2,572
Fair Value	28,760	25,477
Residential mortgage-backed
Summary of Investment Holdings [Line Items]
Amortized Cost	392	422
Allowance for Credit Loss	4	6
Gross Unrealized Gains	13	12
Gross Unrealized Losses	68	53
Fair Value	333	375
Commercial mortgage-backed
Summary of Investment Holdings [Line Items]
Amortized Cost	1,691	1,569
Allowance for Credit Loss	0	0
Gross Unrealized Gains	4	1
Gross Unrealized Losses	87	147
Fair Value	1,608	1,423
Other asset-backed securities
Summary of Investment Holdings [Line Items]
Amortized Cost	4,557	4,830
Allowance for Credit Loss	15	0
Gross Unrealized Gains	25	6
Gross Unrealized Losses	171	309
Fair Value	$ 4,396	$ 4,527

Investments - Debt Securities M

Investments - Debt Securities Maturities (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Amortized Cost
Due in 1 year or less	$ 1,879
Due after 1 year through 5 years	11,043
Due after 5 years through 10 years	12,859
Due after 10 years through 20 years	8,896
Due after 20 years	7,229
Amortized Cost	48,546	$ 47,065
Allowance for Credit Loss
Due in 1 year or less	0
Due after 1 year through 5 years	16
Due after 5 years through 10 years	9
Due after 10 years through 20 years	0
Due after 20 years	0
Allowance for Credit Loss	44	21
Gross Unrealized Gains
Due in 1 year or less	4
Due after 1 year through 5 years	108
Due after 5 years through 10 years	236
Due after 10 years through 20 years	106
Due after 20 years	37
Gross Unrealized Gains	533	259
Gross Unrealized Losses
Due in 1 year or less	8
Due after 1 year through 5 years	149
Due after 5 years through 10 years	662
Due after 10 years through 20 years	1,137
Due after 20 years	1,454
Gross Unrealized Losses	3,736	4,660
Fair Value
Due in 1 year or less	1,875
Due after 1 year through 5 years	10,986
Due after 5 years through 10 years	12,424
Due after 10 years through 20 years	7,865
Due after 20 years	5,812
Debt securities	45,299	42,643
Residential mortgage-backed
Amortized Cost
Without single maturity	392
Amortized Cost	392	422
Allowance for Credit Loss
Without single maturity	4
Allowance for Credit Loss	4	6
Gross Unrealized Gains
Without single maturity	13
Gross Unrealized Gains	13	12
Gross Unrealized Losses
Without single maturity	68
Gross Unrealized Losses	68	53
Fair Value
Without single maturity	333
Debt securities	333	375
Commercial mortgage-backed
Amortized Cost
Without single maturity	1,691
Amortized Cost	1,691	1,569
Allowance for Credit Loss
Without single maturity	0
Allowance for Credit Loss	0	0
Gross Unrealized Gains
Without single maturity	4
Gross Unrealized Gains	4	1
Gross Unrealized Losses
Without single maturity	87
Gross Unrealized Losses	87	147
Fair Value
Without single maturity	1,608
Debt securities	1,608	1,423
Other asset-backed securities
Amortized Cost
Without single maturity	4,557
Amortized Cost	4,557	4,830
Allowance for Credit Loss
Without single maturity	15
Allowance for Credit Loss	15	0
Gross Unrealized Gains
Without single maturity	25
Gross Unrealized Gains	25	6
Gross Unrealized Losses
Without single maturity	171
Gross Unrealized Losses	171	309
Fair Value
Without single maturity	4,396
Debt securities	$ 4,396	$ 4,527

Investments - Residential Mortg

Investments - Residential Mortgage-Backed Securities (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Summary of Investment Holdings [Line Items]
Amortized Cost	$ 48,546	$ 47,065
Allowance for Credit Loss	44	21
Gross Unrealized Gains	533	259
Gross Unrealized Losses	3,736	4,660
Fair Value	45,299	42,643
Non-agency RMBS
Summary of Investment Holdings [Line Items]
Amortized Cost	238	242
Allowance for Credit Loss	4	6
Gross Unrealized Gains	11	10
Gross Unrealized Losses	57	39
Fair Value	188	207
Non-agency RMBS | Prime
Summary of Investment Holdings [Line Items]
Amortized Cost	144	164
Allowance for Credit Loss	2	2
Gross Unrealized Gains	1	1
Gross Unrealized Losses	14	19
Fair Value	129	144
Non-agency RMBS | Alt-A
Summary of Investment Holdings [Line Items]
Amortized Cost	88	71
Allowance for Credit Loss	2	3
Gross Unrealized Gains	6	5
Gross Unrealized Losses	43	20
Fair Value	49	53
Non-agency RMBS | Subprime
Summary of Investment Holdings [Line Items]
Amortized Cost	6	7
Allowance for Credit Loss	0	1
Gross Unrealized Gains	4	4
Gross Unrealized Losses	0	0
Fair Value	$ 10	$ 10

Investments - Debt Securities i

Investments - Debt Securities in Continuous Unrealized Loss Position (Details) $ in Millions	Sep. 30, 2024 USD ($) security	Dec. 31, 2023 USD ($) security
Summary of Investment Holdings [Line Items]
Less than 12 months, gross unrealized losses	$ 112	$ 143
Less than 12 months, fair value	$ 2,211	$ 2,776
Less than 12 months, # of securities | security	275	385
12 months or longer, gross unrealized losses	$ 3,624	$ 4,517
12 months or longer, fair value	$ 25,224	$ 30,323
12 months or longer, # of securities | security	3,106	3,695
Total, gross unrealized losses	$ 3,736	$ 4,660
Total, fair value	$ 27,435	$ 33,099
Total, # of securities | security	3,285	3,968
U.S. government securities
Summary of Investment Holdings [Line Items]
Less than 12 months, gross unrealized losses	$ 41	$ 52
Less than 12 months, fair value	$ 291	$ 306
Less than 12 months, # of securities | security	7	11
12 months or longer, gross unrealized losses	$ 746	$ 793
12 months or longer, fair value	$ 2,065	$ 2,774
12 months or longer, # of securities | security	23	23
Total, gross unrealized losses	$ 787	$ 845
Total, fair value	$ 2,356	$ 3,080
Total, # of securities | security	28	30
Other government securities
Summary of Investment Holdings [Line Items]
Less than 12 months, gross unrealized losses	$ 0	$ 1
Less than 12 months, fair value	$ 0	$ 51
Less than 12 months, # of securities | security	0	9
12 months or longer, gross unrealized losses	$ 192	$ 220
12 months or longer, fair value	$ 1,277	$ 1,301
12 months or longer, # of securities | security	136	151
Total, gross unrealized losses	$ 192	$ 221
Total, fair value	$ 1,277	$ 1,352
Total, # of securities | security	136	157
Public utilities
Summary of Investment Holdings [Line Items]
Less than 12 months, gross unrealized losses	$ 5	$ 11
Less than 12 months, fair value	$ 160	$ 287
Less than 12 months, # of securities | security	20	32
12 months or longer, gross unrealized losses	$ 388	$ 502
12 months or longer, fair value	$ 3,795	$ 4,105
12 months or longer, # of securities | security	459	491
Total, gross unrealized losses	$ 393	$ 513
Total, fair value	$ 3,955	$ 4,392
Total, # of securities | security	468	513
Corporate securities
Summary of Investment Holdings [Line Items]
Less than 12 months, gross unrealized losses	$ 52	$ 50
Less than 12 months, fair value	$ 1,210	$ 1,331
Less than 12 months, # of securities | security	187	227
12 months or longer, gross unrealized losses	$ 1,986	$ 2,522
12 months or longer, fair value	$ 14,797	$ 17,457
12 months or longer, # of securities | security	1,890	2,207
Total, gross unrealized losses	$ 2,038	$ 2,572
Total, fair value	$ 16,007	$ 18,788
Total, # of securities | security	2,003	2,355
Residential mortgage-backed
Summary of Investment Holdings [Line Items]
Less than 12 months, gross unrealized losses	$ 2	$ 2
Less than 12 months, fair value	$ 36	$ 48
Less than 12 months, # of securities | security	6	45
12 months or longer, gross unrealized losses	$ 66	$ 51
12 months or longer, fair value	$ 203	$ 251
12 months or longer, # of securities | security	207	219
Total, gross unrealized losses	$ 68	$ 53
Total, fair value	$ 239	$ 299
Total, # of securities | security	210	262
Commercial mortgage-backed
Summary of Investment Holdings [Line Items]
Less than 12 months, gross unrealized losses	$ 11	$ 0
Less than 12 months, fair value	$ 183	$ 46
Less than 12 months, # of securities | security	17	6
12 months or longer, gross unrealized losses	$ 76	$ 147
12 months or longer, fair value	$ 1,127	$ 1,294
12 months or longer, # of securities | security	156	177
Total, gross unrealized losses	$ 87	$ 147
Total, fair value	$ 1,310	$ 1,340
Total, # of securities | security	171	182
Other asset-backed securities
Summary of Investment Holdings [Line Items]
Less than 12 months, gross unrealized losses	$ 1	$ 27
Less than 12 months, fair value	$ 331	$ 707
Less than 12 months, # of securities | security	38	55
12 months or longer, gross unrealized losses	$ 170	$ 282
12 months or longer, fair value	$ 1,960	$ 3,141
12 months or longer, # of securities | security	235	427
Total, gross unrealized losses	$ 171	$ 309
Total, fair value	$ 2,291	$ 3,848
Total, # of securities | security	269	469

Investments - Rollforward of Al

Investments - Rollforward of Allowance for Debt Securities Credit Loss (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Balance	$ 27	$ 16	$ 21	$ 23
Additions for which credit loss was not previously recorded	16	26	17	59
Changes for securities with previously recorded credit loss	9	2	16	4
Additions for purchases of PCD debt securities	0	0	0	0
Reductions from charge-offs	(6)	0	(6)	0
Reductions for securities disposed	(2)	(1)	(4)	(26)
Securities intended/required to be sold before recovery of amortized cost basis	0	(17)	0	(34)
Balance	44	26	44	26
Accrued interest receivable on debt securities	446	416	446	416
U.S. government securities
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Balance	0	0	0	0
Additions for which credit loss was not previously recorded	0	0	0	0
Changes for securities with previously recorded credit loss	0	0	0	0
Additions for purchases of PCD debt securities	0	0	0	0
Reductions from charge-offs	0	0	0	0
Reductions for securities disposed	0	0	0	0
Securities intended/required to be sold before recovery of amortized cost basis	0	0	0	0
Balance	0	0	0	0
Other government securities
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Balance	0	3	0	2
Additions for which credit loss was not previously recorded	0	2	0	2
Changes for securities with previously recorded credit loss	0	0	0	1
Additions for purchases of PCD debt securities	0	0	0	0
Reductions from charge-offs	0	0	0	0
Reductions for securities disposed	0	0	0	0
Securities intended/required to be sold before recovery of amortized cost basis	0	(2)	0	(2)
Balance	0	3	0	3
Public utilities
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Balance	0	0	0	0
Additions for which credit loss was not previously recorded	16	0	16	0
Changes for securities with previously recorded credit loss	0	0	0	0
Additions for purchases of PCD debt securities	0	0	0	0
Reductions from charge-offs	0	0	0	0
Reductions for securities disposed	0	0	0	0
Securities intended/required to be sold before recovery of amortized cost basis	0	0	0	0
Balance	16	0	16	0
Corporate securities
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Balance	13	7	15	15
Additions for which credit loss was not previously recorded	0	15	0	48
Changes for securities with previously recorded credit loss	2	2	2	1
Additions for purchases of PCD debt securities	0	0	0	0
Reductions from charge-offs	(6)	0	(6)	0
Reductions for securities disposed	0	(1)	(2)	(24)
Securities intended/required to be sold before recovery of amortized cost basis	0	(6)	0	(23)
Balance	9	17	9	17
Residential mortgage-backed
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Balance	6	6	6	6
Additions for which credit loss was not previously recorded	0	0	0	0
Changes for securities with previously recorded credit loss	0	0	0	2
Additions for purchases of PCD debt securities	0	0	0	0
Reductions from charge-offs	0	0	0	0
Reductions for securities disposed	(2)	0	(2)	(2)
Securities intended/required to be sold before recovery of amortized cost basis	0	0	0	0
Balance	4	6	4	6
Commercial mortgage-backed
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Balance	0	0	0	0
Additions for which credit loss was not previously recorded	0	9	0	9
Changes for securities with previously recorded credit loss	0	0	0	0
Additions for purchases of PCD debt securities	0	0	0	0
Reductions from charge-offs	0	0	0	0
Reductions for securities disposed	0	0	0	0
Securities intended/required to be sold before recovery of amortized cost basis	0	(9)	0	(9)
Balance	0	0	0	0
Other asset-backed securities
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Balance	8	0	0	0
Additions for which credit loss was not previously recorded	0	0	1	0
Changes for securities with previously recorded credit loss	7	0	14	0
Additions for purchases of PCD debt securities	0	0	0	0
Reductions from charge-offs	0	0	0	0
Reductions for securities disposed	0	0	0	0
Securities intended/required to be sold before recovery of amortized cost basis	0	0	0	0
Balance	$ 15	$ 0	$ 15	$ 0

Investments - Sources of Net In

Investments - Sources of Net Investment Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Net Investment Income [Line Items]
Investment expenses	$ (110)	$ (112)	$ (352)	$ (277)
Net investment income excluding funds withheld assets	457	458	1,384	1,248
Net investment income	726	761	2,208	2,110
Variable Interest Entity, Primary Beneficiary
Net Investment Income [Line Items]
Increase (decrease) in fair value of notes issued	(44)	(70)	(150)	(144)
Debt securities
Net Investment Income [Line Items]
Total investment income excluding funds withheld assets	393	432	1,191	1,152
Equity securities
Net Investment Income [Line Items]
Total investment income excluding funds withheld assets	3	(4)	6	(5)
Mortgage loans
Net Investment Income [Line Items]
Total investment income excluding funds withheld assets	83	81	248	235
Policy loans
Net Investment Income [Line Items]
Total investment income excluding funds withheld assets	17	17	50	50
Limited partnerships
Net Investment Income [Line Items]
Total investment income excluding funds withheld assets	20	20	106	19
Other investment income
Net Investment Income [Line Items]
Total investment income excluding funds withheld assets	51	24	135	74
Total investment income excluding funds withheld assets
Net Investment Income [Line Items]
Total investment income excluding funds withheld assets	567	570	1,736	1,525
Funds withheld assets
Net Investment Income [Line Items]
Investment expenses	(15)	(19)	(47)	(56)
Net investment income	269	303	824	862
Debt securities, at fair value under the fair value option
Net Investment Income [Line Items]
Net investment income	$ (23)	$ 51	$ (1)	$ 43

Investments - Net Gains (Losses

Investments - Net Gains (Losses) on Derivatives and Investments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Available-for-sale securities
Realized gains on sale	$ 4	$ 11	$ 21	$ 17
Realized losses on sale	(2)	(102)	(114)	(145)
Credit loss income (expense)	(11)	(18)	(11)	(29)
Credit loss income (expense) on mortgage loans	8	(28)	6	(88)
Other	(44)	10	16	10
Net gains (losses) excluding derivatives and funds withheld assets	(45)	(127)	(82)	(235)
Net gains (losses) on derivative instruments	(413)	267	(4,537)	(4,743)
Net gains (losses) on derivatives and investments	102	(335)	(4,132)	(5,173)
Net gains (losses) on funds withheld reinsurance treaties	(784)	159	(1,199)	(648)
Total net gains (losses) on derivatives and investments	(682)	(176)	(5,331)	(5,821)
Derivatives excluding funds withheld under reinsurance treaties
Available-for-sale securities
Net gains (losses) on derivative instruments	147	(208)	(4,050)	(4,938)
Derivatives related to funds withheld under reinsurance treaties
Available-for-sale securities
Net gains (losses) on derivative instruments	(560)	475	(487)	195
Net gains (losses) on funds withheld reinsurance treaties	$ (784)	$ 159	$ (1,199)	$ (648)

Investments - Asset and Liabili

Investments - Asset and Liability Information for Consolidated VIEs (Details) - USD ($) $ in Millions	Sep. 30, 2024	Jun. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022
Assets
Debt securities, trading	$ 73		$ 68
Equity securities	213		394
Other invested assets	2,747		2,466
Other assets	797		1,294
Total assets	345,662		330,255
Liabilities
Securities lending payable	26		19
Total liabilities	334,755		319,921
Equity
Noncontrolling interests	10,907	$ 10,284	10,334	$ 10,253	$ 9,423	$ 9,378
Related Party
Liabilities
Notes issued by consolidated VIEs, at fair value under fair value option	2,366		1,988
Nonrelated Party
Liabilities
Notes issued by consolidated VIEs, at fair value under fair value option	2,586		2,277
Variable Interest Entity, Primary Beneficiary
Assets
Debt securities, at fair value under fair value option	2,459		2,037
Debt securities, trading	73		68
Equity securities	6		7
Other invested assets	553		396
Cash and cash equivalents	167		93
Other assets	66		49
Total assets	3,324		2,650
Liabilities
Other liabilities	244		98
Securities lending payable	1		2
Total liabilities	2,611		2,088
Equity
Noncontrolling interests	209		164
Variable Interest Entity, Primary Beneficiary | Related Party
Liabilities
Notes issued by consolidated VIEs, at fair value under fair value option	2,366		1,988
Variable Interest Entity, Primary Beneficiary | Nonrelated Party
Liabilities
Notes issued by consolidated VIEs, at fair value under fair value option	$ 2,610		$ 2,086

Investments - Commercial and Re

Investments - Commercial and Residential Loans (Details) - USD ($) $ in Millions	Sep. 30, 2024	Jun. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022
Financing Receivable, Allowance for Credit Loss [Line Items]
Mortgage loans	$ 9,564		$ 10,082
Financing receivables, accrued interest receivable	42			$ 45
Mortgage loans, allowance for credit loss	148	$ 160	165	$ 200	$ 162	$ 95
Commercial mortgage loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Mortgage loans, allowance for credit loss	143		160
Residential mortgage loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Mortgage loans, allowance for credit loss	5		5
Commercial mortgage loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Mortgage loans	9,114		9,562
Financing receivables, accrued interest receivable	36		39
Residential mortgage loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Mortgage loans	882		1,001
Financing receivables, accrued interest receivable	$ 6		$ 7

Investments - Rollforward of Mo

Investments - Rollforward of Mortgages Allowance for Credit Loss (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Balance	$ 160	$ 162	$ 165	$ 95
Charge offs, net of recoveries	(3)	0	(3)	0
Additions from purchase of PCD mortgage loans	0	0	0	0
Provision (release)	(9)	38	(14)	105
Balance	148	200	148	200
Financing receivables, accrued interest receivable	42	45	42	45
Accrued interest written off	1	2	1	2
Apartment
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Balance	27	16	28	16
Charge offs, net of recoveries	(3)	0	(3)	0
Additions from purchase of PCD mortgage loans	0	0	0	0
Provision (release)	(4)	8	(5)	8
Balance	20	24	20	24
Hotel
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Balance	5	7	4	20
Charge offs, net of recoveries	0	0	0	0
Additions from purchase of PCD mortgage loans	0	0	0	0
Provision (release)	0	(1)	1	(14)
Balance	5	6	5	6
Office
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Balance	70	91	78	15
Charge offs, net of recoveries	0	0	0	0
Additions from purchase of PCD mortgage loans	0	0	0	0
Provision (release)	(4)	30	(12)	106
Balance	66	121	66	121
Retail
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Balance	27	25	27	21
Charge offs, net of recoveries	0	0	0	0
Additions from purchase of PCD mortgage loans	0	0	0	0
Provision (release)	5	0	5	4
Balance	32	25	32	25
Warehouse
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Balance	19	12	17	16
Charge offs, net of recoveries	0	0	0	0
Additions from purchase of PCD mortgage loans	0	0	0	0
Provision (release)	(1)	4	1	0
Balance	18	16	18	16
Other
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Balance	7	3	6	3
Charge offs, net of recoveries	0	0	0	0
Additions from purchase of PCD mortgage loans	0	0	0	0
Provision (release)	(5)	0	(4)	0
Balance	2	3	2	3
Residential Mortgage
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Balance	5	8	5	4
Charge offs, net of recoveries	0	0	0	0
Additions from purchase of PCD mortgage loans	0	0	0	0
Provision (release)	0	(3)	0	1
Balance	$ 5	$ 5	$ 5	$ 5

Investments - Schedule of Impai

Investments - Schedule of Impaired Residential Mortgage Loans (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Recorded investment	$ 32	$ 24
Unpaid principal balance	36	27
Related loan allowance	2	1
Average recorded investment	29	19
Investment income recognized	$ 0	$ 1

Investments - Information About

Investments - Information About Credit Quality and Vintage Year of Commercial Mortgage Loans (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Financing Receivable, Credit Quality Indicator [Line Items]
Year one	$ 542	$ 879
Year two	843	1,140
Year three	1,045	1,453
Year four	1,133	855
Year five	753	1,408
Prior	5,676	4,824
Revolving Loans	4	4
Total	$ 9,996	$ 10,563
% of Total	100%	100%
Commercial mortgage loans
Financing Receivable, Credit Quality Indicator [Line Items]
Year one	$ 449	$ 683
Year two	688	963
Year three	950	1,288
Year four	1,011	812
Year five	716	1,375
Prior	5,296	4,437
Revolving Loans	4	4
Total	$ 9,114	$ 9,562
% of Total	100%	100%
Residential mortgage loans
Financing Receivable, Credit Quality Indicator [Line Items]
Year one	$ 93	$ 196
Year two	155	177
Year three	95	165
Year four	122	43
Year five	37	33
Prior	380	387
Revolving Loans	0	0
Total	$ 882	$ 1,001
% of Total	100%	100%
Residential mortgage loans | Performing
Financing Receivable, Credit Quality Indicator [Line Items]
Year one	$ 93	$ 193
Year two	139	136
Year three	44	155
Year four	115	36
Year five	31	30
Prior	355	361
Revolving Loans	0	0
Total	$ 777	$ 911
% of Total	88%	91%
Residential mortgage loans | Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Year one	$ 0	$ 3
Year two	16	41
Year three	51	10
Year four	7	7
Year five	6	3
Prior	25	26
Revolving Loans	0	0
Total	$ 105	$ 90
% of Total	12%	9%
Greater than 1.20x | Commercial mortgage loans
Financing Receivable, Credit Quality Indicator [Line Items]
Year one	$ 433	$ 546
Year two	577	611
Year three	677	932
Year four	680	667
Year five	678	1,302
Prior	4,990	4,189
Revolving Loans	4	4
Total	$ 8,039	$ 8,251
% of Total	88%	86%
1.00x - 1.20x | Commercial mortgage loans
Financing Receivable, Credit Quality Indicator [Line Items]
Year one	$ 16	$ 129
Year two	103	277
Year three	196	356
Year four	331	145
Year five	38	30
Prior	207	191
Revolving Loans	0	0
Total	$ 891	$ 1,128
% of Total	10%	12%
Less than 1.00x | Commercial mortgage loans
Financing Receivable, Credit Quality Indicator [Line Items]
Year one	$ 0	$ 8
Year two	8	75
Year three	77	0
Year four	0	0
Year five	0	43
Prior	99	57
Revolving Loans	0	0
Total	$ 184	$ 183
% of Total	2%	2%
Less than 70% | Commercial mortgage loans
Financing Receivable, Credit Quality Indicator [Line Items]
Year one	$ 432	$ 659
Year two	639	800
Year three	579	937
Year four	636	653
Year five	518	1,251
Prior	4,799	4,300
Revolving Loans	4	4
Total	$ 7,607	$ 8,604
% of Total	83%	90%
70% - 80% | Commercial mortgage loans
Financing Receivable, Credit Quality Indicator [Line Items]
Year one	$ 17	$ 24
Year two	49	138
Year three	204	325
Year four	352	122
Year five	170	61
Prior	262	41
Revolving Loans	0	0
Total	$ 1,054	$ 711
% of Total	12%	7%
80% - 100% | Commercial mortgage loans
Financing Receivable, Credit Quality Indicator [Line Items]
Year one	$ 0	$ 0
Year two	0	25
Year three	167	0
Year four	23	37
Year five	0	41
Prior	172	93
Revolving Loans	0	0
Total	$ 362	$ 196
% of Total	4%	2%
Greater than 100% | Commercial mortgage loans
Financing Receivable, Credit Quality Indicator [Line Items]
Year one	$ 0	$ 0
Year two	0	0
Year three	0	26
Year four	0	0
Year five	28	22
Prior	63	3
Revolving Loans	0	0
Total	$ 91	$ 51
% of Total	1%	1%

Investments - Mortgages by Stan

Investments - Mortgages by Standing (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	$ 9,996,000,000	$ 10,563,000,000
Restructured	40,000,000	0
In the Process of Foreclosure	32,000,000	24,000,000
In Good Standing
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	9,849,000,000	10,473,000,000
Greater than 90 Days Delinquent
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	75,000,000	66,000,000
Commercial mortgage loans
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	9,114,000,000	9,562,000,000
Restructured	40,000,000	0
In the Process of Foreclosure	0	0
Commercial mortgage loans | In Good Standing
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	9,072,000,000	9,562,000,000
Commercial mortgage loans | Greater than 90 Days Delinquent
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	2,000,000	0
Commercial mortgage loans | Apartment
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	2,515,000,000	2,841,000,000
Restructured	0	0
In the Process of Foreclosure	0	0
Commercial mortgage loans | Apartment | In Good Standing
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	2,515,000,000	2,841,000,000
Commercial mortgage loans | Apartment | Greater than 90 Days Delinquent
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	0	0
Commercial mortgage loans | Hotel
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	821,000,000	767,000,000
Restructured	0	0
In the Process of Foreclosure	0	0
Commercial mortgage loans | Hotel | In Good Standing
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	821,000,000	767,000,000
Commercial mortgage loans | Hotel | Greater than 90 Days Delinquent
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	0	0
Commercial mortgage loans | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	1,302,000,000	1,379,000,000
Restructured	40,000,000	0
In the Process of Foreclosure	0	0
Commercial mortgage loans | Office | In Good Standing
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	1,260,000,000	1,379,000,000
Commercial mortgage loans | Office | Greater than 90 Days Delinquent
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	2,000,000	0
Commercial mortgage loans | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	1,830,000,000	1,864,000,000
Restructured	0	0
In the Process of Foreclosure	0	0
Commercial mortgage loans | Retail | In Good Standing
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	1,830,000,000	1,864,000,000
Commercial mortgage loans | Retail | Greater than 90 Days Delinquent
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	0	0
Commercial mortgage loans | Warehouse
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	2,053,000,000	2,016,000,000
Restructured	0	0
In the Process of Foreclosure	0	0
Commercial mortgage loans | Warehouse | In Good Standing
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	2,053,000,000	2,016,000,000
Commercial mortgage loans | Warehouse | Greater than 90 Days Delinquent
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	0	0
Commercial mortgage loans | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	593,000,000	695,000,000
Restructured	0	0
In the Process of Foreclosure	0	0
Commercial mortgage loans | Other | In Good Standing
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	593,000,000	695,000,000
Commercial mortgage loans | Other | Greater than 90 Days Delinquent
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	0	0
Residential mortgage loans
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	882,000,000	1,001,000,000
Residential mortgage loans | Residential
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	882,000,000	1,001,000,000
Restructured	0	0
In the Process of Foreclosure	32,000,000	24,000,000
Residential mortgage loans | Residential | Financial Asset Acquired with Credit Deterioration
Financing Receivable, Credit Quality Indicator [Line Items]
In the Process of Foreclosure	3,000,000	5,000,000
Residential mortgage loans | Residential | In Good Standing
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	777,000,000	911,000,000
Residential mortgage loans | Residential | Greater than 90 Days Delinquent
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	73,000,000	66,000,000
Residential mortgage loans | Residential | Greater than 90 Days Delinquent | Financial Asset Acquired with Credit Deterioration
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	18,000,000	22,000,000
Mezzanine loans | Apartment | In Good Standing
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	350,000,000	368,000,000
Mezzanine loans | Hotel | In Good Standing
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	27,000,000	21,000,000
Mezzanine loans | Office | In Good Standing
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	138,000,000	171,000,000
Mezzanine loans | Retail | In Good Standing
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	32,000,000	32,000,000
Mezzanine loans | Warehouse | In Good Standing
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	268,000,000	287,000,000
Mezzanine loans | Other | In Good Standing
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	23,000,000	48,000,000
Restructured Mezzanine And Bridge Loans | Office | In Good Standing
Financing Receivable, Credit Quality Indicator [Line Items]
Carrying Value	$ 24,000,000	$ 0

Investments - Loans Modified to

Investments - Loans Modified to Borrowers Experiencing Financial Difficulty (Details) - Commercial mortgage loans - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized Cost Basis	$ 0	$ 0	$ 24	$ 17	$ 40	$ 17
Percent of Total Class	0%	0%	0.26%	0.18%
Extension of term			3 years	3 years
30-89 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized Cost Basis					0	0
90+ Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized Cost Basis					$ 0	$ 0

Derivative Instruments - Aggreg

Derivative Instruments - Aggregate Contractual Notional Amounts and Fair Values of Derivatives (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Assets
Fair Value	$ 295	$ 390
Liabilities
Fair Value	425	1,210
Freestanding derivatives
Derivative [Line Items]
Contractual/Notional Amount	91,613	117,657
Assets
Fair Value	260	341
Liabilities
Fair Value	395	1,176
Net Fair Value, Asset (Liability)	(135)	(835)
Freestanding derivatives | Cross-currency swaps
Derivative [Line Items]
Contractual/Notional Amount	1,714	1,665
Assets
Fair Value	133	123
Liabilities
Fair Value	131	116
Net Fair Value, Asset (Liability)	2	7
Freestanding derivatives | Equity index call options
Derivative [Line Items]
Contractual/Notional Amount	1,000
Assets
Fair Value	36
Liabilities
Fair Value	0
Net Fair Value, Asset (Liability)	36
Freestanding derivatives | Equity index futures
Derivative [Line Items]
Contractual/Notional Amount	30,711	24,739
Assets
Fair Value	0	0
Liabilities
Fair Value	0	0
Net Fair Value, Asset (Liability)	0	0
Freestanding derivatives | Equity index put options
Derivative [Line Items]
Contractual/Notional Amount	14,000	26,000
Assets
Fair Value	76	59
Liabilities
Fair Value	0	0
Net Fair Value, Asset (Liability)	76	59
Freestanding derivatives | Interest rate swaps
Derivative [Line Items]
Contractual/Notional Amount	5,978	6,228
Assets
Fair Value	4	5
Liabilities
Fair Value	87	132
Net Fair Value, Asset (Liability)	(83)	(127)
Freestanding derivatives | Put-swaptions
Derivative [Line Items]
Contractual/Notional Amount	3,500	23,500
Assets
Fair Value	11	153
Liabilities
Fair Value	141	905
Net Fair Value, Asset (Liability)	(130)	(752)
Freestanding derivatives | Interest rate futures
Derivative [Line Items]
Contractual/Notional Amount	32,767	33,926
Assets
Fair Value	0	0
Liabilities
Fair Value	0	0
Net Fair Value, Asset (Liability)	0	0
Freestanding derivatives | Total return swaps
Derivative [Line Items]
Contractual/Notional Amount	1,943	1,599
Assets
Fair Value	0	1
Liabilities
Fair Value	36	23
Net Fair Value, Asset (Liability)	(36)	(22)
Embedded derivatives
Assets
Fair Value	0	0
Liabilities
Fair Value	3,624	2,090
Net Fair Value, Asset (Liability)	(3,624)	(2,090)
Embedded derivatives | Fixed index annuity embedded derivatives
Assets
Fair Value	0	0
Liabilities
Fair Value	825	866
Net Fair Value, Asset (Liability)	(825)	(866)
Embedded derivatives | Registered index linked annuity embedded derivatives
Assets
Fair Value	0	0
Liabilities
Fair Value	2,799	1,224
Net Fair Value, Asset (Liability)	(2,799)	(1,224)
Derivatives related to funds withheld under reinsurance treaties
Derivative [Line Items]
Contractual/Notional Amount	1,307	1,568
Assets
Fair Value	2,027	2,517
Liabilities
Fair Value	30	34
Net Fair Value, Asset (Liability)	1,997	2,483
Derivatives related to funds withheld under reinsurance treaties | Cross-currency swaps
Derivative [Line Items]
Contractual/Notional Amount	158	158
Assets
Fair Value	14	14
Liabilities
Fair Value	1	1
Net Fair Value, Asset (Liability)	13	13
Derivatives related to funds withheld under reinsurance treaties | Cross-currency forwards
Derivative [Line Items]
Contractual/Notional Amount	1,149	1,410
Assets
Fair Value	21	35
Liabilities
Fair Value	29	33
Net Fair Value, Asset (Liability)	(8)	2
Derivatives related to funds withheld under reinsurance treaties | Funds withheld embedded derivative
Assets
Fair Value	1,992	2,468
Liabilities
Fair Value	0	0
Net Fair Value, Asset (Liability)	1,992	2,468
Derivative assets
Derivative [Line Items]
Contractual/Notional Amount	92,920	119,225
Assets
Fair Value	2,287	2,858
Derivative liabilities
Liabilities
Fair Value	4,049	3,300
Derivative
Liabilities
Net Fair Value, Asset (Liability)	$ (1,762)	$ (442)

Derivative Instruments - Gains

Derivative Instruments - Gains and Losses, and Change in Fair Value of Derivatives (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) on derivative instruments	$ (413)	$ 267	$ (4,537)	$ (4,743)
Derivatives excluding funds withheld under reinsurance treaties
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) on derivative instruments	147	(208)	(4,050)	(4,938)
Derivatives related to funds withheld under reinsurance treaties
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) on derivative instruments	(560)	475	(487)	195
Cross-currency swaps | Derivatives excluding funds withheld under reinsurance treaties
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) on derivative instruments	14	(16)	(28)	(42)
Cross-currency swaps | Derivatives related to funds withheld under reinsurance treaties
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) on derivative instruments	(2)	60	1	58
Equity index call options | Derivatives excluding funds withheld under reinsurance treaties
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) on derivative instruments	29	(192)	29	(100)
Equity index futures | Derivatives excluding funds withheld under reinsurance treaties
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) on derivative instruments	(514)	(5)	(1,677)	(2,712)
Equity index put options | Derivatives excluding funds withheld under reinsurance treaties
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) on derivative instruments	(103)	45	(295)	(1,362)
Interest rate swaps | Derivatives excluding funds withheld under reinsurance treaties
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) on derivative instruments	76	(137)	(25)	(189)
Interest rate swaps - cleared | Derivatives excluding funds withheld under reinsurance treaties
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) on derivative instruments	0	0	0	(10)
Put-swaptions | Derivatives excluding funds withheld under reinsurance treaties
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) on derivative instruments	173	(1,013)	(460)	(840)
Interest rate futures | Derivatives excluding funds withheld under reinsurance treaties
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) on derivative instruments	994	938	(351)	537
Total return swaps | Derivatives excluding funds withheld under reinsurance treaties
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) on derivative instruments	(82)	70	(280)	(93)
Fixed index annuity embedded derivatives | Derivatives excluding funds withheld under reinsurance treaties
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) on derivative instruments	(4)	0	(16)	(4)
Registered index linked annuity embedded derivatives | Derivatives excluding funds withheld under reinsurance treaties
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) on derivative instruments	(436)	102	(947)	(123)
Cross-currency forwards | Derivatives related to funds withheld under reinsurance treaties
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) on derivative instruments	(28)	(36)	(12)	(57)
Funds withheld embedded derivative | Derivatives related to funds withheld under reinsurance treaties
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) on derivative instruments	$ (530)	$ 451	$ (476)	$ 194

Derivative Instruments - Narrat

Derivative Instruments - Narrative (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Derivative [Line Items]
Derivative assets by counterparty	$ 139,000,000	$ 117,000,000
Derivative assets, held collateral	139,000,000	841,000,000
Derivative liabilities by counterparty	269,000,000	937,000,000
Derivative liabilities, held collateral	297,000,000	751,000,000
Derivative disbursement obligation	0	910,000,000
Derivative claim	28,000,000	0
Derivative asset, pledged collateral	1,954,000,000	2,616,000,000
Embedded derivatives
Derivative [Line Items]
Net fair value, derivative asset (liability)	(3,624,000,000)	(2,090,000,000)
Derivatives related to funds withheld under reinsurance treaties
Derivative [Line Items]
Net fair value, derivative asset (liability)	1,997,000,000	2,483,000,000
Derivatives related to funds withheld under reinsurance treaties | Funds withheld embedded derivative
Derivative [Line Items]
Net fair value, derivative asset (liability)	$ 1,992,000,000	$ 2,468,000,000

Derivative Instruments - Gross

Derivative Instruments - Gross and Net Information About Financial Instruments Subject to Master Netting Arrangements (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Freestanding derivative assets
Gross Amounts Recognized	$ 295,000,000	$ 390,000,000
Gross Amounts Offset in the Condensed Consolidated Balance Sheets	0	0
Net Amounts Presented in the Condensed Consolidated Balance Sheets	295,000,000	390,000,000
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Financial Instruments	156,000,000	273,000,000
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Cash Collateral	130,000,000	108,000,000
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Securities Collateral	0	0
Net Amount	9,000,000	9,000,000
Freestanding derivative liabilities
Gross Amounts Recognized	425,000,000	1,210,000,000
Gross Amounts Offset in the Condensed Consolidated Balance Sheets	0	0
Net Amounts Presented in the Condensed Consolidated Balance Sheets	425,000,000	1,210,000,000
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Financial Instruments	156,000,000	273,000,000
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Cash Collateral	7,000,000	6,000,000
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Securities Collateral	254,000,000	744,000,000
Net Amount	8,000,000	187,000,000
Securities loaned
Gross Amounts Recognized	26,000,000	19,000,000
Gross Amounts Offset in the Condensed Consolidated Balance Sheets	0	0
Net Amounts Presented in the Condensed Consolidated Balance Sheets	26,000,000	19,000,000
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Financial Instruments	0	0
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Cash Collateral	26,000,000	19,000,000
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Securities Collateral	0	0
Net Amount	0	0
Repurchase agreements
Gross Amounts Recognized	794,000,000	0
Gross Amounts Offset in the Condensed Consolidated Balance Sheets	0	0
Net Amounts Presented in the Condensed Consolidated Balance Sheets	794,000,000	0
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Financial Instruments	0	0
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Cash Collateral	0	0
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Securities Collateral	794,000,000	0
Net Amount	0	0
Repurchase agreements - collateral upgrade
Gross Amounts Recognized	1,551,000,000	0
Gross Amounts Offset in the Condensed Consolidated Balance Sheets	(1,551,000,000)
Net Amounts Presented in the Condensed Consolidated Balance Sheets	0
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Financial Instruments	0
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Cash Collateral	0
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Securities Collateral	0
Net Amount	0
Total financial liabilities
Gross Amounts Recognized	2,796,000,000	1,229,000,000
Gross Amounts Offset in the Condensed Consolidated Balance Sheets	(1,551,000,000)	0
Net Amounts Presented in the Condensed Consolidated Balance Sheets	1,245,000,000	1,229,000,000
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Financial Instruments	156,000,000	273,000,000
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Cash Collateral	33,000,000	25,000,000
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Securities Collateral	1,048,000,000	744,000,000
Net Amount	$ 8,000,000	$ 187,000,000

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value and Carrying Value of Financial Instruments (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Assets
Debt securities	$ 45,299	$ 42,643
Equity securities	213	394
Mortgage loans	9,564	10,082
Policy loans	4,453	4,399
Freestanding derivative instruments	295	390
FHLBI capital stock	127	108
Cash and cash equivalents	3,061	2,688
Reinsurance recoverable on market risk benefits	22,959	25,422
Market risk benefit assets	7,615	6,737
Separate account assets	235,037	219,656
Liabilities
Annuity reserves	34,361	33,161
Market risk benefit liabilities	4,384	4,785
Reserves for guaranteed investment contracts	556	700
Trust instruments supported by funding agreements	5,461	5,756
FHLB funding agreements	1,912	1,950
Funds withheld payable under reinsurance treaties	18,103	19,952
Long-term debt	2,033	2,037
Securities lending payable	26	19
Freestanding derivative instruments	425	1,210
Repurchase agreements	794
FHLB advances		250
Separate account liabilities	235,037	219,656
Variable Interest Entity, Primary Beneficiary
Assets
Equity securities	6	7
Liabilities
Securities lending payable	1	2
Carrying Value
Assets
Debt securities	45,299	42,643
Equity securities	213	394
Mortgage loans	9,996	10,563
Limited partnerships	2,393	2,132
Policy loans	4,453	4,399
Freestanding derivative instruments	295	390
FHLBI capital stock	127	108
Cash and cash equivalents	3,061	2,688
Reinsurance recoverable on market risk benefits	149	149
Market risk benefit assets	7,615	6,737
Separate account assets	235,037	219,656
Liabilities
Annuity reserves	37,985	35,251
Market risk benefit liabilities	4,384	4,785
Reserves for guaranteed investment contracts	556	700
Trust instruments supported by funding agreements	5,461	5,756
FHLB funding agreements	1,912	1,950
Funds withheld payable under reinsurance treaties	18,103	19,952
Long-term debt	2,033	2,037
Securities lending payable	26	19
Freestanding derivative instruments	425	1,210
Repurchase agreements	794	0
FHLB advances	0	250
Separate account liabilities	235,037	219,656
Carrying Value | Variable Interest Entity, Primary Beneficiary
Liabilities
Notes issued by consolidated VIEs	2,366	1,988
Fair Value
Assets
Debt securities	45,299	42,643
Equity securities	213	394
Mortgage loans	9,609	9,994
Limited partnerships	2,393	2,132
Policy loans	4,453	4,399
Freestanding derivative instruments	295	390
FHLBI capital stock	127	108
Cash and cash equivalents	3,061	2,688
Reinsurance recoverable on market risk benefits	149	149
Market risk benefit assets	7,615	6,737
Separate account assets	235,037	219,656
Liabilities
Annuity reserves	39,321	33,678
Market risk benefit liabilities	4,384	4,785
Reserves for guaranteed investment contracts	549	674
Trust instruments supported by funding agreements	5,426	5,601
FHLB funding agreements	1,859	1,893
Funds withheld payable under reinsurance treaties	18,103	19,952
Long-term debt	1,888	1,851
Securities lending payable	26	19
Freestanding derivative instruments	425	1,210
Repurchase agreements	794	0
FHLB advances	0	250
Separate account liabilities	235,037	219,656
Fair Value | Variable Interest Entity, Primary Beneficiary
Liabilities
Notes issued by consolidated VIEs	$ 2,366	$ 1,988

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details) - USD ($)	3 Months Ended			9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value option, debt securities	$ 2,937,000,000	$ 2,153,000,000		$ 2,937,000,000
Debt securities	45,299,000,000	42,643,000,000		45,299,000,000
Transfers from Level 3 to Level 2	18,000,000		$ (12,000,000)	34,000,000	$ 19,000,000
Transfers from Level 2 to Level 3	63,000,000	1,336,000,000	(9,000,000)	67,000,000	(1,000,000)
Transfers from Level 3 to NAV	$ 0		$ (29,000,000)	$ 0	$ (22,000,000)
FHLBI capital stock, stock price (in usd per share)	$ 100			$ 100
Unobservable Inputs | Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	$ 46,000,000	93,000,000		$ 46,000,000
Funds withheld assets
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value option, assets carrying amount	4,121,000,000	4,054,000,000		4,121,000,000
Fair Value
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value option, market risk benefit, debt securities	323,000,000	0		323,000,000
Debt securities	45,299,000,000	42,643,000,000		45,299,000,000
Variable Interest Entity, Primary Beneficiary
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value option, debt securities	2,459,000,000	2,037,000,000		2,459,000,000
Variable Interest Entity, Primary Beneficiary | Fair Value
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Notes issued by consolidated VIEs, at fair value under fair value option	$ 2,366,000,000	$ 1,988,000,000		$ 2,366,000,000

Fair Value Measurements - Fai_2

Fair Value Measurements - Fair Value Option (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Fair Value, Option, Quantitative Disclosures [Line Items]
Fair value	$ 432	$ 481
Aggregate contractual principal	9,564	10,082
Mortgage loans
Fair Value, Option, Quantitative Disclosures [Line Items]
Aggregate contractual principal	$ 441	$ 491

Fair Value Measurements - Asset

Fair Value Measurements - Assets and Liabilities Carried at Fair Value by Hierarchy (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Assets
Debt securities	$ 45,299	$ 42,643
Equity securities	213	394
Mortgage loans	432	481
Limited partnerships	172	135
Policy loans	3,535	3,457
Freestanding derivative instruments	295	390
Cash and cash equivalents	3,061	2,688
Reinsurance recoverable on market risk benefits	149	149
Market risk benefit assets	7,615	6,737
Separate account assets	235,037	219,656
Total	295,808	276,730
Liabilities
Embedded derivative liabilities	3,624	2,090
Funds withheld payable under reinsurance treaties	1,719	1,158
Freestanding derivative instruments	425	1,210
Market risk benefit liabilities	4,384	4,785
Total	12,518	11,231
Limited partnership investments measured at NAV	2,221	1,997
Related Party
Liabilities
Notes issued by consolidated VIEs	2,366	1,988
Level 1
Assets
Equity securities	0	182
Mortgage loans	0	0
Limited partnerships	0	0
Policy loans	0	0
Freestanding derivative instruments	0	0
Cash and cash equivalents	3,061	2,688
Reinsurance recoverable on market risk benefits	0	0
Market risk benefit assets	0	0
Separate account assets	0	0
Total	6,510	7,182
Liabilities
Embedded derivative liabilities	0	0
Funds withheld payable under reinsurance treaties	0	0
Freestanding derivative instruments	0	0
Market risk benefit liabilities	0	0
Total	0	0
Level 1 | Related Party
Liabilities
Notes issued by consolidated VIEs	0	0
Level 2
Assets
Equity securities	206	204
Mortgage loans	0	0
Limited partnerships	0	0
Policy loans	0	0
Freestanding derivative instruments	295	390
Cash and cash equivalents	0	0
Reinsurance recoverable on market risk benefits	0	0
Market risk benefit assets	0	0
Separate account assets	235,037	219,656
Total	276,134	257,332
Liabilities
Embedded derivative liabilities	3,624	2,090
Funds withheld payable under reinsurance treaties	0	0
Freestanding derivative instruments	425	1,210
Market risk benefit liabilities	0	0
Total	6,415	5,288
Level 2 | Related Party
Liabilities
Notes issued by consolidated VIEs	2,366	1,988
Level 3
Assets
Equity securities	7	8
Mortgage loans	432	481
Limited partnerships	172	135
Policy loans	3,535	3,457
Freestanding derivative instruments	0	0
Cash and cash equivalents	0	0
Reinsurance recoverable on market risk benefits	149	149
Market risk benefit assets	7,615	6,737
Separate account assets	0	0
Total	13,164	12,216
Liabilities
Embedded derivative liabilities	0	0
Funds withheld payable under reinsurance treaties	1,719	1,158
Freestanding derivative instruments	0	0
Market risk benefit liabilities	4,384	4,785
Total	6,103	5,943
Level 3 | RILA embedded derivatives
Liabilities
Embedded derivative liabilities	2,799	1,224
Level 3 | Fixed index annuity embedded derivatives
Liabilities
Embedded derivative liabilities	825	866
Level 3 | Related Party
Liabilities
Notes issued by consolidated VIEs	0	0
U.S. government securities
Assets
Debt securities	3,449	4,312
U.S. government securities | Level 1
Assets
Debt securities	3,449	4,312
U.S. government securities | Level 2
Assets
Debt securities	0	0
U.S. government securities | Level 3
Assets
Debt securities	0	0
Other government securities
Assets
Debt securities	1,340	1,402
Other government securities | Level 1
Assets
Debt securities	0	0
Other government securities | Level 2
Assets
Debt securities	1,184	1,252
Other government securities | Level 3
Assets
Debt securities	156	150
Public utilities
Assets
Debt securities	5,413	5,127
Public utilities | Level 1
Assets
Debt securities	0	0
Public utilities | Level 2
Assets
Debt securities	5,326	5,086
Public utilities | Level 3
Assets
Debt securities	87	41
Corporate securities
Assets
Debt securities	28,760	25,477
Corporate securities | Level 1
Assets
Debt securities	0	0
Corporate securities | Level 2
Assets
Debt securities	28,650	25,394
Corporate securities | Level 3
Assets
Debt securities	110	83
Residential mortgage-backed
Assets
Debt securities	333	375
Residential mortgage-backed | Level 1
Assets
Debt securities	0	0
Residential mortgage-backed | Level 2
Assets
Debt securities	333	375
Residential mortgage-backed | Level 3
Assets
Debt securities	0	0
Commercial mortgage-backed
Assets
Debt securities	1,608	1,423
Commercial mortgage-backed | Level 1
Assets
Debt securities	0	0
Commercial mortgage-backed | Level 2
Assets
Debt securities	1,608	1,423
Commercial mortgage-backed | Level 3
Assets
Debt securities	0	0
Other asset-backed securities
Assets
Debt securities	4,396	4,527
Other asset-backed securities | Level 1
Assets
Debt securities	0	0
Other asset-backed securities | Level 2
Assets
Debt securities	3,495	3,552
Other asset-backed securities | Level 3
Assets
Debt securities	901	975
Derivatives related to funds withheld under reinsurance treaties
Assets
Freestanding derivative instruments	2,027	2,517
Liabilities
Freestanding derivative instruments	30	34
Derivatives related to funds withheld under reinsurance treaties | Funds withheld embedded derivative
Assets
Freestanding derivative instruments	1,992	2,468
Liabilities
Freestanding derivative instruments	$ 0	$ 0

Fair Value Measurements - Balan

Fair Value Measurements - Balances of Level 3 Assets and Liabilities Measured at Fair Value with Corresponding Price Sources (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Assets
Debt securities	$ 45,299	$ 42,643
Equity securities	213	394
Mortgage loans	432	481
Limited partnerships	172	135
Policy loans	4,453	4,399
Reinsurance recoverable on market risk benefits	22,959	25,422
Market risk benefit assets	7,615	6,737
Total	295,808	276,730
Liabilities
Funds withheld payable under reinsurance treaties	18,103	19,952
Market risk benefit liabilities	4,384	4,785
Total	12,518	11,231
Freestanding derivative instruments	295	390
Other government securities
Assets
Debt securities	1,340	1,402
Public utilities
Assets
Debt securities	5,413	5,127
Corporate securities
Assets
Debt securities	28,760	25,477
Other asset-backed securities
Assets
Debt securities	4,396	4,527
Derivatives related to funds withheld under reinsurance treaties
Liabilities
Freestanding derivative instruments	2,027	2,517
Derivatives related to funds withheld under reinsurance treaties | Funds withheld embedded derivative
Liabilities
Freestanding derivative instruments	1,992	2,468
Level 3
Assets
Equity securities	7	8
Mortgage loans	432	481
Limited partnerships	172	135
Policy loans	3,535	3,457
Reinsurance recoverable on market risk benefits	149	149
Market risk benefit assets	7,615	6,737
Total	13,164	12,216
Liabilities
Funds withheld payable under reinsurance treaties	1,719	1,158
Market risk benefit liabilities	4,384	4,785
Total	6,103	5,943
Freestanding derivative instruments	0	0
Level 3 | Internal
Assets
Equity securities	1	1
Mortgage loans	0	0
Limited partnerships	1	1
Policy loans	3,535	3,457
Reinsurance recoverable on market risk benefits	149	149
Market risk benefit assets	7,615	6,737
Total	11,345	10,436
Liabilities
Funds withheld payable under reinsurance treaties	1,719	1,158
Market risk benefit liabilities	4,384	4,785
Total	6,103	5,943
Level 3 | External
Assets
Equity securities	6	7
Mortgage loans	432	481
Limited partnerships	171	134
Policy loans	0	0
Reinsurance recoverable on market risk benefits	0	0
Market risk benefit assets	0	0
Total	1,819	1,780
Liabilities
Funds withheld payable under reinsurance treaties	0	0
Market risk benefit liabilities	0	0
Total	0	0
Level 3 | Other government securities
Assets
Debt securities	156	150
Level 3 | Other government securities | Internal
Assets
Debt securities	0	0
Level 3 | Other government securities | External
Assets
Debt securities	156	150
Level 3 | Public utilities
Assets
Debt securities	87	41
Level 3 | Public utilities | Internal
Assets
Debt securities	44	41
Level 3 | Public utilities | External
Assets
Debt securities	43	0
Level 3 | Corporate securities
Assets
Debt securities	110	83
Level 3 | Corporate securities | Internal
Assets
Debt securities	0	0
Level 3 | Corporate securities | External
Assets
Debt securities	110	83
Level 3 | Other asset-backed securities
Assets
Debt securities	901	975
Level 3 | Other asset-backed securities | Internal
Assets
Debt securities	0	50
Level 3 | Other asset-backed securities | External
Assets
Debt securities	$ 901	$ 925

Fair Value Measurements - Quant

Fair Value Measurements - Quantitative Information on Significant Internally-Priced Level 3 Assets and Liabilities (Details) $ in Millions	Sep. 30, 2024 USD ($)	Dec. 31, 2023 USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Reinsurance recoverable on market risk benefits	$ 22,959	$ 25,422
Market risk benefit assets	7,615	6,737
Market risk benefit liabilities	4,384	4,785
Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Reinsurance recoverable on market risk benefits	149	149
Market risk benefit assets	7,615	6,737
Market risk benefit liabilities	4,384	4,785
Level 3 | Discounted cash flow
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Reinsurance recoverable on market risk benefits	149	149
Market risk benefit assets	7,615	6,737
Market risk benefit liabilities	$ 4,384	$ 4,785
Level 3 | Discounted cash flow | Long-term Equity Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Reinsurance recoverable on market risk benefits, measurement input	0.1850	0.1850
Market risk benefit, assets, measurement input	0.1850	0.1850
Market risk benefit, liabilities, measurement input	0.1850	0.1850
Level 3 | Discounted cash flow | Minimum | Mortality
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Reinsurance recoverable on market risk benefits, measurement input	0.0001	0.0001
Market risk benefit, assets, measurement input	0.0001	0.0001
Market risk benefit, liabilities, measurement input	0.0001	0.0001
Level 3 | Discounted cash flow | Minimum | Lapse
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Reinsurance recoverable on market risk benefits, measurement input	0.0147	0.0147
Market risk benefit, assets, measurement input	0.0005	0.0005
Market risk benefit, liabilities, measurement input	0.0005	0.0005
Level 3 | Discounted cash flow | Minimum | Utilization
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Reinsurance recoverable on market risk benefits, measurement input	0	0
Market risk benefit, assets, measurement input	0	0
Market risk benefit, liabilities, measurement input	0	0
Level 3 | Discounted cash flow | Minimum | Withdrawal
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Reinsurance recoverable on market risk benefits, measurement input	0.4750	0.4750
Market risk benefit, assets, measurement input	0.1125	0.1125
Market risk benefit, liabilities, measurement input	0.1125	0.1125
Level 3 | Discounted cash flow | Minimum | Non-performance risk adjustment
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Reinsurance recoverable on market risk benefits, measurement input	0.0010	0.0010
Market risk benefit, assets, measurement input	0.0083	0.0070
Market risk benefit, liabilities, measurement input	0.0083	0.0070
Level 3 | Discounted cash flow | Maximum | Mortality
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Reinsurance recoverable on market risk benefits, measurement input	0.2071	0.2071
Market risk benefit, assets, measurement input	0.2346	0.2346
Market risk benefit, liabilities, measurement input	0.2346	0.2346
Level 3 | Discounted cash flow | Maximum | Lapse
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Reinsurance recoverable on market risk benefits, measurement input	0.0855	0.0855
Market risk benefit, assets, measurement input	0.3706	0.3706
Market risk benefit, liabilities, measurement input	0.3706	0.3706
Level 3 | Discounted cash flow | Maximum | Utilization
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Reinsurance recoverable on market risk benefits, measurement input	0.5000	0.5000
Market risk benefit, assets, measurement input	1	1
Market risk benefit, liabilities, measurement input	1	1
Level 3 | Discounted cash flow | Maximum | Withdrawal
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Reinsurance recoverable on market risk benefits, measurement input	0.5000	0.5000
Market risk benefit, assets, measurement input	1	1
Market risk benefit, liabilities, measurement input	1	1
Level 3 | Discounted cash flow | Maximum | Non-performance risk adjustment
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Reinsurance recoverable on market risk benefits, measurement input	0.0129	0.0150
Market risk benefit, assets, measurement input	0.0185	0.0211
Market risk benefit, liabilities, measurement input	0.0185	0.0211

Fair Value Measurements - Level

Fair Value Measurements - Level 3 Rollforwards (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Assets
Purchases, Sales, Issuances and Settlements	$ (28,000,000)	$ 10,000,000	$ (178,000,000)	$ (142,000,000)
Transfers in and/or (out of ) Level 3	0	(29,000,000)	0	(22,000,000)
Funds withheld payable under reinsurance treaties
Liabilities
Fair Value	(1,161,000,000)	(701,000,000)	(1,158,000,000)	(424,000,000)
Total Realized/Unrealized Gains (Losses) Included in Net Income (Loss)	(601,000,000)	481,000,000	(657,000,000)	119,000,000
Total Realized/Unrealized Gains (Losses) Included in Other Comprehensive Income (Loss)	0	0	0	0
Purchases, Sales, Issuances and Settlements	43,000,000	(27,000,000)	96,000,000	58,000,000
Transfers in and/or (out of ) Level 3	0	0	0	0
Fair Value	(1,719,000,000)	(247,000,000)	(1,719,000,000)	(247,000,000)
Market risk benefit liabilities
Liabilities
Fair Value	(3,890,000,000)	(4,463,000,000)	(4,785,000,000)	(5,662,000,000)
Total Realized/Unrealized Gains (Losses) Included in Net Income (Loss)	(260,000,000)	1,545,000,000	1,184,000,000	3,224,000,000
Total Realized/Unrealized Gains (Losses) Included in Other Comprehensive Income (Loss)	(234,000,000)	(999,000,000)	(783,000,000)	(1,479,000,000)
Purchases, Sales, Issuances and Settlements	0	0	0	0
Transfers in and/or (out of ) Level 3	0	0	0	0
Fair Value	(4,384,000,000)	(3,917,000,000)	(4,384,000,000)	(3,917,000,000)
Debt securities | Other government securities
Assets
Fair Value	151,000,000		150,000,000
Total Realized/Unrealized Gains (Losses) Included in Net Income (Loss)	0		0
Total Realized/Unrealized Gains (Losses) Included in Other Comprehensive Income (Loss)	5,000,000		6,000,000
Purchases, Sales, Issuances and Settlements	0		0
Transfers in and/or (out of ) Level 3	0		0
Fair Value	156,000,000		156,000,000
Debt securities | Public utilities
Assets
Fair Value	44,000,000		41,000,000
Total Realized/Unrealized Gains (Losses) Included in Net Income (Loss)	0		(1,000,000)
Total Realized/Unrealized Gains (Losses) Included in Other Comprehensive Income (Loss)	(12,000,000)		(11,000,000)
Purchases, Sales, Issuances and Settlements	0		3,000,000
Transfers in and/or (out of ) Level 3	55,000,000		55,000,000
Fair Value	87,000,000		87,000,000
Debt securities | Corporate securities
Assets
Fair Value	73,000,000	21,000,000	83,000,000	56,000,000
Total Realized/Unrealized Gains (Losses) Included in Net Income (Loss)	3,000,000	(2,000,000)	8,000,000	(11,000,000)
Total Realized/Unrealized Gains (Losses) Included in Other Comprehensive Income (Loss)	2,000,000	0	1,000,000	0
Purchases, Sales, Issuances and Settlements	21,000,000	22,000,000	19,000,000	18,000,000
Transfers in and/or (out of ) Level 3	11,000,000	3,000,000	(1,000,000)	(19,000,000)
Fair Value	110,000,000	44,000,000	110,000,000	44,000,000
Debt securities | Other asset-backed securities
Assets
Fair Value	919,000,000		975,000,000
Total Realized/Unrealized Gains (Losses) Included in Net Income (Loss)	(1,000,000)		(1,000,000)
Total Realized/Unrealized Gains (Losses) Included in Other Comprehensive Income (Loss)	15,000,000		15,000,000
Purchases, Sales, Issuances and Settlements	(11,000,000)		(67,000,000)
Transfers in and/or (out of ) Level 3	(21,000,000)		(21,000,000)
Fair Value	901,000,000		901,000,000
Equity securities
Assets
Fair Value	7,000,000	86,000,000	8,000,000	122,000,000
Total Realized/Unrealized Gains (Losses) Included in Net Income (Loss)	0	(2,000,000)	(1,000,000)	(37,000,000)
Total Realized/Unrealized Gains (Losses) Included in Other Comprehensive Income (Loss)	0	0	0	0
Purchases, Sales, Issuances and Settlements	0	0	0	0
Transfers in and/or (out of ) Level 3	0	0	0	(1,000,000)
Fair Value	7,000,000	84,000,000	7,000,000	84,000,000
Mortgage loans
Assets
Fair Value	430,000,000	509,000,000	481,000,000	582,000,000
Total Realized/Unrealized Gains (Losses) Included in Net Income (Loss)	4,000,000	(5,000,000)	1,000,000	(7,000,000)
Total Realized/Unrealized Gains (Losses) Included in Other Comprehensive Income (Loss)	0	0	0	0
Purchases, Sales, Issuances and Settlements	(2,000,000)	(28,000,000)	(50,000,000)	(99,000,000)
Transfers in and/or (out of ) Level 3	0	0	0	0
Fair Value	432,000,000	476,000,000	432,000,000	476,000,000
Limited partnerships
Assets
Fair Value	152,000,000	422,000,000	135,000,000	440,000,000
Total Realized/Unrealized Gains (Losses) Included in Net Income (Loss)	12,000,000	(17,000,000)	19,000,000	(39,000,000)
Total Realized/Unrealized Gains (Losses) Included in Other Comprehensive Income (Loss)	0	0	0	0
Purchases, Sales, Issuances and Settlements	8,000,000	(10,000,000)	18,000,000	1,000,000
Transfers in and/or (out of ) Level 3	0	29,000,000	0	22,000,000
Fair Value	172,000,000	424,000,000	172,000,000	424,000,000
Policy loans
Assets
Fair Value	3,511,000,000	3,438,000,000	3,457,000,000	3,419,000,000
Total Realized/Unrealized Gains (Losses) Included in Net Income (Loss)	68,000,000	(32,000,000)	179,000,000	75,000,000
Total Realized/Unrealized Gains (Losses) Included in Other Comprehensive Income (Loss)	0	0	0	0
Purchases, Sales, Issuances and Settlements	(44,000,000)	26,000,000	(101,000,000)	(62,000,000)
Transfers in and/or (out of ) Level 3	0	0	0	0
Fair Value	3,535,000,000	3,432,000,000	3,535,000,000	3,432,000,000
Reinsurance recoverable on market risk benefits
Assets
Fair Value	121,000,000	194,000,000	149,000,000	221,000,000
Total Realized/Unrealized Gains (Losses) Included in Net Income (Loss)	28,000,000	(27,000,000)	0	(54,000,000)
Total Realized/Unrealized Gains (Losses) Included in Other Comprehensive Income (Loss)	0	0	0	0
Purchases, Sales, Issuances and Settlements	0	0	0	0
Transfers in and/or (out of ) Level 3	0	0	0	0
Fair Value	149,000,000	167,000,000	149,000,000	167,000,000
Market risk benefit assets
Assets
Fair Value	8,556,000,000	5,957,000,000	6,737,000,000	4,865,000,000
Total Realized/Unrealized Gains (Losses) Included in Net Income (Loss)	(941,000,000)	858,000,000	878,000,000	1,950,000,000
Total Realized/Unrealized Gains (Losses) Included in Other Comprehensive Income (Loss)	0	0	0	0
Purchases, Sales, Issuances and Settlements	0	0	0	0
Transfers in and/or (out of ) Level 3	0	0	0	0
Fair Value	$ 7,615,000,000	$ 6,815,000,000	$ 7,615,000,000	$ 6,815,000,000

Fair Value Measurements - Purch

Fair Value Measurements - Purchases, Sales, Issuances and Settlements (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Assets
Purchases	$ 196	$ 73	$ 420	$ 226
Sales	(180)	(89)	(497)	(306)
Issuances	8	76	71	111
Settlements	(52)	(50)	(172)	(173)
Total	(28)	10	(178)	(142)
Funds withheld payable under reinsurance treaties
Liabilities
Purchases	0	0	0	0
Sales	0	0	0	0
Issuances	(13)	(96)	(357)	(132)
Settlements	56	69	453	190
Total	43	(27)	96	58
Debt securities | Public utilities
Assets
Purchases	0		3
Sales	0		0
Issuances	0		0
Settlements	0		0
Total	0		3
Debt securities | Corporate securities
Assets
Purchases	30	27	43	27
Sales	(9)	(5)	(24)	(9)
Issuances	0	0	0	0
Settlements	0	0	0	0
Total	21	22	19	18
Debt securities | Other asset-backed securities
Assets
Purchases	93		200
Sales	(104)		(267)
Issuances	0		0
Settlements	0		0
Total	(11)		(67)
Mortgage loans
Assets
Purchases	65	45	156	180
Sales	(67)	(73)	(206)	(279)
Issuances	0	0	0	0
Settlements	0	0	0	0
Total	(2)	(28)	(50)	(99)
Limited partnerships
Assets
Purchases	8	1	18	19
Sales	0	(11)	0	(18)
Issuances	0	0	0	0
Settlements	0	0	0	0
Total	8	(10)	18	1
Policy loans
Assets
Purchases	0	0	0	0
Sales	0	0	0	0
Issuances	8	76	71	111
Settlements	(52)	(50)	(172)	(173)
Total	$ (44)	$ 26	$ (101)	$ (62)

Fair Value Measurements - Gains

Fair Value Measurements - Gains (Losses) by Location (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Funds withheld payable under reinsurance treaties
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]
Included in Net Income	$ (601)	$ 481	$ (657)	$ 119
Included in OCI	0	0	0	0
Market risk benefit liabilities
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]
Included in Net Income	(260)	1,545	1,184	3,224
Included in OCI	(234)	(999)	(783)	(1,479)
Debt securities | Other government securities
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]
Included in Net Income	0	0	0	0
Included in OCI	5	0	6	0
Debt securities | Public utilities
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]
Included in Net Income	0	0	(1)	0
Included in OCI	(12)	0	(11)	0
Debt securities | Corporate securities
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]
Included in Net Income	1	2	2	(7)
Included in OCI	2	0	1	0
Debt securities | Other asset-backed securities
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]
Included in Net Income	1	0	0	0
Included in OCI	9	0	9	0
Equity securities
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]
Included in Net Income	0	(2)	0	(37)
Included in OCI	0	0	0	0
Mortgage loans
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]
Included in Net Income	4	(5)	1	(7)
Included in OCI	0	0	0	0
Limited partnerships
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]
Included in Net Income	18	(17)	19	(39)
Included in OCI	0	0	0	0
Policy loans
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]
Included in Net Income	68	(32)	179	75
Included in OCI	0	0	0	0
Reinsurance recoverable on market risk benefits
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]
Included in Net Income	28	(27)	0	(54)
Included in OCI	0	0	0	0
Market risk benefit assets
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]
Included in Net Income	(941)	858	878	1,950
Included in OCI	$ 0	$ 0	$ 0	$ 0

Fair Value Measurements - Finan

Fair Value Measurements - Financial Instruments Not Reported at Fair Value (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Assets
Mortgage loans	$ 9,564	$ 10,082
Policy loans	918	942
FHLBI capital stock	127	108
Liabilities
Annuity reserves	34,361	33,161
Reserves for guaranteed investment contracts	556	700
Trust instruments supported by funding agreements	5,461	5,756
FHLB funding agreements	1,912	1,950
Funds withheld payable under reinsurance treaties	16,384	18,794
Long-term debt	2,033	2,037
Securities lending payable	26	19
Repurchase agreements	794
FHLB advances		250
Separate account liabilities	235,037	219,656
Fair Value
Assets
Mortgage loans	9,177	9,513
Policy loans	918	942
FHLBI capital stock	127	108
Liabilities
Annuity reserves	35,697	31,588
Reserves for guaranteed investment contracts	549	674
Trust instruments supported by funding agreements	5,426	5,601
FHLB funding agreements	1,859	1,893
Funds withheld payable under reinsurance treaties	16,384	18,794
Long-term debt	1,888	1,851
Securities lending payable	26	19
Repurchase agreements	794
FHLB advances		250
Separate account liabilities	235,037	219,656
Fair Value | Level 1
Assets
Mortgage loans	0	0
Policy loans	0	0
FHLBI capital stock	127	108
Liabilities
Annuity reserves	0	0
Reserves for guaranteed investment contracts	0	0
Trust instruments supported by funding agreements	0	0
FHLB funding agreements	0	0
Funds withheld payable under reinsurance treaties	0	0
Long-term debt	0	0
Securities lending payable	0	0
Repurchase agreements	0
FHLB advances		0
Separate account liabilities	0	0
Fair Value | Level 2
Assets
Mortgage loans	0	0
Policy loans	0	0
FHLBI capital stock	0	0
Liabilities
Annuity reserves	0	0
Reserves for guaranteed investment contracts	0	0
Trust instruments supported by funding agreements	0	0
FHLB funding agreements	0	0
Funds withheld payable under reinsurance treaties	0	0
Long-term debt	1,888	1,851
Securities lending payable	26	19
Repurchase agreements	794
FHLB advances		250
Separate account liabilities	235,037	219,656
Fair Value | Level 3
Assets
Mortgage loans	9,177	9,513
Policy loans	918	942
FHLBI capital stock	0	0
Liabilities
Annuity reserves	35,697	31,588
Reserves for guaranteed investment contracts	549	674
Trust instruments supported by funding agreements	5,426	5,601
FHLB funding agreements	1,859	1,893
Funds withheld payable under reinsurance treaties	16,384	18,794
Long-term debt	0	0
Securities lending payable	0	0
Repurchase agreements	0
FHLB advances		0
Separate account liabilities	$ 0	$ 0

Deferred Acquisition Costs - Ro

Deferred Acquisition Costs - Rollforward of Deferred Acquisition Costs (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance, beginning of period	$ 12,302
Variable Annuities balance, end of period	11,986	$ 12,302
Other product lines, end of period	513	335
Total balance, end of period	11,986	12,302
Variable annuity
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance, beginning of period	11,967	12,699
Deferrals of acquisition costs	308	394
Amortization	(802)	(1,126)
Variable Annuities balance, end of period	$ 11,473	$ 11,967

Reinsurance - Narrative (Detail

Reinsurance - Narrative (Details) $ in Millions		9 Months Ended
	Jun. 01, 2020 USD ($)	Sep. 30, 2024 USD ($) treaty	Dec. 31, 2023 USD ($)
Effects of Reinsurance [Line Items]
Reinsurance recoverable, allowance for credit losses		$ 25	$ 29
Athene | Letter of credit
Effects of Reinsurance [Line Items]
Maximum borrowing capacity	$ 1,200
Trust account assets		$ 80
Athene
Effects of Reinsurance [Line Items]
Reinsurance quota share basis	100%
Reinsurance agreement, ceding commission	$ 1,200
SRZ
Effects of Reinsurance [Line Items]
Number of retro treaties | treaty		3
Coinsurance percentage		100%

Reinsurance - Components of Rei

Reinsurance - Components of Reinsurance Recoverable (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Reserves:
Claims liability and other	$ 660	$ 669
Total	22,959	25,422
Annuity benefits
Reserves:
Reserves	16,411	18,873
Life
Reserves:
Reserves	5,380	5,370
Accident and health
Reserves:
Reserves	$ 508	$ 510

Reinsurance - Components of Com

Reinsurance - Components of Company's Reinsurance Recoverable on Market Risk Benefits (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Effects of Reinsurance [Line Items]
Reinsurance recoverable on market risk benefits, at fair value	$ 149	$ 149
Variable annuity
Effects of Reinsurance [Line Items]
Reinsurance recoverable on market risk benefits, at fair value	78	90
Other product lines
Effects of Reinsurance [Line Items]
Reinsurance recoverable on market risk benefits, at fair value	$ 71	$ 59

Reinsurance - Assets and Liabil

Reinsurance - Assets and Liabilities Held in Support of Reserves (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Assets
Total assets	$ 18,355	$ 20,226
Liabilities
Total liabilities	18,103	19,952
Derivatives related to funds withheld under reinsurance treaties
Liabilities
Net fair value, derivative asset (liability)	1,997	2,483
Funds withheld embedded derivative | Derivatives related to funds withheld under reinsurance treaties
Liabilities
Net fair value, derivative asset (liability)	1,992	2,468
Debt securities, available-for-sale
Assets
Total assets	10,344	11,526
Debt securities, at fair value under the fair value option
Assets
Total assets	155	116
Equity securities
Assets
Total assets	148	151
Mortgage loans
Assets
Total assets	2,658	3,067
Mortgage loans, at fair value under the fair value option
Assets
Total assets	432	481
Policy loans
Assets
Total assets	3,548	3,471
Freestanding derivative instruments, net
Assets
Total assets	5	15
Other invested assets
Assets
Total assets	752	709
Cash and cash equivalents
Assets
Total assets	224	543
Accrued investment income
Assets
Total assets	118	146
Other assets and liabilities, net
Assets
Total assets	(29)	1
Funds held under reinsurance treaties
Liabilities
Total liabilities	$ 18,103	$ 19,952

Reinsurance - Sources of Income

Reinsurance - Sources of Income Related to Funds Withheld Under Reinsurance Treaties (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Effects of Reinsurance [Line Items]
Other investment expenses on funds withheld assets	$ (110)	$ (112)	$ (352)	$ (277)
Total net investment income	726	761	2,208	2,110
Funds withheld assets
Effects of Reinsurance [Line Items]
Total investment income on funds withheld assets	284	322	871	918
Other investment expenses on funds withheld assets	(15)	(19)	(47)	(56)
Total net investment income	269	303	824	862
Debt securities | Funds withheld assets
Effects of Reinsurance [Line Items]
Total investment income on funds withheld assets	133	162	415	494
Debt securities, at fair value under the fair value option | Funds withheld assets
Effects of Reinsurance [Line Items]
Total investment income on funds withheld assets	1	1	2	3
Equity securities | Funds withheld assets
Effects of Reinsurance [Line Items]
Total investment income on funds withheld assets	8	2	17	(36)
Mortgage loans | Funds withheld assets
Effects of Reinsurance [Line Items]
Total investment income on funds withheld assets	47	48	141	174
Mortgage loans, at fair value under the fair value option | Funds withheld assets
Effects of Reinsurance [Line Items]
Total investment income on funds withheld assets	4	(5)	1	(7)
Policy loans | Funds withheld assets
Effects of Reinsurance [Line Items]
Total investment income on funds withheld assets	82	80	246	238
Limited partnerships | Funds withheld assets
Effects of Reinsurance [Line Items]
Total investment income on funds withheld assets	11	17	39	32
Other investment income | Funds withheld assets
Effects of Reinsurance [Line Items]
Total investment income on funds withheld assets	$ 3	$ 13	$ 13	$ 16

Reinsurance - Gains and Losses

Reinsurance - Gains and Losses on Funds Withheld Reinsurance Treaties (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Available-for-sale securities
Realized gains on sale	$ 4	$ 11	$ 21	$ 17
Realized losses on sale	(2)	(102)	(114)	(145)
Net gains (losses) on derivative instruments			(4,050)	(4,938)
Net gains (losses) on funds withheld payable under reinsurance treaties			(1,199)	(648)
Embedded derivative gain (loss)	(413)	267	(4,537)	(4,743)
Funds withheld assets
Available-for-sale securities
Realized gains on sale	2	8	5	24
Realized losses on sale	(13)	(13)	(43)	(61)
Credit loss expense	(12)	(10)	(18)	(8)
Credit loss expense on mortgage loans	1	(10)	8	(17)
Other	16	(16)	6	(4)
Net gains (losses) on non-derivative investments	(6)	(41)	(42)	(66)
Net gains (losses) on derivative instruments	(30)	24	(11)	1
Net gains (losses) on funds withheld payable under reinsurance treaties	(748)	176	(1,146)	(583)
Total net gains (losses) on derivatives and investments	(784)	159	(1,199)	(648)
Derivatives related to funds withheld under reinsurance treaties
Available-for-sale securities
Embedded derivative gain (loss)	(560)	475	(487)	195
Derivatives related to funds withheld under reinsurance treaties | Funds withheld embedded derivative
Available-for-sale securities
Embedded derivative gain (loss)	$ (530)	$ 451	$ (476)	$ 194

Reserves for Future Policy Be_3

Reserves for Future Policy Benefits and Claims Payable - Reserve for Future Policy Benefits and Claims Payable Balances (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Liability for Future Policy Benefit, Activity [Line Items]
Reserves for future policy benefits	$ 9,046	$ 9,299
Additional liabilities	1,104	1,153
Other future policy benefits and claims payable	1,393	1,446
Reserves for future policy benefits and claims payable	11,543	11,898
Payout Annuities
Liability for Future Policy Benefit, Activity [Line Items]
Reserves for future policy benefits	1,143	1,090
Closed Block Life
Liability for Future Policy Benefit, Activity [Line Items]
Reserves for future policy benefits	3,847	3,994
Closed Block Annuity
Liability for Future Policy Benefit, Activity [Line Items]
Reserves for future policy benefits	$ 4,056	$ 4,215

Reserves for Future Policy Be_4

Reserves for Future Policy Benefits and Claims Payable - Balances of and Changes in Liability for Future Policy Benefits (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Payout Annuities
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]
Balance, beginning of period	$ 0	$ 0
Beginning of period cumulative effect of changes in discount rate assumptions	0	0
Beginning balance at original discount rate	0	0
Effect of changes in cash flow assumptions		0	$ 0
Effect of actual variances from expected experience		0	0
Balance adjusted for variances from expectation		0	0
Issuances	0	0
Interest accrual	0	0
Net premiums collected	0	0
Ending balance at original discount rate	0	0
End of period cumulative effect of changes in discount rate assumptions	0	0
Balance, end of period	0	0
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Balance, beginning of period	1,090	1,042
Beginning of period cumulative effect of changes in discount rate assumptions	(99)	(132)
Beginning balance, including deferred profit liability	42	40
Beginning balance at original discount rate (including DPL of $42, $0 and $626 in September 30, 2024, and $40, $0 and $671 in December 31, 2023 for payout annuities, closed block life and closed block annuity, respectively)	1,189	1,174
Effect of changes in cash flow assumptions		0	0
Effect of actual variances from expected experience		(32)	(16)
Balance adjusted for variances from expectation		1,157	1,158
Issuances	126	117
Interest accrual	34	43
Benefits payments	(102)	(129)
Ending balance, including deferred profit liability	46	42
Ending balance of original discount rate (including DPL of $46, $0 and $590 in September 30, 2024, and $42, $0 and $626 in December 31, 2023 for payout annuities, closed block life and closed block annuity, respectively)	1,215	1,189
End of period cumulative effect of changes in discount rate assumptions	(72)	(99)
Balance, end of period	1,143	1,090
Reserves for future policy benefits	1,143	1,090
Less: Reinsurance recoverable	113	94
Reserves for future policy benefits, after reinsurance recoverable	1,030	996
Closed Block Life
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]
Balance, beginning of period	1,140	1,287
Beginning of period cumulative effect of changes in discount rate assumptions	113	161
Beginning balance at original discount rate	1,253	1,448
Effect of changes in cash flow assumptions		0	22
Effect of actual variances from expected experience		(20)	(95)
Balance adjusted for variances from expectation		1,233	1,375
Issuances	3	6
Interest accrual	33	38
Net premiums collected	(99)	(166)
Ending balance at original discount rate	1,170	1,253
End of period cumulative effect of changes in discount rate assumptions	(88)	(113)
Balance, end of period	1,082	1,140
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Balance, beginning of period	5,134	5,448
Beginning of period cumulative effect of changes in discount rate assumptions	(767)	(958)
Beginning balance, including deferred profit liability	0	0
Beginning balance at original discount rate (including DPL of $42, $0 and $626 in September 30, 2024, and $40, $0 and $671 in December 31, 2023 for payout annuities, closed block life and closed block annuity, respectively)	5,901	6,406
Effect of changes in cash flow assumptions		0	65
Effect of actual variances from expected experience		(4)	(95)
Balance adjusted for variances from expectation		5,897	6,376
Issuances	8	15
Interest accrual	127	195
Benefits payments	(460)	(685)
Ending balance, including deferred profit liability	0	0
Ending balance of original discount rate (including DPL of $46, $0 and $590 in September 30, 2024, and $42, $0 and $626 in December 31, 2023 for payout annuities, closed block life and closed block annuity, respectively)	5,572	5,901
End of period cumulative effect of changes in discount rate assumptions	(643)	(767)
Balance, end of period	4,929	5,134
Reserves for future policy benefits	3,847	3,994
Less: Reinsurance recoverable	2,135	2,200
Reserves for future policy benefits, after reinsurance recoverable	1,712	1,794
Closed Block Annuity
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]
Balance, beginning of period	0	0
Beginning of period cumulative effect of changes in discount rate assumptions	0	0
Beginning balance at original discount rate	0	0
Effect of changes in cash flow assumptions		0	0
Effect of actual variances from expected experience		0	0
Balance adjusted for variances from expectation		0	0
Issuances	0	0
Interest accrual	0	0
Net premiums collected	0	0
Ending balance at original discount rate	0	0
End of period cumulative effect of changes in discount rate assumptions	0	0
Balance, end of period	0	0
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Balance, beginning of period	4,215	4,434
Beginning of period cumulative effect of changes in discount rate assumptions	(185)	(275)
Beginning balance, including deferred profit liability	626	671
Beginning balance at original discount rate (including DPL of $42, $0 and $626 in September 30, 2024, and $40, $0 and $671 in December 31, 2023 for payout annuities, closed block life and closed block annuity, respectively)	4,400	4,709
Effect of changes in cash flow assumptions		0	(3)
Effect of actual variances from expected experience		0	(8)
Balance adjusted for variances from expectation		4,400	$ 4,698
Issuances	0	1
Interest accrual	138	194
Benefits payments	(359)	(493)
Ending balance, including deferred profit liability	590	626
Ending balance of original discount rate (including DPL of $46, $0 and $590 in September 30, 2024, and $42, $0 and $626 in December 31, 2023 for payout annuities, closed block life and closed block annuity, respectively)	4,179	4,400
End of period cumulative effect of changes in discount rate assumptions	(123)	(185)
Balance, end of period	4,056	4,215
Reserves for future policy benefits	4,056	4,215
Less: Reinsurance recoverable	4	4
Reserves for future policy benefits, after reinsurance recoverable	$ 4,052	$ 4,211

Reserves for Future Policy Be_5

Reserves for Future Policy Benefits and Claims Payable - Weighted Average Duration (Details)	Sep. 30, 2024	Dec. 31, 2023
Payout Annuities
Liability for Future Policy Benefit, Activity [Line Items]
Weighted average duration (years)	7 years 1 month 6 days	7 years
Closed Block Life
Liability for Future Policy Benefit, Activity [Line Items]
Weighted average duration (years)	7 years 1 month 6 days	7 years 2 months 12 days
Closed Block Annuity
Liability for Future Policy Benefit, Activity [Line Items]
Weighted average duration (years)	6 years 10 months 24 days	7 years

Reserves for Future Policy Be_6

Reserves for Future Policy Benefits and Claims Payable - Undiscounted and Discounted Expected Future Gross Premiums (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Payout Annuities
Liability for Future Policy Benefit, Activity [Line Items]
Expected future benefit payments, undiscounted	$ 1,649	$ 1,579
Expected future benefit payments, discounted	1,097	1,043
Expected future gross premiums, undiscounted	0	0
Expected future gross premiums, discounted	0	0
Closed Block Life
Liability for Future Policy Benefit, Activity [Line Items]
Expected future benefit payments, undiscounted	7,257	7,729
Expected future benefit payments, discounted	5,043	5,251
Expected future gross premiums, undiscounted	4,675	5,056
Expected future gross premiums, discounted	2,931	3,119
Closed Block Annuity
Liability for Future Policy Benefit, Activity [Line Items]
Expected future benefit payments, undiscounted	5,131	5,421
Expected future benefit payments, discounted	3,443	3,565
Expected future gross premiums, undiscounted	0	0
Expected future gross premiums, discounted	$ 0	$ 0

Reserves for Future Policy Be_7

Reserves for Future Policy Benefits and Claims Payable - Revenue and Interest Related to Non-Participating Contracts (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Liability for Future Policy Benefit, Activity [Line Items]
Gross Premiums	$ 266	$ 363
Interest Expense	266	394
Payout Annuities
Liability for Future Policy Benefit, Activity [Line Items]
Gross Premiums	34	22
Interest Expense	34	43
Closed Block Life
Liability for Future Policy Benefit, Activity [Line Items]
Gross Premiums	232	340
Interest Expense	94	157
Closed Block Annuity
Liability for Future Policy Benefit, Activity [Line Items]
Gross Premiums	0	1
Interest Expense	$ 138	$ 194

Reserves for Future Policy Be_8

Reserves for Future Policy Benefits and Claims Payable - Weighted Average Interest Rates for Future Policy Benefits (Details)	Sep. 30, 2024	Dec. 31, 2023
Payout Annuities
Liability for Future Policy Benefit, Activity [Line Items]
Interest accretion rate	4%	3.86%
Current discount rate	4.89%	5.12%
Closed Block Life
Liability for Future Policy Benefit, Activity [Line Items]
Interest accretion rate	3.07%	3.07%
Current discount rate	4.96%	5.06%
Closed Block Annuity
Liability for Future Policy Benefit, Activity [Line Items]
Interest accretion rate	4.40%	4.40%
Current discount rate	4.90%	5.12%

Reserves for Future Policy Be_9

Reserves for Future Policy Benefits and Claims Payable - Rollforward of Additional Liabilities, Closed Block Life (Details) - Closed Block Life - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Additional Liability, Long-Duration Insurance [Roll Forward]
Balance, beginning of period	$ 1,170	$ 1,172
Effect of changes in cash flow assumptions	0	44
Effect of actual variances from expected experience	10	46
Interest accrual	42	56
Net assessments collected	(101)	(148)
Balance, end of period	1,121	1,170
As Previously Reported
Additional Liability, Long-Duration Insurance [Roll Forward]
Balance, beginning of period	1,153	1,131
Balance, end of period	1,104	1,153
Cumulative effect of changes in shadow adjustments
Additional Liability, Long-Duration Insurance [Roll Forward]
Balance, beginning of period	(17)	(41)
Balance, end of period	$ (17)	$ (17)

Reserves for Future Policy B_10

Reserves for Future Policy Benefits and Claims Payable - Weighted Average Duration, Closed Block Life (Details)	Sep. 30, 2024	Dec. 31, 2023
Closed Block Life
Liability for Future Policy Benefit, Activity [Line Items]
Weighted average duration (years)	9 years 6 months	9 years 8 months 12 days

Reserves for Future Policy B_11

Reserves for Future Policy Benefits and Claims Payable - Assessments and Interest Expense, Closed Block Life (Details) - Closed Block Life - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Liability for Future Policy Benefit, Activity [Line Items]
Assessments	$ (101)	$ (148)
Interest Expense	$ 42	$ 56

Reserves for Future Policy B_12

Reserves for Future Policy Benefits and Claims Payable - Weighted Average Current Discount Rate, Closed Block Life (Details)	Sep. 30, 2024	Dec. 31, 2023
Closed Block Life
Liability for Future Policy Benefit, Activity [Line Items]
Weighted average current discount rate	4.98%	4.97%

Other Contract Holder Funds - N

Other Contract Holder Funds - Narrative (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Policyholder Account Balance [Line Items]
Debt carrying value	$ 2,033,000,000	$ 2,037,000,000
FHLBI capital stock	127,000,000	108,000,000
Funding agreements	2,000,000,000	2,300,000,000
Other borrowings on mortgage-related securities and commercial mortgage loans	$ 3,000,000,000	$ 3,500,000,000
All Annuity Accounts | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Account values, percentage	94%	92%
Closed Block Life | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Account values, percentage	82%	64%
Fair Value
Policyholder Account Balance [Line Items]
FHLBI capital stock	$ 127,000,000	$ 108,000,000
Global Medium Term Note | Medium term notes
Policyholder Account Balance [Line Items]
Debt face amount	27,000,000,000
Debt carrying value	$ 5,500,000,000	$ 5,800,000,000

Other Contract Holder Funds - L

Other Contract Holder Funds - Liabilities for Other Contract Holder Funds (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Liability for Future Policy Benefit, Activity [Line Items]
Total other contract holder funds	$ 57,334	$ 55,319
Payout Annuity
Liability for Future Policy Benefit, Activity [Line Items]
Total other contract holder funds	852	860
Variable Annuity
Liability for Future Policy Benefit, Activity [Line Items]
Total other contract holder funds	7,509	8,396
Fixed Annuity
Liability for Future Policy Benefit, Activity [Line Items]
Total other contract holder funds	9,593	9,736
Fixed Indexed Annuities
Liability for Future Policy Benefit, Activity [Line Items]
Total other contract holder funds	8,990	10,243
RILA
Liability for Future Policy Benefit, Activity [Line Items]
Total other contract holder funds	10,250	5,219
Closed Block Life
Liability for Future Policy Benefit, Activity [Line Items]
Total other contract holder funds	10,884	11,039
Closed Block Annuity
Liability for Future Policy Benefit, Activity [Line Items]
Total other contract holder funds	1,163	1,252
Institutional Products
Liability for Future Policy Benefit, Activity [Line Items]
Total other contract holder funds	7,929	8,406
Other Product Lines
Liability for Future Policy Benefit, Activity [Line Items]
Total other contract holder funds	$ 164	$ 168

Other Contract Holder Funds - R

Other Contract Holder Funds - Rollforward of Other Contract Holder Funds (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Payout Annuity
Policyholder Account Balance [Roll Forward]
Balance as of beginning of year	$ 860	$ 837
Deposits	165	202
Surrenders, withdrawals and benefits	(194)	(231)
Net transfers from (to) separate accounts	0	0
Investment performance / change in value of equity option	0	0
Interest credited	21	25
Policy charges and other	0	27
Balance as of ending of year	852	860
Variable Annuity
Policyholder Account Balance [Roll Forward]
Balance as of beginning of year	8,396	10,259
Deposits	544	995
Surrenders, withdrawals and benefits	(1,596)	(1,788)
Net transfers from (to) separate accounts	51	(1,256)
Investment performance / change in value of equity option	0	0
Interest credited	171	273
Policy charges and other	(57)	(87)
Balance as of ending of year	7,509	8,396
Fixed Annuity
Policyholder Account Balance [Roll Forward]
Balance as of beginning of year	9,736	11,696
Deposits	1,080	234
Surrenders, withdrawals and benefits	(1,339)	(2,406)
Net transfers from (to) separate accounts	0	0
Investment performance / change in value of equity option	0	0
Interest credited	233	342
Policy charges and other	(117)	(130)
Balance as of ending of year	9,593	9,736
Fixed Indexed Annuities
Policyholder Account Balance [Roll Forward]
Balance as of beginning of year	10,243	11,787
Deposits	127	211
Surrenders, withdrawals and benefits	(1,610)	(1,954)
Net transfers from (to) separate accounts	0	0
Investment performance / change in value of equity option	108	51
Interest credited	135	210
Policy charges and other	(13)	(62)
Balance as of ending of year	8,990	10,243
RILA
Policyholder Account Balance [Roll Forward]
Balance as of beginning of year	5,219	1,875
Deposits	4,187	2,890
Surrenders, withdrawals and benefits	(130)	(70)
Net transfers from (to) separate accounts	0	0
Investment performance / change in value of equity option	950	509
Interest credited	24	14
Policy charges and other	0	1
Balance as of ending of year	10,250	5,219
Closed Block Life
Policyholder Account Balance [Roll Forward]
Balance as of beginning of year	11,039	11,215
Deposits	218	307
Surrenders, withdrawals and benefits	(462)	(738)
Net transfers from (to) separate accounts	0	0
Investment performance / change in value of equity option	0	0
Interest credited	455	730
Policy charges and other	(366)	(475)
Balance as of ending of year	10,884	11,039
Closed Block Annuity
Policyholder Account Balance [Roll Forward]
Balance as of beginning of year	1,252	1,319
Deposits	3	4
Surrenders, withdrawals and benefits	(125)	(115)
Net transfers from (to) separate accounts	0	0
Investment performance / change in value of equity option	0	0
Interest credited	33	44
Policy charges and other	0	0
Balance as of ending of year	1,163	1,252
Total
Policyholder Account Balance [Roll Forward]
Balance as of beginning of year	46,745	48,988
Deposits	6,324	4,843
Surrenders, withdrawals and benefits	(5,456)	(7,302)
Net transfers from (to) separate accounts	51	(1,256)
Investment performance / change in value of equity option	1,058	560
Interest credited	1,072	1,638
Policy charges and other	(553)	(726)
Balance as of ending of year	$ 49,241	$ 46,745

Other Contract Holder Funds - W

Other Contract Holder Funds - Weighted Average Crediting Rate, Net Amount at Risk and Cash Surrender Value (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Payout Annuity
Policyholder Account Balance [Line Items]
Weighted-average crediting rate	3.29%	2.91%
Net amount at risk	$ 0	$ 0
Cash surrender value	$ 0	$ 0
Variable Annuity
Policyholder Account Balance [Line Items]
Weighted-average crediting rate	3.04%	3.25%
Net amount at risk	$ 0	$ 0
Cash surrender value	$ 7,449	$ 8,306
Fixed Annuity
Policyholder Account Balance [Line Items]
Weighted-average crediting rate	3.24%	3.51%
Net amount at risk	$ 0	$ 0
Cash surrender value	$ 9,447	$ 9,639
Fixed Indexed Annuities
Policyholder Account Balance [Line Items]
Weighted-average crediting rate	2%	2.05%
Net amount at risk	$ 0	$ 0
Cash surrender value	$ 8,778	$ 9,999
RILA
Policyholder Account Balance [Line Items]
Weighted-average crediting rate	0.31%	0.27%
Net amount at risk	$ 0	$ 0
Cash surrender value	$ 9,837	$ 4,896
Closed Block Life
Policyholder Account Balance [Line Items]
Weighted-average crediting rate	5.57%	6.61%
Net amount at risk	$ 15,937	$ 16,619
Cash surrender value	$ 10,817	$ 10,970
Closed Block Annuity
Policyholder Account Balance [Line Items]
Weighted-average crediting rate	3.78%	3.51%
Net amount at risk	$ 0	$ 0
Cash surrender value	$ 1,162	$ 1,252

Other Contract Holder Funds - A

Other Contract Holder Funds - Account Balances by Guaranteed Minimum Interest Rates (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Variable Annuities
Policyholder Account Balance [Line Items]
Account values with crediting rates	$ 7,509	$ 8,396
Variable Annuities | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	$ 11	$ 13
Variable Annuities | 0.00%-1.50% | Minimum
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	0%	0%
Variable Annuities | 0.00%-1.50% | Maximum
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	1.50%	1.50%
Variable Annuities | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	$ 159	$ 173
Variable Annuities | 1.51%-2.50% | Minimum
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	1.51%	1.51%
Variable Annuities | 1.51%-2.50% | Maximum
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	2.50%	2.50%
Variable Annuities | Greater than 2.50%
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	2.50%	2.50%
Account values with crediting rates	$ 7,339	$ 8,210
Variable Annuities | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Account values with crediting rates	7,498	8,359
Variable Annuities | At Guaranteed Minimum | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Variable Annuities | At Guaranteed Minimum | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	159	173
Variable Annuities | At Guaranteed Minimum | Greater than 2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	7,339	8,186
Variable Annuities | 1 Basis Point-50 Basis Points Above
Policyholder Account Balance [Line Items]
Account values with crediting rates	11	12
Variable Annuities | 1 Basis Point-50 Basis Points Above | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	11	12
Variable Annuities | 1 Basis Point-50 Basis Points Above | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Variable Annuities | 1 Basis Point-50 Basis Points Above | Greater than 2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Variable Annuities | 51 Basis Points-150 Basis Points Above
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	1
Variable Annuities | 51 Basis Points-150 Basis Points Above | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	1
Variable Annuities | 51 Basis Points-150 Basis Points Above | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Variable Annuities | 51 Basis Points-150 Basis Points Above | Greater than 2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Variable Annuities | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	24
Variable Annuities | Greater Than 150 Basis Points Above | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Variable Annuities | Greater Than 150 Basis Points Above | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Variable Annuities | Greater Than 150 Basis Points Above | Greater than 2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	24
Fixed Annuities
Policyholder Account Balance [Line Items]
Account values with crediting rates	2,177	1,218
Fixed Annuities | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	$ 114	$ 143
Fixed Annuities | 0.00%-1.50% | Minimum
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	0%	0%
Fixed Annuities | 0.00%-1.50% | Maximum
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	1.50%	1.50%
Fixed Annuities | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	$ 27	$ 31
Fixed Annuities | 1.51%-2.50% | Minimum
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	1.51%	1.51%
Fixed Annuities | 1.51%-2.50% | Maximum
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	2.50%	2.50%
Fixed Annuities | Greater than 2.50%
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	2.50%	2.50%
Account values with crediting rates	$ 2,036	$ 1,044
Fixed Annuities | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Account values with crediting rates	1,794	767
Fixed Annuities | At Guaranteed Minimum | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	28	17
Fixed Annuities | At Guaranteed Minimum | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	25	29
Fixed Annuities | At Guaranteed Minimum | Greater than 2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	1,741	721
Fixed Annuities | 1 Basis Point-50 Basis Points Above
Policyholder Account Balance [Line Items]
Account values with crediting rates	90	107
Fixed Annuities | 1 Basis Point-50 Basis Points Above | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	46	55
Fixed Annuities | 1 Basis Point-50 Basis Points Above | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	1	1
Fixed Annuities | 1 Basis Point-50 Basis Points Above | Greater than 2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	43	51
Fixed Annuities | 51 Basis Points-150 Basis Points Above
Policyholder Account Balance [Line Items]
Account values with crediting rates	41	72
Fixed Annuities | 51 Basis Points-150 Basis Points Above | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	39	70
Fixed Annuities | 51 Basis Points-150 Basis Points Above | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	1	1
Fixed Annuities | 51 Basis Points-150 Basis Points Above | Greater than 2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	1	1
Fixed Annuities | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Account values with crediting rates	252	272
Fixed Annuities | Greater Than 150 Basis Points Above | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	1	1
Fixed Annuities | Greater Than 150 Basis Points Above | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Fixed Annuities | Greater Than 150 Basis Points Above | Greater than 2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	251	271
Fixed Indexed Annuities
Policyholder Account Balance [Line Items]
Account values with crediting rates	179	152
Fixed Indexed Annuities | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	$ 52	$ 59
Fixed Indexed Annuities | 0.00%-1.50% | Minimum
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	0%	0%
Fixed Indexed Annuities | 0.00%-1.50% | Maximum
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	1.50%	1.50%
Fixed Indexed Annuities | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	$ 0	$ 0
Fixed Indexed Annuities | 1.51%-2.50% | Minimum
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	1.51%	1.51%
Fixed Indexed Annuities | 1.51%-2.50% | Maximum
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	2.50%	2.50%
Fixed Indexed Annuities | Greater than 2.50%
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	2.50%	2.50%
Account values with crediting rates	$ 127	$ 93
Fixed Indexed Annuities | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Account values with crediting rates	21	25
Fixed Indexed Annuities | At Guaranteed Minimum | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	3	4
Fixed Indexed Annuities | At Guaranteed Minimum | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Fixed Indexed Annuities | At Guaranteed Minimum | Greater than 2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	18	21
Fixed Indexed Annuities | 1 Basis Point-50 Basis Points Above
Policyholder Account Balance [Line Items]
Account values with crediting rates	9	9
Fixed Indexed Annuities | 1 Basis Point-50 Basis Points Above | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	9	9
Fixed Indexed Annuities | 1 Basis Point-50 Basis Points Above | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Fixed Indexed Annuities | 1 Basis Point-50 Basis Points Above | Greater than 2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Fixed Indexed Annuities | 51 Basis Points-150 Basis Points Above
Policyholder Account Balance [Line Items]
Account values with crediting rates	88	65
Fixed Indexed Annuities | 51 Basis Points-150 Basis Points Above | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	2	3
Fixed Indexed Annuities | 51 Basis Points-150 Basis Points Above | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Fixed Indexed Annuities | 51 Basis Points-150 Basis Points Above | Greater than 2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	86	62
Fixed Indexed Annuities | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Account values with crediting rates	61	53
Fixed Indexed Annuities | Greater Than 150 Basis Points Above | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	38	43
Fixed Indexed Annuities | Greater Than 150 Basis Points Above | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Fixed Indexed Annuities | Greater Than 150 Basis Points Above | Greater than 2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	23	10
RILA
Policyholder Account Balance [Line Items]
Account values with crediting rates	101	63
RILA | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	$ 13	$ 12
RILA | 0.00%-1.50% | Minimum
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	0%	0%
RILA | 0.00%-1.50% | Maximum
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	1.50%	1.50%
RILA | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	$ 0	$ 0
RILA | 1.51%-2.50% | Minimum
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	1.51%	1.51%
RILA | 1.51%-2.50% | Maximum
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	2.50%	2.50%
RILA | Greater than 2.50%
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	2.50%	2.50%
Account values with crediting rates	$ 88	$ 51
RILA | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Account values with crediting rates	85	46
RILA | At Guaranteed Minimum | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	6	7
RILA | At Guaranteed Minimum | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
RILA | At Guaranteed Minimum | Greater than 2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	79	39
RILA | 1 Basis Point-50 Basis Points Above
Policyholder Account Balance [Line Items]
Account values with crediting rates	9	12
RILA | 1 Basis Point-50 Basis Points Above | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
RILA | 1 Basis Point-50 Basis Points Above | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
RILA | 1 Basis Point-50 Basis Points Above | Greater than 2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	9	12
RILA | 51 Basis Points-150 Basis Points Above
Policyholder Account Balance [Line Items]
Account values with crediting rates	4	4
RILA | 51 Basis Points-150 Basis Points Above | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	4	4
RILA | 51 Basis Points-150 Basis Points Above | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
RILA | 51 Basis Points-150 Basis Points Above | Greater than 2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
RILA | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Account values with crediting rates	3	1
RILA | Greater Than 150 Basis Points Above | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	3	1
RILA | Greater Than 150 Basis Points Above | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
RILA | Greater Than 150 Basis Points Above | Greater than 2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Closed Block Life
Policyholder Account Balance [Line Items]
Account values with crediting rates	6,678	6,874
Closed Block Life | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	$ 0	$ 0
Closed Block Life | 0.00%-1.50% | Minimum
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	0%	0%
Closed Block Life | 0.00%-1.50% | Maximum
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	1.50%	1.50%
Closed Block Life | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	$ 12	$ 0
Closed Block Life | 1.51%-2.50% | Minimum
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	1.51%	1.51%
Closed Block Life | 1.51%-2.50% | Maximum
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	2.50%	2.50%
Closed Block Life | Greater than 2.50%
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	2.50%	2.50%
Account values with crediting rates	$ 6,666	$ 6,874
Closed Block Life | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Account values with crediting rates	5,507	4,425
Closed Block Life | At Guaranteed Minimum | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Closed Block Life | At Guaranteed Minimum | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	1	0
Closed Block Life | At Guaranteed Minimum | Greater than 2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	5,506	4,425
Closed Block Life | 1 Basis Point-50 Basis Points Above
Policyholder Account Balance [Line Items]
Account values with crediting rates	420	1,830
Closed Block Life | 1 Basis Point-50 Basis Points Above | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Closed Block Life | 1 Basis Point-50 Basis Points Above | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	11	0
Closed Block Life | 1 Basis Point-50 Basis Points Above | Greater than 2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	409	1,830
Closed Block Life | 51 Basis Points-150 Basis Points Above
Policyholder Account Balance [Line Items]
Account values with crediting rates	746	603
Closed Block Life | 51 Basis Points-150 Basis Points Above | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Closed Block Life | 51 Basis Points-150 Basis Points Above | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Closed Block Life | 51 Basis Points-150 Basis Points Above | Greater than 2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	746	603
Closed Block Life | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Account values with crediting rates	5	16
Closed Block Life | Greater Than 150 Basis Points Above | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Closed Block Life | Greater Than 150 Basis Points Above | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Closed Block Life | Greater Than 150 Basis Points Above | Greater than 2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	5	16
Closed Block Annuity
Policyholder Account Balance [Line Items]
Account values with crediting rates	1,021	1,101
Closed Block Annuity | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	$ 0	$ 0
Closed Block Annuity | 0.00%-1.50% | Minimum
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	0%	0%
Closed Block Annuity | 0.00%-1.50% | Maximum
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	1.50%	1.50%
Closed Block Annuity | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	$ 13	$ 13
Closed Block Annuity | 1.51%-2.50% | Minimum
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	1.51%	1.51%
Closed Block Annuity | 1.51%-2.50% | Maximum
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	2.50%	2.50%
Closed Block Annuity | Greater than 2.50%
Policyholder Account Balance [Line Items]
Range of Guaranteed Minimum Crediting Rate	2.50%	2.50%
Account values with crediting rates	$ 1,008	$ 1,088
Closed Block Annuity | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Account values with crediting rates	963	896
Closed Block Annuity | At Guaranteed Minimum | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Closed Block Annuity | At Guaranteed Minimum | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Closed Block Annuity | At Guaranteed Minimum | Greater than 2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	963	896
Closed Block Annuity | 1 Basis Point-50 Basis Points Above
Policyholder Account Balance [Line Items]
Account values with crediting rates	20	169
Closed Block Annuity | 1 Basis Point-50 Basis Points Above | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Closed Block Annuity | 1 Basis Point-50 Basis Points Above | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Closed Block Annuity | 1 Basis Point-50 Basis Points Above | Greater than 2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	20	169
Closed Block Annuity | 51 Basis Points-150 Basis Points Above
Policyholder Account Balance [Line Items]
Account values with crediting rates	26	24
Closed Block Annuity | 51 Basis Points-150 Basis Points Above | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Closed Block Annuity | 51 Basis Points-150 Basis Points Above | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	1	1
Closed Block Annuity | 51 Basis Points-150 Basis Points Above | Greater than 2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	25	23
Closed Block Annuity | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Account values with crediting rates	12	12
Closed Block Annuity | Greater Than 150 Basis Points Above | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	0	0
Closed Block Annuity | Greater Than 150 Basis Points Above | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	12	12
Closed Block Annuity | Greater Than 150 Basis Points Above | Greater than 2.50%
Policyholder Account Balance [Line Items]
Account values with crediting rates	$ 0	$ 0

Separate Account Assets and L_3

Separate Account Assets and Liabilities - Narrative (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Separate Account, Liability [Line Items]
Separate account assets	$ 235,037	$ 219,656
Jackson National Separate Account II
Separate Account, Liability [Line Items]
Separate account assets	$ 216	$ 198

Separate Account Assets and L_4

Separate Account Assets and Liabilities - Rollforward of the Separate Account Balance for Variable Annuities (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Separate Account, Liability [Roll Forward]
Balance as of beginning of period	$ 219,656
Balance as of end of period, gross	235,037	$ 219,656
Total Variable Annuities
Separate Account, Liability [Roll Forward]
Balance as of beginning of period	219,381	195,550
Deposits	7,244	8,545
Surrenders, withdrawals and benefits	(19,519)	(17,029)
Net transfer from (to) general account	(51)	1,256
Investment performance	29,794	33,807
Policy charges and other	(2,113)	(2,748)
Balance as of end of period, gross	234,736	219,381
Cash surrender value	$ 229,939	$ 214,395

Separate Account Assets and L_5

Separate Account Assets and Liabilities - Reconciliation of the Separate Account Balance in the Consolidated Balance Sheets (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Separate Account, Liability [Line Items]
Separate account assets	$ 235,037	$ 219,656
Variable Annuities
Separate Account, Liability [Line Items]
Separate account assets	234,736	219,381
Other Product Lines
Separate Account, Liability [Line Items]
Separate account assets	$ 301	$ 275

Separate Account Assets and L_6

Separate Account Assets and Liabilities - Aggregate Fair Value of Assets, by Major Investment Asset Category (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Fair Value, Separate Account Investment [Line Items]
Separate account assets	$ 235,037	$ 219,656
Equity
Fair Value, Separate Account Investment [Line Items]
Separate account assets	167,216	154,020
Bond
Fair Value, Separate Account Investment [Line Items]
Separate account assets	20,242	19,801
Balanced
Fair Value, Separate Account Investment [Line Items]
Separate account assets	44,531	42,831
Money Market
Fair Value, Separate Account Investment [Line Items]
Separate account assets	2,747	2,729
Total Variable Annuities
Fair Value, Separate Account Investment [Line Items]
Separate account assets	234,736	219,381
Other Product Lines
Fair Value, Separate Account Investment [Line Items]
Separate account assets	$ 301	$ 275

Market Risk Benefits - Reconcil

Market Risk Benefits - Reconciliation of the Market Risk Benefits Balance (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Market Risk Benefit [Line Items]
Market risk benefit - (assets)	$ (7,615)	$ (6,737)
Market risk benefit - liabilities	4,384	4,785
Market risk benefit - net (asset) liability	(3,231)	(1,952)
Variable Annuity
Market Risk Benefit [Line Items]
Market risk benefit - (assets)	(7,611)	(6,732)
Market risk benefit - liabilities	4,311	4,732
Market risk benefit - net (asset) liability	(3,300)	(2,000)	$ 767
Other Product Lines
Market Risk Benefit [Line Items]
Market risk benefit - (assets)	(4)	(5)
Market risk benefit - liabilities	73	53
Market risk benefit - net (asset) liability	$ 69	$ 48

Market Risk Benefits - Rollforw

Market Risk Benefits - Rollforward of the Net MRB (Assets) Liabilities for Variable Annuities (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Market Risk Benefit [Roll Forward]
Net MRB balance, beginning of period	$ (1,952)
Net MRB balance, end of period, gross	(3,231)	$ (1,952)
Reinsurance recoverable on market risk benefits at fair value, end of period	(149)	(149)
Variable annuity
Market Risk Benefit [Roll Forward]
Net MRB balance, beginning of period	(2,000)	767
Beginning of period cumulative effect of changes in non-performance risk	972	2,185
Net MRB balance, beginning of period, before effect of changes in non-performance risk	(1,028)	2,952
Effect of changes in interest rates	(601)	(733)
Effect of fund performance	(3,567)	(5,401)
Effect of changes in equity index volatility	(143)	(1,107)
Effect of expected policyholder behavior	610	612
Effect of actual policyholder behavior different from expected	514	483
Effect of time	1,100	1,829
Effect of changes in assumptions	7	337
Net MRB balance, end of period, before effect of changes in non-performance risk	(3,108)	(1,028)
End of period cumulative effect of changes in non-performance risk	192	972
Net MRB balance, end of period, gross	(3,300)	(2,000)
Reinsurance recoverable on market risk benefits at fair value, end of period	(78)	(90)
Net MRB balance, end of period, net of reinsurance	$ (3,378)	$ (2,090)
Weighted average attained age (years)	70 years	69 years
Net amount at risk	$ 5,527	$ 8,225

Long-Term Debt - Carrying Value

Long-Term Debt - Carrying Values (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Schedule of Long Term and Short Term Debt Instruments [Line Items]
Total long-term debt	$ 2,033	$ 2,037
Senior Notes | Senior Notes due 2027
Schedule of Long Term and Short Term Debt Instruments [Line Items]
Total long-term debt	398	398
Senior Notes | Senior Notes due 2031
Schedule of Long Term and Short Term Debt Instruments [Line Items]
Total long-term debt	496	495
Senior Notes | Senior Notes due 2032
Schedule of Long Term and Short Term Debt Instruments [Line Items]
Total long-term debt	347	347
Senior Notes | Senior Notes due 2051
Schedule of Long Term and Short Term Debt Instruments [Line Items]
Total long-term debt	490	490
Surplus notes due 2027
Schedule of Long Term and Short Term Debt Instruments [Line Items]
Total long-term debt	250	250
FHLBI bank loans due 2034 & 2035
Schedule of Long Term and Short Term Debt Instruments [Line Items]
Total long-term debt	$ 52	$ 57

Long-Term Debt - Maturity (Deta

Long-Term Debt - Maturity (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Debt Disclosure [Abstract]
2025	$ 0
2026	0
2027	648
2028	0
2029 and thereafter	1,385
Total	$ 2,033	$ 2,037

Long-Term Debt - Narrative (Det

Long-Term Debt - Narrative (Details) - Line of Credit - USD ($)	Apr. 06, 2023	Feb. 24, 2023
Uncommitted Money Market Line Credit Agreement
Schedule of Long Term and Short Term Debt Instruments [Line Items]
Maximum borrowing capacity	$ 500,000,000
Minimum cash advance request	$ 100,000
Revolving credit facility
Schedule of Long Term and Short Term Debt Instruments [Line Items]
Maximum borrowing capacity		$ 1,000,000,000
Accordion feature, higher borrowing capacity option		$ 500,000,000
Consolidated net worth percentage		70%
Net worth percentage, increase adjustment from equity issuances		50%
Ratio of indebtedness to net capital		0.35
Letter of credit
Schedule of Long Term and Short Term Debt Instruments [Line Items]
Maximum borrowing capacity		$ 500,000,000

Federal Home Loan Bank Advanc_2

Federal Home Loan Bank Advances (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Other Liabilities Disclosure [Abstract]
Federal home loan bank advances	$ 0		$ 0		$ 250,000,000
Interest expense on advances	$ 1,000,000	$ 0	$ 4,000,000	$ 6,000,000

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Income Tax Contingency [Line Items]
Effective income tax rate	19.30%	20.50%	3.90%	13.80%	0.50%
Corporate alternative minimum tax, decrease			$ 158
Corporate alternative minimum tax, deferred tax asset			158
Deferred tax asset for credit carryover resulting in no impact to total tax expense	$ 7	$ 450	7	$ 450
Income tax expense (benefit)	(113)	$ 712	24	$ 399
2023 Tax Returns
Income Tax Contingency [Line Items]
Corporate alternative minimum tax, decrease			263
Corporate alternative minimum tax, deferred tax asset			263
Unrealized Tax Losses, Available-For-Sale Securities
Income Tax Contingency [Line Items]
Decrease in valuation allowance	(295)		(218)
Tax benefit recorded to other comprehensive income	306		206
Income tax expense (benefit)	11		(12)
Deferred tax assets valuation allowance	$ 471		$ 471		$ 689

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Millions	Sep. 30, 2024 USD ($)
Unfunded partnership investment commitment
Other Commitments [Line Items]
Unfunded commitments	$ 966
Unfunded loan and debt securities commitments
Other Commitments [Line Items]
Unfunded commitments	$ 669

Operating Costs and Other Exp_3

Operating Costs and Other Expenses (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating Costs And Other Expenses [Abstract]
Asset-based commission expenses	$ 285	$ 259	$ 843	$ 764
Other commission expenses	261	190	691	541
Sub-advisor expenses	82	80	244	234
General and administrative expenses	310	232	839	706
Deferral of acquisition costs	(196)	(135)	(512)	(383)
Total operating costs and other expenses	$ 742	$ 626	$ 2,105	$ 1,862

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Loss) - Schedule of Changes in Accumulated Other Comprehensive Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance beginning of period	$ 10,284	$ 9,423	$ 10,334	$ 9,378
Change in unrealized gains (losses) of investments	1,735	(1,405)	1,134	(958)
Change in current discount rate - reserve for future policy benefits	(280)	254	(132)	204
Change in non-performance risk on market risk benefits	(235)	(999)	(783)	(1,479)
Change in unrealized gains (losses) - other	(5)	3	(2)	(8)
Change in deferred tax asset	33	247	148	318
Other comprehensive income (loss) before reclassifications	1,248	(1,900)	365	(1,923)
Reclassifications from AOCI, net of tax	(5)	78	60	114
Total other comprehensive income (loss)	1,243	(1,822)	425	(1,809)
Balance end of period	10,907	10,253	10,907	10,253
AOCI Including Portion Attributable to Noncontrolling Interest
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance beginning of period	(3,626)	(3,365)	(2,808)	(3,378)
Balance end of period	(2,383)	$ (5,187)	(2,383)	$ (5,187)
AOCI Including Portion Attributable to Noncontrolling Interest | Funds withheld assets
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance beginning of period			(1,612)
Balance end of period	$ (1,336)		$ (1,336)

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Income (Loss) - Reclassifications (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Net unrealized gain (loss), before income taxes	$ 102	$ (335)	$ (4,132)	$ (5,173)
Income tax expense (benefit)	(113)	712	24	399
Reclassifications, net of income taxes	(466)	2,790	618	2,514
Reclassification out of Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income (Loss) [Line Items]
Income tax expense (benefit)	(13)	20	3	30
Reclassifications, net of income taxes	(5)	78	60	114
Reclassification out of Accumulated Other Comprehensive Income | Net unrealized gain (loss)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Net unrealized gain (loss), before income taxes	(18)	98	63	144
Reclassification out of Accumulated Other Comprehensive Income | Net realized gain (loss) on investments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Net unrealized gain (loss), before income taxes	20	112	96	188
Reclassification out of Accumulated Other Comprehensive Income | Other impaired securities
Accumulated Other Comprehensive Income (Loss) [Line Items]
Net unrealized gain (loss), before income taxes	$ (38)	$ (14)	$ (33)	$ (44)

Equity - Preferred Stock (Detai

Equity - Preferred Stock (Details) - USD ($) $ / shares in Units, $ in Millions		9 Months Ended
	Mar. 13, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Class of Stock [Line Items]
Preferred stock, liquidation preference (in usd per share)		$ 25,000		$ 25,000
Net proceeds received		$ 0	$ 533
Investment, Variable Interest Rate, Type [Extensible Enumeration]	US Treasury (UST) Interest Rate [Member]
Noncumulative Preferred Stock
Class of Stock [Line Items]
Initial dividend rate	8%
Variable dividend rate	3.728%
Depositary Shares
Class of Stock [Line Items]
Shares issued and sold (in shares)	22,000,000
Preferred stock, liquidation preference (in usd per share)	$ 25
Net proceeds received	$ 533
Depositary Shares | Any time prior to March 30, 2028
Class of Stock [Line Items]
Preferred stock, liquidation preference (in usd per share)	$ 25.50
Depositary Shares | Within 90 days after the occurrence of a regulatory capital event
Class of Stock [Line Items]
Preferred stock, liquidation preference (in usd per share)	25
Depositary Shares | On or after March 30, 2028
Class of Stock [Line Items]
Preferred stock, liquidation preference (in usd per share)	$ 25
Depositary Shares | Noncumulative Preferred Stock
Class of Stock [Line Items]
Fractional interest	0.10%
Preferred stock, liquidation preference (in usd per share)	$ 25,000
Call/dividend rate reset period	5 years
Depositary Shares | Noncumulative Preferred Stock | Any time prior to March 30, 2028
Class of Stock [Line Items]
Preferred stock, liquidation preference (in usd per share)	$ 25,500
Depositary Shares | Noncumulative Preferred Stock | Within 90 days after the occurrence of a regulatory capital event
Class of Stock [Line Items]
Preferred stock, liquidation preference (in usd per share)	25,000
Depositary Shares | Noncumulative Preferred Stock | On or after March 30, 2028
Class of Stock [Line Items]
Preferred stock, liquidation preference (in usd per share)	$ 25,000

Equity - Dividends Paid (Detail

Equity - Dividends Paid (Details) - $ / shares	3 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023
Class of Stock [Line Items]
Preferred stock dividends paid per share (in usd per share)	$ 500	$ 500	$ 500	$ 500	$ 594.44
Common stock dividends paid per share (in usd per share)	0.70	0.70	0.70	0.62	0.62	$ 0.62
Depositary Shares
Class of Stock [Line Items]
Preferred stock dividends paid per share (in usd per share)	$ 0.50	$ 0.50	$ 0.50	$ 0.50000	$ 0.59444

Equity - Common Stock (Details)

Equity - Common Stock (Details) - $ / shares	Sep. 30, 2024	Dec. 31, 2023
Equity [Abstract]
Common stock, authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, par value (in usd per share)	$ 0.01	$ 0.01

Equity - Share Repurchase Progr

Equity - Share Repurchase Program (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Aug. 01, 2024	Feb. 27, 2023
Equity [Abstract]
Share repurchase authorized		$ 750	$ 450
Excise tax	$ 3

Equity - Share Repurchase Activ

Equity - Share Repurchase Activities (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended	3 Months Ended							9 Months Ended		10 Months Ended	12 Months Ended
	Nov. 01, 2024	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Nov. 01, 2024	Dec. 31, 2023
Equity, Class of Treasury Stock [Line Items]
Total Payments		$ 113				$ 72			$ 343	$ 236
Share repurchase program
Equity, Class of Treasury Stock [Line Items]
Number of Shares Repurchased (in shares)		1,352,821	1,294,473	2,157,372	1,512,263	1,873,727	1,394,797	1,721,737				6,502,524
Total Payments		$ 113	$ 90	$ 116	$ 67	$ 71	$ 47	$ 70				$ 255
Average Price Paid Per Share (in usd per share)		$ 83.39	$ 69.16	$ 53.76	$ 44.37	$ 38.13	$ 33.87	$ 40.42				$ 39.27
Share repurchase program | Subsequent Event
Equity, Class of Treasury Stock [Line Items]
Number of Shares Repurchased (in shares)	489,284										5,293,950
Total Payments	$ 48										$ 367
Average Price Paid Per Share (in usd per share)	$ 98.12										$ 69.19

Equity - Changes in Number of S

Equity - Changes in Number of Shares of Common Stock Outstanding (Details)	9 Months Ended
	Sep. 30, 2024 shares
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance, outstanding (in shares)	78,660,221
Share-based compensation programs (in shares)	495,506
Shares repurchased under repurchase program (in shares)	(4,804,666)
Ending balance, outstanding (in shares)	74,351,061
Common Stock Issued
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance, outstanding (in shares)	94,481,006
Share-based compensation programs (in shares)	3,403
Shares repurchased under repurchase program (in shares)	0
Ending balance, outstanding (in shares)	94,484,409
Treasury Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance, outstanding (in shares)	(15,820,785)
Share-based compensation programs (in shares)	492,103
Shares repurchased under repurchase program (in shares)	(4,804,666)
Ending balance, outstanding (in shares)	(20,133,348)

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Earnings Per Share [Abstract]
Net income (loss) attributable to Jackson Financial Inc.	$ (469)	$ 2,773	$ 601	$ 2,493
Less: Preferred stock dividends	11	11	33	24
Net income (loss) attributable to Jackson Financial Inc. common shareholders	$ (480)	$ 2,762	$ 568	$ 2,469
Weighted average shares of common stock outstanding - basic (in shares)	75,374,073	82,061,813	76,673,053	82,432,264
Dilutive common shares (in shares)	0	760,005	701,495	2,108,923
Weighted average shares of common stock outstanding - diluted (in shares)	75,374,073	82,821,818	77,374,548	84,541,187
Earnings per share—common stock
Basic (in usd per share)	$ (6.37)	$ 33.66	$ 7.41	$ 29.95
Diluted (in usd per share)	$ (6.37)	$ 33.35	$ 7.34	$ 29.20
Shares excluded from diluted EPS calculation (in shares)	751,646

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event	Nov. 01, 2024 $ / shares
Subsequent Event [Line Items]
Common stock dividend declared (in usd per share)	$ 0.70
Depositary Shares
Subsequent Event [Line Items]
Common stock dividend declared (in usd per share)	$ 0.50
Noncumulative Preferred Stock
Subsequent Event [Line Items]
Fractional interest	0.10%